0001104659-22-120302.txt : 20221118 0001104659-22-120302.hdr.sgml : 20221118 20221118161603 ACCESSION NUMBER: 0001104659-22-120302 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 56 CONFORMED PERIOD OF REPORT: 20220930 FILED AS OF DATE: 20221118 DATE AS OF CHANGE: 20221118 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Property Solutions Acquisition Corp. II CENTRAL INDEX KEY: 0001833235 STANDARD INDUSTRIAL CLASSIFICATION: BLANK CHECKS [6770] IRS NUMBER: 853851769 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-40087 FILM NUMBER: 221402126 BUSINESS ADDRESS: STREET 1: 64 MADISON AVE, SUITE 1009 CITY: NEW YORK STATE: NY ZIP: 10065 BUSINESS PHONE: (646) 502-9845 MAIL ADDRESS: STREET 1: 64 MADISON AVE, SUITE 1009 CITY: NEW YORK STATE: NY ZIP: 10065 10-Q 1 psagu-20220930x10q.htm FORM 10-Q
3283900032839000328390002477961279250007925000792500078206960001833235--12-31Q3false20220011390001139000792500079250003283900079250003283900079250003283900079250002477961278206963283900032839000007925000792500031700000317000000.030.100.120.020.030.100.120.02P10D0.030.030.100.100.120.120.020.020.250.25150001500018000180000P30DP30D0.25http://fasb.org/us-gaap/2022#FairValueAdjustmentOfWarrants0001833235psagu:PublicWarrantsMember2022-09-300001833235psagu:CommonClassaSubjectToRedemptionMember2022-09-300001833235psagu:CommonClassaSubjectToRedemptionMember2021-12-310001833235psagu:CommonClassaSubjectToRedemptionMember2022-01-012022-09-300001833235us-gaap:CommonClassBMemberus-gaap:CommonStockMember2021-01-012021-03-310001833235psagu:FounderSharesMemberpsagu:PropertySolutionsAcquisitionSponsorIiLlcMemberus-gaap:CommonClassBMember2020-11-102020-11-100001833235psagu:PropertySolutionsAcquisitionSponsorIiLlcMemberus-gaap:CommonClassBMember2021-03-032021-03-030001833235psagu:FounderSharesMemberus-gaap:CommonClassBMember2021-03-032021-03-030001833235psagu:FounderSharesMemberus-gaap:CommonClassBMember2021-02-042021-02-040001833235us-gaap:RetainedEarningsMember2022-09-300001833235us-gaap:RetainedEarningsMember2022-06-3000018332352022-06-300001833235us-gaap:RetainedEarningsMember2022-03-3100018332352022-03-310001833235us-gaap:RetainedEarningsMember2021-12-310001833235us-gaap:RetainedEarningsMember2021-09-300001833235us-gaap:AdditionalPaidInCapitalMember2021-09-300001833235us-gaap:RetainedEarningsMember2021-06-300001833235us-gaap:AdditionalPaidInCapitalMember2021-06-3000018332352021-06-300001833235us-gaap:RetainedEarningsMember2021-03-310001833235us-gaap:AdditionalPaidInCapitalMember2021-03-3100018332352021-03-310001833235us-gaap:RetainedEarningsMember2020-12-310001833235us-gaap:AdditionalPaidInCapitalMember2020-12-310001833235psagu:PublicWarrantsMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2022-09-300001833235psagu:PrivatePlacementWarrantsMemberus-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2022-09-300001833235psagu:PrivatePlacementWarrantsMember2022-09-300001833235psagu:PublicWarrantsMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2021-12-310001833235psagu:PrivatePlacementWarrantsMemberus-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2021-12-310001833235psagu:PrivatePlacementWarrantsMember2021-12-310001833235us-gaap:IPOMember2022-09-300001833235us-gaap:PrivatePlacementMember2021-03-120001833235us-gaap:IPOMember2021-03-120001833235psagu:PublicOfferingMember2021-03-120001833235us-gaap:IPOMember2021-03-080001833235us-gaap:CommonClassBMemberus-gaap:CommonStockMember2022-09-300001833235us-gaap:CommonClassAMemberus-gaap:CommonStockMember2022-09-300001833235us-gaap:CommonClassBMemberus-gaap:CommonStockMember2022-06-300001833235us-gaap:CommonClassAMemberus-gaap:CommonStockMember2022-06-300001833235us-gaap:CommonClassBMemberus-gaap:CommonStockMember2022-03-310001833235us-gaap:CommonClassAMemberus-gaap:CommonStockMember2022-03-310001833235us-gaap:CommonClassBMemberus-gaap:CommonStockMember2021-12-310001833235us-gaap:CommonClassAMemberus-gaap:CommonStockMember2021-12-310001833235us-gaap:CommonClassBMemberus-gaap:CommonStockMember2021-09-300001833235us-gaap:CommonClassAMemberus-gaap:CommonStockMember2021-09-300001833235us-gaap:CommonClassBMemberus-gaap:CommonStockMember2021-06-300001833235us-gaap:CommonClassAMemberus-gaap:CommonStockMember2021-06-300001833235us-gaap:CommonClassBMemberus-gaap:CommonStockMember2021-03-310001833235us-gaap:CommonClassAMemberus-gaap:CommonStockMember2021-03-310001833235us-gaap:CommonClassBMemberus-gaap:CommonStockMember2020-12-310001833235us-gaap:CommonClassAMemberus-gaap:CommonStockMember2020-12-310001833235us-gaap:WarrantMemberus-gaap:CommonClassAMember2022-09-300001833235us-gaap:WarrantMember2022-09-300001833235psagu:FounderSharesMember2021-02-182021-02-180001833235psagu:FounderSharesMember2021-02-180001833235psagu:IndependentDirectorsMemberpsagu:PropertySolutionsAcquisitionSponsorIiLlcMemberus-gaap:CommonClassBMember2021-03-032021-03-030001833235psagu:D.AmsterdamMemberpsagu:PropertySolutionsAcquisitionSponsorIiLlcMemberus-gaap:CommonClassBMember2021-03-032021-03-030001833235psagu:A.SavarMemberpsagu:PropertySolutionsAcquisitionSponsorIiLlcMemberus-gaap:CommonClassBMember2021-03-032021-03-030001833235psagu:A.EbushMemberpsagu:PropertySolutionsAcquisitionSponsorIiLlcMemberus-gaap:CommonClassBMember2021-03-032021-03-030001833235psagu:IndependentDirectorsMemberpsagu:PropertySolutionsAcquisitionSponsorIiLlcMemberus-gaap:CommonClassBMember2021-02-182021-02-180001833235psagu:D.AmsterdamMemberpsagu:PropertySolutionsAcquisitionSponsorIiLlcMemberus-gaap:CommonClassBMember2021-02-182021-02-180001833235psagu:A.SavarMemberpsagu:PropertySolutionsAcquisitionSponsorIiLlcMemberus-gaap:CommonClassBMember2021-02-182021-02-180001833235psagu:A.EbushMemberpsagu:PropertySolutionsAcquisitionSponsorIiLlcMemberus-gaap:CommonClassBMember2021-02-182021-02-180001833235psagu:PromissoryNoteWithRelatedPartyMember2021-03-082021-03-080001833235psagu:AdministrativeSupportAgreementMember2022-07-012022-09-300001833235us-gaap:AccruedLiabilitiesMemberpsagu:AdministrativeSupportAgreementMember2022-01-012022-09-300001833235psagu:AdministrativeSupportAgreementMember2022-01-012022-09-300001833235psagu:AdministrativeSupportAgreementMember2021-07-012021-09-300001833235us-gaap:AccruedLiabilitiesMemberpsagu:AdministrativeSupportAgreementMember2021-01-012021-12-310001833235psagu:AdministrativeSupportAgreementMember2021-01-012021-09-300001833235psagu:PrivatePlacementUnitsMemberpsagu:PropertySolutionsAcquisitionSponsorIiLlcAndEarlybirdcapitalInc.Memberpsagu:PartialExerciseOfUnderwritersOverAllotmentOptionMember2021-03-122021-03-120001833235psagu:EarlyBirdCapitalIncMemberpsagu:PrivatePlacementWarrantsMemberus-gaap:PrivatePlacementMember2021-03-082021-03-0800018332352021-03-080001833235psagu:PromissoryNoteWithRelatedPartyMember2022-09-300001833235psagu:WorkingCapitalLoansWarrantMemberpsagu:RelatedPartyLoansMember2021-12-310001833235psagu:PromissoryNoteWithRelatedPartyMember2021-12-310001833235us-gaap:RetainedEarningsMember2022-07-012022-09-300001833235us-gaap:RetainedEarningsMember2022-04-012022-06-3000018332352022-04-012022-06-300001833235us-gaap:RetainedEarningsMember2022-01-012022-03-310001833235us-gaap:RetainedEarningsMember2021-07-012021-09-300001833235us-gaap:AdditionalPaidInCapitalMember2021-07-012021-09-300001833235us-gaap:RetainedEarningsMember2021-04-012021-06-300001833235us-gaap:AdditionalPaidInCapitalMember2021-04-012021-06-3000018332352021-04-012021-06-3000018332352022-01-012022-03-310001833235psagu:PrivatePlacementWarrantsMemberus-gaap:FairValueInputsLevel3Member2022-09-300001833235psagu:PrivatePlacementWarrantsMemberus-gaap:FairValueInputsLevel3Member2022-06-300001833235psagu:PrivatePlacementWarrantsMemberus-gaap:FairValueInputsLevel3Member2022-03-310001833235psagu:PrivatePlacementWarrantsMemberus-gaap:FairValueInputsLevel3Member2021-12-310001833235psagu:PrivatePlacementWarrantsMemberus-gaap:FairValueInputsLevel3Member2021-09-300001833235psagu:PrivatePlacementWarrantsMemberus-gaap:FairValueInputsLevel3Member2021-06-300001833235psagu:PublicWarrantsMemberus-gaap:FairValueInputsLevel3Member2021-03-310001833235psagu:PrivatePlacementWarrantsMemberus-gaap:FairValueInputsLevel3Member2021-03-310001833235psagu:PublicWarrantsMemberus-gaap:FairValueInputsLevel3Memberus-gaap:OverAllotmentOptionMember2021-01-012021-03-310001833235psagu:PublicWarrantsMemberus-gaap:FairValueInputsLevel3Memberus-gaap:IPOMember2021-01-012021-03-310001833235psagu:PrivatePlacementWarrantsMemberus-gaap:FairValueInputsLevel3Memberus-gaap:OverAllotmentOptionMember2021-01-012021-03-310001833235psagu:PrivatePlacementWarrantsMemberus-gaap:FairValueInputsLevel3Memberus-gaap:IPOMember2021-01-012021-03-310001833235psagu:PrivatePlacementWarrantsMemberus-gaap:FairValueInputsLevel3Member2022-07-012022-09-300001833235psagu:PrivatePlacementWarrantsMemberus-gaap:FairValueInputsLevel3Member2022-04-012022-06-300001833235psagu:PrivatePlacementWarrantsMemberus-gaap:FairValueInputsLevel3Member2022-01-012022-03-310001833235psagu:PrivatePlacementWarrantsMemberus-gaap:FairValueInputsLevel3Member2021-07-012021-09-300001833235psagu:PrivatePlacementWarrantsMemberus-gaap:FairValueInputsLevel3Member2021-04-012021-06-300001833235psagu:PublicWarrantsMemberus-gaap:FairValueInputsLevel3Member2021-01-012021-03-310001833235psagu:PrivatePlacementWarrantsMemberus-gaap:FairValueInputsLevel3Member2021-01-012021-03-310001833235psagu:PublicWarrantsMemberus-gaap:FairValueInputsLevel3Member2022-07-012022-09-300001833235psagu:PublicWarrantsMemberus-gaap:FairValueInputsLevel3Member2022-01-012022-09-300001833235psagu:PublicWarrantsMemberus-gaap:FairValueInputsLevel3Member2021-07-012021-09-300001833235psagu:PublicWarrantsMemberus-gaap:FairValueInputsLevel3Member2021-04-012021-06-300001833235psagu:PublicWarrantsMemberus-gaap:FairValueInputsLevel3Member2021-01-012021-09-300001833235us-gaap:CommonClassBMember2022-07-012022-09-300001833235us-gaap:CommonClassAMember2022-07-012022-09-300001833235us-gaap:CommonClassBMember2022-01-012022-09-300001833235us-gaap:CommonClassBMember2021-07-012021-09-300001833235us-gaap:CommonClassAMember2021-07-012021-09-300001833235us-gaap:CommonClassBMember2021-01-012021-09-300001833235us-gaap:CommonClassAMember2021-01-012021-09-300001833235psagu:PrivatePlacementWarrantsMemberus-gaap:MeasurementInputSharePriceMember2022-09-300001833235psagu:PrivatePlacementWarrantsMemberus-gaap:MeasurementInputRiskFreeInterestRateMember2022-09-300001833235psagu:PrivatePlacementWarrantsMemberus-gaap:MeasurementInputPriceVolatilityMember2022-09-300001833235psagu:PrivatePlacementWarrantsMemberus-gaap:MeasurementInputExpectedDividendRateMember2022-09-300001833235psagu:PrivatePlacementWarrantsMemberus-gaap:MeasurementInputExercisePriceMember2022-09-300001833235psagu:PrivatePlacementWarrantsMemberus-gaap:MeasurementInputSharePriceMember2021-12-310001833235psagu:PrivatePlacementWarrantsMemberus-gaap:MeasurementInputRiskFreeInterestRateMember2021-12-310001833235psagu:PrivatePlacementWarrantsMemberus-gaap:MeasurementInputPriceVolatilityMember2021-12-310001833235psagu:PrivatePlacementWarrantsMemberus-gaap:MeasurementInputExpectedDividendRateMember2021-12-310001833235psagu:PrivatePlacementWarrantsMemberus-gaap:MeasurementInputExercisePriceMember2021-12-310001833235psagu:FounderSharesMemberus-gaap:CommonClassBMember2021-03-030001833235psagu:CommonClassaNotSubjectToRedemptionMember2022-09-300001833235psagu:CommonClassaNotSubjectToRedemptionMember2021-12-310001833235psagu:PrivatePlacementWarrantsMemberus-gaap:PrivatePlacementMember2021-03-310001833235psagu:PrivatePlacementUnitsMemberpsagu:PropertySolutionsAcquisitionSponsorIiLlcAndEarlybirdcapitalInc.Memberpsagu:PartialExerciseOfUnderwritersOverAllotmentOptionMember2021-03-120001833235psagu:PrivatePlacementUnitsMemberpsagu:PropertySolutionsAcquisitionSponsorIiLlcMemberus-gaap:PrivatePlacementMember2021-03-080001833235psagu:PrivatePlacementUnitsMemberpsagu:PropertySolutionsAcquisitionSponsorIiLlcMemberus-gaap:OverAllotmentOptionMember2021-03-080001833235psagu:PrivatePlacementUnitsMemberpsagu:EarlybirdcapitalInc.Memberus-gaap:PrivatePlacementMember2021-03-080001833235psagu:PrivatePlacementUnitsMemberpsagu:EarlybirdcapitalInc.Memberus-gaap:OverAllotmentOptionMember2021-03-080001833235psagu:PrivatePlacementWarrantsMemberus-gaap:CommonClassAMemberus-gaap:PrivatePlacementMember2021-03-120001833235psagu:PublicWarrantsMemberus-gaap:CommonClassAMember2021-03-1200018332352021-09-3000018332352020-12-310001833235us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2022-09-300001833235us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2021-12-310001833235psagu:FounderSharesMember2022-01-012022-09-300001833235psagu:PublicWarrantsMember2022-01-012022-09-300001833235us-gaap:RetainedEarningsMember2021-01-012021-03-310001833235us-gaap:AdditionalPaidInCapitalMember2021-01-012021-03-3100018332352021-01-012021-03-310001833235us-gaap:CommonClassAMemberus-gaap:CommonStockMember2021-01-012021-03-310001833235psagu:PublicOfferingMember2021-03-122021-03-120001833235psagu:PartialExerciseOfUnderwritersOverAllotmentOptionMember2021-03-122021-03-120001833235us-gaap:IPOMember2021-03-082021-03-080001833235us-gaap:PrivatePlacementMember2021-03-122021-03-120001833235psagu:FounderSharesMemberpsagu:PropertySolutionsAcquisitionSponsorIiLlcMemberus-gaap:CommonClassAMember2022-01-012022-09-300001833235us-gaap:OverAllotmentOptionMember2022-01-012022-09-300001833235psagu:FounderSharesMemberpsagu:PropertySolutionsAcquisitionSponsorIiLlcMember2022-01-012022-09-300001833235psagu:PrivatePlacementWarrantsMember2022-01-012022-09-300001833235psagu:AdministrativeSupportAgreementMember2021-03-032021-03-030001833235psagu:CommonClassaSubjectToRedemptionMember2021-01-012021-12-310001833235psagu:FounderSharesMemberpsagu:PropertySolutionsAcquisitionSponsorIiLlcMember2021-03-122021-03-120001833235psagu:PrivatePlacementUnitsMemberus-gaap:PrivatePlacementMember2021-03-122021-03-120001833235psagu:PublicWarrantsMember2021-03-122021-03-1200018332352021-03-122021-03-120001833235psagu:PrivatePlacementUnitsMemberus-gaap:CommonClassAMemberus-gaap:PrivatePlacementMember2021-03-122021-03-120001833235us-gaap:CommonClassAMember2021-03-122021-03-120001833235psagu:FounderSharesMemberpsagu:PropertySolutionsAcquisitionSponsorIiLlcMemberus-gaap:CommonClassBMember2021-03-120001833235psagu:PromissoryNoteWithRelatedPartyMember2020-11-100001833235srt:ScenarioPreviouslyReportedMember2021-01-012021-09-300001833235srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember2021-01-012021-09-3000018332352022-07-012022-09-3000018332352021-07-012021-09-300001833235psagu:PrivatePlacementWarrantsMemberus-gaap:MeasurementInputMaturityMember2022-01-012022-09-300001833235psagu:PrivatePlacementWarrantsMemberus-gaap:MeasurementInputMaturityMember2021-01-012021-12-3100018332352021-12-3100018332352021-12-0300018332352021-03-1200018332352022-09-300001833235us-gaap:CommonClassAMember2022-09-300001833235us-gaap:CommonClassAMember2021-12-310001833235us-gaap:CommonClassBMember2022-09-300001833235us-gaap:CommonClassBMember2021-12-310001833235psagu:WorkingCapitalLoansWarrantMemberpsagu:RelatedPartyLoansMember2022-09-300001833235psagu:PrivatePlacementUnitsMemberpsagu:PropertySolutionsAcquisitionSponsorIiLlcAndEarlybirdcapitalInc.Memberus-gaap:PrivatePlacementMember2021-03-080001833235psagu:EarlyBirdCapitalIncMemberpsagu:PrivatePlacementWarrantsMemberus-gaap:PrivatePlacementMember2021-03-080001833235psagu:RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Memberus-gaap:WarrantMember2022-01-012022-09-300001833235psagu:RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Memberus-gaap:WarrantMember2022-01-012022-09-300001833235us-gaap:WarrantMember2022-01-012022-09-3000018332352021-01-012021-09-300001833235us-gaap:CommonClassAMember2022-01-012022-09-300001833235psagu:WarrantsEachWholeWarrantExercisableForOneShareOfClassCommonStockAtExercisePriceMember2022-01-012022-09-300001833235psagu:UnitsEachConsistingOfOneShareOfClassCommonStockAndOneFourthOfOneWarrantMember2022-01-012022-09-300001833235us-gaap:CommonClassBMember2022-11-180001833235us-gaap:CommonClassAMember2022-11-180001833235psagu:UnitsEachConsistingOfOneShareOfClassCommonStockAndOneFourthOfOneWarrantMember2022-11-1800018332352022-01-012022-09-30xbrli:sharesiso4217:USDxbrli:pureiso4217:USDxbrli:sharespsagu:Dpsagu:Votepsagu:item

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(MARK ONE)

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarter ended September 30, 2022

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from                  to

Commission file number: 001-40087

PROPERTY SOLUTIONS ACQUISITION CORP. II

(Exact Name of Registrant as Specified in Its Charter)

Delaware

    

85-3851769

(State or other jurisdiction of

incorporation or organization)

 

(I.R.S. Employer

Identification No.) 

654 Madison Avenue, Suite 1009

New York, New York 10065

(Address of principal executive offices)

(646) 502-9845

(Issuer’s telephone number)

Not Applicable

(Former name or former address, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

    

Trading Symbol(s)

    

Name of each exchange on which registered

Units, each consisting of one share of
Class A Common Stock, and one-
fourth of one Warrant to acquire one
share of Class A Common Stock

 

PSAGU

 

The Nasdaq Stock Market LLC

Class A Common Stock, par value $0.0001
per share

 

PSAG

 

The Nasdaq Stock Market LLC

Warrants, each whole Warrant
exercisable for one share of Class A
Common Stock at an exercise price of
$11.50

 

PSAGW

 

The Nasdaq Stock Market LLC

Check whether the issuer (1) filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the past 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes   No 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes   No 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See definitions of “large accelerated filer”, “accelerated filer”, “smaller reporting company”, and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer  

Accelerated filer

Non-accelerated filer  

Smaller reporting company  

 

Emerging growth company  

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes   No 

As of November 18 2022, 3,334,749 units, each unit consisting of one share of Class A common stock and one-fourth of one warrant, 29,504,251 shares of Class A common stock, $0.0001 par value, and 7,925,000 shares of Class B common stock, par value $0.0001 per share, were issued and outstanding.

PROPERTY SOLUTIONS ACQUISITION CORP. II

FORM 10-Q FOR THE QUARTER ENDED SEPTEMBER 30, 2022

TABLE OF CONTENTS

Page

Part I. Financial Information

1

Item 1.

Financial Statements

1

Condensed Balance Sheets as of September 30, 2022 (Unaudited) and December 31, 2021

1

Condensed Statements of Operations for the three and nine months ended September 30, 2022 and 2021 (Unaudited)

2

Condensed Statements of Changes in Stockholders’ Deficit for the three and nine months ended September 30, 2022 and 2021 (Unaudited)

3

Condensed Statements of Cash Flows for the nine months ended September 30, 2022 and 2021 (Unaudited)

4

Notes to Condensed Financial Statements (Unaudited)

5

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

21

Item 3.

Quantitative and Qualitative Disclosures Regarding Market Risk

24

Item 4.

Controls and Procedures

25

Part II. Other Information

26

Item 1.

Legal Proceedings

26

Item 1A.

Risk Factors

26

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds

28

Item 3.

Defaults Upon Senior Securities

28

Item 4.

Mine Safety Disclosures

28

Item 5.

Other Information

28

Item 6.

Exhibits

28

Part III. Signatures

29

PART I - FINANCIAL INFORMATION

Item 1. Interim Financial Statements.

PROPERTY SOLUTIONS ACQUISITION CORP. II

CONDENSED BALANCE SHEETS

    

September 30, 2022

    

December 31, 2021

(Unaudited)

ASSETS

Current assets

Cash

$

10,582

$

531,984

Prepaid expenses- Short-term

 

105,517

 

209,207

Total Current Assets

116,099

741,191

 

 

Prepaid expenses- Long-term

34,590

Marketable securities held in Trust Account

318,684,239

317,025,510

TOTAL ASSETS

$

318,800,338

$

317,801,291

LIABILITIES AND STOCKHOLDERS’ DEFICIT

 

  

 

  

Current liabilities

Accrued expenses

$

222,028

$

285,139

Income taxes payable

355,835

Total Current Liabilities

577,863

285,139

Warrant Liability

 

488,085

 

4,629,712

Deferred underwriting fee payable

 

11,095,000

 

11,095,000

Total Liabilities

 

11,985,498

 

16,009,851

 

  

 

  

Commitments

 

  

 

  

Class A common stock, $0.0001 par value, subject to possible redemption, 31,700,000 shares at redemption value of approximately $10.04 and $10.00 at September 30, 2022 and December 31, 2021, respectively

318,338,616

317,000,000

 

  

 

  

Stockholders’ Deficit

 

  

 

  

Preferred stock, $0.0001 par value; 1,000,000 shares authorized; none issued or outstanding

 

 

Class A common stock, $0.0001 par value; 100,000,000 shares authorized; 1,139,000 shares issued and outstanding (excluding 31,700,000 shares subject to possible redemption) at September 30, 2022 and December 31, 2021

 

114

 

114

Class B common stock, $0.0001 par value; 10,000,000 shares authorized; 7,925,000 shares issued and outstanding at September 30, 2022 and December 31, 2021

 

793

 

793

Additional paid-in capital

 

 

Accumulated deficit

 

(11,700,133)

 

(15,209,467)

Total Stockholders’ Deficit

 

(11,699,226)

 

(15,208,560)

TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIT

$

318,800,338

$

317,801,291

The accompanying notes are an integral part of the unaudited condensed financial statements.

1

PROPERTY SOLUTIONS ACQUISITION CORP. II

CONDENSED STATEMENTS OF OPERATIONS

(UNAUDITED)

Three Months Ended

Nine Months Ended

September 30, 

September 30, 

    

2022

    

2021

    

2022

    

2021

Formation and operational costs

$

227,288

$

313,026

$

938,389

$

619,403

Loss from operations

(227,288)

(313,026)

(938,389)

(619,403)

Other income:

Interest earned on marketable securities held in Trust Account

1,297,528

4,080

1,973,888

20,391

Unrealized gain on marketable securities held in Trust Account

181,283

26,659

Representative Share Transaction Costs

(68,476)

Change in fair value of overallotment liability

196,475

Change in fair value of warrant liability

81,348

4,230,070

4,141,627

1,626,950

Transaction costs allocable to warrant liability

(402,827)

Total other income, net

1,560,159

4,234,150

6,142,174

1,372,513

Income before provision for income taxes

1,332,871

3,921,124

5,203,785

753,110

Provision for income taxes

(203,138)

(355,835)

Net income

$

1,129,733

$

3,921,124

$

4,847,950

$

753,110

 

 

 

 

Basic and diluted weighted average shares outstanding, Class A Common stock

 

32,839,000

 

32,839,000

 

32,839,000

 

24,779,612

Basic and diluted net income per common share, Class A

$

0.03

$

0.10

$

0.12

$

0.02

Basic and diluted weighted average shares outstanding, Class B Common stock

 

7,925,000

 

7,925,000

 

7,925,000

 

7,820,696

Diluted net income per share, Class B Common stock

$

0.03

$

0.10

$

0.12

$

0.02

The accompanying notes are an integral part of the unaudited condensed financial statements.

2

PROPERTY SOLUTIONS ACQUISITION CORP. II

CONDENSED STATEMENTS OF CHANGES IN STOCKHOLDERS’ DEFICIT

(UNAUDITED)

THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2022

Class A

Class B

Additional

Total

Common Stock

Common Stock

Paid-in

Accumulated

Stockholders’

    

Shares

    

Amount

    

Shares

    

Amount

    

Capital

    

Deficit

    

Deficit

Balance — January 1, 2022

1,139,000

$

114

7,925,000

$

793

$

$

(15,209,467)

$

(15,208,560)

 

Net income

 

 

 

 

1,610,657

 

1,610,657

Balance — March 31, 2022

1,139,000

114

7,925,000

793

$

(13,598,810)

(13,597,903)

Remeasurement to amount subject to redemption

(265,640)

(265,640)

Net income

2,107,560

2,107,560

Balance — June 30, 2022

 

1,139,000

114

7,925,000

793

(11,756,890)

(11,755,983)

 

Remeasurement to amount subject to redemption

 

 

 

 

(1,072,976)

 

(1,072,976)

Net income

 

1,129,733

1,129,733

 

Balance — September 30, 2022

 

1,139,000

$

114

7,925,000

$

793

$

$

(11,700,133)

$

(11,699,226)

THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2021

Class A

Class B

Additional

Total

Common Stock

Common Stock

Paid-in

Accumulated

Stockholders’

    

Shares

    

Amount

    

Shares

    

Amount

    

Capital

    

Deficit

    

Deficit

Balance — January 1, 2021

$

8,625,000

$

863

$

24,137

$

(1,540)

$

23,460

Sale of 839,000 Private Placement Units

839,000

84

8,203,648

8,203,732

Issuance of Representative Shares

300,000

30

2,999,970

3,000,000

Forfeiture of Founder Shares

(700,000)

(70)

70

Remeasurement to amount subject to redemption

(11,227,825)

(16,690,878)

(27,918,703)

Net loss

 

 

 

 

(396,332)

 

(396,332)

Balance — March 31, 2021

 

1,139,000

114

7,925,000

793

(17,088,750)

(17,087,843)

Net loss

 

(2,899,681)

(2,899,681)

Balance – June 30, 2021

1,139,000

$

114

7,925,000

$

793

$

$

(19,988,431)

$

(19,987,524)

Net income

 

3,921,124

3,921,124

Balance – September 30, 2021

 

1,139,000

$

114

7,925,000

$

793

$

$

(16,067,307)

$

(16,066,400)

The accompanying notes are an integral part of the unaudited condensed financial statements.

3

ROPERTY SOLUTIONS ACQUISITION CORP. II

CONDENSED STATEMENTS OF CASH FLOWS

(UNAUDITED)

Nine Months Ended

September 30, 

    

2022

    

2021

Cash Flows from Operating Activities:

  

Net income

$

4,847,950

$

753,110

Adjustments to reconcile net income to net cash used in operating activities:

 

 

Interest earned on marketable securities held in Trust Account

(1,973,888)

(20,391)

Unrealized gain on marketable securities held in Trust Account

(26,659)

Change in fair value of warrant liability

(4,141,627)

(1,626,950)

Change in fair value of over-allotment liability

(196,475)

Transaction costs allocable to representative shares

68,476

Transaction costs allocable to warrant liabilities

402,827

Changes in operating assets and liabilities:

Prepaid expenses

138,280

(311,182)

Accrued expenses

 

(63,111)

 

191,548

Income taxes payable

355,835

Net cash used in operating activities

 

(863,220)

(739,037)

Cash Flows from Investing Activities:

Investment of cash into Trust Account

(317,000,000)

Cash withdrawn from Trust Account to pay franchise and income taxes

341,818

Net cash provided by (used in) investing activities

341,818

(317,000,000)

 

  

  

Cash Flows from Financing Activities:

 

  

 

  

Proceeds from sale of Units, net of underwriting discounts paid

 

310,660,000

Proceeds from sale of Private Placement Units

8,390,000

Proceeds from issuance of Representative Shares

870

Repayment of promissory note-related party

 

 

(200,000)

Payment of offering costs

 

 

(634,441)

Net cash provided by financing activities

 

318,216,429

 

  

 

  

Net Change in Cash

 

(521,402)

477,392

Cash — Beginning of period

 

531,984

 

165,000

Cash — End of period

$

10,582

$

642,392

 

 

Non-Cash investing and financing activities:

 

 

Offering costs included in accrued offering costs

$

$

358,417

Initial classification of Public Warrants

$

$

7,053,250

Initial classification of Private Warrants

$

$

186,678

Initial classification of over-allotment liability

$

$

294,078

Deferred underwriting fee payable

$

$

11,095,000

Forfeiture of Founder Shares

$

$

(70)

Remeasurement of common stock subject to possible redemption

$

1,338,616

$

The accompanying notes are an integral part of the unaudited condensed financial statements.

4

Table of Contents

PROPERTY SOLUTIONS ACQUISITION CORP. II

NOTES TO CONDENSED FINANCIAL STATEMENTS

SEPTEMBER 30, 2022

(Unaudited)

NOTE 1. DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS

Property Solutions Acquisition Corp. II (the “Company”) was incorporated in Delaware on October 29, 2020. The Company is a blank check company formed for the purpose of entering into a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or other similar business combination with one or more businesses or entities (the “Business Combination”).

The Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies.

As of September 30, 2022, the Company had not commenced any operations. All activity through September 30, 2022 relates to the Company’s formation, initial public offering (“Initial Public Offering”), which is described below, and subsequent to the Initial Public Offering, identifying a target company for a Business Combination. The Company will not generate any operating revenues until after the completion of a Business Combination, at the earliest. The Company will generate non-operating income in the form of interest income from the proceeds derived from the Initial Public Offering. The Company has selected December 31 as its fiscal year end.

The registration statement for the Company’s Initial Public Offering was declared effective on March 3, 2021. On March 8, 2021, the Company consummated the Initial Public Offering of 30,000,000 units (the “Units” and, with respect to the shares of Class A common stock included in the Units sold, the “Public Shares”), at $10.00 per Unit, generating gross proceeds of $300,000,000, which is described in Note 4.

Simultaneously with the closing of the Initial Public Offering, the Company consummated the sale of 805,000 units (the “Private Placement Units”) at a price of $10.00 per Private Placement Unit in a private placement to Property Solutions Acquisition Sponsor II, LLC (the “Sponsor”) and EarlyBirdCapital, Inc. (“EarlyBirdCapital”), generating gross proceeds of $8,050,000, which is described in Note 5.

On March 12, 2021, the underwriters partially exercised their over-allotment option (see Note 4), resulting in an additional 1,700,000 Units issued for an aggregate amount of $17,000,000. In connection with the underwriters’ partial exercise of their over-allotment option, the Company also consummated the sale of an additional 34,000 Private Placement Units at $10.00 per Private Placement Unit, generating total proceeds of $340,000 (see Note 5).

Transaction costs amounted to $18,140,741, consisting of $6,340,000 of underwriting fees, $11,095,000 of deferred underwriting fees and $705,741 of other offering costs.

Following the closing of the Initial Public Offering on March 8, 2021 and the partial exercise of the underwriter’s over-allotment option on March 12, 2021, an amount of $317,000,000 ($10.00 per Unit) from the net proceeds of the sale of the Units in the Initial Public Offering and the sale of the Private Placement Units was placed in a trust account (the “Trust Account”), and are invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act of 1940, as amended (the “Investment Company Act”), with a maturity of 185 days or less, or in any open-ended investment company that holds itself out as a money market fund meeting the conditions of Rule 2a-7 of the Investment Company Act, as determined by the Company, until the earlier of: (i) the consummation of a Business Combination or (ii) the distribution of the funds in the Trust Account, as described below.

The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of the Private Placement Units, although substantially all of the net proceeds are intended to be applied generally toward completing a Business Combination. The Company must complete a Business Combination having an aggregate fair market value of at least 80% of the assets held in the Trust Account (excluding deferred underwriting commissions and taxes payable on income earned on the Trust Account) at the time of the agreement to enter into an initial Business Combination. The Company will only complete a Business Combination if the post Business Combination company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act. There is no assurance that the Company will be able to successfully complete a Business Combination.

5

Table of Contents

PROPERTY SOLUTIONS ACQUISITION CORP. II

NOTES TO CONDENSED FINANCIAL STATEMENTS

SEPTEMBER 30, 2022

(UNAUDITED)

The Company will provide its stockholders with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a stockholder meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek stockholder approval of a Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The public stockholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then in the Trust Account (initially anticipated to be $10.00 per Public Share, plus any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations). There will be no redemption rights upon the completion of a Business Combination with respect to the Company’s warrants.

The Company will proceed with a Business Combination if the Company has net tangible assets of at least $5,000,001 immediately prior to or upon such consummation of a Business Combination and, if the Company seeks stockholder approval, a majority of the shares voted are voted in favor of the Business Combination. If a stockholder vote is not required by law and the Company does not decide to hold a stockholder vote for business or other legal reasons, the Company will, pursuant to its Amended and Restated Certificate of Incorporation (the “Amended and Restated Certificate of Incorporation”), conduct the redemptions pursuant to the tender offer rules of the U.S. Securities and Exchange Commission (the “SEC”) and file tender offer documents with the SEC containing substantially the same information as would be included in a proxy statement prior to completing a Business Combination. If, however, stockholder approval of the transaction is required by law, or the Company decides to obtain stockholder approval for business or legal reasons, the Company will offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. If the Company seeks stockholder approval in connection with a Business Combination, the Sponsor and EarlyBirdCapital have agreed to vote their Founder Shares (as defined in Note 6), Representative Shares (as defined in Note 7), Private Shares (as defined in Note 5) and any Public Shares purchased during or after the Initial Public Offering (a) in favor of approving a Business Combination and (b) not to convert any shares in connection with a stockholder vote to approve a Business Combination or sell any shares to the Company in a tender offer in connection with a Business Combination. Additionally, public stockholders may elect to redeem their Public Shares, without voting, and if they do vote, irrespective of whether they vote for or against the proposed Business Combination.

The Sponsor has agreed (a) to waive its redemption rights with respect to the Founder Shares, Private Shares and Public Shares held by it in connection with the completion of a Business Combination and (b) not to propose an amendment to the Amended and Restated Certificate of Incorporation that would affect a public stockholders’ ability to convert or sell their shares to the Company in connection with a Business Combination or affect the substance or timing of the Company’s obligation to redeem 100% of its Public Shares if the Company does not complete a Business Combination, unless the Company provides the public stockholders with the opportunity to redeem their Public Shares in conjunction with any such amendment.

The Company will have until March 8, 2023 to complete a Business Combination (the “Combination Period”). If the Company is unable to complete a Business Combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account including interest earned on the funds held in the Trust Account and not previously released to the Company to pay taxes, divided by the number of then outstanding Public Shares, which redemption will completely extinguish public stockholders’ rights as stockholders (including the right to receive further liquidating distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company’s remaining stockholders and the Company’s board of directors, dissolve and liquidate, subject in each case to the Company’s obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law. There will be no redemption rights or liquidating distributions with respect to the Company’s warrants, which will expire worthless if the Company fails to complete a Business Combination within the Combination Period.

6

Table of Contents

PROPERTY SOLUTIONS ACQUISITION CORP. II

NOTES TO CONDENSED FINANCIAL STATEMENTS

SEPTEMBER 30, 2022

(UNAUDITED)

The Sponsor and EarlyBirdCapital have agreed to waive their liquidation rights with respect to the Founder Shares, Representative Shares and Private Shares if the Company fails to complete a Business Combination within the Combination Period. However, if the Sponsor or EarlyBirdCapital acquire Public Shares in or after the Initial Public Offering, such Public Shares will be entitled to liquidating distributions from the Trust Account if the Company fails to complete a Business Combination within the Combination Period. The underwriter has agreed to waive its rights to the deferred underwriting commission (see Note 7) held in the Trust Account in the event the Company does not complete a Business Combination within the Combination Period and, in such event, such amounts will be included with the funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the assets remaining available for distribution will be less than the Initial Public Offering price per Unit ($10.00).

In order to protect the amounts held in the Trust Account, the Sponsor has agreed to be liable to the Company if and to the extent any claims by a vendor for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account to below $10.00 per Public Share, except as to any claims by a third party who executed a valid and enforceable agreement with the Company waiving any right, title, interest or claim of any kind they may have in or to any monies held in the Trust Account and except as to any claims under the Company’s indemnity of the underwriters of Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers, prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account.

Liquidity and Going Concern

As of September 30, 2022, the Company had $10,582 in its operating bank accounts and working capital deficit of $76,141, when accounting for the Company’s ability to use interest income to pay towards tax liabilities.

Until the consummation of a Business Combination, the Company will be using the funds not held in the Trust Account for identifying and evaluating prospective acquisition candidates, performing due diligence on prospective target businesses, paying for travel expenditures, selecting the target business to acquire, and structuring, negotiating and consummating the Business Combination.

The Company will need to raise further additional capital through loans or additional investments from its Sponsor, stockholders, officers, directors, or third parties. In addition to the loan commitment described herein, the Company’s officers, directors and Sponsor may, but are not obligated to, loan the Company funds, from time to time or at any time, in whatever amount they deem reasonable in their sole discretion, to meet the Company’s working capital needs. Accordingly, the Company may not be able to obtain additional financing. If the Company is unable to raise additional capital, it may be required to take additional measures to conserve liquidity, which could include, but not necessarily be limited to, curtailing operations, suspending the pursuit of a potential transaction, and reducing overhead expenses. The Company cannot provide any assurance that new financing will be available to it on commercially acceptable terms, if at all. These conditions raise substantial doubt about the Company’s ability to continue as a going concern through March 8, 2023, the Company’s liquidation date, and/or through twelve months from the issuance of these financial statements. These financial statements do not include any adjustments relating to the recovery of the recorded assets or the classification of the liabilities that might be necessary should the Company be unable to continue as a going concern.

Risks and Uncertainties

Management continues to evaluate the impact of the COVID-19 pandemic and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company’s financial position and/or search for a target company, the specific impact is not readily determinable as of the date of the financial statement. The financial statement does not include any adjustments that might result from the outcome of this uncertainty.

7

Table of Contents

PROPERTY SOLUTIONS ACQUISITION CORP. II

NOTES TO CONDENSED FINANCIAL STATEMENTS

SEPTEMBER 30, 2022

(UNAUDITED)

In February 2022, the Russian Federation and Belarus commenced a military action with the country of Ukraine. As a result of this action, various nations, including the United States, have instituted economic sanctions against the Russian Federation and Belarus. Further, the impact of this action and related sanctions on the world economy are not determinable as of the date of these financial statements. The specific impact on the Company’s financial condition, results of operations, and cash flows is also not determinable as of the date of these financial statements.

Inflation Reduction Act of 2022

On August 16, 2022, the Inflation Reduction Act of 2022 (the “IR Act”) was signed into federal law. The IR Act provides for, among other things, a new U.S. federal 1% excise tax on certain repurchases of stock by publicly traded U.S. domestic corporations and certain U.S. domestic subsidiaries of publicly traded foreign corporations occurring on or after January 1, 2023. The excise tax is imposed on the repurchasing corporation itself, not its shareholders from which shares are repurchased. The amount of the excise tax is generally 1% of the fair market value of the shares repurchased at the time of the repurchase. However, for purposes of calculating the excise tax, repurchasing corporations are permitted to net the fair market value of certain new stock issuances against the fair market value of stock repurchases during the same taxable year. In addition, certain exceptions apply to the excise tax. The U.S. Department of the Treasury (the “Treasury”) has been given authority to provide regulations and other guidance to carry out and prevent the abuse or avoidance of the excise tax.

Any redemption or other repurchase that occurs after December 31, 2022, in connection with a Business Combination, extension vote or otherwise, may be subject to the excise tax. Whether and to what extent the Company would be subject to the excise tax in connection with a Business Combination, extension vote or otherwise would depend on a number of factors, including (i) the fair market value of the redemptions and repurchases in connection with the Business Combination, extension or otherwise, (ii) the structure of a Business Combination, (iii) the nature and amount of any “PIPE” or other equity issuances in connection with a Business Combination (or otherwise issued not in connection with a Business Combination but issued within the same taxable year of a Business Combination) and (iv) the content of regulations and other guidance from the Treasury. In addition, because the excise tax would be payable by the Company and not by the redeeming holder, the mechanics of any required payment of the excise tax have not been determined. The foregoing could cause a reduction in the cash available on hand to complete a Business Combination and in the Company’s ability to complete a Business Combination.

NOTE 2. REVISION OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS

In connection with the preparation of the Company’s financial statements as of December 31, 2021, Management identified errors made in its historical financial statements where, at the closing of the Company’s Initial Public Offering, the Company did not record a liability related to the underwriter’s option to exercise their over-allotment. Additionally, the Company did not appropriately apply the correct equity presentation or allocation of offering costs related to the Company’s issued representative shares, furthermore, the Company has revised operating costs for the nine months ended September 30, 2021, due to a reclassification of legal expenses between quarters. These errors were recorded and presented within the financial statements as of December 31, 2021. This revision note is presenting the changes from the previously reported balances to the adjusted balances as of and for the nine months ended September 30, 2021 for comparative purposes of these condensed financial statements. These errors resulted in an adjustment to the net income.

The impact of the revision on the Company’s financial statements is reflected in the following table.

    

As Previously

    

    

Statement of Operations for the Nine Months Ended September 30, 2021

Reported

Adjustment

As Revised

Change in fair value of over-allotment liability

$

$

196,475

$

196,475

Transaction costs allocable to representative shares

$

$

(68,476)

$

(68,476)

Net Loss

$

625,111

$

127,999

$

753,110

8

Table of Contents

PROPERTY SOLUTIONS ACQUISITION CORP. II

NOTES TO CONDENSED FINANCIAL STATEMENTS

SEPTEMBER 30, 2022

(UNAUDITED)

    

As Previously

    

    

Statement of Stockholders’ Deficit for the Nine Months Ended September 30, 2021

Reported

Adjustment

As Revised

Issuance of representative shares

870

2,999,130

3,000,000

Remeasurement to amount subject to redemption

(24,791,574)

3,127,129

$

(27,918,703)

Net loss

$

625,111

$

127,999

$

753,110

    

As Previously

    

    

Statement of Cashflows for the Nine Months Ended September 30, 2021

Reported

Adjustment

As Revised

Change in fair value of over-allotment liability

$

$

(196,475)

$

(196,475)

Transaction costs allocable to representative shares

$

$

68,476

$

68,476

Net loss

$

625,111

$

127,999

$

753,110

Initial classification of over-allotment Liability

$

$

294,708

$

294,078

NOTE 3. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation

The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X of the Securities and Exchange Commission (“SEC”). Certain information or footnote disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented.

The accompanying unaudited condensed financial statements should be read in conjunction with the Company’s Annual Report on Form 10-K as filed with the SEC on April 18, 2022. The interim results for the three and nine months ended September 30, 2022 are not necessarily indicative of the results to be expected for the year ending December 31, 2022 or for any future periods.

Emerging Growth Company

The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved.

Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statement with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.

9

Table of Contents

PROPERTY SOLUTIONS ACQUISITION CORP. II

NOTES TO CONDENSED FINANCIAL STATEMENTS

SEPTEMBER 30, 2022

(UNAUDITED)

Use of Estimates

The preparation of the condensed financial statements in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.

Making estimates require management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. One of the more significant accounting estimates included in these condensed financial statements is the determination of the fair value of the warrant liabilities. Such estimates may be subject to change as more current information becomes available and accordingly the actual results could differ significantly from those estimates.

Cash and Cash Equivalents

The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of September 30, 2022 and December 31, 2021.

Marketable Securities Held in Trust Account

At September 30, 2022 and December 31, 2021, substantially all of the assets held in the Trust Account were held in U.S. Treasury securities. All of the Company’s investments held in the Trust Account are classified as trading securities. Trading securities are presented on the balance sheets at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of investments held in Trust Account are included in interest earned on marketable securities held in Trust Account in the accompanying statements of operations. The estimated fair values of investments held in Trust Account are determined using available market information.

Warrant Liabilities

The Company accounts for the Public Warrants (as defined in Note 4) and Private Placement Warrants (together with the Public Warrants, the “Warrants”) in accordance with the guidance contained in ASC 815-40, under which the Warrants do not meet the criteria for equity treatment and must be recorded as liabilities. Accordingly, the Company classifies the Warrants as liabilities at their fair value and adjusts the Warrants to fair value in respect of each reporting period. This liability is subject to re-measurement at each balance sheet date until the Warrants are exercised, and any change in fair value is recognized in the statements of operations. The Private Placement Warrants and the Public Warrants for periods where no observable traded price was available are valued using a Binomial lattice model.

Offering Costs

Offering costs consisted of legal, accounting and other expenses incurred through the Initial Public Offering that were directly related to the Initial Public Offering. Offering costs were allocated to the separable financial instruments issued in the Initial Public Offering based on a relative fair value basis, compared to total proceeds received. Offering costs allocated to warrant liabilities and representative shares were expensed as incurred in the statements of operations. Offering costs associated with the Class A common stock issued were charged to temporary equity. Offering costs amounted to $705,741, of which $234,438 was charged to temporary equity and $471,303 was expensed as incurred in the statements of operation upon the completion of the Initial Public Offering. In addition, the underwriter was paid $6,340,000 at closing of the Initial Public Offering and a deferred underwriting fee of $11,095,000 was charged against equity and presented on the accompanying consolidated balance sheets.

10

Table of Contents

PROPERTY SOLUTIONS ACQUISITION CORP. II

NOTES TO CONDENSED FINANCIAL STATEMENTS

SEPTEMBER 30, 2022

(UNAUDITED)

Class A Common Stock Subject to Possible Redemption

The Company accounts for its Class A common stock subject to possible redemption in accordance with the guidance in ASC 480. Class A common stock subject to mandatory redemption are classified as a liability instrument and are measured at fair value. Conditionally redeemable common stock (including common stock that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, common stock are classified as stockholders’ equity. The Company’s Class A common stock feature certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, at September 30, 2022 and December 31, 2021, Class A common stock subject to possible redemption are presented as temporary equity, outside of the stockholders’ equity section of the Company’s condensed balance sheets.

The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable common stock to equal the redemption value at the end of each reporting period. Immediately upon the closing of the Initial Public Offering, the Company recognized the accretion from initial book value to redemption amount value. The change in the carrying value of redeemable Class A common stock resulted in charges against additional paid-in capital and accumulated deficit.

At September 30, 2022 and December 31, 2021, the Class A common stock reflected in the condensed balance sheets are reconciled in the following table:

Gross proceeds

    

$

317,000,000

Less:

 

  

Proceeds allocated to Public Warrants

(7,053,250)

Class A common stock issuance costs

(20,865,453)

Plus:

  

Remeasurement to amount subject to redemption

27,918,703

Class A common stock subject to possible redemption, December 31, 2021

317,000,000

Plus:

Remeasurement to amount subject to redemption

1,338,616

Class A common stock subject to possible redemption, September 30, 2022

$

318,338,616

Income Taxes

The Company accounts for income taxes under ASC 740, “Income Taxes.” ASC 740, Income Taxes, requires the recognition of deferred tax assets and liabilities for both the expected impact of differences between the unaudited condensed financial statements and tax basis of assets and liabilities and for the expected future tax benefit to be derived from tax loss and tax credit carry forwards. ASC 740 additionally requires a valuation allowance to be established when it is more likely than not that all or a portion of deferred tax assets will not be realized. As of September 30, 2022 and December 31, 2021, the Company’s deferred tax asset had a full valuation allowance recorded against it.

The Company’s effective tax rate was 15.24% and 0.00% for the three months ended September 30, 2022 and 2021, respectively, and 6.84% and 0.00% for the nine months ended September 30, 2022 and 2021, respectively. The effective tax rate differs from the statutory tax rate of 21% for the three and nine months ended September 30, 2022 and 2021, due to changes in fair value in warrant liability, and the valuation allowance on the deferred tax assets.

ASC 740 also clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. ASC 740 also provides guidance on derecognition, classification, interest and penalties, accounting in interim period, disclosure and transition.

11

Table of Contents

PROPERTY SOLUTIONS ACQUISITION CORP. II

NOTES TO CONDENSED FINANCIAL STATEMENTS

SEPTEMBER 30, 2022

(UNAUDITED)

The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of September 30, 2022 and December 31, 2021. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position.

The Company has identified the United States as its only “major” tax jurisdiction. The Company is subject to income taxation by major taxing authorities since inception. These examinations may include questioning the timing and amount of deductions, the nexus of income among various tax jurisdictions and compliance with federal and state tax laws. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months.

Net Income (Loss) per Common Share

The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share”. Net income (loss) per common stock is computed by dividing net income (loss) by the weighted average number of common stock outstanding for the period. The Company applies the two-class method in calculating earnings per share. Accretion associated with the redeemable shares of Class A common stock is excluded from earnings per share as the redemption value approximates fair value.

The calculation of diluted income (loss) per share does not consider the effect of the warrants issued in connection with the (i) Initial Public Offering, and (ii) the private placement since the exercise of the warrants is contingent upon the occurrence of future events. The warrants are exercisable to purchase 8,134,750 Class A common stock in the aggregate. As of September 30, 2022 and 2021, the Company did not have any dilutive securities or other contracts that could, potentially, be exercised or converted into common stock and then share in the earnings of the Company. As a result, diluted net loss per common stock is the same as basic net loss per common stock for the periods presented.

The following table reflects the calculation of basic and diluted net income (loss) per common share (in dollars, except per share amounts):

Three Months Ended 

Nine Months Ended 

September 30, 2022

 

September 30, 2021

September 30, 2022

 

September 30, 2021

    

Class A

    

Class B

    

Class A

    

Class B

    

Class A

    

Class B

    

Class A

    

Class B

Basic and diluted net income per ordinary share

 

  

  

 

  

  

Numerator:

 

  

  

 

  

  

Allocation of net income, as adjusted

$

910,100

$

219,633

$

3,158,811

$

762,313

$

3,905,452

$

942,498

$

572,441

$

180,669

Denominator:

 

  

 

  

 

  

 

  

Basic and diluted weighted average ordinary share outstanding

32,839,000

7,925,000

32,839,000

7,925,000

32,839,000

7,925,000

24,779,612

7,820,696

Basic and diluted net income per ordinary share

$

0.03

$

0.03

$

0.10

$

0.10

$

0.12

$

0.12

$

0.02

$

0.02

Concentration of Credit Risk

Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times may exceed the Federal Depository Insurance Coverage of $250,000. The Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account.

Fair Value of Financial Instruments

The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC Topic 820, “Fair Value Measurement,” approximates the carrying amounts represented in the accompanying condensed balance sheets, primarily due to their short-term nature, excluding the Warrant liability (see Note 10).

12

Table of Contents

PROPERTY SOLUTIONS ACQUISITION CORP. II

NOTES TO CONDENSED FINANCIAL STATEMENTS

SEPTEMBER 30, 2022

(UNAUDITED)

Recent Accounting Standards

In August 2020, the FASB issued Accounting Standards Update (“ASU”) No. 2020-06, Debt –debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging – Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity (“ASU 2020-06”), which simplifies accounting for convertible instruments by removing major separation models required under current U.S. GAAP. The ASU also removes certain settlement conditions that are required for equity-linked contracts to qualify for the derivative scope exception, and it simplifies the diluted earnings per share calculation in certain areas. The Company adopted ASU 2020-06 in January 2022. Adoption of the ASU did not impact the Company’s financial position, results of operations or cash flows.

The Company’s management does not believe that any other recently issued, but not yet effective, accounting standards if currently adopted would have a material effect on the accompanying unaudited condensed financial statements.

NOTE 4. PUBLIC OFFERING

Pursuant to the Initial Public Offering, the Company sold 31,700,000 Units, inclusive of 1,700,000 Units sold to the underwriters on March 12, 2021 upon the underwriters’ election to partially exercise their over-allotment option, at a purchase price of $10.00 per Unit. Each Unit consists of one share of the Company’s Class A common stock and one-fourth of one redeemable warrant (“Public Warrant”). Each Public Warrant entitles the holder to purchase one share of Class A common stock at an exercise price of $11.50 per whole share (see Note 9).

NOTE 5. PRIVATE PLACEMENT

Simultaneously with the closing of the Initial Public Offering, the Sponsor and EarlyBirdCapital purchased an aggregate of 805,000 Private Placement Units at a price of $10.00 per Private Placement Unit in a private placement. The Sponsor purchased 655,000 Private Placement Units and EarlyBirdCapital purchased 150,000 Private Placement Units. The Sponsor agreed to purchase up to an additional 67,500 Private Placement Units and EarlyBirdCapital agreed to purchase up to an additional 22,500 Private Placement Units if the over-allotment option was exercised in full. On March 12, 2021, the Sponsor and EarlyBirdCapital purchased 34,000 Private Placement Units for an additional aggregate purchase price of $340,000 in connection with the partial exercise of the underwriter’s over-allotment option. Each Private Placement Unit consists of one share of Class A common stock (“Private Share”) and one-fourth of one redeemable warrant (“Private Placement Warrant”). Each Private Placement Warrant will entitle the holder to purchase one share of Class A common stock at a price of $11.50 per full share, subject to adjustment (see Note 9). The proceeds from the Private Placement Units were added to the proceeds from the Initial Public Offering held in the Trust Account. If the Company does not complete a Business Combination within the Combination Period, the proceeds from the sale of the Private Placement Units will be used to fund the redemption of the Public Shares (subject to the requirements of applicable law).

NOTE 6. RELATED PARTY TRANSACTIONS

Founder Shares

On November 10, 2020, the Sponsor paid $25,000 to cover certain offering costs of the Company in consideration for 5,750,000 shares of Class B common stock (the “Founder Shares”). On February 4, 2021, the Company effectuated a 1:1.25 stock split of its Class B common stock and on March 3, 2021, the Company effectuated a 1.2 stock split of its Class B common stock, which resulted in an aggregate of 8,625,000 Founder Shares outstanding. The Founder Shares include an aggregate of up to 700,000 shares that remain subject to forfeiture by the Sponsor following the underwriters’ election to partially exercise their over-allotment option (see Note 7), so that the Sponsor and the Company’s independent directors will collectively own 20% of the Company’s issued and outstanding shares after the Initial Public Offering (assuming the Sponsor did not purchase any Public Shares in the Initial Public Offering and excluding the Private Shares). As a result of the underwriters’ election to partially exercise their over-allotment option, a total of 425,000 Founder Shares are no longer subject to forfeiture and 700,000 Founder Shares were forfeited resulting in an aggregate of 7,925,000 Founder Shares outstanding.

13

Table of Contents

PROPERTY SOLUTIONS ACQUISITION CORP. II

NOTES TO CONDENSED FINANCIAL STATEMENTS

SEPTEMBER 30, 2022

(UNAUDITED)

The Sponsor has agreed, subject to limited exceptions, not to transfer, assign or sell any of the Founder Shares until the earlier to occur of: (A) one year after the completion of a Business Combination and (B) subsequent to a Business Combination, (x) if the reported closing price of the Class A common stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after a Business Combination, or (y) the date on which the Company completes a liquidation, merger, capital stock exchange or other similar transaction that results in all of the Public Stockholders having the right to exchange their shares of common stock for cash, securities or other property.

On February 18, 2021, the sponsor transferred 15,000 shares of Class B common stock to the independent directors of D. Amsterdam, A. Ebush, and A. Savar for a total of 45,000 shares transferred. On March 3, 2021, the company effectuated a 1.2 stock split of our common stock which resulted in the total amount of Class B common stock transferred to each director to be 18,000 for a total of 54,000 shares.

The transfer of the Founders Shares is in the scope of FASB ASC Topic 718, “Compensation-Stock Compensation” (“ASC 718”). Under ASC 718, stock-based compensation associated with equity-classified awards is measured at fair value upon the grant date. The value of the transferred Founders Shares on the grant date of February 18, 2021 was $6.91 per share for a total aggregate value of $373,140. The Founders Shares were granted subject to a performance condition (i.e., the occurrence of a Business Combination). Compensation expense related to the Founders Shares is recognized only when the performance condition is probable of occurrence under the applicable accounting literature in this circumstance. As of September 30, 2022, the Company determined that a Business Combination is not considered probable, and, therefore, no stock-based compensation expense has been recognized. Stock-based compensation would be recognized at the date a Business Combination is considered probable (i.e., upon consummation of a Business Combination) in an amount equal to the number of Founders Shares times the grant date fair value per share (unless subsequently modified) less the amount initially received for the purchase of the Founders Shares.

Administrative Services Agreement

The Company agreed, commencing on March 3, 2021 through the earlier of the Company’s consummation of a Business Combination and its liquidation, to pay an affiliate of the Company’s executive officers a total of $10,000 per month for office space and general and administrative services. For the three months and nine months ended September 30, 2022, the Company incurred $30,000 and $90,000 in fees for these services, respectively, of which $10,000 of such amount is included in accrued expenses in the accompanying balance sheets. For the three months and nine months ended September 30, 2021, the Company incurred $30,000 and $70,000 in fees for these services, respectively. As of December 31, 2021 there was $10,000 of such fees included in accounts payable and accrued expenses.

Promissory Note — Related Party

On November 10, 2020, the Company issued an unsecured promissory note to the Sponsor (the “Promissory Note”), pursuant to which the Company could borrow up to an aggregate principal amount of $300,000. The Promissory Note was non-interest bearing and payable on the earlier of (i) December 31, 2021, (ii) the consummation of the Initial Public Offering or (ii) the date on which the Company determines not to proceed with the Initial Public Offering. As of September 30, 2022 and December 31, 2021, there was no amount outstanding under the Promissory Note. The outstanding amount of $200,000 was repaid at the closing of the Initial Public Offering on March 8, 2021.

14

Table of Contents

PROPERTY SOLUTIONS ACQUISITION CORP. II

NOTES TO CONDENSED FINANCIAL STATEMENTS

SEPTEMBER 30, 2022

(UNAUDITED)

Related Party Loans

In addition, in order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If the Company completes a Business Combination, the Company would repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company. Otherwise, the Working Capital Loans would be repaid only out of funds held outside the Trust Account. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans, but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. Except for the foregoing, the terms of such Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans. The Working Capital Loans would either be repaid upon consummation of a Business Combination, without interest, or, at the lender’s discretion, up to $1,500,000 of such Working Capital Loans may be convertible into units of the post Business Combination entity at a price of $10.00 per unit. The units would be identical to the Private Placement Units. As of September 30, 2022 or December 31, 2021, no amounts have been withdrawn or are outstanding relating to these Working Capital Loans.

NOTE 7. COMMITMENTS

Registration Rights

Pursuant to a registration rights agreement entered into on March 3, 2021, the holders of the Founder Shares and Representative Shares, as well as the holders of the Private Placement Units and any units that may be issued in payment of Working Capital Loans made to the Company, have registration rights to require the Company to register for resale of any of the Company’s securities held by them. The holder of these securities and the Sponsor are entitled to make unlimited demands that the Company register such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the completion of a Business Combination. Notwithstanding anything to the contrary, EarlyBirdCapital may only make a demand on one occasion and only during the five-year period beginning on the effective date of the Initial Public Offering. In addition, EarlyBirdCapital may participate in a “piggy-back” registration only during the seven-year period beginning on the effective date of the Initial Public Offering. The Company will bear the expenses incurred in connection with the filing of any such registration statements. However, the registration and stockholder rights agreement provides that the Company will not permit any registration statement filed under the Securities Act to become effective until termination of the applicable lock-up period. The registration rights and stockholder agreement does not contain liquidated damages or other cash settlement provisions resulting from delays in registering the Company’s securities. The Company will bear the expenses incurred in connection with the filing of any such registration statements.

Underwriting Agreement

The Company granted the underwriters a 45-day option from the date of the Initial Public Offering to purchase up to 4,500,000 additional Units to cover over-allotments, if any, at the Initial Public Offering price, less the underwriting discounts and commissions. On March 12, 2021, the underwriter’s election to partially exercise the over-allotment option to purchase an additional 1,700,000 Units and forfeited their option to purchase an additional 2,800,000 Units.

The underwriters are entitled to a deferred fee of $0.35 per Unit, or $10,500,000 in the aggregate (or $12,075,000 in the aggregate if the underwriters’ over-allotment option is exercised in full). The deferred fee will become payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement.

NOTE 8. STOCKHOLDERS’ DEFICIT

Preferred Stock —The Company is authorized to issue 1,000,000 shares of preferred stock with a par value of $0.0001 per share. At March 8, 2021, there were no shares of preferred stock issued or outstanding. At September 30, 2022 and December 31, 2021, there were no shares of preferred stock issued or outstanding.

15

Table of Contents

PROPERTY SOLUTIONS ACQUISITION CORP. II

NOTES TO CONDENSED FINANCIAL STATEMENTS

SEPTEMBER 30, 2022

(UNAUDITED)

Class A Common StockThe Company is authorized to issue up to 100,000,000 shares of Class A common stock with a par value of $0.0001 per share. At September 30, 2022 and December 31, 2021, there were 32,839,000 shares of Class A common stock issued and outstanding, including 31,700,000 Class A common stock subject to possible redemption which are presented as temporary equity.

Class B Common StockThe Company is authorized to issue up to 10,000,000 shares of Class B common stock with a par value of $0.0001 per share. Holders of the Company’s common stock are entitled to one vote for each share. At September 30, 2022 and December 31, 2021, there were 7,925,000 shares of common stock issued and outstanding.

Holders of Class A common stock and holders of Class B common stock will vote together as a single class on all matters submitted to a vote of the Company’s stockholders except as otherwise required by law.

The shares of Class B common stock will automatically convert into Class A common stock at the time of a Business Combination, or earlier at the option of the holder, on a one-for-one basis, subject to adjustment. In the case that additional shares of Class A common stock, or equity-linked securities, are issued or deemed issued in excess of the amounts offered in this prospectus and related to the closing of a Business Combination, the ratio at which shares of Class B common stock shall convert into shares of Class A common stock will be adjusted (unless the Sponsor agrees to waive such adjustment with respect to any such issuance or deemed issuance, including a specified future issuance) so that the number of shares of Class A common stock issuable upon conversion of all shares of Class B common stock will equal, in the aggregate, on an as-converted basis, 20% of the sum of the total number of all shares of common stock outstanding upon completion of the Initial Public Offering plus all shares of Class A common stock and equity-linked securities issued or deemed issued in connection with a Business Combination (after giving effect to any redemptions of shares of Class A common stock by public stockholders, excluding any Private Placement Units issued to the Sponsor, officers or directors upon conversion of Working Capital Loans). The Sponsor may also elect to convert their shares of Class B common stock into an equal number of shares of Class A common stock, subject to adjustment as provided above, at any time.

NOTE 9. WARRANTS

Public Warrants may only be exercised for a whole number of shares. No fractional warrants will be issued upon separation of the Units and only whole warrants will trade. The Public Warrants will become exercisable 30 days after the completion of a Business Combination. The Public Warrants will expire five years after the completion of a Business Combination or earlier upon redemption or liquidation.

The Company will not be obligated to deliver any shares of Class A common stock pursuant to the exercise of a warrant and will have no obligation to settle such warrant exercise unless a registration statement under the Securities Act covering the issuance of the shares of Class A common stock underlying the warrants is then effective and a prospectus relating thereto is current, subject to the Company satisfying its obligations with respect to registration. No warrant will be exercisable and the Company will not be obligated to issue shares of Class A common stock upon exercise of a warrant unless Class A common stock issuable upon such warrant exercise has been registered, qualified or deemed to be exempt under the securities laws of the state of residence of the registered holder of the warrants.

The Company has agreed that as soon as practicable, but in no event later than 20 business days after the closing of a Business Combination, it will use its reasonable best efforts to file with the SEC a registration statement for the registration, under the Securities Act, of the shares of Class A common stock issuable upon exercise of the warrants. The Company will use its reasonable best efforts to cause the same to become effective and to maintain the effectiveness of such registration statement, and a current prospectus relating thereto, until the expiration of the warrants in accordance with the provisions of the warrant agreement. If a registration statement covering the shares of Class A common stock issuable upon exercise of the warrants is not effective by the ninetieth day after the closing of a Business Combination, warrant holders may, until such time as there is an effective registration statement and during any period when the Company will have failed to maintain an effective registration statement, exercise warrants on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act or another exemption.

16

Table of Contents

PROPERTY SOLUTIONS ACQUISITION CORP. II

NOTES TO CONDENSED FINANCIAL STATEMENTS

SEPTEMBER 30, 2022

(UNAUDITED)

Redemption of warrants when the price per Class A common stock equals or exceeds $18.00. Once the warrants become exercisable, the Company may redeem the outstanding warrants (except with respect to the Private Placement Warrants):

in whole and not in part;
at a price of $0.01 per warrant;
upon not less than 30 days’ prior written notice of redemption, or the 30-day redemption period, to each warrant holder; and
if, and only if, the reported closing price of the Class A common stock equals or exceeds $18.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within a 30-trading day period commencing once the warrants become exercisable and ending three business days before the Company sends the notice of redemption to the warrant holders.

If and when the warrants become redeemable by the Company, the Company may exercise its redemption right even if the Company is unable to register or qualify the underlying securities for sale under all applicable state securities laws.

Redemption of warrants when the price per Class A common stock equals or exceeds $10.00. Once the warrants become exercisable, the Company may redeem the outstanding warrants:

in whole and not in part;
at $0.10 per warrant upon a minimum of 30 days’ prior written notice of redemption provided that during such 30 day period holders will be able to exercise their warrants on a cashless basis prior to redemption and receive that number of shares based on the redemption date and the “fair market value” of our shares of Class A common stock (as defined below) except as otherwise described below; provided, further, that if the warrants are not exercised on a cashless basis or otherwise during such 30 day period, the Company shall redeem such warrants for $0.10 per share;
if, and only if, the Private Placement Warrants are also concurrently called for redemption at the same price (equal to a number of shares of Class A common stock) as the outstanding Public Warrants, as described above; and
if, and only if, there is an effective registration statement covering the issuance of the shares of Class A common stock issuable upon exercise of the warrants and a current prospectus relating thereto available throughout the 30-day period after written notice of redemption is given.

If the Company calls the Public Warrants for redemption, management will have the option to require all holders that wish to exercise the Public Warrants to do so on a “cashless basis,” as described in the warrant agreement. The exercise price and number of shares of Class A common stock issuable upon exercise of the warrants may be adjusted in certain circumstances including in the event of a stock dividend, or recapitalization, reorganization, merger or consolidation. However, except as described below, the warrants will not be adjusted for issuances of Class A common stock at a price below its exercise price. Additionally, in no event will the Company be required to net cash settle the warrants. If the Company is unable to complete a Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect to their warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with the respect to such warrants. Accordingly, the warrants may expire worthless.

In addition, if (x) the Company issues additional shares of Class A common stock or equity-linked securities for capital raising purposes in connection with the closing of a Business Combination at an issue price or effective issue price of less than $9.20 per share of Class A common stock (with such issue price or effective issue price to be determined in good faith by the Company’s board of directors, and in the case of any such issuance to the Sponsor or their affiliates, without taking into account any Founder Shares held by them prior to such issuance), or the Newly Issued Price, (y) the aggregate gross proceeds from such issuances represent more than 50% of the total equity proceeds, and interest thereon, available for the funding of a Business Combination on the date of the consummation of a Business Combination (net of redemptions), and (z) the volume weighted average trading price of the Company’s Class A common stock during the 20 trading day period starting on the trading day after the day on which the Company consummates Business Combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of (i) the Market Value and (ii) the Newly Issued Price and the $18.00 per share redemption trigger price will be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market Value and the Newly Issued Price.

17

Table of Contents

PROPERTY SOLUTIONS ACQUISITION CORP. II

NOTES TO CONDENSED FINANCIAL STATEMENTS

SEPTEMBER 30, 2022

(UNAUDITED)

The Private Placement Warrants are identical to the Public Warrants underlying the Units sold in the Initial Public Offering, except that the Private Placement Warrants and the Class A common stock issuable upon the exercise of the Private Placement Warrants will not be transferable, assignable or salable until 30 days after the completion of a Business Combination, subject to certain limited exceptions. Additionally, the Private Placement Warrants will be exercisable on a cashless basis and will be non-redeemable so long as they are held by the initial purchasers or their permitted transferees. If the Private Placement Warrants are held by someone other than the initial purchasers or their permitted transferees, the Private Placement Warrants will be redeemable by the Company and exercisable by such holders on the same basis as the Public Warrants.

Representative Shares

The Company issued 300,000 shares of Class A common stock (the “Representative Shares”) to the designees of EarlyBirdCapital for an aggregate purchase price of $870. The Company accounted for the Representative Shares as an offering cost of the Initial Public Offering, with a corresponding credit to stockholders’ equity. The Company estimated the fair value of the Representative Shares to be $3,000,000, based upon the price of the Units sold in the Initial Public Offering. The holders of the Representative Shares have agreed not to transfer, assign or sell any such shares until the completion of a Business Combination. In addition, the holders have agreed (i) to waive their conversion rights (or right to participate in any tender offer) with respect to such shares in connection with the completion of a Business Combination and (ii) to waive their rights to liquidating distributions from the Trust Account with respect to such shares if the Company fails to complete a Business Combination within the Combination Period.

The Representative Shares have been deemed compensation by FINRA and are therefore subject to a lock-up for a period of 180 days immediately following the effective date of the registration statement related to the Initial Public Offering pursuant to Rule 5110(e)(1) of FINRA’s NASD Conduct Rules. Pursuant to FINRA Rule 5110(e)(1), these securities will not be the subject of any hedging, short sale, derivative, put or call transaction that would result in the economic disposition of the securities by any person for a period of 180 days immediately following the effective date of the registration statements related to the Initial Public Offering, nor may they be sold, transferred, assigned, pledged or hypothecated for a period of 180 days immediately following the effective date of the registration statements related to the Initial Public Offering except to any underwriter and selected dealer participating in the Initial Public Offering and their bona fide officers or partners.

NOTE 10. FAIR VALUE MEASUREMENTS

The Company follows the guidance in ASC 820 for its financial assets and liabilities that are re-measured and reported at fair value at each reporting period, and non-financial assets and liabilities that are re-measured and reported at fair value at least annually.

The fair value of the Company’s financial assets and liabilities reflects management’s estimate of amounts that the Company would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and liabilities:

Level 1:Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis.
Level 2:Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active.
Level 3:Unobservable inputs based on our assessment of the assumptions that market participants would use in pricing the asset or liability.

18

Table of Contents

PROPERTY SOLUTIONS ACQUISITION CORP. II

NOTES TO CONDENSED FINANCIAL STATEMENTS

SEPTEMBER 30, 2022

(UNAUDITED)

The following table presents information about the Company’s assets that are measured at fair value on a recurring basis at September 30, 2022, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value:

    

    

September 30, 

    

December 31,

Description

Level

 

2022

 

2021

Assets:

 

  

 

  

 

  

Marketable securities held in Trust Account

 

1

$

318,684,239

$

317,025,510

Liabilities:

 

  

 

  

 

  

Warrant Liability - Private Placement Warrants

3

$

12,585

$

119,375

Warrant Liability - Public Warrants

 

1

$

475,500

$

4,510,337

The Public Warrants and Private Placement Warrants were accounted for as liabilities in accordance with ASC 815-40 and are presented within warrant liabilities on our accompanying September 30, 2022 and December 31, 2021 condensed balance sheets. The warrant liabilities are measured at fair value at inception and on a recurring basis, with changes in fair value presented within change in fair value of warrant liabilities in the condensed statements of operations.

Initial Measurement

The Company established the initial fair value for the Public and Private Placement Warrants on March 8, 2021, the date of the Company’s Initial Public Offering, using a binomial lattice model. The Company allocated the proceeds received from (i) the sale of Units (which is inclusive of one share of Class A common stock and one-fourth of one Public Warrant), (ii) the sale of Private Placement Warrants, and (iii) the issuance of Class B common stock, first to the Warrants based on their fair values as determined at initial measurement, with the remaining proceeds allocated to Class A common stock subject to possible redemption, Class A common stock and Class B common stock based on their relative fair values at the initial measurement date. The warrants were classified as Level 3 at the initial measurement date due to the use of unobservable inputs.

Subsequent Measurement

The warrants are measured at fair value on a recurring basis. The subsequent measurement of the Public Warrants as of September 30, 2022 is classified as Level 1 due to the use of an observable market quote in an active market. The subsequent measurement of the Private Placement Warrants was calculated using a Black Scholes model which is considered a Level 3 measurement.

The key inputs into the binomial lattice model for the Private Placement Warrants were as follows at September 30, 2022 and December 31, 2021:

September 30, 

December 31, 

Input

    

2022

    

2021

Risk-free interest rate

 

4.12

%

1.19

%

Effective expiration date

 

06/06/2024

7/23/2026

Dividend yield

0.00

%

 

0.00

%

Expected volatility

6.4

%

 

12.1

%

Exercise price

$

11.50

$

11.50

Unit Price

$

9.81

$

9.71

As of September 30, 2022 and December 31, 2021, the aggregate values of the Private Placement Warrants were $0.01 million and $0.12 million, respectively.

19

Table of Contents

PROPERTY SOLUTIONS ACQUISITION CORP. II

NOTES TO CONDENSED FINANCIAL STATEMENTS

SEPTEMBER 30, 2022

(UNAUDITED)

The following table presents the changes in the fair value of Level 3 warrant liabilities for the three months and nine months ended September 30, 2022:

    

Private Placement 

Warrant Liability

Fair value as of December 31, 2021

$

119,375

Change in fair value

 

(50,471)

Fair value as of March 31, 2022

68,904

Change in fair value

(54,221)

Fair value as of June 30, 2022

14,683

Change in fair value

(2,098)

Fair value as of September 30, 2022

$

12,585

The following table presents the changes in the fair value of Level 3 warrant liabilities for the three months and nine months ended September 30, 2021:

Private Placement

Public

    

Warrant Liability

    

Warrant Liability

Fair value as of January 1, 2021

$

$

Issuance of warrants on March 8, 2021 (IPO)

 

179,113

 

6,675,000

Issuance of warrants on March 12, 2021 (Over Allotment)

 

7,565

 

378,250

Change in fair value

 

(12,585)

 

(475,500)

Fair value as of March 31, 2021

174,903

6,577,750

Change in fair value

79,705

3,011,500

Transfer from Level 3 to Level 1

(9,589,250)

Fair value as of June 30, 2021

253,798

Change in fair value

(109,070)

Fair value as of September 30, 2021

$

144,728

$

Transfers to/from Levels 1, 2 and 3 are recognized at the end of the reporting period in which a change in valuation technique or methodology occurs. For the three and nine months ended September 30, 2022, there were no transfers from Level 3 measurements. The estimated fair value of the Public Warrants transferred from a Level 3 measurement to a Level 1 fair value measurement during the three and nine months ended September 30, 2021 was $9,589,250.

NOTE 11. SUBSEQUENT EVENTS

The Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the condensed financial statements were issued. Based upon this review, the Company did not identify any subsequent events that would have required adjustment or disclosure in the condensed financial statements.

20

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

References in this report (the “Quarterly Report”) to “we,” “us” or the “Company” refer to Property Solutions Acquisition Corp. II. References to our “management” or our “management team” refer to our officers and directors, and references to the “Sponsor” refer to Property Solutions Acquisition Sponsor II, LLC. The following discussion and analysis of the Company’s financial condition and results of operations should be read in conjunction with the financial statements and the notes thereto contained elsewhere in this Quarterly Report. Certain information contained in the discussion and analysis set forth below includes forward-looking statements that involve risks and uncertainties.

Special Note Regarding Forward-Looking Statements

This Quarterly Report includes “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Exchange Act that are not historical facts and involve risks and uncertainties that could cause actual results to differ materially from those expected and projected. All statements, other than statements of historical fact included in this Form 10-Q including, without limitation, statements in this “Management’s Discussion and Analysis of Financial Condition and Results of Operations” regarding the completion of the Proposed Business Combination (as defined below), the Company’s financial position, business strategy and the plans and objectives of management for future operations, are forward-looking statements. Words such as “expect,” “believe,” “anticipate,” “intend,” “estimate,” “seek” and variations and similar words and expressions are intended to identify such forward-looking statements. Such forward-looking statements relate to future events or future performance, but reflect management’s current beliefs, based on information currently available. A number of factors could cause actual events, performance or results to differ materially from the events, performance and results discussed in the forward-looking statements, including that the conditions of the Proposed Business Combination are not satisfied. For information identifying important factors that could cause actual results to differ materially from those anticipated in the forward-looking statements, please refer to the Risk Factors section of the Company’s Annual Report on Form 10-K filed with the U.S. Securities and Exchange Commission (the “SEC”). The Company’s securities filings can be accessed on the EDGAR section of the SEC’s website at www.sec.gov. Except as expressly required by applicable securities law, the Company disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise.

This Management’s Discussion and Analysis of Financial Condition and Results of Operations has been amended and restated to give effect to the restatement of our financial statements as of December 31, 2020, March 31, 2021, and June 30, 2021. Management identified errors made in its historical financial statements where, at the closing of our Initial Public Offering, we improperly valued our Class A common stock subject to possible redemption. We previously determined the Class A common stock subject to possible redemption to be equal to the redemption value of $10.00 per share of Class A common stock while also taking into consideration a redemption cannot result in net tangible assets being less than $5,000,001. Management determined that the Class A common stock issued during the Initial Public Offering can be redeemed or become redeemable subject to the occurrence of future events considered outside of the Company’s control. Therefore, management concluded that the redemption value should include all Class A common stock subject to possible redemption, resulting in the Class A common stock subject to possible redemption being equal to their redemption value. As a result, management has noted a reclassification error related to temporary equity and permanent equity. This resulted in a restatement to the initial carrying value of the Class A common stock subject to possible redemption with the offset recorded to additional paid-in capital (to the extent available), accumulated deficit and Class A common stock.

Overview

We are a blank check company formed under the laws of the State of Delaware on October 29, 2020 for the purpose of effecting a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or other similar business combination with one or more businesses or entities. We intend to effectuate our Business Combination using cash from the proceeds of the Initial Public Offering and the sale of the Private Placement Units, our capital stock, debt or a combination of cash, stock and debt.

We expect to continue to incur significant costs in the pursuit of our acquisition plans. We cannot assure you that our plans to complete a Business Combination will be successful.

21

Results of Operations

We have neither engaged in any operations nor generated any revenues to date. Our only activities from October 29, 2020 (inception) through September 30, 2022 were organizational activities, those necessary to prepare for the Initial Public Offering, described below,and identifying a target company for a Business Combination. We do not expect to generate any operating revenues until after the completion of our Business Combination. We generate non-operating income in the form of interest income on marketable securities held in the Trust Account. We incur expenses as a result of being a public company (for legal, financial reporting, accounting and auditing compliance), as well as for due diligence expenses.

For the three months ended September 30, 2022, we had a net income of $1,129,733, which consists of change in fair value of warrant liability of $81,348, interest earned on marketable securities held in Trust Account of $1,297,528 and unrealized gain on marketable securities held in the Trust Account of $181,283, offset by a provision for income taxes of $203,138 and operating costs of $227,288.

For the nine months ended September 30, 2022, we had a net income of $4,847,950, which consists of change in fair value of warrant liability of $4,141,627, interest earned on marketable securities held in Trust Account of $1,973,888 and unrealized gain on marketable securities held in the Trust Account of $26,659, offset by a provision for income taxes of $355,835 and operating costs of $938,389.

For the three months ended September 30, 2021, we had a net income of $3,921,124, which consists of change in fair value of warrant liability of $4,230,070 and interest earned on marketable securities held in Trust Account of $4,080, offset by operating costs of $313,026.

For the nine months ended September 30, 2021, we had a net income of $753,110, which consists of change in fair value of warrant liability of $1,626,950 and interest earned on marketable securities held in Trust Account of $20,391, offset by transaction related to warrant liability of $402,827, representative share transaction costs of $68,476, change in fair value of over-allotment liability of $196,475 and operating cost of $619,403.

Liquidity and Capital Resources

On March 8, 2021, we consummated the Initial Public Offering of 30,000,000 Units at $10.00 per Unit, generating gross proceeds of $300,000,000. Simultaneously with the closing of the Initial Public Offering, we consummated the sale of 805,000 Private Placement Units at a price of $10.00 per Private Placement Unit in a private placement to the Sponsor and EarlyBirdCapital, generating gross proceeds of $8,050,000.

On March 12, 2021, the underwriters partially exercised their over-allotment option, resulting in an additional 1,700,000 Units issued for an aggregate amount of $17,000,000. In connection with the underwriters’ partial exercise of their over-allotment option, the Company also consummated the sale of an additional 34,000 Private Placement Units at $10.00 per Private Placement Units, generating total proceeds of $340,000.

Following the Initial Public Offering, the partial exercise of the over-allotment option, and the sale of the Private Placement Units, total of $17,000,000 was deposited into the Trust Account. We incurred $18,140,741 in Initial Public Offering related costs, including $6,340,000 of cash underwriting fees, 11,095,000 of deferred underwriting fees and $705,741 of other offering costs.

For the nine months ended September 30, 2022, cash used in operating activities was $863,220. Net income of $4,847,950 was affected by a change in fair value of warrant liability of $4,141,627 and interest earned on marketable securities held in the Trust Account of $1,973,888, and unrealized loss on marketable securities held in Trust Account of $26,659. Changes in operating assets and liabilities provided $431,004 of cash for operating activities.

For the nine months ended September 30, 2021, cash used in operating activities was $739,037. Net income of $753,110 was affected by transaction costs allocated to warrants of $402,827, change in fair value of warrant liability of $1,626,950, representative share transaction costs of $68,476, change in fair value of over-allotment liability of $196,475 and interest earned on marketable securities held in the Trust Account of $20,391. Changes in operating assets and liabilities used $119,634 of cash for operating activities.

As of September 30, 2022, we had marketable securities held in the Trust Account of $318,684,239 (including approximately $1,684,239 of interest income and net unrealized loss) consisting of U.S. Treasury Bills with a maturity of 185 days or less. Interest income on the

22

balance in the Trust Account may be used by us to pay taxes. Through September 30, 2022, we have withdrawn an amount of $341,818 under interest earned from the Trust Account to pay income tax obligations.

We intend to use substantially all of the funds held in the Trust Account, including any amounts representing interest earned on the Trust Account (less income taxes payable), to complete our Business Combination. To the extent that our capital stock or debt is used, in whole or in part, as consideration to complete our Business Combination, the remaining proceeds held in the Trust Account will be used as working capital to finance the operations of the target business or businesses, make other acquisitions and pursue our growth strategies.

As of September 30, 2022, we had cash of $10,582. We intend to use the funds held outside the Trust Account primarily to identify and evaluate target businesses, perform business due diligence on prospective target businesses, travel to and from the offices, plants or similar locations of prospective target businesses or their representatives or owners, review corporate documents and material agreements of prospective target businesses, and structure, negotiate and complete a Business Combination.

In order to fund working capital deficiencies or finance transaction costs in connection with a Business Combination, the Sponsor, or certain of our officers and directors or their affiliates may, but are not obligated to, loan us funds as may be required. If we complete a Business Combination, we would repay such loaned amounts. In the event that a Business Combination does not close, we may use a portion of the working capital held outside the Trust Account to repay such loaned amounts but no proceeds from our Trust Account would be used for such repayment. Up to $1,500,000 of such loans may be convertible into units at a price of $10.00 per unit, at the option of the lender. The units would be identical to the Private Placement Units.

Going Concern

We have until March 8, 2023 to consummate an initial business combination. It is uncertain that we will have sufficient liquidity to fund the working capital needs of the Company until the liquidation date and/or through twelve months from the issuance of this report. Additionally, it is uncertain that we will be able to consummate an initial business combination by this time. The Company may not have sufficient liquidity to fund the working capital needs of the Company until March 8, 2023, the liquidation date, and/or through twelve months from the issuance of this report. If an initial business combination is not consummated by the liquidation date, there will be a mandatory liquidation and subsequent dissolution. Management has determined that the mandatory liquidation, should an initial business combination not occur, and potential subsequent dissolution raises substantial doubt about our ability to continue as a going concern. No adjustments have been made to the carrying amounts of assets or liabilities should we be required to liquidate after March 8, 2023.

Off-Balance Sheet Arrangements

We have no obligations, assets or liabilities, which would be considered off-balance sheet arrangements as of September 30, 2022. We do not participate in transactions that create relationships with unconsolidated entities or financial partnerships, often referred to as variable interest entities, which would have been established for the purpose of facilitating off-balance sheet arrangements. We have not entered into any off-balance sheet financing arrangements, established any special purpose entities, guaranteed any debt or commitments of other entities, or purchased any non-financial assets.

Contractual Obligations

We do not have any long-term debt, capital lease obligations, operating lease obligations or long-term liabilities, other than an agreement to pay an affiliate of the Company’s executive officers a total of $10,000 per month for office space and general and administrative services. We began incurring these fees on March 3, 2021 and will continue to incur these fees monthly until the earlier of the completion of the Business Combination and our liquidation.

The underwriters are entitled to a deferred fee of $0.35 per Unit, or $11,095,000 in the aggregate. The deferred fee will become payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement.

23

Critical Accounting Policies

The preparation of condensed financial statements and related disclosures in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and income and expenses during the periods reported. Actual results could materially differ from those estimates. We have identified the following critical accounting policies:

Warrant Liability

The Company accounts for the warrants in accordance with the guidance contained in ASC 815-40 under which the warrants do not meet the criteria for equity treatment and must be recorded as liabilities. Accordingly, the Company classifies the warrants as liabilities at their fair value and adjust the Private Placement Warrants to fair value at each reporting period. This liability is subject to re-measurement at each balance sheet date until exercised, and any change in fair value is recognized in our statements of operations. The warrants are valued using a binomial lattice model.

Common Stock Subject to Possible Redemption

We account for our common stock subject to possible conversion in accordance with the guidance in Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” Common stock subject to mandatory redemption is classified as a liability instrument and measured at fair value. Conditionally redeemable common stock (including common stock that features redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within our control) is classified as temporary equity. At all other times, common stock is classified as stockholders’ equity. Our common stock features certain redemption rights that are considered to be outside of our control and subject to occurrence of uncertain future events. Accordingly, common stock subject to possible redemption is presented at redemption value as temporary equity, outside of the stockholders’ equity section of our condensed balance sheets.

Net Income (Loss) Per Common Share

Net income (loss) per common stock is computed by dividing net income (loss) by the weighted average number of common stock outstanding for the period. The Company applies the two-class method in calculating earnings per share. Accretion associated with the redeemable shares of Class A common stock is excluded from earnings per share as the redemption value approximates fair value.

Recent Accounting Standards

In August 2020, the FASB issued Accounting Standards Update (“ASU”) No. 2020-06, Debt –debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging – Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity (“ASU 2020-06”), which simplifies accounting for convertible instruments by removing major separation models required under current U.S. GAAP. The ASU also removes certain settlement conditions that are required for equity-linked contracts to qualify for the derivative scope exception, and it simplifies the diluted earnings per share calculation in certain areas. We adopted ASU 2020-06 in January 2022. Adoption of the ASU did not impact our financial position, results of operations or cash flows.

We do not believe that there are any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on our condensed financial statements.

Item 3. Quantitative and Qualitative Disclosures About Market Risk

Not required for smaller reporting companies.

24

Item 4. Controls and Procedures

Evaluation of Disclosure Controls and Procedures

Disclosure controls and procedures are designed to ensure that information required to be disclosed by us in our Exchange Act reports is recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our principal executive officer and principal financial officer or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.

As required by Rules 13a-15 and 15d-15 under the Exchange Act, our Chief Executive Officer and Chief Financial Officer carried out an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures as of September 30, 2022. Based on this evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that our disclosure controls and procedures were not effective, due to the material weakness in our internal control over financial reporting related to the Company’s accounting for complex financial instruments and accounting for accruals. As a result, we performed additional analysis as deemed necessary to ensure that our financial statements were prepared in accordance with U.S. generally accepted accounting principles. Accordingly, management believes that the financial statements included in this Form 10-Q present fairly in all material respects our financial position, results of operations and cash flows for the period presented.

Management intends to implement remediation steps to improve our disclosure controls and procedures and our internal control over financial reporting. Specifically, we intend to expand and improve our review process for complex securities, related accounting standards and accounting for accruals. We have improved this process by enhancing access to accounting literature, identification of third-party professionals with whom to consult regarding complex accounting applications and consideration of additional staff with the requisite experience and training to supplement existing accounting professionals.

Changes in Internal Control over Financial Reporting

There were no changes in our internal control over financial reporting (as such term is defined in Rules 13a-15(f) and 15d-15(f) of the Exchange Act) during the most recent fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

25

PART II - OTHER INFORMATION

Item 1. Legal Proceedings.

None.

Item 1A. Risk Factors.

Factors that could cause our actual results to differ materially from those in this report include the risk factors described in our Annual Report on Form 10-K filed with the SEC on April 18, 2022 and the risk factors set forth below. Any of these factors could result in a significant or material adverse effect on our results of operations or financial condition. Additional risk factors not currently known to us or that we currently deem immaterial may also impair our business or results of operations. You should review the risk factors below for a discussion of important factors that could cause actual results to differ materially from the results described in or implied by the forward-looking statements contained in this Report. We may disclose changes to such factors or disclose additional factors from time to time in our future filings with the SEC.

Risks Related to Our Business and Financial Position

Changes in laws or regulations or in how such laws or regulations are interpreted or applied, or a failure to comply with any laws, regulations, interpretations or applications, may adversely affect our business, including our ability to negotiate and complete our initial business combination.

On March 30, 2022, the SEC issued proposed rules relating to, among other items, disclosures in business combination transactions involving SPACs and private operating companies; the financial statement requirements applicable to transactions involving shell companies; the use of projections in SEC filings in connection with proposed business combination transactions; the potential liability of certain participants in proposed business combination transactions; and the extent to which SPACs could become subject to regulation under the Investment Company Act of 1940, as amended, including a proposed rule that would provide SPACs a safe harbor from treatment as an investment company if they satisfy certain conditions that limit a SPAC’s duration, asset composition, business purpose and activities. These rules, if adopted, whether in the form proposed or in a revised form, may increase the costs of and the time needed to negotiate and complete an initial business combination, and may constrain the circumstances under which we could complete an initial business combination.

We may be subject to the Excise Tax included in the Inflation Reduction Act of 2022 in connection with redemptions of our common stock after December 31, 2022.

On August 16, 2022, President Biden signed into law the Inflation Reduction Act of 2022 (H.R. 5376) (the “IRA”), which among other things, beginning in 2023, will impose a 1% excise tax on any domestic corporation that repurchases or buybacks public company stock after December 31, 2022 (the “Excise Tax”). The company is assessing the potential impact of the Act.

The total taxable value of shares repurchased is reduced by the fair market value of and newly issued shares during the taxable year. Because we are a Delaware corporation and our securities trade on Nasdaq, we may be deemed a “covered corporation” within the meaning of the IRA. Redemption rights are ubiquitous to nearly all SPACs. Shareholders have the ability to require the SPAC to repurchase their shares prior to the merger in what is known as a redemption right, essentially getting their money back. There are two possible scenarios in which redemption rights come into play. First, they can be exercised by the shareholders themselves because they are exiting the transaction, or second, they can be triggered because the SPAC did not find a target with which to merge. While not free from doubt, absent any further guidance from Congress, the Excise Tax may apply to any redemptions of our common stock after December 31, 2022, including redemptions in connection with an initial business combination, unless an exemption is available. Issuances of securities in connection with our initial business combination transaction (including any PIPE transaction at the time of our initial business combination) are expected to reduce the amount of the Excise Tax in connection with redemptions occurring in the same calendar year, but the number of securities redeemed may exceed the number of securities issued. Moreover, the fair market value of any stock redeemed may exceed the fair market value of any stock issued. Consequently, Excise Tax may reduce the amount of cash we have available to complete a business combination and may make a transaction with us less appealing to potential business combination targets. Further, the application of the Excise Tax in the event of a liquidation is uncertain. The Company will continue to assess the potential impact of the IR Act and the impact on SPACs.

26

Risks Related to Our Proposed Initial Business Combination

We may hold all funds in the Trust Account in cash until the earlier of consummation of our initial business combination or liquidation.

With respect to the regulation of special purpose acquisition companies like the Company (“SPACs”), on March 30, 2022, the SEC issued proposed rules (the “SPAC Rule Proposals”) relating to, among other items, disclosures in business combination transactions involving SPACs and private operating companies; the condensed financial statement requirements applicable to transactions involving shell companies; the use of projections by SPACs in SEC filings in connection with proposed business combination transactions; the potential liability of certain participants in proposed business combination transactions; and the extent to which SPACs could become subject to regulation under the Investment Company Act of 1940, as amended (the “Investment Company Act”), including a proposed rule that would provide SPACs a safe harbor from treatment as an investment company if they satisfy certain conditions that limit a SPAC’s duration, asset composition, business purpose and activities.

The funds in the Trust Account have, since our IPO, been held only in U.S. government treasury obligations with a maturity of 185 days or less or in money market funds investing solely in U.S. government treasury obligations and meeting certain conditions under Rule 2a-7 under the Investment Company Act. However, to mitigate the risk of us being deemed to have been operating as an unregistered investment company (including under the subjective test of Section 3(a)(1)(A) of the Investment Company Act), we may, and likely will, on or prior to the 24-month anniversary of the effective date of the registration statement filed in connection with our IPO (the “IPO Registration Statement”), should our Company continue to exist to such date, instruct Continental, the trustee with respect to the Trust Account, to liquidate the U.S. government treasury obligations or money market funds held in the Trust Account and thereafter to hold all funds in the Trust Account in cash until the earlier of consummation of our initial business combination or liquidation. As a result, following such liquidation, we will likely receive minimal interest, if any, on the funds held in the Trust Account, which would reduce the dollar amount our public shareholders would receive upon any redemption or liquidation of the Company.

General Risk Factors

The current economic downturn may lead to increased difficulty in completing our initial business combination.

Our ability to consummate our initial business combination may depend, in part, on worldwide economic conditions. In recent months, we have observed increased economic uncertainty in the United States and abroad. Impacts of such economic weakness include:

falling overall demand for goods and services, leading to reduced profitability;
reduced credit availability;
higher borrowing costs;
reduced liquidity;
volatility in credit, equity and foreign exchange markets; and
bankruptcies.

These developments could lead to inflation, higher interest rates, and uncertainty about business continuity, which may adversely affect the business of our potential target businesses and create difficulties in obtaining debt or equity financing for our initial business combination, as well as leading to an increase in the number of public stockholders exercising redemption rights in connection therewith.

Recent volatility in capital markets and lower market prices for our securities may affect our ability to obtain financing for our initial business combination through sales of shares of our common stock or issuance of indebtedness.

With uncertainty in the capital markets and other factors, financing for our initial business combination may not be available on terms favorable to us or at all. If we raise additional funds through further issuances of equity or convertible debt securities, our existing stockholders could suffer significant dilution, and any new equity securities we issue could have rights, preferences, and privileges

27

superior to those of holders of our common stock. Any debt financing secured by us could involve additional restrictive covenants relating to our capital-raising activities and other financial and operational matters, which may limit the operations and growth of the surviving company of our initial business combination. If we are unable to obtain adequate financing or financing on terms satisfactory to us, we could face significant limitations on our ability to complete our initial business combination.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

None.

Item 3. Defaults Upon Senior Securities.

None.

Item 4. Mine Safety Disclosures.

None.

Item 5. Other Information.

None.

Item 6. Exhibits.

The following exhibits are filed as part of, or incorporated by reference into, this Quarterly Report on Form 10-Q.

No.

   

Description of Exhibit

31.1*

Certification of Principal Executive Officer Pursuant to Securities Exchange Act Rules 13a-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

31.2*

Certification of Principal Financial Officer Pursuant to Securities Exchange Act Rules 13a-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

32.1**

Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

32.2**

Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

101.INS*

Inline XBRL Instance Document.

101.SCH*

Inline XBRL Taxonomy Extension Schema Document.

101.CAL*

Inline XBRL Taxonomy Extension Calculation Linkbase Document.

101.DEF*

Inline XBRL Taxonomy Extension Definition Linkbase Document.

101.LAB*

Inline XBRL Taxonomy Extension Labels Linkbase Document.

101.PRE*

Inline XBRL Taxonomy Extension Presentation Linkbase Document.

104

Cover Page Data File (the cover page XBRL tags are embedded within the iXBRL document).

*

Filed herewith.

**

Furnished herewith.

28

SIGNATURES

In accordance with the requirements of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

    

PROPERTY SOLUTIONS ACQUISITION CORP. II

 

 

 

Date: November 18, 2022

By:

/s/ Jordan Vogel

 

Name:

Jordan Vogel

 

Title:

Co-Chief Executive Officer

 

 

(Principal Executive Officer)

 

 

 

Date: November 18, 2022

By:

/s/ Aaron Feldman

 

Name:

Aaron Feldman

 

Title:

Co-Chief Executive Officer

 

 

(Principal Financial and Accounting Officer)

29

EX-31.1 2 psagu-20220930xex31d1.htm EXHIBIT 31.1

EXHIBIT 31.1

CERTIFICATION OF CHIEF EXECUTIVE OFFICER

PURSUANT TO RULE 13A-14(A) UNDER THE SECURITIES EXCHANGE ACT OF 1934,

AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Jordan Vogel, certify that:

1.

I have reviewed this Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2022 of Property Solutions Acquisition Corp. II;

2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.

The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under my supervision, to ensure that material information relating to the registrant, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b)

(Paragraph omitted pursuant to Exchange Act Rules 13a-14(a) and 15d-15(a));

c)

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report my conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d)

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting.

5.

The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

10

Date: November 18, 2022

/s/ Jordan Vogel

Jordan Vogel

Co-Chief Executive Officer

(Principal Executive Officer)


EX-31.2 3 psagu-20220930xex31d2.htm EXHIBIT 31.2

EXHIBIT 31.2

CERTIFICATION OF CHIEF FINANCIAL OFFICER

PURSUANT TO RULE 13A-14(A) UNDER THE SECURITIES EXCHANGE ACT OF 1934,

AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Aaron Feldman, certify that:

1.

I have reviewed this Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2022 of Property Solutions Acquisition Corp. II;

2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.

The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under my supervision, to ensure that material information relating to the registrant, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b)

(Paragraph omitted pursuant to Exchange Act Rules 13a-14(a) and 15d-15(a));

c)

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report my conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d)

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting.

5.

The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: November 18, 2022

/s/ Aaron Feldman

Aaron Feldman

Co-Chief Executive Officer

(Principal Financial and Accounting Officer)


EX-32.1 4 psagu-20220930xex32d1.htm EXHIBIT 32.1

EXHIBIT 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Property Solutions Acquisition Corp. II (the “Company”) on Form 10-Q for the quarterly period ended September 30, 2022, as filed with the Securities and Exchange Commission (the “Report”), I, Jordan Vogel, Co-Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge:

1.

The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2.

The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

10

Dated: November 18, 2022

/s/ Jordan Vogel

Jordan Vogel

Co-Chief Executive Officer

(Principal Executive Officer)


EX-32.2 5 psagu-20220930xex32d2.htm EXHIBIT 32.2

EXHIBIT 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Property Solutions Acquisition Corp. II (the “Company”) on Form 10-Q for the quarterly period ended September 30, 2022, as filed with the Securities and Exchange Commission (the “Report”), I, Aaron Feldman, Co-Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge:

1.

The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2.

The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Dated: November 18, 2022

/s/ Aaron Feldman

Aaron Feldman

Co-Chief Executive Officer

(Principal Financial and Accounting Officer)


EX-101.SCH 6 psagu-20220930.xsd XBRL TAXONOMY EXTENSION SCHEMA 99900 - Disclosure - Standard And Custom Axis Domain Defaults link:presentationLink link:calculationLink link:definitionLink 00100 - Statement - CONDENSED BALANCE SHEETS link:presentationLink link:calculationLink link:definitionLink 00200 - Statement - CONDENSED STATEMENTS OF OPERATIONS link:presentationLink link:calculationLink link:definitionLink 00400 - Statement - CONDENSED STATEMENTS OF CASH FLOWS link:presentationLink link:calculationLink link:definitionLink 40101 - Disclosure - DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS (Details) link:presentationLink link:calculationLink link:definitionLink 00090 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 00105 - Statement - CONDENSED BALANCE SHEETS (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00300 - Statement - CONDENSED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT link:presentationLink link:calculationLink link:definitionLink 00305 - Statement - CONDENSED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 40201 - Disclosure - REVISION OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS - Schedule of impact of revision on financial statements (Details) link:presentationLink link:calculationLink link:definitionLink 40301 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) link:presentationLink link:calculationLink link:definitionLink 40302 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Class A common stock reflected in the balance sheet (Details) link:presentationLink link:calculationLink link:definitionLink 40303 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Schedule of calculation of basic and diluted net income (loss) per common share (Details) link:presentationLink link:calculationLink link:definitionLink 40401 - Disclosure - PUBLIC OFFERING (Details) link:presentationLink link:calculationLink link:definitionLink 40501 - Disclosure - PRIVATE PLACEMENT (Details) link:presentationLink link:calculationLink link:definitionLink 40601 - Disclosure - RELATED PARTY TRANSACTIONS - Founder Shares (Details) link:presentationLink link:calculationLink link:definitionLink 40602 - Disclosure - RELATED PARTY TRANSACTIONS (Details) link:presentationLink link:calculationLink link:definitionLink 40701 - Disclosure - COMMITMENTS (Details) link:presentationLink link:calculationLink link:definitionLink 40802 - Disclosure - STOCKHOLDERS' DEFICIT - Common Stock (Details) link:presentationLink link:calculationLink link:definitionLink 40901 - Disclosure - WARRANTS (Details) link:presentationLink link:calculationLink link:definitionLink 41001 - Disclosure - FAIR VALUE MEASUREMENTS (Details) link:presentationLink link:calculationLink link:definitionLink 41002 - Disclosure - FAIR VALUE MEASUREMENTS - Initial and subsequent measurement of key inputs for Warrants (Details) link:presentationLink link:calculationLink link:definitionLink 41003 - Disclosure - FAIR VALUE MEASUREMENTS - Change in the Fair Value of the Warrant Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 41004 - Disclosure - FAIR VALUE MEASUREMENTS - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 10101 - Disclosure - DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS link:presentationLink link:calculationLink link:definitionLink 10201 - Disclosure - REVISION OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS link:presentationLink link:calculationLink link:definitionLink 10301 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES link:presentationLink link:calculationLink link:definitionLink 10401 - Disclosure - PUBLIC OFFERING link:presentationLink link:calculationLink link:definitionLink 10501 - Disclosure - PRIVATE PLACEMENT link:presentationLink link:calculationLink link:definitionLink 10601 - Disclosure - RELATED PARTY TRANSACTIONS link:presentationLink link:calculationLink link:definitionLink 10701 - Disclosure - COMMITMENTS link:presentationLink link:calculationLink link:definitionLink 10801 - Disclosure - STOCKHOLDERS' DEFICIT link:presentationLink link:calculationLink link:definitionLink 10901 - Disclosure - WARRANTS link:presentationLink link:calculationLink link:definitionLink 11001 - Disclosure - FAIR VALUE MEASUREMENTS link:presentationLink link:calculationLink link:definitionLink 11101 - Disclosure - SUBSEQUENT EVENTS link:presentationLink link:calculationLink link:definitionLink 20302 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) link:presentationLink link:calculationLink link:definitionLink 30203 - Disclosure - REVISION OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS (Tables) link:presentationLink link:calculationLink link:definitionLink 30303 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) link:presentationLink link:calculationLink link:definitionLink 31003 - Disclosure - FAIR VALUE MEASUREMENTS (Tables) link:presentationLink link:calculationLink link:definitionLink 40801 - Disclosure - STOCKHOLDERS' DEFICIT - Preferred Stock (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 7 psagu-20220930_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.DEF 8 psagu-20220930_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 9 psagu-20220930_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE EX-101.PRE 10 psagu-20220930_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 11 R1.htm IDEA: XBRL DOCUMENT v3.22.2.2
Document and Entity Information - shares
9 Months Ended
Sep. 30, 2022
Nov. 18, 2022
Document Information [Line Items]    
Document Type 10-Q  
Document Quarterly Report true  
Document Transition Report false  
Document Period End Date Sep. 30, 2022  
Document Fiscal Year Focus 2022  
Entity File Number 001-40087  
Entity Registrant Name PROPERTY SOLUTIONS ACQUISITION CORP. II  
Entity Incorporation, State or Country Code DE  
Entity Tax Identification Number 85-3851769  
Entity Address, Address Line One 654 Madison Avenue, Suite 1009  
Entity Address, City or Town New York  
Entity Address State Or Province NY  
Entity Address, Postal Zip Code 10065  
City Area Code 646  
Local Phone Number 502-9845  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company true  
Entity Ex Transition Period false  
Entity Shell Company true  
Entity Central Index Key 0001833235  
Current Fiscal Year End Date --12-31  
Document Fiscal Period Focus Q3  
Amendment Flag false  
Units, each consisting of one share of Class A Common Stock and one-fourth of one Warrant    
Document Information [Line Items]    
Title of 12(b) Security Units, each consisting of one share ofClass A Common Stock, and one-fourth of one Warrant to acquire oneshare of Class A Common Stock  
Trading Symbol PSAGU  
Security Exchange Name NASDAQ  
Entity Common Stock, Shares Outstanding   3,334,749
Common Class A [Member]    
Document Information [Line Items]    
Title of 12(b) Security Class A Common Stock, par value $0.0001 per share  
Trading Symbol PSAG  
Security Exchange Name NASDAQ  
Entity Common Stock, Shares Outstanding   29,504,251
Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50    
Document Information [Line Items]    
Title of 12(b) Security Warrants, each whole Warrantexercisable for one share of Class ACommon Stock at an exercise price of $11.50  
Trading Symbol PSAGW  
Security Exchange Name NASDAQ  
Common Class B [Member]    
Document Information [Line Items]    
Entity Common Stock, Shares Outstanding   7,925,000
XML 12 R2.htm IDEA: XBRL DOCUMENT v3.22.2.2
CONDENSED BALANCE SHEETS - USD ($)
Sep. 30, 2022
Dec. 31, 2021
Current assets    
Cash $ 10,582 $ 531,984
Prepaid expenses- Short-term 105,517 209,207
Total Current Assets 116,099 741,191
Prepaid expenses- Long-term 0 34,590
Marketable securities held in Trust Account 318,684,239 317,025,510
TOTAL ASSETS 318,800,338 317,801,291
Current liabilities    
Accrued expenses 222,028 285,139
Income taxes payable 355,835 0
Total Current Liabilities 577,863 285,139
Warrant Liability 488,085 4,629,712
Deferred underwriting fee payable 11,095,000 11,095,000
Total Liabilities 11,985,498 16,009,851
Commitments
Stockholders' Deficit    
Preferred stock, $0.0001 par value; 1,000,000 shares authorized; none issued or outstanding 0 0
Additional paid-in capital 0 0
Accumulated deficit (11,700,133) (15,209,467)
Total Stockholders' Deficit (11,699,226) (15,208,560)
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT 318,800,338 317,801,291
Class A common stock subject to redemption    
Current liabilities    
Class A common stock, $0.0001 par value, subject to possible redemption, 31,700,000 shares at redemption value of approximately $10.04 and $10.00 at September 30, 2022 and December 31, 2021, respectively 318,338,616 317,000,000
Class A common stock not subject to redemption    
Stockholders' Deficit    
Common stock 114 114
Class B Common Stock    
Stockholders' Deficit    
Common stock $ 793 $ 793
XML 13 R3.htm IDEA: XBRL DOCUMENT v3.22.2.2
CONDENSED BALANCE SHEETS (Parenthetical) - $ / shares
Sep. 30, 2022
Dec. 31, 2021
Preferred stock, par value, (per share) $ 0.0001 $ 0.0001
Preferred stock, shares authorized 1,000,000 1,000,000
Preferred stock, shares issued 0 0
Preferred stock, shares outstanding 0 0
Class A Common Stock    
Common shares, par value, (per share) $ 0.0001 $ 0.0001
Common shares, shares authorized 100,000,000 100,000,000
Class A common stock subject to redemption    
Temporary Equity, Par or Stated Value Per Share $ 0.0001 $ 0.0001
Temporary equity, shares outstanding 31,700,000 31,700,000
Temporary equity, redemption value per share $ 10.04 $ 10.00
Class A common stock not subject to redemption    
Common shares, shares issued 1,139,000 1,139,000
Common shares, shares outstanding 1,139,000 1,139,000
Class B Common Stock    
Common shares, par value, (per share) $ 0.0001 $ 0.0001
Common shares, shares authorized 10,000,000 10,000,000
Common shares, shares issued 7,925,000 7,925,000
Common shares, shares outstanding 7,925,000 7,925,000
XML 14 R4.htm IDEA: XBRL DOCUMENT v3.22.2.2
CONDENSED STATEMENTS OF OPERATIONS - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Formation and operational costs $ 227,288 $ 313,026 $ 938,389 $ 619,403
Loss from operations (227,288) (313,026) (938,389) (619,403)
Other income:        
Interest earned on marketable securities held in Trust Account 1,297,528 4,080 1,973,888 20,391
Unrealized gain on marketable securities held in Trust Account 181,283 0 26,659 0
Representative Share Transaction Costs       (68,476)
Change in fair value of overallotment liability     0 196,475
Change in fair value of warrant liability 81,348 4,230,070 4,141,627 1,626,950
Transaction costs allocable to warrant liability 0 0 0 (402,827)
Total other income, net 1,560,159 4,234,150 6,142,174 1,372,513
Income before provision for income taxes 1,332,871 3,921,124 5,203,785 753,110
Provision for income taxes (203,138)   (355,835)  
Net income $ 1,129,733 $ 3,921,124 $ 4,847,950 $ 753,110
Class A Common Stock        
Other income:        
Weighted Average Number of Shares Outstanding, Basic 32,839,000 32,839,000 32,839,000 24,779,612
Weighted Average Number of Shares Outstanding, Diluted 32,839,000 32,839,000 32,839,000 24,779,612
Earnings Per Share, Basic $ 0.03 $ 0.10 $ 0.12 $ 0.02
Earnings Per Share, Diluted $ 0.03 $ 0.10 $ 0.12 $ 0.02
Class B Common Stock        
Other income:        
Weighted Average Number of Shares Outstanding, Basic 7,925,000 7,925,000 7,925,000 7,820,696
Weighted Average Number of Shares Outstanding, Diluted 7,925,000 7,925,000 7,925,000 7,820,696
Earnings Per Share, Basic $ 0.03 $ 0.10 $ 0.12 $ 0.02
Earnings Per Share, Diluted $ 0.03 $ 0.10 $ 0.12 $ 0.02
XML 15 R5.htm IDEA: XBRL DOCUMENT v3.22.2.2
CONDENSED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT - USD ($)
Class A Common Stock
Common Stock
Class B Common Stock
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Total
Balance at the beginning at Dec. 31, 2020 $ 0 $ 863 $ 24,137 $ (1,540) $ 23,460
Balance at the beginning (in shares) at Dec. 31, 2020 0 8,625,000      
Increase (Decrease) in Stockholders' Equity          
Sale of 839,000 Private Placement Units $ 84   8,203,648 0 8,203,732
Sale of 839,000 Private Placement Units (in shares) 839,000        
Issuance of Representative Shares $ 30   2,999,970 0 3,000,000
Issuance of Representative Shares (in shares) 300,000        
Forfeiture of Founder Shares   $ (70) 70 0  
Forfeiture of Founder Shares (in Shares)   (700,000)      
Remeasurement to amount subject to redemption     (11,227,825) (16,690,878) (27,918,703)
Net income (loss)     0 (396,332) (396,332)
Balance at the end at Mar. 31, 2021 $ 114 $ 793 0 (17,088,750) (17,087,843)
Balance at the end (in shares) at Mar. 31, 2021 1,139,000 7,925,000      
Balance at the beginning at Dec. 31, 2020 $ 0 $ 863 24,137 (1,540) 23,460
Balance at the beginning (in shares) at Dec. 31, 2020 0 8,625,000      
Increase (Decrease) in Stockholders' Equity          
Issuance of Representative Shares         3,000,000
Forfeiture of Founder Shares         (70)
Remeasurement to amount subject to redemption         27,918,703
Net income (loss)         753,110
Balance at the end at Sep. 30, 2021 $ 114 $ 793 0 (16,067,307) (16,066,400)
Balance at the end (in shares) at Sep. 30, 2021 1,139,000 7,925,000      
Balance at the beginning at Mar. 31, 2021 $ 114 $ 793 0 (17,088,750) (17,087,843)
Balance at the beginning (in shares) at Mar. 31, 2021 1,139,000 7,925,000      
Increase (Decrease) in Stockholders' Equity          
Net income (loss)     0 (2,899,681) (2,899,681)
Balance at the end at Jun. 30, 2021 $ 114 $ 793 0 (19,988,431) (19,987,524)
Balance at the end (in shares) at Jun. 30, 2021 1,139,000 7,925,000      
Increase (Decrease) in Stockholders' Equity          
Net income (loss)     0 3,921,124 3,921,124
Balance at the end at Sep. 30, 2021 $ 114 $ 793 $ 0 (16,067,307) (16,066,400)
Balance at the end (in shares) at Sep. 30, 2021 1,139,000 7,925,000      
Balance at the beginning at Dec. 31, 2021 $ 114 $ 793   (15,209,467) (15,208,560)
Balance at the beginning (in shares) at Dec. 31, 2021 1,139,000 7,925,000      
Increase (Decrease) in Stockholders' Equity          
Net income (loss)       1,610,657 1,610,657
Balance at the end at Mar. 31, 2022 $ 114 $ 793   (13,598,810) (13,597,903)
Balance at the end (in shares) at Mar. 31, 2022 1,139,000 7,925,000      
Balance at the beginning at Dec. 31, 2021 $ 114 $ 793   (15,209,467) (15,208,560)
Balance at the beginning (in shares) at Dec. 31, 2021 1,139,000 7,925,000      
Increase (Decrease) in Stockholders' Equity          
Issuance of Representative Shares         $ 870
Issuance of Representative Shares (in shares)         300,000
Net income (loss)         $ 4,847,950
Balance at the end at Sep. 30, 2022 $ 114 $ 793   (11,700,133) (11,699,226)
Balance at the end (in shares) at Sep. 30, 2022 1,139,000 7,925,000      
Balance at the beginning at Mar. 31, 2022 $ 114 $ 793   (13,598,810) (13,597,903)
Balance at the beginning (in shares) at Mar. 31, 2022 1,139,000 7,925,000      
Increase (Decrease) in Stockholders' Equity          
Remeasurement to amount subject to redemption       (265,640) (265,640)
Net income (loss)       2,107,560 2,107,560
Balance at the end at Jun. 30, 2022 $ 114 $ 793   (11,756,890) (11,755,983)
Balance at the end (in shares) at Jun. 30, 2022 1,139,000 7,925,000      
Increase (Decrease) in Stockholders' Equity          
Remeasurement to amount subject to redemption       (1,072,976) (1,072,976)
Net income (loss)       1,129,733 1,129,733
Balance at the end at Sep. 30, 2022 $ 114 $ 793   $ (11,700,133) $ (11,699,226)
Balance at the end (in shares) at Sep. 30, 2022 1,139,000 7,925,000      
XML 16 R6.htm IDEA: XBRL DOCUMENT v3.22.2.2
CONDENSED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT (Parenthetical)
Mar. 31, 2021
shares
Private Placement | Private Placement Warrants  
Sale of Private Placement Units (in shares) 839,000
XML 17 R7.htm IDEA: XBRL DOCUMENT v3.22.2.2
CONDENSED STATEMENTS OF CASH FLOWS - USD ($)
9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Cash Flows from Operating Activities:    
Net income $ 4,847,950 $ 753,110
Adjustments to reconcile net income to net cash used in operating activities:    
Interest earned on marketable securities held in Trust Account (1,973,888) (20,391)
Unrealized gain on marketable securities held in Trust Account (26,659) 0
Change in fair value of warrant liability (4,141,627) (1,626,950)
Change in fair value of over-allotment liability 0 (196,475)
Transaction costs allocable to representative shares 0 68,476
Transaction costs allocable to warrant liabilities 0 402,827
Changes in operating assets and liabilities:    
Prepaid expenses 138,280 (311,182)
Accrued expenses (63,111) 191,548
Income taxes payable 355,835  
Net cash used in operating activities (863,220) (739,037)
Cash Flows from Investing Activities:    
Investment of cash into Trust Account 0 (317,000,000)
Cash withdrawn from Trust Account to pay franchise and income taxes 341,818  
Net cash provided by (used in) investing activities 341,818 (317,000,000)
Cash Flows from Financing Activities:    
Proceeds from sale of Units, net of underwriting discounts paid 0 310,660,000
Proceeds from sale of Private Placement Units 0 8,390,000
Proceeds from issuance of Representative Shares 0 870
Repayment of promissory note-related party 0 (200,000)
Payment of offering costs 0 (634,441)
Net cash provided by financing activities 0 318,216,429
Net Change in Cash (521,402) 477,392
Cash - Beginning of period 531,984 165,000
Cash - End of period 10,582 642,392
Non-Cash investing and financing activities:    
Offering costs included in accrued offering costs 0 358,417
Initial classification of Public Warrants 0 7,053,250
Initial classification of Private Warrants   186,678
Initial classification of over-allotment liability   294,078
Deferred underwriting fee payable 0 11,095,000
Forfeiture of Founder Shares   (70)
Remeasurement of common stock subject to possible redemption $ 1,338,616 $ 0
XML 18 R8.htm IDEA: XBRL DOCUMENT v3.22.2.2
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS
9 Months Ended
Sep. 30, 2022
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS  
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS

NOTE 1. DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS

Property Solutions Acquisition Corp. II (the “Company”) was incorporated in Delaware on October 29, 2020. The Company is a blank check company formed for the purpose of entering into a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or other similar business combination with one or more businesses or entities (the “Business Combination”).

The Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies.

As of September 30, 2022, the Company had not commenced any operations. All activity through September 30, 2022 relates to the Company’s formation, initial public offering (“Initial Public Offering”), which is described below, and subsequent to the Initial Public Offering, identifying a target company for a Business Combination. The Company will not generate any operating revenues until after the completion of a Business Combination, at the earliest. The Company will generate non-operating income in the form of interest income from the proceeds derived from the Initial Public Offering. The Company has selected December 31 as its fiscal year end.

The registration statement for the Company’s Initial Public Offering was declared effective on March 3, 2021. On March 8, 2021, the Company consummated the Initial Public Offering of 30,000,000 units (the “Units” and, with respect to the shares of Class A common stock included in the Units sold, the “Public Shares”), at $10.00 per Unit, generating gross proceeds of $300,000,000, which is described in Note 4.

Simultaneously with the closing of the Initial Public Offering, the Company consummated the sale of 805,000 units (the “Private Placement Units”) at a price of $10.00 per Private Placement Unit in a private placement to Property Solutions Acquisition Sponsor II, LLC (the “Sponsor”) and EarlyBirdCapital, Inc. (“EarlyBirdCapital”), generating gross proceeds of $8,050,000, which is described in Note 5.

On March 12, 2021, the underwriters partially exercised their over-allotment option (see Note 4), resulting in an additional 1,700,000 Units issued for an aggregate amount of $17,000,000. In connection with the underwriters’ partial exercise of their over-allotment option, the Company also consummated the sale of an additional 34,000 Private Placement Units at $10.00 per Private Placement Unit, generating total proceeds of $340,000 (see Note 5).

Transaction costs amounted to $18,140,741, consisting of $6,340,000 of underwriting fees, $11,095,000 of deferred underwriting fees and $705,741 of other offering costs.

Following the closing of the Initial Public Offering on March 8, 2021 and the partial exercise of the underwriter’s over-allotment option on March 12, 2021, an amount of $317,000,000 ($10.00 per Unit) from the net proceeds of the sale of the Units in the Initial Public Offering and the sale of the Private Placement Units was placed in a trust account (the “Trust Account”), and are invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act of 1940, as amended (the “Investment Company Act”), with a maturity of 185 days or less, or in any open-ended investment company that holds itself out as a money market fund meeting the conditions of Rule 2a-7 of the Investment Company Act, as determined by the Company, until the earlier of: (i) the consummation of a Business Combination or (ii) the distribution of the funds in the Trust Account, as described below.

The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of the Private Placement Units, although substantially all of the net proceeds are intended to be applied generally toward completing a Business Combination. The Company must complete a Business Combination having an aggregate fair market value of at least 80% of the assets held in the Trust Account (excluding deferred underwriting commissions and taxes payable on income earned on the Trust Account) at the time of the agreement to enter into an initial Business Combination. The Company will only complete a Business Combination if the post Business Combination company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act. There is no assurance that the Company will be able to successfully complete a Business Combination.

The Company will provide its stockholders with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a stockholder meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek stockholder approval of a Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The public stockholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then in the Trust Account (initially anticipated to be $10.00 per Public Share, plus any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations). There will be no redemption rights upon the completion of a Business Combination with respect to the Company’s warrants.

The Company will proceed with a Business Combination if the Company has net tangible assets of at least $5,000,001 immediately prior to or upon such consummation of a Business Combination and, if the Company seeks stockholder approval, a majority of the shares voted are voted in favor of the Business Combination. If a stockholder vote is not required by law and the Company does not decide to hold a stockholder vote for business or other legal reasons, the Company will, pursuant to its Amended and Restated Certificate of Incorporation (the “Amended and Restated Certificate of Incorporation”), conduct the redemptions pursuant to the tender offer rules of the U.S. Securities and Exchange Commission (the “SEC”) and file tender offer documents with the SEC containing substantially the same information as would be included in a proxy statement prior to completing a Business Combination. If, however, stockholder approval of the transaction is required by law, or the Company decides to obtain stockholder approval for business or legal reasons, the Company will offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. If the Company seeks stockholder approval in connection with a Business Combination, the Sponsor and EarlyBirdCapital have agreed to vote their Founder Shares (as defined in Note 6), Representative Shares (as defined in Note 7), Private Shares (as defined in Note 5) and any Public Shares purchased during or after the Initial Public Offering (a) in favor of approving a Business Combination and (b) not to convert any shares in connection with a stockholder vote to approve a Business Combination or sell any shares to the Company in a tender offer in connection with a Business Combination. Additionally, public stockholders may elect to redeem their Public Shares, without voting, and if they do vote, irrespective of whether they vote for or against the proposed Business Combination.

The Sponsor has agreed (a) to waive its redemption rights with respect to the Founder Shares, Private Shares and Public Shares held by it in connection with the completion of a Business Combination and (b) not to propose an amendment to the Amended and Restated Certificate of Incorporation that would affect a public stockholders’ ability to convert or sell their shares to the Company in connection with a Business Combination or affect the substance or timing of the Company’s obligation to redeem 100% of its Public Shares if the Company does not complete a Business Combination, unless the Company provides the public stockholders with the opportunity to redeem their Public Shares in conjunction with any such amendment.

The Company will have until March 8, 2023 to complete a Business Combination (the “Combination Period”). If the Company is unable to complete a Business Combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account including interest earned on the funds held in the Trust Account and not previously released to the Company to pay taxes, divided by the number of then outstanding Public Shares, which redemption will completely extinguish public stockholders’ rights as stockholders (including the right to receive further liquidating distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company’s remaining stockholders and the Company’s board of directors, dissolve and liquidate, subject in each case to the Company’s obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law. There will be no redemption rights or liquidating distributions with respect to the Company’s warrants, which will expire worthless if the Company fails to complete a Business Combination within the Combination Period.

The Sponsor and EarlyBirdCapital have agreed to waive their liquidation rights with respect to the Founder Shares, Representative Shares and Private Shares if the Company fails to complete a Business Combination within the Combination Period. However, if the Sponsor or EarlyBirdCapital acquire Public Shares in or after the Initial Public Offering, such Public Shares will be entitled to liquidating distributions from the Trust Account if the Company fails to complete a Business Combination within the Combination Period. The underwriter has agreed to waive its rights to the deferred underwriting commission (see Note 7) held in the Trust Account in the event the Company does not complete a Business Combination within the Combination Period and, in such event, such amounts will be included with the funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the assets remaining available for distribution will be less than the Initial Public Offering price per Unit ($10.00).

In order to protect the amounts held in the Trust Account, the Sponsor has agreed to be liable to the Company if and to the extent any claims by a vendor for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account to below $10.00 per Public Share, except as to any claims by a third party who executed a valid and enforceable agreement with the Company waiving any right, title, interest or claim of any kind they may have in or to any monies held in the Trust Account and except as to any claims under the Company’s indemnity of the underwriters of Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers, prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account.

Liquidity and Going Concern

As of September 30, 2022, the Company had $10,582 in its operating bank accounts and working capital deficit of $76,141, when accounting for the Company’s ability to use interest income to pay towards tax liabilities.

Until the consummation of a Business Combination, the Company will be using the funds not held in the Trust Account for identifying and evaluating prospective acquisition candidates, performing due diligence on prospective target businesses, paying for travel expenditures, selecting the target business to acquire, and structuring, negotiating and consummating the Business Combination.

The Company will need to raise further additional capital through loans or additional investments from its Sponsor, stockholders, officers, directors, or third parties. In addition to the loan commitment described herein, the Company’s officers, directors and Sponsor may, but are not obligated to, loan the Company funds, from time to time or at any time, in whatever amount they deem reasonable in their sole discretion, to meet the Company’s working capital needs. Accordingly, the Company may not be able to obtain additional financing. If the Company is unable to raise additional capital, it may be required to take additional measures to conserve liquidity, which could include, but not necessarily be limited to, curtailing operations, suspending the pursuit of a potential transaction, and reducing overhead expenses. The Company cannot provide any assurance that new financing will be available to it on commercially acceptable terms, if at all. These conditions raise substantial doubt about the Company’s ability to continue as a going concern through March 8, 2023, the Company’s liquidation date, and/or through twelve months from the issuance of these financial statements. These financial statements do not include any adjustments relating to the recovery of the recorded assets or the classification of the liabilities that might be necessary should the Company be unable to continue as a going concern.

Risks and Uncertainties

Management continues to evaluate the impact of the COVID-19 pandemic and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company’s financial position and/or search for a target company, the specific impact is not readily determinable as of the date of the financial statement. The financial statement does not include any adjustments that might result from the outcome of this uncertainty.

In February 2022, the Russian Federation and Belarus commenced a military action with the country of Ukraine. As a result of this action, various nations, including the United States, have instituted economic sanctions against the Russian Federation and Belarus. Further, the impact of this action and related sanctions on the world economy are not determinable as of the date of these financial statements. The specific impact on the Company’s financial condition, results of operations, and cash flows is also not determinable as of the date of these financial statements.

Inflation Reduction Act of 2022

On August 16, 2022, the Inflation Reduction Act of 2022 (the “IR Act”) was signed into federal law. The IR Act provides for, among other things, a new U.S. federal 1% excise tax on certain repurchases of stock by publicly traded U.S. domestic corporations and certain U.S. domestic subsidiaries of publicly traded foreign corporations occurring on or after January 1, 2023. The excise tax is imposed on the repurchasing corporation itself, not its shareholders from which shares are repurchased. The amount of the excise tax is generally 1% of the fair market value of the shares repurchased at the time of the repurchase. However, for purposes of calculating the excise tax, repurchasing corporations are permitted to net the fair market value of certain new stock issuances against the fair market value of stock repurchases during the same taxable year. In addition, certain exceptions apply to the excise tax. The U.S. Department of the Treasury (the “Treasury”) has been given authority to provide regulations and other guidance to carry out and prevent the abuse or avoidance of the excise tax.

Any redemption or other repurchase that occurs after December 31, 2022, in connection with a Business Combination, extension vote or otherwise, may be subject to the excise tax. Whether and to what extent the Company would be subject to the excise tax in connection with a Business Combination, extension vote or otherwise would depend on a number of factors, including (i) the fair market value of the redemptions and repurchases in connection with the Business Combination, extension or otherwise, (ii) the structure of a Business Combination, (iii) the nature and amount of any “PIPE” or other equity issuances in connection with a Business Combination (or otherwise issued not in connection with a Business Combination but issued within the same taxable year of a Business Combination) and (iv) the content of regulations and other guidance from the Treasury. In addition, because the excise tax would be payable by the Company and not by the redeeming holder, the mechanics of any required payment of the excise tax have not been determined. The foregoing could cause a reduction in the cash available on hand to complete a Business Combination and in the Company’s ability to complete a Business Combination.

XML 19 R9.htm IDEA: XBRL DOCUMENT v3.22.2.2
REVISION OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS
9 Months Ended
Sep. 30, 2022
REVISION OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS  
REVISION OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS

NOTE 2. REVISION OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS

In connection with the preparation of the Company’s financial statements as of December 31, 2021, Management identified errors made in its historical financial statements where, at the closing of the Company’s Initial Public Offering, the Company did not record a liability related to the underwriter’s option to exercise their over-allotment. Additionally, the Company did not appropriately apply the correct equity presentation or allocation of offering costs related to the Company’s issued representative shares, furthermore, the Company has revised operating costs for the nine months ended September 30, 2021, due to a reclassification of legal expenses between quarters. These errors were recorded and presented within the financial statements as of December 31, 2021. This revision note is presenting the changes from the previously reported balances to the adjusted balances as of and for the nine months ended September 30, 2021 for comparative purposes of these condensed financial statements. These errors resulted in an adjustment to the net income.

The impact of the revision on the Company’s financial statements is reflected in the following table.

    

As Previously

    

    

Statement of Operations for the Nine Months Ended September 30, 2021

Reported

Adjustment

As Revised

Change in fair value of over-allotment liability

$

$

196,475

$

196,475

Transaction costs allocable to representative shares

$

$

(68,476)

$

(68,476)

Net Loss

$

625,111

$

127,999

$

753,110

    

As Previously

    

    

Statement of Stockholders’ Deficit for the Nine Months Ended September 30, 2021

Reported

Adjustment

As Revised

Issuance of representative shares

870

2,999,130

3,000,000

Remeasurement to amount subject to redemption

(24,791,574)

3,127,129

$

(27,918,703)

Net loss

$

625,111

$

127,999

$

753,110

    

As Previously

    

    

Statement of Cashflows for the Nine Months Ended September 30, 2021

Reported

Adjustment

As Revised

Change in fair value of over-allotment liability

$

$

(196,475)

$

(196,475)

Transaction costs allocable to representative shares

$

$

68,476

$

68,476

Net loss

$

625,111

$

127,999

$

753,110

Initial classification of over-allotment Liability

$

$

294,708

$

294,078

XML 20 R10.htm IDEA: XBRL DOCUMENT v3.22.2.2
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
9 Months Ended
Sep. 30, 2022
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES  
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

NOTE 3. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation

The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X of the Securities and Exchange Commission (“SEC”). Certain information or footnote disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented.

The accompanying unaudited condensed financial statements should be read in conjunction with the Company’s Annual Report on Form 10-K as filed with the SEC on April 18, 2022. The interim results for the three and nine months ended September 30, 2022 are not necessarily indicative of the results to be expected for the year ending December 31, 2022 or for any future periods.

Emerging Growth Company

The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved.

Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statement with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.

Use of Estimates

The preparation of the condensed financial statements in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.

Making estimates require management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. One of the more significant accounting estimates included in these condensed financial statements is the determination of the fair value of the warrant liabilities. Such estimates may be subject to change as more current information becomes available and accordingly the actual results could differ significantly from those estimates.

Cash and Cash Equivalents

The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of September 30, 2022 and December 31, 2021.

Marketable Securities Held in Trust Account

At September 30, 2022 and December 31, 2021, substantially all of the assets held in the Trust Account were held in U.S. Treasury securities. All of the Company’s investments held in the Trust Account are classified as trading securities. Trading securities are presented on the balance sheets at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of investments held in Trust Account are included in interest earned on marketable securities held in Trust Account in the accompanying statements of operations. The estimated fair values of investments held in Trust Account are determined using available market information.

Warrant Liabilities

The Company accounts for the Public Warrants (as defined in Note 4) and Private Placement Warrants (together with the Public Warrants, the “Warrants”) in accordance with the guidance contained in ASC 815-40, under which the Warrants do not meet the criteria for equity treatment and must be recorded as liabilities. Accordingly, the Company classifies the Warrants as liabilities at their fair value and adjusts the Warrants to fair value in respect of each reporting period. This liability is subject to re-measurement at each balance sheet date until the Warrants are exercised, and any change in fair value is recognized in the statements of operations. The Private Placement Warrants and the Public Warrants for periods where no observable traded price was available are valued using a Binomial lattice model.

Offering Costs

Offering costs consisted of legal, accounting and other expenses incurred through the Initial Public Offering that were directly related to the Initial Public Offering. Offering costs were allocated to the separable financial instruments issued in the Initial Public Offering based on a relative fair value basis, compared to total proceeds received. Offering costs allocated to warrant liabilities and representative shares were expensed as incurred in the statements of operations. Offering costs associated with the Class A common stock issued were charged to temporary equity. Offering costs amounted to $705,741, of which $234,438 was charged to temporary equity and $471,303 was expensed as incurred in the statements of operation upon the completion of the Initial Public Offering. In addition, the underwriter was paid $6,340,000 at closing of the Initial Public Offering and a deferred underwriting fee of $11,095,000 was charged against equity and presented on the accompanying consolidated balance sheets.

Class A Common Stock Subject to Possible Redemption

The Company accounts for its Class A common stock subject to possible redemption in accordance with the guidance in ASC 480. Class A common stock subject to mandatory redemption are classified as a liability instrument and are measured at fair value. Conditionally redeemable common stock (including common stock that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, common stock are classified as stockholders’ equity. The Company’s Class A common stock feature certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, at September 30, 2022 and December 31, 2021, Class A common stock subject to possible redemption are presented as temporary equity, outside of the stockholders’ equity section of the Company’s condensed balance sheets.

The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable common stock to equal the redemption value at the end of each reporting period. Immediately upon the closing of the Initial Public Offering, the Company recognized the accretion from initial book value to redemption amount value. The change in the carrying value of redeemable Class A common stock resulted in charges against additional paid-in capital and accumulated deficit.

At September 30, 2022 and December 31, 2021, the Class A common stock reflected in the condensed balance sheets are reconciled in the following table:

Gross proceeds

    

$

317,000,000

Less:

 

  

Proceeds allocated to Public Warrants

(7,053,250)

Class A common stock issuance costs

(20,865,453)

Plus:

  

Remeasurement to amount subject to redemption

27,918,703

Class A common stock subject to possible redemption, December 31, 2021

317,000,000

Plus:

Remeasurement to amount subject to redemption

1,338,616

Class A common stock subject to possible redemption, September 30, 2022

$

318,338,616

Income Taxes

The Company accounts for income taxes under ASC 740, “Income Taxes.” ASC 740, Income Taxes, requires the recognition of deferred tax assets and liabilities for both the expected impact of differences between the unaudited condensed financial statements and tax basis of assets and liabilities and for the expected future tax benefit to be derived from tax loss and tax credit carry forwards. ASC 740 additionally requires a valuation allowance to be established when it is more likely than not that all or a portion of deferred tax assets will not be realized. As of September 30, 2022 and December 31, 2021, the Company’s deferred tax asset had a full valuation allowance recorded against it.

The Company’s effective tax rate was 15.24% and 0.00% for the three months ended September 30, 2022 and 2021, respectively, and 6.84% and 0.00% for the nine months ended September 30, 2022 and 2021, respectively. The effective tax rate differs from the statutory tax rate of 21% for the three and nine months ended September 30, 2022 and 2021, due to changes in fair value in warrant liability, and the valuation allowance on the deferred tax assets.

ASC 740 also clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. ASC 740 also provides guidance on derecognition, classification, interest and penalties, accounting in interim period, disclosure and transition.

The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of September 30, 2022 and December 31, 2021. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position.

The Company has identified the United States as its only “major” tax jurisdiction. The Company is subject to income taxation by major taxing authorities since inception. These examinations may include questioning the timing and amount of deductions, the nexus of income among various tax jurisdictions and compliance with federal and state tax laws. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months.

Net Income (Loss) per Common Share

The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share”. Net income (loss) per common stock is computed by dividing net income (loss) by the weighted average number of common stock outstanding for the period. The Company applies the two-class method in calculating earnings per share. Accretion associated with the redeemable shares of Class A common stock is excluded from earnings per share as the redemption value approximates fair value.

The calculation of diluted income (loss) per share does not consider the effect of the warrants issued in connection with the (i) Initial Public Offering, and (ii) the private placement since the exercise of the warrants is contingent upon the occurrence of future events. The warrants are exercisable to purchase 8,134,750 Class A common stock in the aggregate. As of September 30, 2022 and 2021, the Company did not have any dilutive securities or other contracts that could, potentially, be exercised or converted into common stock and then share in the earnings of the Company. As a result, diluted net loss per common stock is the same as basic net loss per common stock for the periods presented.

The following table reflects the calculation of basic and diluted net income (loss) per common share (in dollars, except per share amounts):

Three Months Ended 

Nine Months Ended 

September 30, 2022

 

September 30, 2021

September 30, 2022

 

September 30, 2021

    

Class A

    

Class B

    

Class A

    

Class B

    

Class A

    

Class B

    

Class A

    

Class B

Basic and diluted net income per ordinary share

 

  

  

 

  

  

Numerator:

 

  

  

 

  

  

Allocation of net income, as adjusted

$

910,100

$

219,633

$

3,158,811

$

762,313

$

3,905,452

$

942,498

$

572,441

$

180,669

Denominator:

 

  

 

  

 

  

 

  

Basic and diluted weighted average ordinary share outstanding

32,839,000

7,925,000

32,839,000

7,925,000

32,839,000

7,925,000

24,779,612

7,820,696

Basic and diluted net income per ordinary share

$

0.03

$

0.03

$

0.10

$

0.10

$

0.12

$

0.12

$

0.02

$

0.02

Concentration of Credit Risk

Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times may exceed the Federal Depository Insurance Coverage of $250,000. The Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account.

Fair Value of Financial Instruments

The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC Topic 820, “Fair Value Measurement,” approximates the carrying amounts represented in the accompanying condensed balance sheets, primarily due to their short-term nature, excluding the Warrant liability (see Note 10).

Recent Accounting Standards

In August 2020, the FASB issued Accounting Standards Update (“ASU”) No. 2020-06, Debt –debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging – Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity (“ASU 2020-06”), which simplifies accounting for convertible instruments by removing major separation models required under current U.S. GAAP. The ASU also removes certain settlement conditions that are required for equity-linked contracts to qualify for the derivative scope exception, and it simplifies the diluted earnings per share calculation in certain areas. The Company adopted ASU 2020-06 in January 2022. Adoption of the ASU did not impact the Company’s financial position, results of operations or cash flows.

The Company’s management does not believe that any other recently issued, but not yet effective, accounting standards if currently adopted would have a material effect on the accompanying unaudited condensed financial statements.

XML 21 R11.htm IDEA: XBRL DOCUMENT v3.22.2.2
PUBLIC OFFERING
9 Months Ended
Sep. 30, 2022
PUBLIC OFFERING  
PUBLIC OFFERING

NOTE 4. PUBLIC OFFERING

Pursuant to the Initial Public Offering, the Company sold 31,700,000 Units, inclusive of 1,700,000 Units sold to the underwriters on March 12, 2021 upon the underwriters’ election to partially exercise their over-allotment option, at a purchase price of $10.00 per Unit. Each Unit consists of one share of the Company’s Class A common stock and one-fourth of one redeemable warrant (“Public Warrant”). Each Public Warrant entitles the holder to purchase one share of Class A common stock at an exercise price of $11.50 per whole share (see Note 9).

XML 22 R12.htm IDEA: XBRL DOCUMENT v3.22.2.2
PRIVATE PLACEMENT
9 Months Ended
Sep. 30, 2022
PRIVATE PLACEMENT.  
PRIVATE PLACEMENT

NOTE 5. PRIVATE PLACEMENT

Simultaneously with the closing of the Initial Public Offering, the Sponsor and EarlyBirdCapital purchased an aggregate of 805,000 Private Placement Units at a price of $10.00 per Private Placement Unit in a private placement. The Sponsor purchased 655,000 Private Placement Units and EarlyBirdCapital purchased 150,000 Private Placement Units. The Sponsor agreed to purchase up to an additional 67,500 Private Placement Units and EarlyBirdCapital agreed to purchase up to an additional 22,500 Private Placement Units if the over-allotment option was exercised in full. On March 12, 2021, the Sponsor and EarlyBirdCapital purchased 34,000 Private Placement Units for an additional aggregate purchase price of $340,000 in connection with the partial exercise of the underwriter’s over-allotment option. Each Private Placement Unit consists of one share of Class A common stock (“Private Share”) and one-fourth of one redeemable warrant (“Private Placement Warrant”). Each Private Placement Warrant will entitle the holder to purchase one share of Class A common stock at a price of $11.50 per full share, subject to adjustment (see Note 9). The proceeds from the Private Placement Units were added to the proceeds from the Initial Public Offering held in the Trust Account. If the Company does not complete a Business Combination within the Combination Period, the proceeds from the sale of the Private Placement Units will be used to fund the redemption of the Public Shares (subject to the requirements of applicable law).

XML 23 R13.htm IDEA: XBRL DOCUMENT v3.22.2.2
RELATED PARTY TRANSACTIONS
9 Months Ended
Sep. 30, 2022
RELATED PARTY TRANSACTIONS  
RELATED PARTY TRANSACTIONS

NOTE 6. RELATED PARTY TRANSACTIONS

Founder Shares

On November 10, 2020, the Sponsor paid $25,000 to cover certain offering costs of the Company in consideration for 5,750,000 shares of Class B common stock (the “Founder Shares”). On February 4, 2021, the Company effectuated a 1:1.25 stock split of its Class B common stock and on March 3, 2021, the Company effectuated a 1.2 stock split of its Class B common stock, which resulted in an aggregate of 8,625,000 Founder Shares outstanding. The Founder Shares include an aggregate of up to 700,000 shares that remain subject to forfeiture by the Sponsor following the underwriters’ election to partially exercise their over-allotment option (see Note 7), so that the Sponsor and the Company’s independent directors will collectively own 20% of the Company’s issued and outstanding shares after the Initial Public Offering (assuming the Sponsor did not purchase any Public Shares in the Initial Public Offering and excluding the Private Shares). As a result of the underwriters’ election to partially exercise their over-allotment option, a total of 425,000 Founder Shares are no longer subject to forfeiture and 700,000 Founder Shares were forfeited resulting in an aggregate of 7,925,000 Founder Shares outstanding.

The Sponsor has agreed, subject to limited exceptions, not to transfer, assign or sell any of the Founder Shares until the earlier to occur of: (A) one year after the completion of a Business Combination and (B) subsequent to a Business Combination, (x) if the reported closing price of the Class A common stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after a Business Combination, or (y) the date on which the Company completes a liquidation, merger, capital stock exchange or other similar transaction that results in all of the Public Stockholders having the right to exchange their shares of common stock for cash, securities or other property.

On February 18, 2021, the sponsor transferred 15,000 shares of Class B common stock to the independent directors of D. Amsterdam, A. Ebush, and A. Savar for a total of 45,000 shares transferred. On March 3, 2021, the company effectuated a 1.2 stock split of our common stock which resulted in the total amount of Class B common stock transferred to each director to be 18,000 for a total of 54,000 shares.

The transfer of the Founders Shares is in the scope of FASB ASC Topic 718, “Compensation-Stock Compensation” (“ASC 718”). Under ASC 718, stock-based compensation associated with equity-classified awards is measured at fair value upon the grant date. The value of the transferred Founders Shares on the grant date of February 18, 2021 was $6.91 per share for a total aggregate value of $373,140. The Founders Shares were granted subject to a performance condition (i.e., the occurrence of a Business Combination). Compensation expense related to the Founders Shares is recognized only when the performance condition is probable of occurrence under the applicable accounting literature in this circumstance. As of September 30, 2022, the Company determined that a Business Combination is not considered probable, and, therefore, no stock-based compensation expense has been recognized. Stock-based compensation would be recognized at the date a Business Combination is considered probable (i.e., upon consummation of a Business Combination) in an amount equal to the number of Founders Shares times the grant date fair value per share (unless subsequently modified) less the amount initially received for the purchase of the Founders Shares.

Administrative Services Agreement

The Company agreed, commencing on March 3, 2021 through the earlier of the Company’s consummation of a Business Combination and its liquidation, to pay an affiliate of the Company’s executive officers a total of $10,000 per month for office space and general and administrative services. For the three months and nine months ended September 30, 2022, the Company incurred $30,000 and $90,000 in fees for these services, respectively, of which $10,000 of such amount is included in accrued expenses in the accompanying balance sheets. For the three months and nine months ended September 30, 2021, the Company incurred $30,000 and $70,000 in fees for these services, respectively. As of December 31, 2021 there was $10,000 of such fees included in accounts payable and accrued expenses.

Promissory Note — Related Party

On November 10, 2020, the Company issued an unsecured promissory note to the Sponsor (the “Promissory Note”), pursuant to which the Company could borrow up to an aggregate principal amount of $300,000. The Promissory Note was non-interest bearing and payable on the earlier of (i) December 31, 2021, (ii) the consummation of the Initial Public Offering or (ii) the date on which the Company determines not to proceed with the Initial Public Offering. As of September 30, 2022 and December 31, 2021, there was no amount outstanding under the Promissory Note. The outstanding amount of $200,000 was repaid at the closing of the Initial Public Offering on March 8, 2021.

Related Party Loans

In addition, in order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If the Company completes a Business Combination, the Company would repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company. Otherwise, the Working Capital Loans would be repaid only out of funds held outside the Trust Account. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans, but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. Except for the foregoing, the terms of such Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans. The Working Capital Loans would either be repaid upon consummation of a Business Combination, without interest, or, at the lender’s discretion, up to $1,500,000 of such Working Capital Loans may be convertible into units of the post Business Combination entity at a price of $10.00 per unit. The units would be identical to the Private Placement Units. As of September 30, 2022 or December 31, 2021, no amounts have been withdrawn or are outstanding relating to these Working Capital Loans.

XML 24 R14.htm IDEA: XBRL DOCUMENT v3.22.2.2
COMMITMENTS
9 Months Ended
Sep. 30, 2022
COMMITMENTS  
COMMITMENTS

NOTE 7. COMMITMENTS

Registration Rights

Pursuant to a registration rights agreement entered into on March 3, 2021, the holders of the Founder Shares and Representative Shares, as well as the holders of the Private Placement Units and any units that may be issued in payment of Working Capital Loans made to the Company, have registration rights to require the Company to register for resale of any of the Company’s securities held by them. The holder of these securities and the Sponsor are entitled to make unlimited demands that the Company register such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the completion of a Business Combination. Notwithstanding anything to the contrary, EarlyBirdCapital may only make a demand on one occasion and only during the five-year period beginning on the effective date of the Initial Public Offering. In addition, EarlyBirdCapital may participate in a “piggy-back” registration only during the seven-year period beginning on the effective date of the Initial Public Offering. The Company will bear the expenses incurred in connection with the filing of any such registration statements. However, the registration and stockholder rights agreement provides that the Company will not permit any registration statement filed under the Securities Act to become effective until termination of the applicable lock-up period. The registration rights and stockholder agreement does not contain liquidated damages or other cash settlement provisions resulting from delays in registering the Company’s securities. The Company will bear the expenses incurred in connection with the filing of any such registration statements.

Underwriting Agreement

The Company granted the underwriters a 45-day option from the date of the Initial Public Offering to purchase up to 4,500,000 additional Units to cover over-allotments, if any, at the Initial Public Offering price, less the underwriting discounts and commissions. On March 12, 2021, the underwriter’s election to partially exercise the over-allotment option to purchase an additional 1,700,000 Units and forfeited their option to purchase an additional 2,800,000 Units.

The underwriters are entitled to a deferred fee of $0.35 per Unit, or $10,500,000 in the aggregate (or $12,075,000 in the aggregate if the underwriters’ over-allotment option is exercised in full). The deferred fee will become payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement.

XML 25 R15.htm IDEA: XBRL DOCUMENT v3.22.2.2
STOCKHOLDERS' DEFICIT
9 Months Ended
Sep. 30, 2022
STOCKHOLDERS' DEFICIT  
STOCKHOLDERS' DEFICIT

NOTE 8. STOCKHOLDERS’ DEFICIT

Preferred Stock —The Company is authorized to issue 1,000,000 shares of preferred stock with a par value of $0.0001 per share. At March 8, 2021, there were no shares of preferred stock issued or outstanding. At September 30, 2022 and December 31, 2021, there were no shares of preferred stock issued or outstanding.

Class A Common StockThe Company is authorized to issue up to 100,000,000 shares of Class A common stock with a par value of $0.0001 per share. At September 30, 2022 and December 31, 2021, there were 32,839,000 shares of Class A common stock issued and outstanding, including 31,700,000 Class A common stock subject to possible redemption which are presented as temporary equity.

Class B Common StockThe Company is authorized to issue up to 10,000,000 shares of Class B common stock with a par value of $0.0001 per share. Holders of the Company’s common stock are entitled to one vote for each share. At September 30, 2022 and December 31, 2021, there were 7,925,000 shares of common stock issued and outstanding.

Holders of Class A common stock and holders of Class B common stock will vote together as a single class on all matters submitted to a vote of the Company’s stockholders except as otherwise required by law.

The shares of Class B common stock will automatically convert into Class A common stock at the time of a Business Combination, or earlier at the option of the holder, on a one-for-one basis, subject to adjustment. In the case that additional shares of Class A common stock, or equity-linked securities, are issued or deemed issued in excess of the amounts offered in this prospectus and related to the closing of a Business Combination, the ratio at which shares of Class B common stock shall convert into shares of Class A common stock will be adjusted (unless the Sponsor agrees to waive such adjustment with respect to any such issuance or deemed issuance, including a specified future issuance) so that the number of shares of Class A common stock issuable upon conversion of all shares of Class B common stock will equal, in the aggregate, on an as-converted basis, 20% of the sum of the total number of all shares of common stock outstanding upon completion of the Initial Public Offering plus all shares of Class A common stock and equity-linked securities issued or deemed issued in connection with a Business Combination (after giving effect to any redemptions of shares of Class A common stock by public stockholders, excluding any Private Placement Units issued to the Sponsor, officers or directors upon conversion of Working Capital Loans). The Sponsor may also elect to convert their shares of Class B common stock into an equal number of shares of Class A common stock, subject to adjustment as provided above, at any time.

XML 26 R16.htm IDEA: XBRL DOCUMENT v3.22.2.2
WARRANTS
9 Months Ended
Sep. 30, 2022
WARRANTS.  
WARRANTS

NOTE 9. WARRANTS

Public Warrants may only be exercised for a whole number of shares. No fractional warrants will be issued upon separation of the Units and only whole warrants will trade. The Public Warrants will become exercisable 30 days after the completion of a Business Combination. The Public Warrants will expire five years after the completion of a Business Combination or earlier upon redemption or liquidation.

The Company will not be obligated to deliver any shares of Class A common stock pursuant to the exercise of a warrant and will have no obligation to settle such warrant exercise unless a registration statement under the Securities Act covering the issuance of the shares of Class A common stock underlying the warrants is then effective and a prospectus relating thereto is current, subject to the Company satisfying its obligations with respect to registration. No warrant will be exercisable and the Company will not be obligated to issue shares of Class A common stock upon exercise of a warrant unless Class A common stock issuable upon such warrant exercise has been registered, qualified or deemed to be exempt under the securities laws of the state of residence of the registered holder of the warrants.

The Company has agreed that as soon as practicable, but in no event later than 20 business days after the closing of a Business Combination, it will use its reasonable best efforts to file with the SEC a registration statement for the registration, under the Securities Act, of the shares of Class A common stock issuable upon exercise of the warrants. The Company will use its reasonable best efforts to cause the same to become effective and to maintain the effectiveness of such registration statement, and a current prospectus relating thereto, until the expiration of the warrants in accordance with the provisions of the warrant agreement. If a registration statement covering the shares of Class A common stock issuable upon exercise of the warrants is not effective by the ninetieth day after the closing of a Business Combination, warrant holders may, until such time as there is an effective registration statement and during any period when the Company will have failed to maintain an effective registration statement, exercise warrants on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act or another exemption.

Redemption of warrants when the price per Class A common stock equals or exceeds $18.00. Once the warrants become exercisable, the Company may redeem the outstanding warrants (except with respect to the Private Placement Warrants):

in whole and not in part;
at a price of $0.01 per warrant;
upon not less than 30 days’ prior written notice of redemption, or the 30-day redemption period, to each warrant holder; and
if, and only if, the reported closing price of the Class A common stock equals or exceeds $18.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within a 30-trading day period commencing once the warrants become exercisable and ending three business days before the Company sends the notice of redemption to the warrant holders.

If and when the warrants become redeemable by the Company, the Company may exercise its redemption right even if the Company is unable to register or qualify the underlying securities for sale under all applicable state securities laws.

Redemption of warrants when the price per Class A common stock equals or exceeds $10.00. Once the warrants become exercisable, the Company may redeem the outstanding warrants:

in whole and not in part;
at $0.10 per warrant upon a minimum of 30 days’ prior written notice of redemption provided that during such 30 day period holders will be able to exercise their warrants on a cashless basis prior to redemption and receive that number of shares based on the redemption date and the “fair market value” of our shares of Class A common stock (as defined below) except as otherwise described below; provided, further, that if the warrants are not exercised on a cashless basis or otherwise during such 30 day period, the Company shall redeem such warrants for $0.10 per share;
if, and only if, the Private Placement Warrants are also concurrently called for redemption at the same price (equal to a number of shares of Class A common stock) as the outstanding Public Warrants, as described above; and
if, and only if, there is an effective registration statement covering the issuance of the shares of Class A common stock issuable upon exercise of the warrants and a current prospectus relating thereto available throughout the 30-day period after written notice of redemption is given.

If the Company calls the Public Warrants for redemption, management will have the option to require all holders that wish to exercise the Public Warrants to do so on a “cashless basis,” as described in the warrant agreement. The exercise price and number of shares of Class A common stock issuable upon exercise of the warrants may be adjusted in certain circumstances including in the event of a stock dividend, or recapitalization, reorganization, merger or consolidation. However, except as described below, the warrants will not be adjusted for issuances of Class A common stock at a price below its exercise price. Additionally, in no event will the Company be required to net cash settle the warrants. If the Company is unable to complete a Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect to their warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with the respect to such warrants. Accordingly, the warrants may expire worthless.

In addition, if (x) the Company issues additional shares of Class A common stock or equity-linked securities for capital raising purposes in connection with the closing of a Business Combination at an issue price or effective issue price of less than $9.20 per share of Class A common stock (with such issue price or effective issue price to be determined in good faith by the Company’s board of directors, and in the case of any such issuance to the Sponsor or their affiliates, without taking into account any Founder Shares held by them prior to such issuance), or the Newly Issued Price, (y) the aggregate gross proceeds from such issuances represent more than 50% of the total equity proceeds, and interest thereon, available for the funding of a Business Combination on the date of the consummation of a Business Combination (net of redemptions), and (z) the volume weighted average trading price of the Company’s Class A common stock during the 20 trading day period starting on the trading day after the day on which the Company consummates Business Combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of (i) the Market Value and (ii) the Newly Issued Price and the $18.00 per share redemption trigger price will be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market Value and the Newly Issued Price.

The Private Placement Warrants are identical to the Public Warrants underlying the Units sold in the Initial Public Offering, except that the Private Placement Warrants and the Class A common stock issuable upon the exercise of the Private Placement Warrants will not be transferable, assignable or salable until 30 days after the completion of a Business Combination, subject to certain limited exceptions. Additionally, the Private Placement Warrants will be exercisable on a cashless basis and will be non-redeemable so long as they are held by the initial purchasers or their permitted transferees. If the Private Placement Warrants are held by someone other than the initial purchasers or their permitted transferees, the Private Placement Warrants will be redeemable by the Company and exercisable by such holders on the same basis as the Public Warrants.

Representative Shares

The Company issued 300,000 shares of Class A common stock (the “Representative Shares”) to the designees of EarlyBirdCapital for an aggregate purchase price of $870. The Company accounted for the Representative Shares as an offering cost of the Initial Public Offering, with a corresponding credit to stockholders’ equity. The Company estimated the fair value of the Representative Shares to be $3,000,000, based upon the price of the Units sold in the Initial Public Offering. The holders of the Representative Shares have agreed not to transfer, assign or sell any such shares until the completion of a Business Combination. In addition, the holders have agreed (i) to waive their conversion rights (or right to participate in any tender offer) with respect to such shares in connection with the completion of a Business Combination and (ii) to waive their rights to liquidating distributions from the Trust Account with respect to such shares if the Company fails to complete a Business Combination within the Combination Period.

The Representative Shares have been deemed compensation by FINRA and are therefore subject to a lock-up for a period of 180 days immediately following the effective date of the registration statement related to the Initial Public Offering pursuant to Rule 5110(e)(1) of FINRA’s NASD Conduct Rules. Pursuant to FINRA Rule 5110(e)(1), these securities will not be the subject of any hedging, short sale, derivative, put or call transaction that would result in the economic disposition of the securities by any person for a period of 180 days immediately following the effective date of the registration statements related to the Initial Public Offering, nor may they be sold, transferred, assigned, pledged or hypothecated for a period of 180 days immediately following the effective date of the registration statements related to the Initial Public Offering except to any underwriter and selected dealer participating in the Initial Public Offering and their bona fide officers or partners.

XML 27 R17.htm IDEA: XBRL DOCUMENT v3.22.2.2
FAIR VALUE MEASUREMENTS
9 Months Ended
Sep. 30, 2022
FAIR VALUE MEASUREMENTS  
FAIR VALUE MEASUREMENTS

NOTE 10. FAIR VALUE MEASUREMENTS

The Company follows the guidance in ASC 820 for its financial assets and liabilities that are re-measured and reported at fair value at each reporting period, and non-financial assets and liabilities that are re-measured and reported at fair value at least annually.

The fair value of the Company’s financial assets and liabilities reflects management’s estimate of amounts that the Company would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and liabilities:

Level 1:Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis.
Level 2:Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active.
Level 3:Unobservable inputs based on our assessment of the assumptions that market participants would use in pricing the asset or liability.

The following table presents information about the Company’s assets that are measured at fair value on a recurring basis at September 30, 2022, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value:

    

    

September 30, 

    

December 31,

Description

Level

 

2022

 

2021

Assets:

 

  

 

  

 

  

Marketable securities held in Trust Account

 

1

$

318,684,239

$

317,025,510

Liabilities:

 

  

 

  

 

  

Warrant Liability - Private Placement Warrants

3

$

12,585

$

119,375

Warrant Liability - Public Warrants

 

1

$

475,500

$

4,510,337

The Public Warrants and Private Placement Warrants were accounted for as liabilities in accordance with ASC 815-40 and are presented within warrant liabilities on our accompanying September 30, 2022 and December 31, 2021 condensed balance sheets. The warrant liabilities are measured at fair value at inception and on a recurring basis, with changes in fair value presented within change in fair value of warrant liabilities in the condensed statements of operations.

Initial Measurement

The Company established the initial fair value for the Public and Private Placement Warrants on March 8, 2021, the date of the Company’s Initial Public Offering, using a binomial lattice model. The Company allocated the proceeds received from (i) the sale of Units (which is inclusive of one share of Class A common stock and one-fourth of one Public Warrant), (ii) the sale of Private Placement Warrants, and (iii) the issuance of Class B common stock, first to the Warrants based on their fair values as determined at initial measurement, with the remaining proceeds allocated to Class A common stock subject to possible redemption, Class A common stock and Class B common stock based on their relative fair values at the initial measurement date. The warrants were classified as Level 3 at the initial measurement date due to the use of unobservable inputs.

Subsequent Measurement

The warrants are measured at fair value on a recurring basis. The subsequent measurement of the Public Warrants as of September 30, 2022 is classified as Level 1 due to the use of an observable market quote in an active market. The subsequent measurement of the Private Placement Warrants was calculated using a Black Scholes model which is considered a Level 3 measurement.

The key inputs into the binomial lattice model for the Private Placement Warrants were as follows at September 30, 2022 and December 31, 2021:

September 30, 

December 31, 

Input

    

2022

    

2021

Risk-free interest rate

 

4.12

%

1.19

%

Effective expiration date

 

06/06/2024

7/23/2026

Dividend yield

0.00

%

 

0.00

%

Expected volatility

6.4

%

 

12.1

%

Exercise price

$

11.50

$

11.50

Unit Price

$

9.81

$

9.71

As of September 30, 2022 and December 31, 2021, the aggregate values of the Private Placement Warrants were $0.01 million and $0.12 million, respectively.

The following table presents the changes in the fair value of Level 3 warrant liabilities for the three months and nine months ended September 30, 2022:

    

Private Placement 

Warrant Liability

Fair value as of December 31, 2021

$

119,375

Change in fair value

 

(50,471)

Fair value as of March 31, 2022

68,904

Change in fair value

(54,221)

Fair value as of June 30, 2022

14,683

Change in fair value

(2,098)

Fair value as of September 30, 2022

$

12,585

The following table presents the changes in the fair value of Level 3 warrant liabilities for the three months and nine months ended September 30, 2021:

Private Placement

Public

    

Warrant Liability

    

Warrant Liability

Fair value as of January 1, 2021

$

$

Issuance of warrants on March 8, 2021 (IPO)

 

179,113

 

6,675,000

Issuance of warrants on March 12, 2021 (Over Allotment)

 

7,565

 

378,250

Change in fair value

 

(12,585)

 

(475,500)

Fair value as of March 31, 2021

174,903

6,577,750

Change in fair value

79,705

3,011,500

Transfer from Level 3 to Level 1

(9,589,250)

Fair value as of June 30, 2021

253,798

Change in fair value

(109,070)

Fair value as of September 30, 2021

$

144,728

$

Transfers to/from Levels 1, 2 and 3 are recognized at the end of the reporting period in which a change in valuation technique or methodology occurs. For the three and nine months ended September 30, 2022, there were no transfers from Level 3 measurements. The estimated fair value of the Public Warrants transferred from a Level 3 measurement to a Level 1 fair value measurement during the three and nine months ended September 30, 2021 was $9,589,250.

XML 28 R18.htm IDEA: XBRL DOCUMENT v3.22.2.2
SUBSEQUENT EVENTS
9 Months Ended
Sep. 30, 2022
SUBSEQUENT EVENTS  
SUBSEQUENT EVENTS

NOTE 11. SUBSEQUENT EVENTS

The Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the condensed financial statements were issued. Based upon this review, the Company did not identify any subsequent events that would have required adjustment or disclosure in the condensed financial statements.

XML 29 R19.htm IDEA: XBRL DOCUMENT v3.22.2.2
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)
9 Months Ended
Sep. 30, 2022
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES  
Basis of Presentation

Basis of Presentation

The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X of the Securities and Exchange Commission (“SEC”). Certain information or footnote disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented.

The accompanying unaudited condensed financial statements should be read in conjunction with the Company’s Annual Report on Form 10-K as filed with the SEC on April 18, 2022. The interim results for the three and nine months ended September 30, 2022 are not necessarily indicative of the results to be expected for the year ending December 31, 2022 or for any future periods.

Emerging Growth Company

Emerging Growth Company

The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved.

Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statement with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.

Use of Estimates

Use of Estimates

The preparation of the condensed financial statements in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.

Making estimates require management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. One of the more significant accounting estimates included in these condensed financial statements is the determination of the fair value of the warrant liabilities. Such estimates may be subject to change as more current information becomes available and accordingly the actual results could differ significantly from those estimates.

Cash and Cash Equivalents

Cash and Cash Equivalents

The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of September 30, 2022 and December 31, 2021.

Marketable Securities Held in Trust Account

Marketable Securities Held in Trust Account

At September 30, 2022 and December 31, 2021, substantially all of the assets held in the Trust Account were held in U.S. Treasury securities. All of the Company’s investments held in the Trust Account are classified as trading securities. Trading securities are presented on the balance sheets at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of investments held in Trust Account are included in interest earned on marketable securities held in Trust Account in the accompanying statements of operations. The estimated fair values of investments held in Trust Account are determined using available market information.

Warrant Liability

Warrant Liabilities

The Company accounts for the Public Warrants (as defined in Note 4) and Private Placement Warrants (together with the Public Warrants, the “Warrants”) in accordance with the guidance contained in ASC 815-40, under which the Warrants do not meet the criteria for equity treatment and must be recorded as liabilities. Accordingly, the Company classifies the Warrants as liabilities at their fair value and adjusts the Warrants to fair value in respect of each reporting period. This liability is subject to re-measurement at each balance sheet date until the Warrants are exercised, and any change in fair value is recognized in the statements of operations. The Private Placement Warrants and the Public Warrants for periods where no observable traded price was available are valued using a Binomial lattice model.

Offering Costs

Offering Costs

Offering costs consisted of legal, accounting and other expenses incurred through the Initial Public Offering that were directly related to the Initial Public Offering. Offering costs were allocated to the separable financial instruments issued in the Initial Public Offering based on a relative fair value basis, compared to total proceeds received. Offering costs allocated to warrant liabilities and representative shares were expensed as incurred in the statements of operations. Offering costs associated with the Class A common stock issued were charged to temporary equity. Offering costs amounted to $705,741, of which $234,438 was charged to temporary equity and $471,303 was expensed as incurred in the statements of operation upon the completion of the Initial Public Offering. In addition, the underwriter was paid $6,340,000 at closing of the Initial Public Offering and a deferred underwriting fee of $11,095,000 was charged against equity and presented on the accompanying consolidated balance sheets.

Class A Common Stock Subject to Possible Redemption

Class A Common Stock Subject to Possible Redemption

The Company accounts for its Class A common stock subject to possible redemption in accordance with the guidance in ASC 480. Class A common stock subject to mandatory redemption are classified as a liability instrument and are measured at fair value. Conditionally redeemable common stock (including common stock that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, common stock are classified as stockholders’ equity. The Company’s Class A common stock feature certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, at September 30, 2022 and December 31, 2021, Class A common stock subject to possible redemption are presented as temporary equity, outside of the stockholders’ equity section of the Company’s condensed balance sheets.

The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable common stock to equal the redemption value at the end of each reporting period. Immediately upon the closing of the Initial Public Offering, the Company recognized the accretion from initial book value to redemption amount value. The change in the carrying value of redeemable Class A common stock resulted in charges against additional paid-in capital and accumulated deficit.

At September 30, 2022 and December 31, 2021, the Class A common stock reflected in the condensed balance sheets are reconciled in the following table:

Gross proceeds

    

$

317,000,000

Less:

 

  

Proceeds allocated to Public Warrants

(7,053,250)

Class A common stock issuance costs

(20,865,453)

Plus:

  

Remeasurement to amount subject to redemption

27,918,703

Class A common stock subject to possible redemption, December 31, 2021

317,000,000

Plus:

Remeasurement to amount subject to redemption

1,338,616

Class A common stock subject to possible redemption, September 30, 2022

$

318,338,616

Income Taxes

Income Taxes

The Company accounts for income taxes under ASC 740, “Income Taxes.” ASC 740, Income Taxes, requires the recognition of deferred tax assets and liabilities for both the expected impact of differences between the unaudited condensed financial statements and tax basis of assets and liabilities and for the expected future tax benefit to be derived from tax loss and tax credit carry forwards. ASC 740 additionally requires a valuation allowance to be established when it is more likely than not that all or a portion of deferred tax assets will not be realized. As of September 30, 2022 and December 31, 2021, the Company’s deferred tax asset had a full valuation allowance recorded against it.

The Company’s effective tax rate was 15.24% and 0.00% for the three months ended September 30, 2022 and 2021, respectively, and 6.84% and 0.00% for the nine months ended September 30, 2022 and 2021, respectively. The effective tax rate differs from the statutory tax rate of 21% for the three and nine months ended September 30, 2022 and 2021, due to changes in fair value in warrant liability, and the valuation allowance on the deferred tax assets.

ASC 740 also clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. ASC 740 also provides guidance on derecognition, classification, interest and penalties, accounting in interim period, disclosure and transition.

The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of September 30, 2022 and December 31, 2021. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position.

The Company has identified the United States as its only “major” tax jurisdiction. The Company is subject to income taxation by major taxing authorities since inception. These examinations may include questioning the timing and amount of deductions, the nexus of income among various tax jurisdictions and compliance with federal and state tax laws. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months.

Net Income (Loss) per Common Share

Net Income (Loss) per Common Share

The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share”. Net income (loss) per common stock is computed by dividing net income (loss) by the weighted average number of common stock outstanding for the period. The Company applies the two-class method in calculating earnings per share. Accretion associated with the redeemable shares of Class A common stock is excluded from earnings per share as the redemption value approximates fair value.

The calculation of diluted income (loss) per share does not consider the effect of the warrants issued in connection with the (i) Initial Public Offering, and (ii) the private placement since the exercise of the warrants is contingent upon the occurrence of future events. The warrants are exercisable to purchase 8,134,750 Class A common stock in the aggregate. As of September 30, 2022 and 2021, the Company did not have any dilutive securities or other contracts that could, potentially, be exercised or converted into common stock and then share in the earnings of the Company. As a result, diluted net loss per common stock is the same as basic net loss per common stock for the periods presented.

The following table reflects the calculation of basic and diluted net income (loss) per common share (in dollars, except per share amounts):

Three Months Ended 

Nine Months Ended 

September 30, 2022

 

September 30, 2021

September 30, 2022

 

September 30, 2021

    

Class A

    

Class B

    

Class A

    

Class B

    

Class A

    

Class B

    

Class A

    

Class B

Basic and diluted net income per ordinary share

 

  

  

 

  

  

Numerator:

 

  

  

 

  

  

Allocation of net income, as adjusted

$

910,100

$

219,633

$

3,158,811

$

762,313

$

3,905,452

$

942,498

$

572,441

$

180,669

Denominator:

 

  

 

  

 

  

 

  

Basic and diluted weighted average ordinary share outstanding

32,839,000

7,925,000

32,839,000

7,925,000

32,839,000

7,925,000

24,779,612

7,820,696

Basic and diluted net income per ordinary share

$

0.03

$

0.03

$

0.10

$

0.10

$

0.12

$

0.12

$

0.02

$

0.02

Concentration of Credit Risk

Concentration of Credit Risk

Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times may exceed the Federal Depository Insurance Coverage of $250,000. The Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account.

Fair Value of Financial Instruments

Fair Value of Financial Instruments

The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC Topic 820, “Fair Value Measurement,” approximates the carrying amounts represented in the accompanying condensed balance sheets, primarily due to their short-term nature, excluding the Warrant liability (see Note 10).

Recent Accounting Standards

Recent Accounting Standards

In August 2020, the FASB issued Accounting Standards Update (“ASU”) No. 2020-06, Debt –debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging – Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity (“ASU 2020-06”), which simplifies accounting for convertible instruments by removing major separation models required under current U.S. GAAP. The ASU also removes certain settlement conditions that are required for equity-linked contracts to qualify for the derivative scope exception, and it simplifies the diluted earnings per share calculation in certain areas. The Company adopted ASU 2020-06 in January 2022. Adoption of the ASU did not impact the Company’s financial position, results of operations or cash flows.

The Company’s management does not believe that any other recently issued, but not yet effective, accounting standards if currently adopted would have a material effect on the accompanying unaudited condensed financial statements.

XML 30 R20.htm IDEA: XBRL DOCUMENT v3.22.2.2
REVISION OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS (Tables)
9 Months Ended
Sep. 30, 2022
REVISION OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS  
Schedule of impact of revision on financial statements

    

As Previously

    

    

Statement of Operations for the Nine Months Ended September 30, 2021

Reported

Adjustment

As Revised

Change in fair value of over-allotment liability

$

$

196,475

$

196,475

Transaction costs allocable to representative shares

$

$

(68,476)

$

(68,476)

Net Loss

$

625,111

$

127,999

$

753,110

    

As Previously

    

    

Statement of Stockholders’ Deficit for the Nine Months Ended September 30, 2021

Reported

Adjustment

As Revised

Issuance of representative shares

870

2,999,130

3,000,000

Remeasurement to amount subject to redemption

(24,791,574)

3,127,129

$

(27,918,703)

Net loss

$

625,111

$

127,999

$

753,110

    

As Previously

    

    

Statement of Cashflows for the Nine Months Ended September 30, 2021

Reported

Adjustment

As Revised

Change in fair value of over-allotment liability

$

$

(196,475)

$

(196,475)

Transaction costs allocable to representative shares

$

$

68,476

$

68,476

Net loss

$

625,111

$

127,999

$

753,110

Initial classification of over-allotment Liability

$

$

294,708

$

294,078

XML 31 R21.htm IDEA: XBRL DOCUMENT v3.22.2.2
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)
9 Months Ended
Sep. 30, 2022
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES  
Schedule of Class A common stock reflected in the condensed balance sheet

Gross proceeds

    

$

317,000,000

Less:

 

  

Proceeds allocated to Public Warrants

(7,053,250)

Class A common stock issuance costs

(20,865,453)

Plus:

  

Remeasurement to amount subject to redemption

27,918,703

Class A common stock subject to possible redemption, December 31, 2021

317,000,000

Plus:

Remeasurement to amount subject to redemption

1,338,616

Class A common stock subject to possible redemption, September 30, 2022

$

318,338,616

Schedule of calculation of basic and diluted net income (loss) per common share

The following table reflects the calculation of basic and diluted net income (loss) per common share (in dollars, except per share amounts):

Three Months Ended 

Nine Months Ended 

September 30, 2022

 

September 30, 2021

September 30, 2022

 

September 30, 2021

    

Class A

    

Class B

    

Class A

    

Class B

    

Class A

    

Class B

    

Class A

    

Class B

Basic and diluted net income per ordinary share

 

  

  

 

  

  

Numerator:

 

  

  

 

  

  

Allocation of net income, as adjusted

$

910,100

$

219,633

$

3,158,811

$

762,313

$

3,905,452

$

942,498

$

572,441

$

180,669

Denominator:

 

  

 

  

 

  

 

  

Basic and diluted weighted average ordinary share outstanding

32,839,000

7,925,000

32,839,000

7,925,000

32,839,000

7,925,000

24,779,612

7,820,696

Basic and diluted net income per ordinary share

$

0.03

$

0.03

$

0.10

$

0.10

$

0.12

$

0.12

$

0.02

$

0.02

XML 32 R22.htm IDEA: XBRL DOCUMENT v3.22.2.2
FAIR VALUE MEASUREMENTS (Tables)
9 Months Ended
Sep. 30, 2022
FAIR VALUE MEASUREMENTS  
Schedule of Company's assets that are measured at fair value on a recurring basis

    

    

September 30, 

    

December 31,

Description

Level

 

2022

 

2021

Assets:

 

  

 

  

 

  

Marketable securities held in Trust Account

 

1

$

318,684,239

$

317,025,510

Liabilities:

 

  

 

  

 

  

Warrant Liability - Private Placement Warrants

3

$

12,585

$

119,375

Warrant Liability - Public Warrants

 

1

$

475,500

$

4,510,337

Schedule of initial and subsequent measurement of key inputs

September 30, 

December 31, 

Input

    

2022

    

2021

Risk-free interest rate

 

4.12

%

1.19

%

Effective expiration date

 

06/06/2024

7/23/2026

Dividend yield

0.00

%

 

0.00

%

Expected volatility

6.4

%

 

12.1

%

Exercise price

$

11.50

$

11.50

Unit Price

$

9.81

$

9.71

Schedule of change in the fair value of the warrant liabilities

    

Private Placement 

Warrant Liability

Fair value as of December 31, 2021

$

119,375

Change in fair value

 

(50,471)

Fair value as of March 31, 2022

68,904

Change in fair value

(54,221)

Fair value as of June 30, 2022

14,683

Change in fair value

(2,098)

Fair value as of September 30, 2022

$

12,585

Private Placement

Public

    

Warrant Liability

    

Warrant Liability

Fair value as of January 1, 2021

$

$

Issuance of warrants on March 8, 2021 (IPO)

 

179,113

 

6,675,000

Issuance of warrants on March 12, 2021 (Over Allotment)

 

7,565

 

378,250

Change in fair value

 

(12,585)

 

(475,500)

Fair value as of March 31, 2021

174,903

6,577,750

Change in fair value

79,705

3,011,500

Transfer from Level 3 to Level 1

(9,589,250)

Fair value as of June 30, 2021

253,798

Change in fair value

(109,070)

Fair value as of September 30, 2021

$

144,728

$

XML 33 R23.htm IDEA: XBRL DOCUMENT v3.22.2.2
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS (Details)
9 Months Ended
Mar. 12, 2021
USD ($)
$ / shares
shares
Mar. 08, 2021
USD ($)
$ / shares
shares
Sep. 30, 2022
USD ($)
item
$ / shares
Sep. 30, 2021
USD ($)
Dec. 31, 2021
USD ($)
Dec. 03, 2021
USD ($)
Mar. 31, 2021
shares
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS              
Purchase price per unit | $ / shares $ 10.00            
Proceeds from sale of Private Placement Units     $ 0 $ 8,390,000      
Transaction costs $ 18,140,741            
Underwriting fees 6,340,000         $ 6,340,000  
Deferred underwriting fee payable 11,095,000   $ 11,095,000   $ 11,095,000 11,095,000  
Other offering costs 705,741         $ 705,741  
Condition for future business combination number of businesses minimum | item     1        
Payments for investment of cash in Trust Account $ 317,000,000   $ 0 $ 317,000,000      
Condition for future business combination use of proceeds percentage     80        
Condition for future business combination threshold percentage ownership     50        
Condition for future business combination threshold net tangible assets     $ 5,000,001        
Obligation to redeem Public Shares if entity does not complete a Business Combination (as a percent)     100.00%        
Redemption period upon closure     10 days        
Operating bank accounts     $ 10,582        
Working capital     $ (76,141)        
Initial Public Offering              
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS              
Number of units sold | shares   30,000,000          
Purchase price per unit | $ / shares $ 10.00 $ 10.00 $ 10.00        
Proceeds from issuance of initial public offering   $ 300,000,000          
Private Placement              
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS              
Purchase price per unit | $ / shares $ 10.00            
Proceeds from issuance of initial public offering $ 340,000            
Sale of an additional Private Placement Units | shares 34,000            
Private Placement | Private Placement Warrants              
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS              
Sale of Private Placement Units (in shares) | shares             839,000
Private Placement | Early Bird Capital | Private Placement Warrants              
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS              
Sale of Private Placement Units (in shares) | shares   805,000          
Price of warrant (in dollars per share) | $ / shares   $ 10.00          
Proceeds from sale of Private Placement Units   $ 8,050,000          
Partial exercise of underwriter's over-allotment option              
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS              
Number of units sold | shares 1,700,000            
Units issued aggregate amount $ 17,000,000            
XML 34 R24.htm IDEA: XBRL DOCUMENT v3.22.2.2
REVISION OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS - Schedule of impact of revision on financial statements (Details) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2022
Jun. 30, 2022
Mar. 31, 2022
Sep. 30, 2021
Jun. 30, 2021
Mar. 31, 2021
Sep. 30, 2022
Sep. 30, 2021
CONDENSED STATEMENTS OF OPERATIONS                
Change in fair value of over-allotment liability             $ 0 $ 196,475
Transaction costs allocable to representative shares             0 (68,476)
Net Loss $ 1,129,733 $ 2,107,560 $ 1,610,657 $ 3,921,124 $ (2,899,681) $ (396,332) 4,847,950 753,110
CONDENSED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT                
Issuance of Representative Shares           3,000,000 870 3,000,000
Remeasurement to amount subject to redemption 1,072,976 265,640       27,918,703   (27,918,703)
Net Loss 1,129,733 2,107,560 1,610,657 3,921,124 (2,899,681) (396,332) 4,847,950 753,110
CONDENSED STATEMENTS OF CASH FLOWS                
Change in fair value of over-allotment liability             0 (196,475)
Transaction costs allocable to representative shares             0 68,476
Net Loss $ 1,129,733 $ 2,107,560 $ 1,610,657 $ 3,921,124 $ (2,899,681) $ (396,332) $ 4,847,950 753,110
Initial classification of over-allotment Liability               294,078
As Previously Reported                
CONDENSED STATEMENTS OF OPERATIONS                
Change in fair value of over-allotment liability               0
Transaction costs allocable to representative shares               0
Net Loss               625,111
CONDENSED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT                
Issuance of Representative Shares               870
Remeasurement to amount subject to redemption               (24,791,574)
Net Loss               625,111
CONDENSED STATEMENTS OF CASH FLOWS                
Change in fair value of over-allotment liability               0
Transaction costs allocable to representative shares               0
Net Loss               625,111
Initial classification of over-allotment Liability               0
Adjustment                
CONDENSED STATEMENTS OF OPERATIONS                
Change in fair value of over-allotment liability               196,475
Transaction costs allocable to representative shares               (68,476)
Net Loss               127,999
CONDENSED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT                
Issuance of Representative Shares               2,999,130
Remeasurement to amount subject to redemption               3,127,129
Net Loss               127,999
CONDENSED STATEMENTS OF CASH FLOWS                
Change in fair value of over-allotment liability               (196,475)
Transaction costs allocable to representative shares               68,476
Net Loss               127,999
Initial classification of over-allotment Liability               $ 294,708
XML 35 R25.htm IDEA: XBRL DOCUMENT v3.22.2.2
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Dec. 31, 2021
Dec. 03, 2021
Mar. 12, 2021
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES              
Cash equivalents $ 0   $ 0   $ 0    
Transaction costs             $ 18,140,741
Other offering costs           $ 705,741 705,741
Sale of stock, other offering costs, temporary equity           234,438  
Sale of stock, other offering costs, expensed           471,303  
Underwriting fees           6,340,000 6,340,000
Deferred Offering Cost Non Current $ 11,095,000   $ 11,095,000   11,095,000 $ 11,095,000 $ 11,095,000
Effective Tax Rate 15.24% 0.00% 6.84% 0.00%      
Statutory federal income tax rate 21.00% 21.00% 21.00% 21.00%      
Unrecognized tax benefits $ 0   $ 0   0    
Unrecognized tax benefits accrued for interest and penalties $ 0   $ 0   $ 0    
Purchase of aggregate shares     8,134,750        
Number of dilutive securities 0   0   0    
XML 36 R26.htm IDEA: XBRL DOCUMENT v3.22.2.2
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Class A common stock reflected in the balance sheet (Details) - Class A common stock subject to redemption - USD ($)
9 Months Ended 12 Months Ended
Sep. 30, 2022
Dec. 31, 2021
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES    
Gross proceeds   $ 317,000,000
Proceeds allocated to Public Warrants   (7,053,250)
Class A common stock issuance costs   (20,865,453)
Remeasurement to amount subject to redemption $ 1,338,616 27,918,703
Class A common stock subject to possible redemption $ 318,338,616 $ 317,000,000
XML 37 R27.htm IDEA: XBRL DOCUMENT v3.22.2.2
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Schedule of calculation of basic and diluted net income (loss) per common share (Details) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Class A Common Stock        
Numerator:        
Allocation of net income, as adjusted $ 910,100 $ 3,158,811 $ 3,905,452 $ 572,441
Denominator:        
Basic weighted average ordinary share outstanding (in shares) 32,839,000 32,839,000 32,839,000 24,779,612
Diluted weighted average ordinary share outstanding (in shares) 32,839,000 32,839,000 32,839,000 24,779,612
Basic net income per ordinary share (in dollars per share) $ 0.03 $ 0.10 $ 0.12 $ 0.02
Diluted net income per ordinary share (in dollars per share) $ 0.03 $ 0.10 $ 0.12 $ 0.02
Class B Common Stock        
Numerator:        
Allocation of net income, as adjusted $ 219,633 $ 762,313 $ 942,498 $ 180,669
Denominator:        
Basic weighted average ordinary share outstanding (in shares) 7,925,000 7,925,000 7,925,000 7,820,696
Diluted weighted average ordinary share outstanding (in shares) 7,925,000 7,925,000 7,925,000 7,820,696
Basic net income per ordinary share (in dollars per share) $ 0.03 $ 0.10 $ 0.12 $ 0.02
Diluted net income per ordinary share (in dollars per share) $ 0.03 $ 0.10 $ 0.12 $ 0.02
XML 38 R28.htm IDEA: XBRL DOCUMENT v3.22.2.2
PUBLIC OFFERING (Details)
Mar. 12, 2021
$ / shares
shares
PUBLIC OFFERING  
Purchase price per unit | $ / shares $ 10.00
Class A Common Stock  
PUBLIC OFFERING  
Number of shares in a unit 1
Public Warrants  
PUBLIC OFFERING  
Number of warrants in a unit (in shares) 0.25
Public Warrants | Class A Common Stock  
PUBLIC OFFERING  
Number of shares issuable per warrant 1
Exercise price of warrants | $ / shares $ 11.50
Public offering  
PUBLIC OFFERING  
Number of units sold 31,700,000
Purchase price per unit | $ / shares $ 10.00
Partial Exercise of Underwriter's Over-Allotment Option [Member]  
PUBLIC OFFERING  
Number of units sold 1,700,000
XML 39 R29.htm IDEA: XBRL DOCUMENT v3.22.2.2
PRIVATE PLACEMENT (Details) - USD ($)
9 Months Ended
Mar. 12, 2021
Sep. 30, 2022
Sep. 30, 2021
Mar. 31, 2021
Mar. 08, 2021
PRIVATE PLACEMENT          
Aggregate purchase price   $ 0 $ 8,390,000    
Class A Common Stock          
PRIVATE PLACEMENT          
Number of shares in a unit 1        
Private Placement | Private Placement Units          
PRIVATE PLACEMENT          
Number of warrants in a unit (in shares) 0.25        
Private Placement | Private Placement Units | Class A Common Stock          
PRIVATE PLACEMENT          
Number of shares in a unit 1        
Private Placement | Private Placement Warrants          
PRIVATE PLACEMENT          
Warrants exercisable to purchase common stock       839,000  
Private Placement | Private Placement Warrants | Class A Common Stock          
PRIVATE PLACEMENT          
Warrants exercisable to purchase common stock 1        
Exercise price of warrants $ 11.50        
Sponsor and EarlyBirdCapital | Partial exercise of underwriter's over-allotment option | Private Placement Units          
PRIVATE PLACEMENT          
Warrants exercisable to purchase common stock 34,000        
Aggregate purchase price $ 340,000        
Sponsor and EarlyBirdCapital | Private Placement | Private Placement Units          
PRIVATE PLACEMENT          
Warrants exercisable to purchase common stock         805,000
Price of warrants (in dollars per share)         $ 10.00
Sponsor | Over-allotment option | Private Placement Units          
PRIVATE PLACEMENT          
Warrants exercisable to purchase common stock         67,500
Sponsor | Private Placement | Private Placement Units          
PRIVATE PLACEMENT          
Warrants exercisable to purchase common stock         655,000
EarlyBirdCapital,Inc. | Over-allotment option | Private Placement Units          
PRIVATE PLACEMENT          
Warrants exercisable to purchase common stock         22,500
EarlyBirdCapital,Inc. | Private Placement | Private Placement Units          
PRIVATE PLACEMENT          
Warrants exercisable to purchase common stock         150,000
XML 40 R30.htm IDEA: XBRL DOCUMENT v3.22.2.2
RELATED PARTY TRANSACTIONS - Founder Shares (Details)
3 Months Ended 9 Months Ended
Mar. 12, 2021
shares
Mar. 03, 2021
shares
Feb. 18, 2021
USD ($)
$ / shares
shares
Feb. 04, 2021
Nov. 10, 2020
USD ($)
shares
Mar. 31, 2021
USD ($)
Sep. 30, 2022
USD ($)
D
$ / shares
shares
Sep. 30, 2021
USD ($)
Dec. 31, 2021
shares
RELATED PARTY TRANSACTIONS                  
Aggregate purchase price | $           $ 3,000,000 $ 870 $ 3,000,000  
Number of shares issued (in shares)             300,000    
Class B Common Stock                  
RELATED PARTY TRANSACTIONS                  
Common shares, shares outstanding             7,925,000   7,925,000
Sponsor | Class B Common Stock                  
RELATED PARTY TRANSACTIONS                  
Stock split ratio   1.2              
Sponsor | Class B Common Stock | Independent Directors                  
RELATED PARTY TRANSACTIONS                  
Number of shares transferred (in shares)     45,000            
Number of shares grant (in shares)   54,000              
Sponsor | Class B Common Stock | D. Amsterdam                  
RELATED PARTY TRANSACTIONS                  
Number of shares transferred (in shares)     15,000            
Number of shares grant (in shares)   18,000              
Sponsor | Class B Common Stock | A. Ebush                  
RELATED PARTY TRANSACTIONS                  
Number of shares transferred (in shares)     15,000            
Number of shares grant (in shares)   18,000              
Sponsor | Class B Common Stock | A. Savar                  
RELATED PARTY TRANSACTIONS                  
Number of shares transferred (in shares)     15,000            
Number of shares grant (in shares)   18,000              
Founder Shares                  
RELATED PARTY TRANSACTIONS                  
Share, per share | $ / shares     $ 6.91            
Total aggregate value of shares | $     $ 373,140            
Stock-based compensation expense | $             $ 0    
Founder Shares | Class B Common Stock                  
RELATED PARTY TRANSACTIONS                  
Stock split ratio   1.2   1.25          
Common shares, shares outstanding   8,625,000              
Founder Shares | Sponsor                  
RELATED PARTY TRANSACTIONS                  
Percentage of issued and outstanding shares after the Initial Public Offering collectively held by initial stockholders 20.00%                
Restrictions on transfer period of time after business combination completion             1 year    
Founder Shares | Sponsor | Class B Common Stock                  
RELATED PARTY TRANSACTIONS                  
Aggregate purchase price | $         $ 25,000        
Number of shares issued (in shares)         5,750,000        
Common shares, shares outstanding 7,925,000                
Maximum shares subject to forfeiture (in shares) 700,000                
Number of shares no longer subject to forfeiture 425,000                
Number of shares forfeited 700,000                
Founder Shares | Sponsor | Class A Common Stock                  
RELATED PARTY TRANSACTIONS                  
Stock price trigger to transfer, assign or sell any shares or warrants of the company, after the completion of the initial business combination (in dollars per share) | $ / shares             $ 12.00    
Threshold trading days for transfer, assign or sale of shares or warrants, after the completion of the initial business combination | D             20    
Threshold consecutive trading days for transfer, assign or sale of shares or warrants, after the completion of the initial business combination | D             30    
Threshold period after the business combination in which the 20 trading days within any 30 trading day period commences             150 days    
XML 41 R31.htm IDEA: XBRL DOCUMENT v3.22.2.2
RELATED PARTY TRANSACTIONS (Details) - USD ($)
3 Months Ended 9 Months Ended 12 Months Ended
Mar. 08, 2021
Mar. 03, 2021
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Dec. 31, 2021
Nov. 10, 2020
RELATED PARTY TRANSACTIONS                
Repayment of promissory note - related party         $ 0 $ 200,000    
Administrative Service Agreement                
RELATED PARTY TRANSACTIONS                
Expenses per month   $ 10,000            
Expenses incurred and paid     $ 30,000 $ 30,000 90,000 $ 70,000    
Promissory Note with Related Party                
RELATED PARTY TRANSACTIONS                
Maximum borrowing capacity of related party promissory note               $ 300,000
Outstanding balance of related party note     0   0   $ 0  
Repayment of promissory note - related party $ 200,000              
Related Party Loans | Working Capital Loans                
RELATED PARTY TRANSACTIONS                
Outstanding balance of related party note     0   0   0  
Loan conversion agreement warrant     $ 1,500,000   $ 1,500,000      
Price of warrant (in dollars per share)     $ 10.00   $ 10.00      
Accrued expenses | Administrative Service Agreement                
RELATED PARTY TRANSACTIONS                
Expenses incurred and paid         $ 10,000   $ 10,000  
XML 42 R32.htm IDEA: XBRL DOCUMENT v3.22.2.2
COMMITMENTS (Details)
9 Months Ended
Mar. 12, 2021
shares
Sep. 30, 2022
USD ($)
item
D
$ / shares
shares
COMMITMENTS    
Maximum number of demands for registration of securities | item   1
Underwriting agreement option period granted | D   45
Number of units for which underwriters forfeited their option to purchase 2,800,000  
Deferred fee per unit | $ / shares   $ 0.35
Aggregate deferred underwriting fee payable | $   $ 10,500,000
Aggregate deferred underwriting fee Payable on full exercise of over allotment option | $   $ 12,075,000
Over-allotment option    
COMMITMENTS    
Number of shares granted to underwriters   4,500,000
Partial exercise of underwriter's over-allotment option    
COMMITMENTS    
Number of units sold 1,700,000  
XML 43 R33.htm IDEA: XBRL DOCUMENT v3.22.2.2
STOCKHOLDERS' DEFICIT - Preferred Stock (Details) - $ / shares
Sep. 30, 2022
Dec. 31, 2021
Mar. 08, 2021
STOCKHOLDERS' DEFICIT      
Preferred shares, shares authorized 1,000,000 1,000,000  
Preferred stock, par value, (per share) $ 0.0001 $ 0.0001  
Preferred shares, shares issued 0 0 0
Preferred shares, shares outstanding 0 0 0
XML 44 R34.htm IDEA: XBRL DOCUMENT v3.22.2.2
STOCKHOLDERS' DEFICIT - Common Stock (Details)
9 Months Ended
Sep. 30, 2022
Vote
$ / shares
shares
Dec. 31, 2021
Vote
$ / shares
shares
Class of Stock    
Ratio to be applied to the stock in the conversion 1  
Class A Common Stock    
Class of Stock    
Common shares, shares authorized (in shares) 100,000,000 100,000,000
Common shares, par value (in dollars per share) | $ / shares $ 0.0001 $ 0.0001
Common shares issued, including stocks subject to redemption (in shares) 32,839,000 32,839,000
Common shares outstanding, including stocks subject to redemption (in shares) 32,839,000 32,839,000
Class A common stock subject to redemption    
Class of Stock    
Class A common stock subject to possible redemption, issued (in shares) 31,700,000 31,700,000
Class A common stock subject to possible redemption, outstanding (in shares) 31,700,000 31,700,000
Class B Common Stock    
Class of Stock    
Common shares, shares authorized (in shares) 10,000,000 10,000,000
Common shares, par value (in dollars per share) | $ / shares $ 0.0001 $ 0.0001
Common shares, votes per share | Vote 1 1
Common shares, shares issued (in shares) 7,925,000 7,925,000
Common shares, shares outstanding (in shares) 7,925,000 7,925,000
Aggregated shares issued upon converted basis (in percent) 20.00%  
XML 45 R35.htm IDEA: XBRL DOCUMENT v3.22.2.2
WARRANTS (Details)
3 Months Ended 9 Months Ended
Mar. 31, 2021
USD ($)
Sep. 30, 2022
USD ($)
D
$ / shares
shares
Sep. 30, 2021
USD ($)
Class of Warrant or Right      
Maximum period after business combination in which to file registration statement   20 days  
Issuance of Representative Shares (in shares) | shares   300,000  
Issuance of Representative Shares | $ $ 3,000,000 $ 870 $ 3,000,000
Estimated fair value of Representative Shares | $   $ 3,000,000  
Warrants      
Class of Warrant or Right      
Threshold trading days for redemption of warrants | D   20  
Share price   $ 9.20  
Percentage of gross proceeds on total equity proceeds   50.00%  
Adjustment of exercise price of warrants based on market value and newly issued price (as a percent)   115.00%  
Adjustment one of redemption price of stock based on market value and newly issued price (as a percent)   180.00%  
Warrants | Class A Common Stock      
Class of Warrant or Right      
Share price   $ 9.20  
Warrants | Redemption of warrants when the price per Class A common stock equals or exceeds $18.00      
Class of Warrant or Right      
Stock price trigger for redemption of warrants (in dollars per share)   18.00  
Redemption price per warrant (in dollars per share)   $ 0.01  
Minimum threshold written notice period for redemption of public warrants   30 days  
Redemption period   30 days  
Threshold trading days for redemption of warrants | D   20  
Threshold consecutive trading days for redemption of warrants | D   30  
Threshold number of business days before sending notice of redemption to warrant holders | D   3  
Warrants | Redemption of warrants when the price per Class A common stock equals or exceeds $10.00      
Class of Warrant or Right      
Stock price trigger for redemption of warrants (in dollars per share)   $ 10.00  
Redemption price per warrant (in dollars per share)   $ 0.10  
Minimum threshold written notice period for redemption of public warrants   30 days  
Redemption period   30 days  
Public Warrants      
Class of Warrant or Right      
Warrant exercise period condition one   30 days  
Public Warrants expiration term   5 years  
Private Placement Warrants      
Class of Warrant or Right      
Restrictions on transfer period of time after business combination completion   30 days  
XML 46 R36.htm IDEA: XBRL DOCUMENT v3.22.2.2
FAIR VALUE MEASUREMENTS (Details) - USD ($)
Sep. 30, 2022
Dec. 31, 2021
Assets:    
Marketable securities held in Trust Account $ 318,684,239 $ 317,025,510
Liabilities:    
Warrant Liability 488,085 4,629,712
Private Placement Warrants    
Liabilities:    
Warrant Liability 10,000.00 120,000
Level 1 | Recurring    
Assets:    
Marketable securities held in Trust Account 318,684,239 317,025,510
Level 1 | Recurring | Public Warrants    
Liabilities:    
Warrant Liability 475,500 4,510,337
Level 3 | Recurring | Private Placement Warrants    
Liabilities:    
Warrant Liability $ 12,585 $ 119,375
XML 47 R37.htm IDEA: XBRL DOCUMENT v3.22.2.2
FAIR VALUE MEASUREMENTS - Initial and subsequent measurement of key inputs for Warrants (Details) - Private Placement Warrants
9 Months Ended 12 Months Ended
Sep. 30, 2022
$ / shares
Dec. 31, 2021
$ / shares
Risk-free interest rate    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis    
Public Warrants and Private Placement Warrants 0.0412 0.0119
Effective expiration date    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis    
Derivative Liability, Measurement Input 06/06/2024 7/23/2026
Dividend yield    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis    
Public Warrants and Private Placement Warrants 0.0000 0.0000
Expected volatility    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis    
Public Warrants and Private Placement Warrants 0.064 0.121
Exercise price    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis    
Public Warrants and Private Placement Warrants 11.50 11.50
Unit Price    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis    
Public Warrants and Private Placement Warrants 9.81 9.71
XML 48 R38.htm IDEA: XBRL DOCUMENT v3.22.2.2
FAIR VALUE MEASUREMENTS - Change in the Fair Value of the Warrant Liabilities (Details) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2022
Jun. 30, 2022
Mar. 31, 2022
Sep. 30, 2021
Jun. 30, 2021
Mar. 31, 2021
Sep. 30, 2022
Sep. 30, 2021
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation                
Fair Value, Liability, Recurring Basis, Unobservable Input Reconciliation, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]     Change in fair value of warrant liability          
Level 3 | Private Placement Warrants                
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation                
Fair value beginning balance $ 14,683 $ 68,904 $ 119,375 $ 253,798 $ 174,903   $ 119,375  
Change in fair value (2,098) (54,221) (50,471) (109,070) 79,705 $ (12,585)    
Fair value ending balance 12,585 $ 14,683 $ 68,904 144,728 253,798 174,903 12,585 $ 144,728
Level 3 | Private Placement Warrants | Initial Public Offering                
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation                
Issuance of warrants           179,113    
Level 3 | Private Placement Warrants | Over-allotment option                
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation                
Issuance of warrants           7,565    
Level 3 | Public Warrants                
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation                
Fair value beginning balance         6,577,750      
Change in fair value         3,011,500 (475,500)    
Transfer from Level 3 to Level 1 $ 0     $ (9,589,250) $ (9,589,250)   $ 0 $ (9,589,250)
Fair value ending balance           6,577,750    
Level 3 | Public Warrants | Initial Public Offering                
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation                
Issuance of warrants           6,675,000    
Level 3 | Public Warrants | Over-allotment option                
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation                
Issuance of warrants           $ 378,250    
XML 49 R39.htm IDEA: XBRL DOCUMENT v3.22.2.2
FAIR VALUE MEASUREMENTS - Additional Information (Details) - USD ($)
3 Months Ended 9 Months Ended
Mar. 12, 2021
Sep. 30, 2022
Sep. 30, 2021
Jun. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Dec. 31, 2021
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis              
Aggregate values of Warrants   $ 488,085     $ 488,085   $ 4,629,712
Class A Common Stock              
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis              
Number of shares in a unit 1            
Public Warrants              
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis              
Number of warrants in a unit (in shares) 0.25            
Public Warrants | Level 3              
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis              
Transfers from Level 3   0 $ 9,589,250 $ 9,589,250 0 $ 9,589,250  
Private Placement Warrants              
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis              
Aggregate values of Warrants   $ 10,000.00     $ 10,000.00   $ 120,000
XML 50 psagu-20220930x10q_htm.xml IDEA: XBRL DOCUMENT 0001833235 psagu:PublicWarrantsMember 2022-09-30 0001833235 psagu:CommonClassaSubjectToRedemptionMember 2022-09-30 0001833235 psagu:CommonClassaSubjectToRedemptionMember 2021-12-31 0001833235 psagu:CommonClassaSubjectToRedemptionMember 2022-01-01 2022-09-30 0001833235 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2021-01-01 2021-03-31 0001833235 psagu:FounderSharesMember psagu:PropertySolutionsAcquisitionSponsorIiLlcMember us-gaap:CommonClassBMember 2020-11-10 2020-11-10 0001833235 psagu:PropertySolutionsAcquisitionSponsorIiLlcMember us-gaap:CommonClassBMember 2021-03-03 2021-03-03 0001833235 psagu:FounderSharesMember us-gaap:CommonClassBMember 2021-03-03 2021-03-03 0001833235 psagu:FounderSharesMember us-gaap:CommonClassBMember 2021-02-04 2021-02-04 0001833235 us-gaap:RetainedEarningsMember 2022-09-30 0001833235 us-gaap:RetainedEarningsMember 2022-06-30 0001833235 2022-06-30 0001833235 us-gaap:RetainedEarningsMember 2022-03-31 0001833235 2022-03-31 0001833235 us-gaap:RetainedEarningsMember 2021-12-31 0001833235 us-gaap:RetainedEarningsMember 2021-09-30 0001833235 us-gaap:AdditionalPaidInCapitalMember 2021-09-30 0001833235 us-gaap:RetainedEarningsMember 2021-06-30 0001833235 us-gaap:AdditionalPaidInCapitalMember 2021-06-30 0001833235 2021-06-30 0001833235 us-gaap:RetainedEarningsMember 2021-03-31 0001833235 us-gaap:AdditionalPaidInCapitalMember 2021-03-31 0001833235 2021-03-31 0001833235 us-gaap:RetainedEarningsMember 2020-12-31 0001833235 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001833235 psagu:PublicWarrantsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2022-09-30 0001833235 psagu:PrivatePlacementWarrantsMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2022-09-30 0001833235 psagu:PrivatePlacementWarrantsMember 2022-09-30 0001833235 psagu:PublicWarrantsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001833235 psagu:PrivatePlacementWarrantsMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001833235 psagu:PrivatePlacementWarrantsMember 2021-12-31 0001833235 us-gaap:IPOMember 2022-09-30 0001833235 us-gaap:PrivatePlacementMember 2021-03-12 0001833235 us-gaap:IPOMember 2021-03-12 0001833235 psagu:PublicOfferingMember 2021-03-12 0001833235 us-gaap:IPOMember 2021-03-08 0001833235 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2022-09-30 0001833235 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2022-09-30 0001833235 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2022-06-30 0001833235 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2022-06-30 0001833235 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2022-03-31 0001833235 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2022-03-31 0001833235 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2021-12-31 0001833235 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2021-12-31 0001833235 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2021-09-30 0001833235 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2021-09-30 0001833235 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2021-06-30 0001833235 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2021-06-30 0001833235 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2021-03-31 0001833235 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2021-03-31 0001833235 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2020-12-31 0001833235 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2020-12-31 0001833235 us-gaap:WarrantMember us-gaap:CommonClassAMember 2022-09-30 0001833235 us-gaap:WarrantMember 2022-09-30 0001833235 psagu:FounderSharesMember 2021-02-18 2021-02-18 0001833235 psagu:FounderSharesMember 2021-02-18 0001833235 psagu:IndependentDirectorsMember psagu:PropertySolutionsAcquisitionSponsorIiLlcMember us-gaap:CommonClassBMember 2021-03-03 2021-03-03 0001833235 psagu:D.AmsterdamMember psagu:PropertySolutionsAcquisitionSponsorIiLlcMember us-gaap:CommonClassBMember 2021-03-03 2021-03-03 0001833235 psagu:A.SavarMember psagu:PropertySolutionsAcquisitionSponsorIiLlcMember us-gaap:CommonClassBMember 2021-03-03 2021-03-03 0001833235 psagu:A.EbushMember psagu:PropertySolutionsAcquisitionSponsorIiLlcMember us-gaap:CommonClassBMember 2021-03-03 2021-03-03 0001833235 psagu:IndependentDirectorsMember psagu:PropertySolutionsAcquisitionSponsorIiLlcMember us-gaap:CommonClassBMember 2021-02-18 2021-02-18 0001833235 psagu:D.AmsterdamMember psagu:PropertySolutionsAcquisitionSponsorIiLlcMember us-gaap:CommonClassBMember 2021-02-18 2021-02-18 0001833235 psagu:A.SavarMember psagu:PropertySolutionsAcquisitionSponsorIiLlcMember us-gaap:CommonClassBMember 2021-02-18 2021-02-18 0001833235 psagu:A.EbushMember psagu:PropertySolutionsAcquisitionSponsorIiLlcMember us-gaap:CommonClassBMember 2021-02-18 2021-02-18 0001833235 psagu:PromissoryNoteWithRelatedPartyMember 2021-03-08 2021-03-08 0001833235 psagu:AdministrativeSupportAgreementMember 2022-07-01 2022-09-30 0001833235 us-gaap:AccruedLiabilitiesMember psagu:AdministrativeSupportAgreementMember 2022-01-01 2022-09-30 0001833235 psagu:AdministrativeSupportAgreementMember 2022-01-01 2022-09-30 0001833235 psagu:AdministrativeSupportAgreementMember 2021-07-01 2021-09-30 0001833235 us-gaap:AccruedLiabilitiesMember psagu:AdministrativeSupportAgreementMember 2021-01-01 2021-12-31 0001833235 psagu:AdministrativeSupportAgreementMember 2021-01-01 2021-09-30 0001833235 psagu:PrivatePlacementUnitsMember psagu:PropertySolutionsAcquisitionSponsorIiLlcAndEarlybirdcapitalInc.Member psagu:PartialExerciseOfUnderwritersOverAllotmentOptionMember 2021-03-12 2021-03-12 0001833235 psagu:PrivatePlacementWarrantsMember us-gaap:PrivatePlacementMember psagu:EarlyBirdCapitalIncMember 2021-03-08 2021-03-08 0001833235 2021-03-08 0001833235 psagu:PromissoryNoteWithRelatedPartyMember 2022-09-30 0001833235 psagu:WorkingCapitalLoansWarrantMember psagu:RelatedPartyLoansMember 2021-12-31 0001833235 psagu:PromissoryNoteWithRelatedPartyMember 2021-12-31 0001833235 us-gaap:RetainedEarningsMember 2022-07-01 2022-09-30 0001833235 us-gaap:RetainedEarningsMember 2022-04-01 2022-06-30 0001833235 2022-04-01 2022-06-30 0001833235 us-gaap:RetainedEarningsMember 2022-01-01 2022-03-31 0001833235 us-gaap:RetainedEarningsMember 2021-07-01 2021-09-30 0001833235 us-gaap:AdditionalPaidInCapitalMember 2021-07-01 2021-09-30 0001833235 us-gaap:RetainedEarningsMember 2021-04-01 2021-06-30 0001833235 us-gaap:AdditionalPaidInCapitalMember 2021-04-01 2021-06-30 0001833235 2021-04-01 2021-06-30 0001833235 2022-01-01 2022-03-31 0001833235 psagu:PrivatePlacementWarrantsMember us-gaap:FairValueInputsLevel3Member 2022-09-30 0001833235 psagu:PrivatePlacementWarrantsMember us-gaap:FairValueInputsLevel3Member 2022-06-30 0001833235 psagu:PrivatePlacementWarrantsMember us-gaap:FairValueInputsLevel3Member 2022-03-31 0001833235 psagu:PrivatePlacementWarrantsMember us-gaap:FairValueInputsLevel3Member 2021-12-31 0001833235 psagu:PrivatePlacementWarrantsMember us-gaap:FairValueInputsLevel3Member 2021-09-30 0001833235 psagu:PrivatePlacementWarrantsMember us-gaap:FairValueInputsLevel3Member 2021-06-30 0001833235 psagu:PublicWarrantsMember us-gaap:FairValueInputsLevel3Member 2021-03-31 0001833235 psagu:PrivatePlacementWarrantsMember us-gaap:FairValueInputsLevel3Member 2021-03-31 0001833235 psagu:PublicWarrantsMember us-gaap:FairValueInputsLevel3Member us-gaap:OverAllotmentOptionMember 2021-01-01 2021-03-31 0001833235 psagu:PublicWarrantsMember us-gaap:FairValueInputsLevel3Member us-gaap:IPOMember 2021-01-01 2021-03-31 0001833235 psagu:PrivatePlacementWarrantsMember us-gaap:FairValueInputsLevel3Member us-gaap:OverAllotmentOptionMember 2021-01-01 2021-03-31 0001833235 psagu:PrivatePlacementWarrantsMember us-gaap:FairValueInputsLevel3Member us-gaap:IPOMember 2021-01-01 2021-03-31 0001833235 psagu:PrivatePlacementWarrantsMember us-gaap:FairValueInputsLevel3Member 2022-07-01 2022-09-30 0001833235 psagu:PrivatePlacementWarrantsMember us-gaap:FairValueInputsLevel3Member 2022-04-01 2022-06-30 0001833235 psagu:PrivatePlacementWarrantsMember us-gaap:FairValueInputsLevel3Member 2022-01-01 2022-03-31 0001833235 psagu:PrivatePlacementWarrantsMember us-gaap:FairValueInputsLevel3Member 2021-07-01 2021-09-30 0001833235 psagu:PrivatePlacementWarrantsMember us-gaap:FairValueInputsLevel3Member 2021-04-01 2021-06-30 0001833235 psagu:PublicWarrantsMember us-gaap:FairValueInputsLevel3Member 2021-01-01 2021-03-31 0001833235 psagu:PrivatePlacementWarrantsMember us-gaap:FairValueInputsLevel3Member 2021-01-01 2021-03-31 0001833235 psagu:PublicWarrantsMember us-gaap:FairValueInputsLevel3Member 2022-07-01 2022-09-30 0001833235 psagu:PublicWarrantsMember us-gaap:FairValueInputsLevel3Member 2022-01-01 2022-09-30 0001833235 psagu:PublicWarrantsMember us-gaap:FairValueInputsLevel3Member 2021-07-01 2021-09-30 0001833235 psagu:PublicWarrantsMember us-gaap:FairValueInputsLevel3Member 2021-04-01 2021-06-30 0001833235 psagu:PublicWarrantsMember us-gaap:FairValueInputsLevel3Member 2021-01-01 2021-09-30 0001833235 us-gaap:CommonClassBMember 2022-07-01 2022-09-30 0001833235 us-gaap:CommonClassAMember 2022-07-01 2022-09-30 0001833235 us-gaap:CommonClassBMember 2022-01-01 2022-09-30 0001833235 us-gaap:CommonClassBMember 2021-07-01 2021-09-30 0001833235 us-gaap:CommonClassAMember 2021-07-01 2021-09-30 0001833235 us-gaap:CommonClassBMember 2021-01-01 2021-09-30 0001833235 us-gaap:CommonClassAMember 2021-01-01 2021-09-30 0001833235 psagu:PrivatePlacementWarrantsMember us-gaap:MeasurementInputSharePriceMember 2022-09-30 0001833235 psagu:PrivatePlacementWarrantsMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2022-09-30 0001833235 psagu:PrivatePlacementWarrantsMember us-gaap:MeasurementInputPriceVolatilityMember 2022-09-30 0001833235 psagu:PrivatePlacementWarrantsMember us-gaap:MeasurementInputExpectedDividendRateMember 2022-09-30 0001833235 psagu:PrivatePlacementWarrantsMember us-gaap:MeasurementInputExercisePriceMember 2022-09-30 0001833235 psagu:PrivatePlacementWarrantsMember us-gaap:MeasurementInputSharePriceMember 2021-12-31 0001833235 psagu:PrivatePlacementWarrantsMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2021-12-31 0001833235 psagu:PrivatePlacementWarrantsMember us-gaap:MeasurementInputPriceVolatilityMember 2021-12-31 0001833235 psagu:PrivatePlacementWarrantsMember us-gaap:MeasurementInputExpectedDividendRateMember 2021-12-31 0001833235 psagu:PrivatePlacementWarrantsMember us-gaap:MeasurementInputExercisePriceMember 2021-12-31 0001833235 psagu:FounderSharesMember us-gaap:CommonClassBMember 2021-03-03 0001833235 psagu:CommonClassaNotSubjectToRedemptionMember 2022-09-30 0001833235 psagu:CommonClassaNotSubjectToRedemptionMember 2021-12-31 0001833235 psagu:PrivatePlacementWarrantsMember us-gaap:PrivatePlacementMember 2021-03-31 0001833235 psagu:PrivatePlacementUnitsMember psagu:PropertySolutionsAcquisitionSponsorIiLlcAndEarlybirdcapitalInc.Member psagu:PartialExerciseOfUnderwritersOverAllotmentOptionMember 2021-03-12 0001833235 psagu:PrivatePlacementUnitsMember psagu:PropertySolutionsAcquisitionSponsorIiLlcMember us-gaap:PrivatePlacementMember 2021-03-08 0001833235 psagu:PrivatePlacementUnitsMember psagu:PropertySolutionsAcquisitionSponsorIiLlcMember us-gaap:OverAllotmentOptionMember 2021-03-08 0001833235 psagu:PrivatePlacementUnitsMember psagu:EarlybirdcapitalInc.Member us-gaap:PrivatePlacementMember 2021-03-08 0001833235 psagu:PrivatePlacementUnitsMember psagu:EarlybirdcapitalInc.Member us-gaap:OverAllotmentOptionMember 2021-03-08 0001833235 psagu:PrivatePlacementWarrantsMember us-gaap:CommonClassAMember us-gaap:PrivatePlacementMember 2021-03-12 0001833235 psagu:PublicWarrantsMember us-gaap:CommonClassAMember 2021-03-12 0001833235 2021-09-30 0001833235 2020-12-31 0001833235 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2022-09-30 0001833235 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001833235 psagu:FounderSharesMember 2022-01-01 2022-09-30 0001833235 psagu:PublicWarrantsMember 2022-01-01 2022-09-30 0001833235 us-gaap:RetainedEarningsMember 2021-01-01 2021-03-31 0001833235 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-03-31 0001833235 2021-01-01 2021-03-31 0001833235 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2021-01-01 2021-03-31 0001833235 psagu:PublicOfferingMember 2021-03-12 2021-03-12 0001833235 psagu:PartialExerciseOfUnderwritersOverAllotmentOptionMember 2021-03-12 2021-03-12 0001833235 us-gaap:IPOMember 2021-03-08 2021-03-08 0001833235 us-gaap:PrivatePlacementMember 2021-03-12 2021-03-12 0001833235 psagu:FounderSharesMember psagu:PropertySolutionsAcquisitionSponsorIiLlcMember us-gaap:CommonClassAMember 2022-01-01 2022-09-30 0001833235 us-gaap:OverAllotmentOptionMember 2022-01-01 2022-09-30 0001833235 psagu:FounderSharesMember psagu:PropertySolutionsAcquisitionSponsorIiLlcMember 2022-01-01 2022-09-30 0001833235 psagu:PrivatePlacementWarrantsMember 2022-01-01 2022-09-30 0001833235 psagu:AdministrativeSupportAgreementMember 2021-03-03 2021-03-03 0001833235 psagu:CommonClassaSubjectToRedemptionMember 2021-01-01 2021-12-31 0001833235 psagu:FounderSharesMember psagu:PropertySolutionsAcquisitionSponsorIiLlcMember 2021-03-12 2021-03-12 0001833235 psagu:PrivatePlacementUnitsMember us-gaap:PrivatePlacementMember 2021-03-12 2021-03-12 0001833235 psagu:PublicWarrantsMember 2021-03-12 2021-03-12 0001833235 2021-03-12 2021-03-12 0001833235 psagu:PrivatePlacementUnitsMember us-gaap:CommonClassAMember us-gaap:PrivatePlacementMember 2021-03-12 2021-03-12 0001833235 us-gaap:CommonClassAMember 2021-03-12 2021-03-12 0001833235 psagu:FounderSharesMember psagu:PropertySolutionsAcquisitionSponsorIiLlcMember us-gaap:CommonClassBMember 2021-03-12 0001833235 psagu:PromissoryNoteWithRelatedPartyMember 2020-11-10 0001833235 srt:ScenarioPreviouslyReportedMember 2021-01-01 2021-09-30 0001833235 srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember 2021-01-01 2021-09-30 0001833235 2022-07-01 2022-09-30 0001833235 2021-07-01 2021-09-30 0001833235 psagu:PrivatePlacementWarrantsMember us-gaap:MeasurementInputMaturityMember 2022-01-01 2022-09-30 0001833235 psagu:PrivatePlacementWarrantsMember us-gaap:MeasurementInputMaturityMember 2021-01-01 2021-12-31 0001833235 2021-12-31 0001833235 2021-12-03 0001833235 2021-03-12 0001833235 2022-09-30 0001833235 us-gaap:CommonClassAMember 2022-09-30 0001833235 us-gaap:CommonClassAMember 2021-12-31 0001833235 us-gaap:CommonClassBMember 2022-09-30 0001833235 us-gaap:CommonClassBMember 2021-12-31 0001833235 psagu:WorkingCapitalLoansWarrantMember psagu:RelatedPartyLoansMember 2022-09-30 0001833235 psagu:PrivatePlacementUnitsMember psagu:PropertySolutionsAcquisitionSponsorIiLlcAndEarlybirdcapitalInc.Member us-gaap:PrivatePlacementMember 2021-03-08 0001833235 psagu:PrivatePlacementWarrantsMember us-gaap:PrivatePlacementMember psagu:EarlyBirdCapitalIncMember 2021-03-08 0001833235 psagu:RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member us-gaap:WarrantMember 2022-01-01 2022-09-30 0001833235 psagu:RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member us-gaap:WarrantMember 2022-01-01 2022-09-30 0001833235 us-gaap:WarrantMember 2022-01-01 2022-09-30 0001833235 2021-01-01 2021-09-30 0001833235 us-gaap:CommonClassAMember 2022-01-01 2022-09-30 0001833235 psagu:WarrantsEachWholeWarrantExercisableForOneShareOfClassCommonStockAtExercisePriceMember 2022-01-01 2022-09-30 0001833235 psagu:UnitsEachConsistingOfOneShareOfClassCommonStockAndOneFourthOfOneWarrantMember 2022-01-01 2022-09-30 0001833235 us-gaap:CommonClassBMember 2022-11-18 0001833235 us-gaap:CommonClassAMember 2022-11-18 0001833235 psagu:UnitsEachConsistingOfOneShareOfClassCommonStockAndOneFourthOfOneWarrantMember 2022-11-18 0001833235 2022-01-01 2022-09-30 shares iso4217:USD pure iso4217:USD shares psagu:D psagu:Vote psagu:item 32839000 32839000 32839000 24779612 7925000 7925000 7925000 7820696 0001833235 --12-31 Q3 false 2022 0 0 1139000 1139000 7925000 7925000 32839000 7925000 32839000 7925000 32839000 7925000 24779612 7820696 32839000 32839000 0 0 7925000 7925000 31700000 31700000 0.03 0.10 0.12 0.02 0.03 0.10 0.12 0.02 P10D 0.03 0.03 0.10 0.10 0.12 0.12 0.02 0.02 0.25 0.25 15000 15000 18000 18000 0 P30D P30D 0.25 http://fasb.org/us-gaap/2022#FairValueAdjustmentOfWarrants 10-Q true 2022-09-30 false 001-40087 PROPERTY SOLUTIONS ACQUISITION CORP. II DE 85-3851769 654 Madison Avenue, Suite 1009 New York NY 10065 646 502-9845 Units, each consisting of one share ofClass A Common Stock, and one-fourth of one Warrant to acquire oneshare of Class A Common Stock PSAGU NASDAQ Class A Common Stock, par value $0.0001 per share PSAG NASDAQ Warrants, each whole Warrantexercisable for one share of Class ACommon Stock at an exercise price of $11.50 PSAGW NASDAQ Yes Yes Non-accelerated Filer true true false true 3334749 29504251 7925000 10582 531984 105517 209207 116099 741191 0 34590 318684239 317025510 318800338 317801291 222028 285139 355835 0 577863 285139 488085 4629712 11095000 11095000 11985498 16009851 0.0001 0.0001 31700000 31700000 10.04 10.00 318338616 317000000 0.0001 0.0001 1000000 1000000 0 0 0 0 0.0001 0.0001 100000000 100000000 1139000 1139000 31700000 31700000 114 114 0.0001 0.0001 10000000 10000000 7925000 7925000 793 793 0 0 -11700133 -15209467 -11699226 -15208560 318800338 317801291 227288 313026 938389 619403 -227288 -313026 -938389 -619403 1297528 4080 1973888 20391 181283 0 26659 0 68476 196475 -81348 -4230070 -4141627 -1626950 0 0 0 402827 1560159 4234150 6142174 1372513 1332871 3921124 5203785 753110 203138 355835 1129733 3921124 4847950 753110 32839000 32839000 32839000 24779612 0.03 0.10 0.12 0.02 7925000 7925000 7925000 7820696 0.03 0.10 0.12 0.02 1139000 114 7925000 793 -15209467 -15208560 1610657 1610657 1139000 114 7925000 793 -13598810 -13597903 265640 265640 2107560 2107560 1139000 114 7925000 793 -11756890 -11755983 1072976 1072976 1129733 1129733 1139000 114 7925000 793 -11700133 -11699226 0 0 8625000 863 24137 -1540 23460 839000 839000 84 8203648 0 8203732 300000 30 2999970 0 3000000 700000 70 -70 0 11227825 16690878 27918703 0 -396332 -396332 1139000 114 7925000 793 0 -17088750 -17087843 0 -2899681 -2899681 1139000 114 7925000 793 0 -19988431 -19987524 0 3921124 3921124 1139000 114 7925000 793 0 -16067307 -16066400 4847950 753110 1973888 20391 26659 -4141627 -1626950 0 196475 0 68476 0 402827 -138280 311182 -63111 191548 355835 -863220 -739037 0 317000000 -341818 341818 -317000000 0 310660000 0 8390000 0 870 0 200000 0 634441 0 318216429 -521402 477392 531984 165000 10582 642392 0 358417 0 7053250 186678 294078 0 11095000 70 1338616 0 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">NOTE 1. DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">Property Solutions Acquisition Corp. II (the “Company”) was incorporated in Delaware on October 29, 2020. The Company is a blank check company formed for the purpose of entering into a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or other similar business combination with one or more businesses or entities (the “Business Combination”).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">The Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">As of September 30, 2022, the Company had not commenced any operations. All activity through September 30, 2022 relates to the Company’s formation, initial public offering (“Initial Public Offering”), which is described below, and subsequent to the Initial Public Offering, identifying a target company for a Business Combination. The Company will not generate any operating revenues until after the completion of a Business Combination, at the earliest. The Company will generate non-operating income in the form of interest income from the proceeds derived from the Initial Public Offering. The Company has selected December 31 as its fiscal year end.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">The registration statement for the Company’s Initial Public Offering was declared effective on March 3, 2021. On March 8, 2021, the Company consummated the Initial Public Offering of 30,000,000 units (the “Units” and, with respect to the shares of Class A common stock included in the Units sold, the “Public Shares”), at $10.00 per Unit, generating gross proceeds of $300,000,000, which is described in Note 4.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">Simultaneously with the closing of the Initial Public Offering, the Company consummated the sale of 805,000 units (the “Private Placement Units”) at a price of $10.00 per Private Placement Unit in a private placement to Property Solutions Acquisition Sponsor II, LLC (the “Sponsor”) and EarlyBirdCapital, Inc. (“EarlyBirdCapital”), generating gross proceeds of $8,050,000, which is described in Note 5.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">On March 12, 2021, the underwriters partially exercised their over-allotment option (see Note 4), resulting in an additional 1,700,000 Units issued for an aggregate amount of $17,000,000. In connection with the underwriters’ partial exercise of their over-allotment option, the Company also consummated the sale of an additional 34,000 Private Placement Units at $10.00 per Private Placement Unit, generating total proceeds of $340,000 (see Note 5).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">Transaction costs amounted to $18,140,741, consisting of $6,340,000 of underwriting fees, $11,095,000 of deferred underwriting fees and $705,741 of other offering costs.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">Following the closing of the Initial Public Offering on March 8, 2021 and the partial exercise of the underwriter’s over-allotment option on March 12, 2021, an amount of $317,000,000 ($10.00 per Unit) from the net proceeds of the sale of the Units in the Initial Public Offering and the sale of the Private Placement Units was placed in a trust account (the “Trust Account”), and are invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act of 1940, as amended (the “Investment Company Act”), with a maturity of 185 days or less, or in any open-ended investment company that holds itself out as a money market fund meeting the conditions of Rule 2a-7 of the Investment Company Act, as determined by the Company, until the earlier of: (i) the consummation of a Business Combination or (ii) the distribution of the funds in the Trust Account, as described below.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of the Private Placement Units, although substantially all of the net proceeds are intended to be applied generally toward completing a Business Combination. The Company must complete a Business Combination having an aggregate fair market value of at least 80% of the assets held in the Trust Account (excluding deferred underwriting commissions and taxes payable on income earned on the Trust Account) at the time of the agreement to enter into an initial Business Combination. The Company will only complete a Business Combination if the post Business Combination company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act. There is no assurance that the Company will be able to successfully complete a Business Combination.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">The Company will provide its stockholders with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a stockholder meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek stockholder approval of a Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The public stockholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then in the Trust Account (initially anticipated to be $10.00 per Public Share, plus any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations). There will be no redemption rights upon the completion of a Business Combination with respect to the Company’s warrants.</p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><span style="font-size:10pt;">The Company will proceed with a Business Combination if the Company has net tangible assets of at least </span><span style="font-size:10pt;">$5,000,001</span><span style="font-size:10pt;"> immediately prior to or upon such consummation of a Business Combination and, if the Company seeks stockholder approval, a majority of the shares voted are voted in favor of the Business Combination. If a stockholder vote is not required by law and the Company does not decide to hold a stockholder vote for business or other legal reasons, the Company will, pursuant to its Amended and Restated Certificate of Incorporation (the “Amended and Restated Certificate of Incorporation”), conduct the redemptions pursuant to the tender offer rules of the U.S. Securities and Exchange Commission (the “SEC”) and file tender offer documents with the SEC containing substantially the same information as would be included in a proxy statement prior to completing a Business Combination. If, however, stockholder approval of the transaction is required by law, or the Company decides to obtain stockholder approval for business or legal reasons, the Company will offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. If the Company seeks stockholder approval in connection with a Business Combination, the Sponsor and EarlyBirdCapital have agreed to vote their Founder Shares (as defined in Note 6), Representative Shares (as defined in Note 7), Private Shares (as defined in Note 5) and any Public Shares purchased during or after the Initial Public Offering (a) in favor of approving a Business Combination and (b) not to convert any shares in connection with a stockholder vote to approve a Business Combination or sell any shares to the Company in a tender offer in connection with a Business Combination. Additionally, public stockholders may elect to redeem their Public Shares,</span> without voting, and if they do vote,<span style="font-size:10pt;"> irrespective of whether they vote for or against the proposed Business Combination.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">The Sponsor has agreed (a) to waive its redemption rights with respect to the Founder Shares, Private Shares and Public Shares held by it in connection with the completion of a Business Combination and (b) not to propose an amendment to the Amended and Restated Certificate of Incorporation that would affect a public stockholders’ ability to convert or sell their shares to the Company in connection with a Business Combination or affect the substance or timing of the Company’s obligation to redeem 100% of its Public Shares if the Company does not complete a Business Combination, unless the Company provides the public stockholders with the opportunity to redeem their Public Shares in conjunction with any such amendment.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">The Company will have until March 8, 2023 to complete a Business Combination (the “Combination Period”). If the Company is unable to complete a Business Combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than <span style="-sec-ix-hidden:Hidden_un6-D6x8AUS886s0HHcAOA;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">ten</span></span> business days thereafter, redeem the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account including interest earned on the funds held in the Trust Account and not previously released to the Company to pay taxes, divided by the number of then outstanding Public Shares, which redemption will completely extinguish public stockholders’ rights as stockholders (including the right to receive further liquidating distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company’s remaining stockholders and the Company’s board of directors, dissolve and liquidate, subject in each case to the Company’s obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law. There will be no redemption rights or liquidating distributions with respect to the Company’s warrants, which will expire worthless if the Company fails to complete a Business Combination within the Combination Period.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">The Sponsor and EarlyBirdCapital have agreed to waive their liquidation rights with respect to the Founder Shares, Representative Shares and Private Shares if the Company fails to complete a Business Combination within the Combination Period. However, if the Sponsor or EarlyBirdCapital acquire Public Shares in or after the Initial Public Offering, such Public Shares will be entitled to liquidating distributions from the Trust Account if the Company fails to complete a Business Combination within the Combination Period. The underwriter has agreed to waive its rights to the deferred underwriting commission (see Note 7) held in the Trust Account in the event the Company does not complete a Business Combination within the Combination Period and, in such event, such amounts will be included with the funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the assets remaining available for distribution will be less than the Initial Public Offering price per Unit ($10.00).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">In order to protect the amounts held in the Trust Account, the Sponsor has agreed to be liable to the Company if and to the extent any claims by a vendor for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account to below $10.00 per Public Share, except as to any claims by a third party who executed a valid and enforceable agreement with the Company waiving any right, title, interest or claim of any kind they may have in or to any monies held in the Trust Account and except as to any claims under the Company’s indemnity of the underwriters of Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers, prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Liquidity and Going Concern</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">As of September 30, 2022, the Company had $10,582 in its operating bank accounts and working capital deficit of $76,141, when accounting for the Company’s ability to use interest income to pay towards tax liabilities.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">Until the consummation of a Business Combination, the Company will be using the funds not held in the Trust Account for identifying and evaluating prospective acquisition candidates, performing due diligence on prospective target businesses, paying for travel expenditures, selecting the target business to acquire, and structuring, negotiating and consummating the Business Combination.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">The Company will need to raise further additional capital through loans or additional investments from its Sponsor, stockholders, officers, directors, or third parties. In addition to the loan commitment described herein, the Company’s officers, directors and Sponsor may, but are not obligated to, loan the Company funds, from time to time or at any time, in whatever amount they deem reasonable in their sole discretion, to meet the Company’s working capital needs. Accordingly, the Company may not be able to obtain additional financing. If the Company is unable to raise additional capital, it may be required to take additional measures to conserve liquidity, which could include, but not necessarily be limited to, curtailing operations, suspending the pursuit of a potential transaction, and reducing overhead expenses. The Company cannot provide any assurance that new financing will be available to it on commercially acceptable terms, if at all. These conditions raise substantial doubt about the Company’s ability to continue as a going concern through March 8, 2023, the Company’s liquidation date, and/or through twelve months from the issuance of these financial statements. These financial statements do not include any adjustments relating to the recovery of the recorded assets or the classification of the liabilities that might be necessary should the Company be unable to continue as a going concern.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Risks and Uncertainties</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">Management continues to evaluate the impact of the COVID-19 pandemic and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company’s financial position and/or search for a target company, the specific impact is not readily determinable as of the date of the financial statement. The financial statement does not include any adjustments that might result from the outcome of this uncertainty.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">In February 2022, the Russian Federation and Belarus commenced a military action with the country of Ukraine. As a result of this action, various nations, including the United States, have instituted economic sanctions against the Russian Federation and Belarus. Further, the impact of this action and related sanctions on the world economy are not determinable as of the date of these financial statements. The specific impact on the Company’s financial condition, results of operations, and cash flows is also not determinable as of the date of these financial statements.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Inflation Reduction Act of 2022</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">On August 16, 2022, the Inflation Reduction Act of 2022 (the “IR Act”) was signed into federal law. The IR Act provides for, among other things, a new U.S. federal 1% excise tax on certain repurchases of stock by publicly traded U.S. domestic corporations and certain U.S. domestic subsidiaries of publicly traded foreign corporations occurring on or after January 1, 2023. The excise tax is imposed on the repurchasing corporation itself, not its shareholders from which shares are repurchased. The amount of the excise tax is generally 1% of the fair market value of the shares repurchased at the time of the repurchase. However, for purposes of calculating the excise tax, repurchasing corporations are permitted to net the fair market value of certain new stock issuances against the fair market value of stock repurchases during the same taxable year. In addition, certain exceptions apply to the excise tax. The U.S. Department of the Treasury (the “Treasury”) has been given authority to provide regulations and other guidance to carry out and prevent the abuse or avoidance of the excise tax.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">Any redemption or other repurchase that occurs after December 31, 2022, in connection with a Business Combination, extension vote or otherwise, may be subject to the excise tax. Whether and to what extent the Company would be subject to the excise tax in connection with a Business Combination, extension vote or otherwise would depend on a number of factors, including (i) the fair market value of the redemptions and repurchases in connection with the Business Combination, extension or otherwise, (ii) the structure of a Business Combination, (iii) the nature and amount of any “PIPE” or other equity issuances in connection with a Business Combination (or otherwise issued not in connection with a Business Combination but issued within the same taxable year of a Business Combination) and (iv) the content of regulations and other guidance from the Treasury. In addition, because the excise tax would be payable by the Company and not by the redeeming holder, the mechanics of any required payment of the excise tax have not been determined. The foregoing could cause a reduction in the cash available on hand to complete a Business Combination and in the Company’s ability to complete a Business Combination.</p> 1 30000000 10.00 300000000 805000 10.00 8050000 1700000 17000000 34000 10.00 340000 18140741 6340000 11095000 705741 317000000 10.00 80 50 10.00 5000001 1 10.00 10.00 10582 -76141 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">NOTE 2. REVISION OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">In connection with the preparation of the Company’s financial statements as of December 31, 2021, Management identified errors made in its historical financial statements where, at the closing of the Company’s Initial Public Offering, the Company did not record a liability related to the underwriter’s option to exercise their over-allotment. Additionally, the Company did not appropriately apply the correct equity presentation or allocation of offering costs related to the Company’s issued representative shares, furthermore, the Company has revised operating costs for the nine months ended September 30, 2021, due to a reclassification of legal expenses between quarters. These errors were recorded and presented within the financial statements as of December 31, 2021. This revision note is presenting the changes from the previously reported balances to the adjusted balances as of and for the nine months ended September 30, 2021 for comparative purposes of these condensed financial statements. These errors resulted in an adjustment to the net income.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">The impact of the revision on the Company’s financial statements is reflected in the following table.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:62.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:62.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As Previously</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:62.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Statement of Operations for the Nine Months Ended September 30, 2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.53%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Reported</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.53%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Adjustment</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As Revised</b></p></td></tr><tr><td style="vertical-align:bottom;width:62.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Change in fair value of over-allotment liability</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 196,475</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 196,475</p></td></tr><tr><td style="vertical-align:bottom;width:62.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Transaction costs allocable to representative shares</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (68,476)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (68,476)</p></td></tr><tr><td style="vertical-align:bottom;width:62.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Net Loss</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 625,111</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 127,999</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 753,110</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:62.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.08%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:62.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As Previously</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:62.34%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Statement of Stockholders’ Deficit for the Nine Months Ended September 30, 2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.09%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Reported</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.13%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Adjustment</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.09%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As Revised</b></p></td></tr><tr><td style="vertical-align:bottom;width:62.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;">Issuance of representative shares</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 870</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,999,130</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,000,000</p></td></tr><tr><td style="vertical-align:bottom;width:62.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;">Remeasurement to amount subject to redemption</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (24,791,574)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,127,129</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (27,918,703)</p></td></tr><tr><td style="vertical-align:bottom;width:62.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;">Net loss</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 625,111</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 127,999</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 753,110</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:62.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:62.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">As Previously</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:62.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">Statement of Cashflows for the Nine Months Ended September 30, 2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.53%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Reported</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.53%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Adjustment</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">As Revised</b></p></td></tr><tr><td style="vertical-align:bottom;width:62.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Change in fair value of over-allotment liability</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (196,475)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (196,475)</p></td></tr><tr><td style="vertical-align:bottom;width:62.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Transaction costs allocable to representative shares</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 68,476</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 68,476</p></td></tr><tr><td style="vertical-align:bottom;width:62.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Net loss</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 625,111</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 127,999</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 753,110</p></td></tr><tr><td style="vertical-align:bottom;width:62.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Initial classification of over-allotment Liability</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 294,708</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 294,078</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:62.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:62.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As Previously</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:62.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Statement of Operations for the Nine Months Ended September 30, 2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.53%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Reported</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.53%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Adjustment</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As Revised</b></p></td></tr><tr><td style="vertical-align:bottom;width:62.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Change in fair value of over-allotment liability</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 196,475</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 196,475</p></td></tr><tr><td style="vertical-align:bottom;width:62.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Transaction costs allocable to representative shares</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (68,476)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (68,476)</p></td></tr><tr><td style="vertical-align:bottom;width:62.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Net Loss</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 625,111</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 127,999</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 753,110</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:62.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.08%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:62.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As Previously</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:62.34%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Statement of Stockholders’ Deficit for the Nine Months Ended September 30, 2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.09%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Reported</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.13%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Adjustment</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.09%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As Revised</b></p></td></tr><tr><td style="vertical-align:bottom;width:62.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;">Issuance of representative shares</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 870</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,999,130</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,000,000</p></td></tr><tr><td style="vertical-align:bottom;width:62.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;">Remeasurement to amount subject to redemption</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (24,791,574)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,127,129</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (27,918,703)</p></td></tr><tr><td style="vertical-align:bottom;width:62.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;">Net loss</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 625,111</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 127,999</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 753,110</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:62.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:62.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">As Previously</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:62.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">Statement of Cashflows for the Nine Months Ended September 30, 2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.53%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Reported</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.53%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Adjustment</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">As Revised</b></p></td></tr><tr><td style="vertical-align:bottom;width:62.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Change in fair value of over-allotment liability</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (196,475)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (196,475)</p></td></tr><tr><td style="vertical-align:bottom;width:62.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Transaction costs allocable to representative shares</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 68,476</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 68,476</p></td></tr><tr><td style="vertical-align:bottom;width:62.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Net loss</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 625,111</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 127,999</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 753,110</p></td></tr><tr><td style="vertical-align:bottom;width:62.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Initial classification of over-allotment Liability</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 294,708</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 294,078</p></td></tr></table> 0 196475 196475 0 68476 68476 625111 127999 753110 870 2999130 3000000 -24791574 3127129 -27918703 625111 127999 753110 0 196475 196475 0 68476 68476 625111 127999 753110 0 294708 294078 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">NOTE 3. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;">Basis of Presentation</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X of the Securities and Exchange Commission (“SEC”). Certain information or footnote disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">The accompanying unaudited condensed financial statements should be read in conjunction with the Company’s Annual Report on Form 10-K as filed with the SEC on April 18, 2022. The interim results for the three and nine months ended September 30, 2022 are not necessarily indicative of the results to be expected for the year ending December 31, 2022 or for any future periods.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;">Emerging Growth Company</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statement with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;">Use of Estimates</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">The preparation of the condensed financial statements in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">Making estimates require management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. One of the more significant accounting estimates included in these condensed financial statements is the determination of the fair value of the warrant liabilities. Such estimates may be subject to change as more current information becomes available and accordingly the actual results could differ significantly from those estimates.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;">Cash and Cash Equivalents</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of September 30, 2022 and December 31, 2021.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;">Marketable Securities Held in Trust Account</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">At September 30, 2022 and December 31, 2021, substantially all of the assets held in the Trust Account were held in U.S. Treasury securities. All of the Company’s investments held in the Trust Account are classified as trading securities. Trading securities are presented on the balance sheets at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of investments held in Trust Account are included in interest earned on marketable securities held in Trust Account in the accompanying statements of operations. The estimated fair values of investments held in Trust Account are determined using available market information.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Warrant Liabilities</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">The Company accounts for the Public Warrants (as defined in Note 4) and Private Placement Warrants (together with the Public Warrants, the “Warrants”) in accordance with the guidance contained in ASC 815-40, under which the Warrants do not meet the criteria for equity treatment and must be recorded as liabilities. Accordingly, the Company classifies the Warrants as liabilities at their fair value and adjusts the Warrants to fair value in respect of each reporting period. This liability is subject to re-measurement at each balance sheet date until the Warrants are exercised, and any change in fair value is recognized in the statements of operations. The Private Placement Warrants and the Public Warrants for periods where no observable traded price was available are valued using a Binomial lattice model.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Offering Costs</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">Offering costs consisted of legal, accounting and other expenses incurred through the Initial Public Offering that were directly related to the Initial Public Offering. Offering costs were allocated to the separable financial instruments issued in the Initial Public Offering based on a relative fair value basis, compared to total proceeds received. Offering costs allocated to warrant liabilities and representative shares were expensed as incurred in the statements of operations. Offering costs associated with the Class A common stock issued were charged to temporary equity. Offering costs amounted to $705,741, of which $234,438 was charged to temporary equity and $471,303 was expensed as incurred in the statements of operation upon the completion of the Initial Public Offering. In addition, the underwriter was paid $6,340,000 at closing of the Initial Public Offering and a deferred underwriting fee of $11,095,000 was charged against equity and presented on the accompanying consolidated balance sheets.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;">Class A Common Stock Subject to Possible Redemption</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company accounts for its Class A common stock subject to possible redemption in accordance with the guidance in ASC 480. Class A common stock subject to mandatory redemption are classified as a liability instrument and are measured at fair value. Conditionally redeemable common stock (including common stock that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, common stock are classified as stockholders’ equity. The Company’s Class A common stock feature certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, at September 30, 2022 and December 31, 2021, Class A common stock subject to possible redemption are presented as temporary equity, outside of the stockholders’ equity section of the Company’s condensed balance sheets.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable common stock to equal the redemption value at the end of each reporting period. Immediately upon the closing of the Initial Public Offering, the Company recognized the accretion from initial book value to redemption amount value. The change in the carrying value of redeemable Class A common stock resulted in charges against additional paid-in capital and accumulated deficit.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">At September 30, 2022 and December 31, 2021, the Class A common stock reflected in the condensed balance sheets are reconciled in the following table:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:83.17%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.84%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:83.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Gross proceeds</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">    </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 317,000,000</p></td></tr><tr><td style="vertical-align:bottom;width:83.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Less:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td></tr><tr><td style="vertical-align:bottom;width:83.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Proceeds allocated to Public Warrants</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (7,053,250)</p></td></tr><tr><td style="vertical-align:bottom;width:83.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Class A common stock issuance costs</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (20,865,453)</p></td></tr><tr><td style="vertical-align:bottom;width:83.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Plus:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td></tr><tr><td style="vertical-align:bottom;width:83.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Remeasurement to amount subject to redemption</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 27,918,703</p></td></tr><tr><td style="vertical-align:bottom;width:83.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Class A common stock subject to possible redemption, December 31, 2021</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"><span style="margin-left:0pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"><span style="margin-left:0pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 317,000,000</p></td></tr><tr><td style="vertical-align:bottom;width:83.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Plus:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:83.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Remeasurement to amount subject to redemption</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.84%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,338,616</p></td></tr><tr><td style="vertical-align:bottom;width:83.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Class A common stock subject to possible redemption, September 30, 2022</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.84%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 318,338,616</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;">Income Taxes</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">The Company accounts for income taxes under ASC 740, “Income Taxes.” ASC 740, Income Taxes, requires the recognition of deferred tax assets and liabilities for both the expected impact of differences between the unaudited condensed financial statements and tax basis of assets and liabilities and for the expected future tax benefit to be derived from tax loss and tax credit carry forwards. ASC 740 additionally requires a valuation allowance to be established when it is more likely than not that all or a portion of deferred tax assets will not be realized. As of September 30, 2022 and December 31, 2021, the Company’s deferred tax asset had a full valuation allowance recorded against it.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">The Company’s effective tax rate was 15.24% and 0.00% for the three months ended September 30, 2022 and 2021, respectively, and 6.84% and 0.00% for the nine months ended September 30, 2022 and 2021, respectively. The effective tax rate differs from the statutory tax rate of 21% for the three and nine months ended September 30, 2022 and 2021, due to changes in fair value in warrant liability, and the valuation allowance on the deferred tax assets.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">ASC 740 also clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. ASC 740 also provides guidance on derecognition, classification, interest and penalties, accounting in interim period, disclosure and transition.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of September 30, 2022 and December 31, 2021. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">The Company has identified the United States as its only “major” tax jurisdiction. The Company is subject to income taxation by major taxing authorities since inception. These examinations may include questioning the timing and amount of deductions, the nexus of income among various tax jurisdictions and compliance with federal and state tax laws. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;">Net Income (Loss) per Common Share</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share”. Net income (loss) per common stock is computed by dividing net income (loss) by the weighted average number of common stock outstanding for the period. The Company applies the two-class method in calculating earnings per share. Accretion associated with the redeemable shares of Class A common stock is excluded from earnings per share as the redemption value approximates fair value.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">The calculation of diluted income (loss) per share does not consider the effect of the warrants issued in connection with the (i) Initial Public Offering, and (ii) the private placement since the exercise of the warrants is contingent upon the occurrence of future events. The warrants are exercisable to purchase 8,134,750 Class A common stock in the aggregate. As of September 30, 2022 and 2021, the Company did not have any dilutive securities or other contracts that could, potentially, be exercised or converted into common stock and then share in the earnings of the Company. As a result, diluted net loss per common stock is the same as basic net loss per common stock for the periods presented.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">The following table reflects the calculation of basic and diluted net income (loss) per common share (in dollars, except per share amounts):</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:24.43%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.59%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.85%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.59%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.85%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.59%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.85%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.6%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.85%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:24.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="11" style="vertical-align:bottom;white-space:nowrap;width:36.29%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Three Months Ended </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="11" style="vertical-align:bottom;white-space:nowrap;width:36.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Nine Months Ended </b></p></td></tr><tr><td style="vertical-align:bottom;width:24.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:17.4%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">September 30, 2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:17.4%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">September 30, 2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:17.4%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">September 30, 2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:17.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">September 30, 2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:24.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.33%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Class A</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.59%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Class B</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.33%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Class A</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.59%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Class B</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.33%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Class A</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.59%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Class B</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.34%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Class A</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.59%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Class B</b></p></td></tr><tr><td style="vertical-align:bottom;width:24.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;"><i style="font-style:italic;">Basic and diluted net income per ordinary share</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td></tr><tr><td style="vertical-align:bottom;width:24.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;">Numerator:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td></tr><tr><td style="vertical-align:bottom;width:24.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;">Allocation of net income, as adjusted</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 910,100</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 219,633</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,158,811</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 762,313</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,905,452</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 942,498</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 572,441</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 180,669</p></td></tr><tr><td style="vertical-align:bottom;width:24.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;">Denominator:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td></tr><tr><td style="vertical-align:bottom;width:24.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;">Basic and diluted weighted average ordinary share outstanding</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.59%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 32,839,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.85%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 7,925,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.59%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 32,839,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.85%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 7,925,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.59%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 32,839,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.85%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 7,925,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.6%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 24,779,612</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.85%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 7,820,696</p></td></tr><tr><td style="vertical-align:bottom;width:24.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;">Basic and diluted net income per ordinary share</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="-sec-ix-hidden:Hidden_UvuQoQwDMEC9zCkpYQJocw;"><span style="font-family:'Times New Roman','Times','serif';font-size:8pt;font-style:normal;font-weight:normal;">$</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 0.03</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="-sec-ix-hidden:Hidden_y5i8V5bwPUaMnbGwkVNfjA;"><span style="font-family:'Times New Roman','Times','serif';font-size:8pt;font-style:normal;font-weight:normal;">$</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 0.03</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="-sec-ix-hidden:Hidden_4Wc_9fQNO0WJ9A9QLZJDMA;"><span style="font-family:'Times New Roman','Times','serif';font-size:8pt;font-style:normal;font-weight:normal;">$</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 0.10</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="-sec-ix-hidden:Hidden_06h6PTcoHkKIK0g_fiszCQ;"><span style="font-family:'Times New Roman','Times','serif';font-size:8pt;font-style:normal;font-weight:normal;">$</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 0.10</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="-sec-ix-hidden:Hidden_s2oaDLmeBEeYTxxypArT0w;"><span style="font-family:'Times New Roman','Times','serif';font-size:8pt;font-style:normal;font-weight:normal;">$</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 0.12</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="-sec-ix-hidden:Hidden_FP7RjKljOEijmUeBpAAIrg;"><span style="font-family:'Times New Roman','Times','serif';font-size:8pt;font-style:normal;font-weight:normal;">$</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 0.12</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="-sec-ix-hidden:Hidden_0O_AJWFQK0iID7lpnIworg;"><span style="font-family:'Times New Roman','Times','serif';font-size:8pt;font-style:normal;font-weight:normal;">$</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 0.02</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="-sec-ix-hidden:Hidden_Z8Y-JODtQkiUx1wmAm-7og;"><span style="font-family:'Times New Roman','Times','serif';font-size:8pt;font-style:normal;font-weight:normal;">$</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 0.02</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;">Concentration of Credit Risk</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times may exceed the Federal Depository Insurance Coverage of $250,000. The Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;">Fair Value of Financial Instruments</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC Topic 820, “Fair Value Measurement,” approximates the carrying amounts represented in the accompanying condensed balance sheets, primarily due to their short-term nature, excluding the Warrant liability (see Note 10).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;">Recent Accounting Standards</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">In August 2020, the FASB issued Accounting Standards Update (“ASU”) No. 2020-06, <i style="font-style:italic;">Debt –debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging – Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity (“ASU 2020-06”)</i>, which simplifies accounting for convertible instruments by removing major separation models required under current U.S. GAAP. The ASU also removes certain settlement conditions that are required for equity-linked contracts to qualify for the derivative scope exception, and it simplifies the diluted earnings per share calculation in certain areas. The Company adopted ASU 2020-06 in January 2022. Adoption of the ASU did not impact the Company’s financial position, results of operations or cash flows.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">The Company’s management does not believe that any other recently issued, but not yet effective, accounting standards if currently adopted would have a material effect on the accompanying unaudited condensed financial statements.</p> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;">Basis of Presentation</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X of the Securities and Exchange Commission (“SEC”). Certain information or footnote disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">The accompanying unaudited condensed financial statements should be read in conjunction with the Company’s Annual Report on Form 10-K as filed with the SEC on April 18, 2022. The interim results for the three and nine months ended September 30, 2022 are not necessarily indicative of the results to be expected for the year ending December 31, 2022 or for any future periods.</p> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;">Emerging Growth Company</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statement with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.</p> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;">Use of Estimates</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">The preparation of the condensed financial statements in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">Making estimates require management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. One of the more significant accounting estimates included in these condensed financial statements is the determination of the fair value of the warrant liabilities. Such estimates may be subject to change as more current information becomes available and accordingly the actual results could differ significantly from those estimates.</p> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;">Cash and Cash Equivalents</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of September 30, 2022 and December 31, 2021.</p> 0 0 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;">Marketable Securities Held in Trust Account</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">At September 30, 2022 and December 31, 2021, substantially all of the assets held in the Trust Account were held in U.S. Treasury securities. All of the Company’s investments held in the Trust Account are classified as trading securities. Trading securities are presented on the balance sheets at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of investments held in Trust Account are included in interest earned on marketable securities held in Trust Account in the accompanying statements of operations. The estimated fair values of investments held in Trust Account are determined using available market information.</p> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Warrant Liabilities</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">The Company accounts for the Public Warrants (as defined in Note 4) and Private Placement Warrants (together with the Public Warrants, the “Warrants”) in accordance with the guidance contained in ASC 815-40, under which the Warrants do not meet the criteria for equity treatment and must be recorded as liabilities. Accordingly, the Company classifies the Warrants as liabilities at their fair value and adjusts the Warrants to fair value in respect of each reporting period. This liability is subject to re-measurement at each balance sheet date until the Warrants are exercised, and any change in fair value is recognized in the statements of operations. The Private Placement Warrants and the Public Warrants for periods where no observable traded price was available are valued using a Binomial lattice model.</p> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Offering Costs</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">Offering costs consisted of legal, accounting and other expenses incurred through the Initial Public Offering that were directly related to the Initial Public Offering. Offering costs were allocated to the separable financial instruments issued in the Initial Public Offering based on a relative fair value basis, compared to total proceeds received. Offering costs allocated to warrant liabilities and representative shares were expensed as incurred in the statements of operations. Offering costs associated with the Class A common stock issued were charged to temporary equity. Offering costs amounted to $705,741, of which $234,438 was charged to temporary equity and $471,303 was expensed as incurred in the statements of operation upon the completion of the Initial Public Offering. In addition, the underwriter was paid $6,340,000 at closing of the Initial Public Offering and a deferred underwriting fee of $11,095,000 was charged against equity and presented on the accompanying consolidated balance sheets.</p> 705741 234438 471303 6340000 11095000 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;">Class A Common Stock Subject to Possible Redemption</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company accounts for its Class A common stock subject to possible redemption in accordance with the guidance in ASC 480. Class A common stock subject to mandatory redemption are classified as a liability instrument and are measured at fair value. Conditionally redeemable common stock (including common stock that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, common stock are classified as stockholders’ equity. The Company’s Class A common stock feature certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, at September 30, 2022 and December 31, 2021, Class A common stock subject to possible redemption are presented as temporary equity, outside of the stockholders’ equity section of the Company’s condensed balance sheets.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable common stock to equal the redemption value at the end of each reporting period. Immediately upon the closing of the Initial Public Offering, the Company recognized the accretion from initial book value to redemption amount value. The change in the carrying value of redeemable Class A common stock resulted in charges against additional paid-in capital and accumulated deficit.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">At September 30, 2022 and December 31, 2021, the Class A common stock reflected in the condensed balance sheets are reconciled in the following table:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:83.17%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.84%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:83.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Gross proceeds</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">    </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 317,000,000</p></td></tr><tr><td style="vertical-align:bottom;width:83.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Less:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td></tr><tr><td style="vertical-align:bottom;width:83.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Proceeds allocated to Public Warrants</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (7,053,250)</p></td></tr><tr><td style="vertical-align:bottom;width:83.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Class A common stock issuance costs</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (20,865,453)</p></td></tr><tr><td style="vertical-align:bottom;width:83.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Plus:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td></tr><tr><td style="vertical-align:bottom;width:83.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Remeasurement to amount subject to redemption</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 27,918,703</p></td></tr><tr><td style="vertical-align:bottom;width:83.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Class A common stock subject to possible redemption, December 31, 2021</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"><span style="margin-left:0pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"><span style="margin-left:0pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 317,000,000</p></td></tr><tr><td style="vertical-align:bottom;width:83.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Plus:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:83.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Remeasurement to amount subject to redemption</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.84%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,338,616</p></td></tr><tr><td style="vertical-align:bottom;width:83.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Class A common stock subject to possible redemption, September 30, 2022</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.84%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 318,338,616</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:83.17%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.84%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:83.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Gross proceeds</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">    </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 317,000,000</p></td></tr><tr><td style="vertical-align:bottom;width:83.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Less:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td></tr><tr><td style="vertical-align:bottom;width:83.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Proceeds allocated to Public Warrants</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (7,053,250)</p></td></tr><tr><td style="vertical-align:bottom;width:83.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Class A common stock issuance costs</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (20,865,453)</p></td></tr><tr><td style="vertical-align:bottom;width:83.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Plus:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td></tr><tr><td style="vertical-align:bottom;width:83.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Remeasurement to amount subject to redemption</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 27,918,703</p></td></tr><tr><td style="vertical-align:bottom;width:83.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Class A common stock subject to possible redemption, December 31, 2021</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"><span style="margin-left:0pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"><span style="margin-left:0pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 317,000,000</p></td></tr><tr><td style="vertical-align:bottom;width:83.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Plus:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:83.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Remeasurement to amount subject to redemption</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.84%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,338,616</p></td></tr><tr><td style="vertical-align:bottom;width:83.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Class A common stock subject to possible redemption, September 30, 2022</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.5%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.84%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 318,338,616</p></td></tr></table> 317000000 -7053250 -20865453 27918703 317000000 1338616 318338616 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;">Income Taxes</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">The Company accounts for income taxes under ASC 740, “Income Taxes.” ASC 740, Income Taxes, requires the recognition of deferred tax assets and liabilities for both the expected impact of differences between the unaudited condensed financial statements and tax basis of assets and liabilities and for the expected future tax benefit to be derived from tax loss and tax credit carry forwards. ASC 740 additionally requires a valuation allowance to be established when it is more likely than not that all or a portion of deferred tax assets will not be realized. As of September 30, 2022 and December 31, 2021, the Company’s deferred tax asset had a full valuation allowance recorded against it.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">The Company’s effective tax rate was 15.24% and 0.00% for the three months ended September 30, 2022 and 2021, respectively, and 6.84% and 0.00% for the nine months ended September 30, 2022 and 2021, respectively. The effective tax rate differs from the statutory tax rate of 21% for the three and nine months ended September 30, 2022 and 2021, due to changes in fair value in warrant liability, and the valuation allowance on the deferred tax assets.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">ASC 740 also clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. ASC 740 also provides guidance on derecognition, classification, interest and penalties, accounting in interim period, disclosure and transition.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of September 30, 2022 and December 31, 2021. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">The Company has identified the United States as its only “major” tax jurisdiction. The Company is subject to income taxation by major taxing authorities since inception. These examinations may include questioning the timing and amount of deductions, the nexus of income among various tax jurisdictions and compliance with federal and state tax laws. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months.</p> 0.1524 0.0000 0.0684 0.0000 0.21 0.21 0.21 0.21 0 0 0 0 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;">Net Income (Loss) per Common Share</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share”. Net income (loss) per common stock is computed by dividing net income (loss) by the weighted average number of common stock outstanding for the period. The Company applies the two-class method in calculating earnings per share. Accretion associated with the redeemable shares of Class A common stock is excluded from earnings per share as the redemption value approximates fair value.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">The calculation of diluted income (loss) per share does not consider the effect of the warrants issued in connection with the (i) Initial Public Offering, and (ii) the private placement since the exercise of the warrants is contingent upon the occurrence of future events. The warrants are exercisable to purchase 8,134,750 Class A common stock in the aggregate. As of September 30, 2022 and 2021, the Company did not have any dilutive securities or other contracts that could, potentially, be exercised or converted into common stock and then share in the earnings of the Company. As a result, diluted net loss per common stock is the same as basic net loss per common stock for the periods presented.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">The following table reflects the calculation of basic and diluted net income (loss) per common share (in dollars, except per share amounts):</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:24.43%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.59%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.85%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.59%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.85%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.59%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.85%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.6%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.85%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:24.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="11" style="vertical-align:bottom;white-space:nowrap;width:36.29%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Three Months Ended </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="11" style="vertical-align:bottom;white-space:nowrap;width:36.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Nine Months Ended </b></p></td></tr><tr><td style="vertical-align:bottom;width:24.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:17.4%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">September 30, 2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:17.4%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">September 30, 2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:17.4%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">September 30, 2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:17.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">September 30, 2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:24.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.33%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Class A</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.59%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Class B</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.33%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Class A</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.59%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Class B</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.33%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Class A</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.59%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Class B</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.34%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Class A</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.59%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Class B</b></p></td></tr><tr><td style="vertical-align:bottom;width:24.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;"><i style="font-style:italic;">Basic and diluted net income per ordinary share</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td></tr><tr><td style="vertical-align:bottom;width:24.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;">Numerator:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td></tr><tr><td style="vertical-align:bottom;width:24.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;">Allocation of net income, as adjusted</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 910,100</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 219,633</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,158,811</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 762,313</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,905,452</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 942,498</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 572,441</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 180,669</p></td></tr><tr><td style="vertical-align:bottom;width:24.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;">Denominator:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td></tr><tr><td style="vertical-align:bottom;width:24.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;">Basic and diluted weighted average ordinary share outstanding</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.59%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 32,839,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.85%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 7,925,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.59%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 32,839,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.85%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 7,925,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.59%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 32,839,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.85%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 7,925,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.6%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 24,779,612</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.85%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 7,820,696</p></td></tr><tr><td style="vertical-align:bottom;width:24.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;">Basic and diluted net income per ordinary share</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="-sec-ix-hidden:Hidden_UvuQoQwDMEC9zCkpYQJocw;"><span style="font-family:'Times New Roman','Times','serif';font-size:8pt;font-style:normal;font-weight:normal;">$</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 0.03</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="-sec-ix-hidden:Hidden_y5i8V5bwPUaMnbGwkVNfjA;"><span style="font-family:'Times New Roman','Times','serif';font-size:8pt;font-style:normal;font-weight:normal;">$</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 0.03</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="-sec-ix-hidden:Hidden_4Wc_9fQNO0WJ9A9QLZJDMA;"><span style="font-family:'Times New Roman','Times','serif';font-size:8pt;font-style:normal;font-weight:normal;">$</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 0.10</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="-sec-ix-hidden:Hidden_06h6PTcoHkKIK0g_fiszCQ;"><span style="font-family:'Times New Roman','Times','serif';font-size:8pt;font-style:normal;font-weight:normal;">$</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 0.10</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="-sec-ix-hidden:Hidden_s2oaDLmeBEeYTxxypArT0w;"><span style="font-family:'Times New Roman','Times','serif';font-size:8pt;font-style:normal;font-weight:normal;">$</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 0.12</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="-sec-ix-hidden:Hidden_FP7RjKljOEijmUeBpAAIrg;"><span style="font-family:'Times New Roman','Times','serif';font-size:8pt;font-style:normal;font-weight:normal;">$</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 0.12</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="-sec-ix-hidden:Hidden_0O_AJWFQK0iID7lpnIworg;"><span style="font-family:'Times New Roman','Times','serif';font-size:8pt;font-style:normal;font-weight:normal;">$</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 0.02</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="-sec-ix-hidden:Hidden_Z8Y-JODtQkiUx1wmAm-7og;"><span style="font-family:'Times New Roman','Times','serif';font-size:8pt;font-style:normal;font-weight:normal;">$</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 0.02</p></td></tr></table> 8134750 0 0 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">The following table reflects the calculation of basic and diluted net income (loss) per common share (in dollars, except per share amounts):</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:24.43%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.59%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.85%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.59%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.85%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.59%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.85%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.6%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.85%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:24.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="11" style="vertical-align:bottom;white-space:nowrap;width:36.29%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Three Months Ended </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="11" style="vertical-align:bottom;white-space:nowrap;width:36.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Nine Months Ended </b></p></td></tr><tr><td style="vertical-align:bottom;width:24.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:17.4%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">September 30, 2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:17.4%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">September 30, 2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:17.4%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">September 30, 2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:17.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">September 30, 2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:24.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.33%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Class A</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.59%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Class B</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.33%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Class A</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.59%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Class B</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.33%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Class A</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.59%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Class B</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.34%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Class A</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.59%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Class B</b></p></td></tr><tr><td style="vertical-align:bottom;width:24.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;"><i style="font-style:italic;">Basic and diluted net income per ordinary share</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td></tr><tr><td style="vertical-align:bottom;width:24.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;">Numerator:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td></tr><tr><td style="vertical-align:bottom;width:24.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;">Allocation of net income, as adjusted</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 910,100</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 219,633</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,158,811</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 762,313</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,905,452</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 942,498</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 572,441</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 180,669</p></td></tr><tr><td style="vertical-align:bottom;width:24.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;">Denominator:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td></tr><tr><td style="vertical-align:bottom;width:24.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;">Basic and diluted weighted average ordinary share outstanding</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.59%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 32,839,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.85%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 7,925,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.59%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 32,839,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.85%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 7,925,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.59%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 32,839,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.85%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 7,925,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.6%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 24,779,612</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.85%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 7,820,696</p></td></tr><tr><td style="vertical-align:bottom;width:24.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;">Basic and diluted net income per ordinary share</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="-sec-ix-hidden:Hidden_UvuQoQwDMEC9zCkpYQJocw;"><span style="font-family:'Times New Roman','Times','serif';font-size:8pt;font-style:normal;font-weight:normal;">$</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 0.03</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="-sec-ix-hidden:Hidden_y5i8V5bwPUaMnbGwkVNfjA;"><span style="font-family:'Times New Roman','Times','serif';font-size:8pt;font-style:normal;font-weight:normal;">$</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 0.03</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="-sec-ix-hidden:Hidden_4Wc_9fQNO0WJ9A9QLZJDMA;"><span style="font-family:'Times New Roman','Times','serif';font-size:8pt;font-style:normal;font-weight:normal;">$</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 0.10</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="-sec-ix-hidden:Hidden_06h6PTcoHkKIK0g_fiszCQ;"><span style="font-family:'Times New Roman','Times','serif';font-size:8pt;font-style:normal;font-weight:normal;">$</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 0.10</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="-sec-ix-hidden:Hidden_s2oaDLmeBEeYTxxypArT0w;"><span style="font-family:'Times New Roman','Times','serif';font-size:8pt;font-style:normal;font-weight:normal;">$</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 0.12</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="-sec-ix-hidden:Hidden_FP7RjKljOEijmUeBpAAIrg;"><span style="font-family:'Times New Roman','Times','serif';font-size:8pt;font-style:normal;font-weight:normal;">$</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 0.12</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="-sec-ix-hidden:Hidden_0O_AJWFQK0iID7lpnIworg;"><span style="font-family:'Times New Roman','Times','serif';font-size:8pt;font-style:normal;font-weight:normal;">$</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 0.02</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="-sec-ix-hidden:Hidden_Z8Y-JODtQkiUx1wmAm-7og;"><span style="font-family:'Times New Roman','Times','serif';font-size:8pt;font-style:normal;font-weight:normal;">$</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 0.02</p></td></tr></table> 910100 219633 3158811 762313 3905452 942498 572441 180669 32839000 7925000 32839000 7925000 32839000 7925000 24779612 7820696 0.03 0.03 0.10 0.10 0.12 0.12 0.02 0.02 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;">Concentration of Credit Risk</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times may exceed the Federal Depository Insurance Coverage of $250,000. The Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account.</p> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;">Fair Value of Financial Instruments</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC Topic 820, “Fair Value Measurement,” approximates the carrying amounts represented in the accompanying condensed balance sheets, primarily due to their short-term nature, excluding the Warrant liability (see Note 10).</p> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;">Recent Accounting Standards</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">In August 2020, the FASB issued Accounting Standards Update (“ASU”) No. 2020-06, <i style="font-style:italic;">Debt –debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging – Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity (“ASU 2020-06”)</i>, which simplifies accounting for convertible instruments by removing major separation models required under current U.S. GAAP. The ASU also removes certain settlement conditions that are required for equity-linked contracts to qualify for the derivative scope exception, and it simplifies the diluted earnings per share calculation in certain areas. The Company adopted ASU 2020-06 in January 2022. Adoption of the ASU did not impact the Company’s financial position, results of operations or cash flows.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">The Company’s management does not believe that any other recently issued, but not yet effective, accounting standards if currently adopted would have a material effect on the accompanying unaudited condensed financial statements.</p> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">NOTE 4. PUBLIC OFFERING</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">Pursuant to the Initial Public Offering, the Company sold 31,700,000 Units, inclusive of 1,700,000 Units sold to the underwriters on March 12, 2021 upon the underwriters’ election to partially exercise their over-allotment option, at a purchase price of $10.00 per Unit. Each Unit consists of one share of the Company’s Class A common stock and <span style="-sec-ix-hidden:Hidden_HjlI32v6kEqxZ3ZFghmEFg;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">one</span></span>-fourth of one redeemable warrant (“Public Warrant”). Each Public Warrant entitles the holder to purchase one share of Class A common stock at an exercise price of $11.50 per whole share (see Note 9).</p> 31700000 1700000 10.00 1 1 11.50 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">NOTE 5. PRIVATE PLACEMENT</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">Simultaneously with the closing of the Initial Public Offering, the Sponsor and EarlyBirdCapital purchased an aggregate of 805,000 Private Placement Units at a price of $10.00 per Private Placement Unit in a private placement. The Sponsor purchased 655,000 Private Placement Units and EarlyBirdCapital purchased 150,000 Private Placement Units. The Sponsor agreed to purchase up to an additional 67,500 Private Placement Units and EarlyBirdCapital agreed to purchase up to an additional 22,500 Private Placement Units if the over-allotment option was exercised in full. On March 12, 2021, the Sponsor and EarlyBirdCapital purchased 34,000 Private Placement Units for an additional aggregate purchase price of $340,000 in connection with the partial exercise of the underwriter’s over-allotment option. Each Private Placement Unit consists of one share of Class A common stock (“Private Share”) and <span style="-sec-ix-hidden:Hidden_SuCz4uLIEkiJrkmHZW94_g;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">one</span></span>-fourth of one redeemable warrant (“Private Placement Warrant”). Each Private Placement Warrant will entitle the holder to purchase one share of Class A common stock at a price of $11.50 per full share, subject to adjustment (see Note 9). The proceeds from the Private Placement Units were added to the proceeds from the Initial Public Offering held in the Trust Account. If the Company does not complete a Business Combination within the Combination Period, the proceeds from the sale of the Private Placement Units will be used to fund the redemption of the Public Shares (subject to the requirements of applicable law).</p> 805000 10.00 655000 150000 67500 22500 34000 340000 1 1 11.50 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">NOTE 6. RELATED PARTY TRANSACTIONS</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;">Founder Shares</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">On November 10, 2020, the Sponsor paid $25,000 to cover certain offering costs of the Company in consideration for 5,750,000 shares of Class B common stock (the “Founder Shares”). On February 4, 2021, the Company effectuated a 1:1.25 stock split of its Class B common stock and on March 3, 2021, the Company effectuated a 1.2 stock split of its Class B common stock, which resulted in an aggregate of 8,625,000 Founder Shares outstanding. The Founder Shares include an aggregate of up to 700,000 shares that remain subject to forfeiture by the Sponsor following the underwriters’ election to partially exercise their over-allotment option (see Note 7), so that the Sponsor and the Company’s independent directors will collectively own 20% of the Company’s issued and outstanding shares after the Initial Public Offering (assuming the Sponsor did not purchase any Public Shares in the Initial Public Offering and excluding the Private Shares). As a result of the underwriters’ election to partially exercise their over-allotment option, a total of 425,000 Founder Shares are no longer subject to forfeiture and 700,000 Founder Shares were forfeited resulting in an aggregate of 7,925,000 Founder Shares outstanding.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">The Sponsor has agreed, subject to limited exceptions, not to transfer, assign or sell any of the Founder Shares until the earlier to occur of: (A) one year after the completion of a Business Combination and (B) subsequent to a Business Combination, (x) if the reported closing price of the Class A common stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after a Business Combination, or (y) the date on which the Company completes a liquidation, merger, capital stock exchange or other similar transaction that results in all of the Public Stockholders having the right to exchange their shares of common stock for cash, securities or other property.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">On February 18, 2021, the sponsor transferred 15,000 <span style="-sec-ix-hidden:Hidden_9X8dgHQhQUmjz7uv6SWpZA;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">shares</span></span> of Class B <span style="-sec-ix-hidden:Hidden_somD4zFwrEKlny8RQWDi0Q;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">common</span></span> stock to the independent directors of D. Amsterdam, A. Ebush, and A. Savar for a total of 45,000 shares transferred. On March 3, 2021, the company effectuated a 1.2 stock split of our common stock which resulted in the total amount of Class B common stock transferred to each director to be 18,000 <span style="-sec-ix-hidden:Hidden_KrmbpBxlnEi7wqmPMU92Zw;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">for</span></span> <span style="-sec-ix-hidden:Hidden_QJLHj-EIakO4EN8XSBX5pA;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">a</span></span> total of 54,000 shares.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">The transfer of the Founders Shares is in the scope of FASB ASC Topic 718, “Compensation-Stock Compensation” (“ASC 718”). Under ASC 718, stock-based compensation associated with equity-classified awards is measured at fair value upon the grant date. The value of the transferred Founders Shares on the grant date of February 18, 2021 was $6.91 per share for a total aggregate value of $373,140. The Founders Shares were granted subject to a performance condition (i.e., the occurrence of a Business Combination). Compensation expense related to the Founders Shares is recognized only when the performance condition is probable of occurrence under the applicable accounting literature in this circumstance. As of September 30, 2022, the Company determined that a Business Combination is not considered probable, and, therefore, no stock-based compensation expense has been recognized. Stock-based compensation would be recognized at the date a Business Combination is considered probable (i.e., upon consummation of a Business Combination) in an amount equal to the number of Founders Shares times the grant date fair value per share (unless subsequently modified) less the amount initially received for the purchase of the Founders Shares.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;">Administrative Services Agreement</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">The Company agreed, commencing on March 3, 2021 through the earlier of the Company’s consummation of a Business Combination and its liquidation, to pay an affiliate of the Company’s executive officers a total of $10,000 per month for office space and general and administrative services. For the three months and nine months ended September 30, 2022, the Company incurred $30,000 and $90,000 in fees for these services, respectively, of which $10,000 of such amount is included in accrued expenses in the accompanying balance sheets. For the three months and nine months ended September 30, 2021, the Company incurred $30,000 and $70,000 in fees for these services, respectively. As of December 31, 2021 there was $10,000 of such fees included in accounts payable and accrued expenses.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;">Promissory Note — Related Party</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">On November 10, 2020, the Company issued an unsecured promissory note to the Sponsor (the “Promissory Note”), pursuant to which the Company could borrow up to an aggregate principal amount of $300,000. The Promissory Note was non-interest bearing and payable on the earlier of (i) December 31, 2021, (ii) the consummation of the Initial Public Offering or (ii) the date on which the Company determines not to proceed with the Initial Public Offering. As of September 30, 2022 and December 31, 2021, there was no amount outstanding under the Promissory Note. The outstanding amount of $200,000 was repaid at the closing of the Initial Public Offering on March 8, 2021.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;">Related Party Loans</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">In addition, in order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If the Company completes a Business Combination, the Company would repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company. Otherwise, the Working Capital Loans would be repaid only out of funds held outside the Trust Account. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans, but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. Except for the foregoing, the terms of such Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans. The Working Capital Loans would either be repaid upon consummation of a Business Combination, without interest, or, at the lender’s discretion, up to $1,500,000 of such Working Capital Loans may be convertible into units of the post Business Combination entity at a price of $10.00 per unit. The units would be identical to the Private Placement Units. As of September 30, 2022 or December 31, 2021, no amounts have been withdrawn or are outstanding relating to these Working Capital Loans.</p> 25000 5750000 1.25 1.2 8625000 700000 0.20 425000 700000 7925000 P1Y 12.00 20 30 P150D 15000 45000 1.2 18000 54000 6.91 373140 0 10000 30000 90000 10000 30000 70000 10000 300000 0 0 200000 1500000 10.00 0 0 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">NOTE 7. COMMITMENTS</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;">Registration Rights</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">Pursuant to a registration rights agreement entered into on March 3, 2021, the holders of the Founder Shares and Representative Shares, as well as the holders of the Private Placement Units and any units that may be issued in payment of Working Capital Loans made to the Company, have registration rights to require the Company to register for resale of any of the Company’s securities held by them. The holder of these securities and the Sponsor are entitled to make unlimited demands that the Company register such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the completion of a Business Combination. Notwithstanding anything to the contrary, EarlyBirdCapital may only make a demand on one occasion and only during the five-year period beginning on the effective date of the Initial Public Offering. In addition, EarlyBirdCapital may participate in a “piggy-back” registration only during the seven-year period beginning on the effective date of the Initial Public Offering. The Company will bear the expenses incurred in connection with the filing of any such registration statements. However, the registration and stockholder rights agreement provides that the Company will not permit any registration statement filed under the Securities Act to become effective until termination of the applicable lock-up period. The registration rights and stockholder agreement does not contain liquidated damages or other cash settlement provisions resulting from delays in registering the Company’s securities. The Company will bear the expenses incurred in connection with the filing of any such registration statements.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;">Underwriting Agreement</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">The Company granted the underwriters a 45-day option from the date of the Initial Public Offering to purchase up to 4,500,000 additional Units to cover over-allotments, if any, at the Initial Public Offering price, less the underwriting discounts and commissions. On March 12, 2021, the underwriter’s election to partially exercise the over-allotment option to purchase an additional 1,700,000 Units and forfeited their option to purchase an additional 2,800,000 Units.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">The underwriters are entitled to a deferred fee of $0.35 per Unit, or $10,500,000 in the aggregate (or $12,075,000 in the aggregate if the underwriters’ over-allotment option is exercised in full). The deferred fee will become payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement.</p> 1 45 4500000 1700000 2800000 0.35 10500000 12075000 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">NOTE 8. STOCKHOLDERS’ DEFICIT</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Preferred Stock</span><span style="font-size:9pt;"> </span>—The Company is authorized to issue 1,000,000 shares of preferred stock with a par value of $0.0001 per share. At March 8, 2021, there were no shares of preferred stock <span style="-sec-ix-hidden:Hidden_9G6D5AGEakWhEZXJZKWWKA;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">issued</span></span> or outstanding. At September 30, 2022 and December 31, 2021, there were no shares of preferred stock issued or outstanding.</p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><span style="font-size:10pt;font-style:italic;font-weight:bold;">Class A Common Stock</span> — <span style="font-size:10pt;">The Company is authorized to issue up to </span><span style="font-size:10pt;">100,000,000</span><span style="font-size:10pt;"> shares of Class A common stock with a par value of </span><span style="font-size:10pt;">$0.0001</span><span style="font-size:10pt;"> per share. At September 30, 2022 and December 31, 2021, there were </span><span style="font-size:10pt;">32,839,000</span><span style="font-size:10pt;"> shares of Class A common stock </span><span style="font-size:10pt;">issued</span><span style="font-size:10pt;"> and outstanding, </span><span style="font-size:10pt;">including</span><span style="font-size:10pt;"> </span><span style="font-size:10pt;">31,700,000</span><span style="font-size:10pt;"> Class A common stock subject to possible redemption which are presented as temporary equity.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><span style="font-size:10pt;font-style:italic;font-weight:bold;">Class B Common Stock</span> — <span style="font-size:10pt;">The Company is authorized to issue up to </span><span style="font-size:10pt;">10,000,000</span><span style="font-size:10pt;"> shares of Class B common stock with a par value of </span><span style="font-size:10pt;">$0.0001</span><span style="font-size:10pt;"> per share. Holders of the Company’s common stock are entitled to </span><span style="font-size:10pt;">one</span><span style="font-size:10pt;"> vote for each share. At September 30, 2022 and December 31, 2021, there were </span><span style="font-size:10pt;">7,925,000</span><span style="font-size:10pt;"> shares of common stock </span><span style="font-size:10pt;">issued</span><span style="font-size:10pt;"> and outstanding.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">Holders of Class A common stock and holders of Class B common stock will vote together as a single class on all matters submitted to a vote of the Company’s stockholders except as otherwise required by law.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">The shares of Class B common stock will automatically convert into Class A common stock at the time of a Business Combination, or earlier at the option of the holder, on a one-for-one basis, subject to adjustment. In the case that additional shares of Class A common stock, or equity-linked securities, are issued or deemed issued in excess of the amounts offered in this prospectus and related to the closing of a Business Combination, the ratio at which shares of Class B common stock shall convert into shares of Class A common stock will be adjusted (unless the Sponsor agrees to waive such adjustment with respect to any such issuance or deemed issuance, including a specified future issuance) so that the number of shares of Class A common stock issuable upon conversion of all shares of Class B common stock will equal, in the aggregate, on an as-converted basis, 20% of the sum of the total number of all shares of common stock outstanding upon completion of the Initial Public Offering plus all shares of Class A common stock and equity-linked securities issued or deemed issued in connection with a Business Combination (after giving effect to any redemptions of shares of Class A common stock by public stockholders, excluding any Private Placement Units issued to the Sponsor, officers or directors upon conversion of Working Capital Loans). The Sponsor may also elect to convert their shares of Class B common stock into an equal number of shares of Class A common stock, subject to adjustment as provided above, at any time.</p> 1000000 1000000 0.0001 0.0001 0 0 0 100000000 100000000 0.0001 0.0001 32839000 32839000 31700000 31700000 10000000 10000000 0.0001 0.0001 1 1 7925000 7925000 1 0.20 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">NOTE 9. WARRANTS</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">Public Warrants may only be exercised for a whole number of shares. No fractional warrants will be issued upon separation of the Units and only whole warrants will trade. The Public Warrants will become exercisable 30 days after the completion of a Business Combination. The Public Warrants will expire five years after the completion of a Business Combination or earlier upon redemption or liquidation.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">The Company will not be obligated to deliver any shares of Class A common stock pursuant to the exercise of a warrant and will have no obligation to settle such warrant exercise unless a registration statement under the Securities Act covering the issuance of the shares of Class A common stock underlying the warrants is then effective and a prospectus relating thereto is current, subject to the Company satisfying its obligations with respect to registration. No warrant will be exercisable and the Company will not be obligated to issue shares of Class A common stock upon exercise of a warrant unless Class A common stock issuable upon such warrant exercise has been registered, qualified or deemed to be exempt under the securities laws of the state of residence of the registered holder of the warrants.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">The Company has agreed that as soon as practicable, but in no event later than 20 business days after the closing of a Business Combination, it will use its reasonable best efforts to file with the SEC a registration statement for the registration, under the Securities Act, of the shares of Class A common stock issuable upon exercise of the warrants. The Company will use its reasonable best efforts to cause the same to become effective and to maintain the effectiveness of such registration statement, and a current prospectus relating thereto, until the expiration of the warrants in accordance with the provisions of the warrant agreement. If a registration statement covering the shares of Class A common stock issuable upon exercise of the warrants is not effective by the ninetieth day after the closing of a Business Combination, warrant holders may, until such time as there is an effective registration statement and during any period when the Company will have failed to maintain an effective registration statement, exercise warrants on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act or another exemption.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Redemption of warrants when the price per Class A common stock equals or exceeds </i><i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">$18.00</i><i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">.</i> Once the warrants become exercisable, the Company may redeem the outstanding warrants (except with respect to the Private Placement Warrants):</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">●</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">in whole and not in part;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">●</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">at a price of </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">$0.01</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> per warrant;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">●</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">upon not less than </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">30 days</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">’ prior written notice of redemption, or the </span><span style="-sec-ix-hidden:Hidden_wDqfXQclVk-q5OmKxzg9hA;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">30-day</span></span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> redemption period, to each warrant holder; and</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">●</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">if, and only if, the reported closing price of the Class A common stock equals or exceeds </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">$18.00</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">20</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> trading days within a </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">30</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">-trading day period commencing once the warrants become exercisable and ending </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">three</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> business days before the Company sends the notice of redemption to the warrant holders.</span></td></tr></table><div style="margin-top:12pt;"/><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">If and when the warrants become redeemable by the Company, the Company may exercise its redemption right even if the Company is unable to register or qualify the underlying securities for sale under all applicable state securities laws.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Redemption of warrants when the price per Class A common stock equals or exceeds $</i><i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">10.00</i><i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">.</i> Once the warrants become exercisable, the Company may redeem the outstanding warrants:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">●</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">in whole and not in part;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">●</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">at </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">$0.10</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> per warrant upon a minimum of </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">30 days</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">’ prior written notice of redemption provided that during such </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">30 day</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> period holders will be able to exercise their warrants on a cashless basis prior to redemption and receive that number of shares based on the redemption date and the “fair market value” of our shares of Class A common stock (as defined below) except as otherwise described below; provided, further, that if the warrants are not exercised on a cashless basis or otherwise during such </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">30 day</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> period, the Company shall redeem such warrants for </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">$0.10</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> per share;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">●</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">if, and only if, the Private Placement Warrants are also concurrently called for redemption at the same price (equal to a number of shares of Class A common stock) as the outstanding Public Warrants, as described above; and</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">●</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">if, and only if, there is an effective registration statement covering the issuance of the shares of Class A common stock issuable upon exercise of the warrants and a current prospectus relating thereto available throughout the </span><span style="-sec-ix-hidden:Hidden_Ue-sp3L7i0q5GRsnIe3l2w;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">30-day</span></span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> period after written notice of redemption is given.</span></td></tr></table><div style="margin-top:12pt;"/><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">If the Company calls the Public Warrants for redemption, management will have the option to require all holders that wish to exercise the Public Warrants to do so on a “cashless basis,” as described in the warrant agreement. The exercise price and number of shares of Class A common stock issuable upon exercise of the warrants may be adjusted in certain circumstances including in the event of a stock dividend, or recapitalization, reorganization, merger or consolidation. However, except as described below, the warrants will not be adjusted for issuances of Class A common stock at a price below its exercise price. Additionally, in no event will the Company be required to net cash settle the warrants. If the Company is unable to complete a Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect to their warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with the respect to such warrants. Accordingly, the warrants may expire worthless.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">In addition, if (x) the Company issues additional shares of Class A common stock or equity-linked securities for capital raising purposes in connection with the closing of a Business Combination at an issue price or effective issue price of less than $9.20 per share of Class A common stock (with such issue price or effective issue price to be determined in good faith by the Company’s board of directors, and in the case of any such issuance to the Sponsor or their affiliates, without taking into account any Founder Shares held by them prior to such issuance), or the Newly Issued Price, (y) the aggregate gross proceeds from such issuances represent more than 50% of the total equity proceeds, and interest thereon, available for the funding of a Business Combination on the date of the consummation of a Business Combination (net of redemptions), and (z) the volume weighted average trading price of the Company’s Class A common stock during the 20 trading day period starting on the trading day after the day on which the Company consummates Business Combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of (i) the Market Value and (ii) the Newly Issued Price and the $18.00 per share redemption trigger price will be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market Value and the Newly Issued Price.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">The Private Placement Warrants are identical to the Public Warrants underlying the Units sold in the Initial Public Offering, except that the Private Placement Warrants and the Class A common stock issuable upon the exercise of the Private Placement Warrants will not be transferable, assignable or salable until 30 days after the completion of a Business Combination, subject to certain limited exceptions. Additionally, the Private Placement Warrants will be exercisable on a cashless basis and will be non-redeemable so long as they are held by the initial purchasers or their permitted transferees. If the Private Placement Warrants are held by someone other than the initial purchasers or their permitted transferees, the Private Placement Warrants will be redeemable by the Company and exercisable by such holders on the same basis as the Public Warrants.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Representative Shares</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">The Company issued 300,000 shares of Class A common stock (the “Representative Shares”) to the designees of EarlyBirdCapital for an aggregate purchase price of $870. The Company accounted for the Representative Shares as an offering cost of the Initial Public Offering, with a corresponding credit to stockholders’ equity. The Company estimated the fair value of the Representative Shares to be $3,000,000, based upon the price of the Units sold in the Initial Public Offering. The holders of the Representative Shares have agreed not to transfer, assign or sell any such shares until the completion of a Business Combination. In addition, the holders have agreed (i) to waive their conversion rights (or right to participate in any tender offer) with respect to such shares in connection with the completion of a Business Combination and (ii) to waive their rights to liquidating distributions from the Trust Account with respect to such shares if the Company fails to complete a Business Combination within the Combination Period.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">The Representative Shares have been deemed compensation by FINRA and are therefore subject to a lock-up for a period of 180 days immediately following the effective date of the registration statement related to the Initial Public Offering pursuant to Rule 5110(e)(1) of FINRA’s NASD Conduct Rules. Pursuant to FINRA Rule 5110(e)(1), these securities will not be the subject of any hedging, short sale, derivative, put or call transaction that would result in the economic disposition of the securities by any person for a period of 180 days immediately following the effective date of the registration statements related to the Initial Public Offering, nor may they be sold, transferred, assigned, pledged or hypothecated for a period of 180 days immediately following the effective date of the registration statements related to the Initial Public Offering except to any underwriter and selected dealer participating in the Initial Public Offering and their bona fide officers or partners.</p> P30D P5Y P20D 18.00 0.01 P30D 18.00 20 30 3 10.00 0.10 P30D P30D P30D 0.10 9.20 0.50 20 9.20 1.15 18.00 1.80 P30D 300000 870 3000000 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">NOTE 10. FAIR VALUE MEASUREMENTS</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">The Company follows the guidance in ASC 820 for its financial assets and liabilities that are re-measured and reported at fair value at each reporting period, and non-financial assets and liabilities that are re-measured and reported at fair value at least annually.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:12pt 0pt 12pt 0pt;">The fair value of the Company’s financial assets and liabilities reflects management’s estimate of amounts that the Company would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and liabilities:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;">Level 1:</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;">Level 2:</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;">Level 3:</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Unobservable inputs based on our assessment of the assumptions that market participants would use in pricing the asset or liability.</span></td></tr></table><div style="margin-top:12pt;"/><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">The following table presents information about the Company’s assets that are measured at fair value on a recurring basis at September 30, 2022, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:65.54%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.6%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:65.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">    </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">September 30, </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December 31,</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:65.54%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Description</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Level</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Assets:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td></tr><tr><td style="vertical-align:bottom;width:65.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Marketable securities held in Trust Account</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">1</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 318,684,239</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 317,025,510</p></td></tr><tr><td style="vertical-align:bottom;width:65.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:65.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Liabilities:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td></tr><tr><td style="vertical-align:bottom;width:65.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Warrant Liability - Private Placement Warrants</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">3</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 12,585</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 119,375</p></td></tr><tr><td style="vertical-align:bottom;width:65.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Warrant Liability - Public Warrants</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">1</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 475,500</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 4,510,337</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">The Public Warrants and Private Placement Warrants were accounted for as liabilities in accordance with ASC 815-40 and are presented within warrant liabilities on our accompanying September 30, 2022 and December 31, 2021 condensed balance sheets. The warrant liabilities are measured at fair value at inception and on a recurring basis, with changes in fair value presented within change in fair value of warrant liabilities in the condensed statements of operations.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Initial Measurement</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">The Company established the initial fair value for the Public and Private Placement Warrants on March 8, 2021, the date of the Company’s Initial Public Offering, using a binomial lattice model. The Company allocated the proceeds received from (i) the sale of Units (which is inclusive of one share of Class A common stock and <span style="-sec-ix-hidden:Hidden_w0lE1dgkuEqMFtoGYaLHzw;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">one</span></span>-fourth of one Public Warrant), (ii) the sale of Private Placement Warrants, and (iii) the issuance of Class B common stock, first to the Warrants based on their fair values as determined at initial measurement, with the remaining proceeds allocated to Class A common stock subject to possible redemption, Class A common stock and Class B common stock based on their relative fair values at the initial measurement date. The warrants were classified as Level 3 at the initial measurement date due to the use of unobservable inputs.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Subsequent Measurement</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">The warrants are measured at fair value on a recurring basis. The subsequent measurement of the Public Warrants as of September 30, 2022 is classified as Level 1 due to the use of an observable market quote in an active market. The subsequent measurement of the Private Placement Warrants was calculated using a Black Scholes model which is considered a Level 3 measurement.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">The key inputs into the binomial lattice model for the Private Placement Warrants were as follows at September 30, 2022 and December 31, 2021:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:72.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:72.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">September 30, </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December 31, </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:72.93%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Input</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:72.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Risk-free interest rate</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 4.12</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1.19</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:72.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Effective expiration date</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">06/06/2024</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">7/23/2026</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:72.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Dividend yield</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 0.00</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 0.00</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:72.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Expected volatility</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 6.4</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 12.1</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:72.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Exercise price</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 11.50</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 11.50</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:72.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Unit Price</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 9.81</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 9.71</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">As of September 30, 2022 and December 31, 2021, the aggregate values of the Private Placement Warrants were $0.01 million and $0.12 million, respectively.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">The following table presents the changes in the fair value of Level 3 warrant liabilities for the three months and nine months ended September 30, 2022:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:83.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:83.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:14.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Private Placement </b></p></td></tr><tr><td style="vertical-align:bottom;width:83.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:14.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Warrant Liability</b></p></td></tr><tr><td style="vertical-align:bottom;width:83.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;">Fair value as of December 31, 2021</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 119,375</p></td></tr><tr><td style="vertical-align:bottom;width:83.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;"><span style="-sec-ix-hidden:Hidden_X73hwNixMkSbkL71q-igsw;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Change in fair value </span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (50,471)</p></td></tr><tr><td style="vertical-align:bottom;width:83.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;">Fair value as of March 31, 2022</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 68,904</p></td></tr><tr><td style="vertical-align:bottom;width:83.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;">Change in fair value</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (54,221)</p></td></tr><tr><td style="vertical-align:bottom;width:83.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;">Fair value as of June 30, 2022</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 14,683</p></td></tr><tr><td style="vertical-align:bottom;width:83.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;">Change in fair value</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (2,098)</p></td></tr><tr><td style="vertical-align:bottom;width:83.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;">Fair value as of September 30, 2022</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.36%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 12,585</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">The following table presents the changes in the fair value of Level 3 warrant liabilities for the three months and nine months ended September 30, 2021:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:70.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:70.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Private Placement</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Public</b></p></td></tr><tr><td style="vertical-align:bottom;width:70.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.63%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Warrant Liability</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.63%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Warrant Liability</b></p></td></tr><tr><td style="vertical-align:bottom;width:70.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;">Fair value as of January 1, 2021</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:70.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 6pt;">Issuance of warrants on March 8, 2021 (IPO)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 179,113</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 6,675,000</p></td></tr><tr><td style="vertical-align:bottom;width:70.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 6pt;">Issuance of warrants on March 12, 2021 (Over Allotment)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 7,565</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 378,250</p></td></tr><tr><td style="vertical-align:bottom;width:70.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 6pt;">Change in fair value </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (12,585)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (475,500)</p></td></tr><tr><td style="vertical-align:bottom;width:70.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 6pt;">Fair value as of March 31, 2021</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 174,903</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 6,577,750</p></td></tr><tr><td style="vertical-align:bottom;width:70.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 6pt;">Change in fair value </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 79,705</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,011,500</p></td></tr><tr><td style="vertical-align:bottom;width:70.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 6pt;">Transfer from Level 3 to Level 1</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (9,589,250)</p></td></tr><tr><td style="vertical-align:bottom;width:70.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 6pt;">Fair value as of June 30, 2021</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 253,798</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:70.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 6pt;">Change in fair value</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (109,070)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:70.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;">Fair value as of September 30, 2021</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 144,728</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt;">Transfers to/from Levels 1, 2 and 3 are recognized at the end of the reporting period in which a change in valuation technique or methodology occurs. For the three and nine months ended September 30, 2022, there were no transfers from Level 3 measurements. The estimated fair value of the Public Warrants transferred from a Level 3 measurement to a Level 1 fair value measurement during the three and nine months ended September 30, 2021 was $9,589,250.</p> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:65.54%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.6%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:65.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">    </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">September 30, </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December 31,</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:65.54%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Description</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Level</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Assets:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td></tr><tr><td style="vertical-align:bottom;width:65.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Marketable securities held in Trust Account</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">1</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 318,684,239</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 317,025,510</p></td></tr><tr><td style="vertical-align:bottom;width:65.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:65.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Liabilities:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td></tr><tr><td style="vertical-align:bottom;width:65.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Warrant Liability - Private Placement Warrants</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">3</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 12,585</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 119,375</p></td></tr><tr><td style="vertical-align:bottom;width:65.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Warrant Liability - Public Warrants</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">1</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 475,500</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 4,510,337</p></td></tr></table> 318684239 317025510 12585 119375 475500 4510337 1 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:72.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:72.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">September 30, </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December 31, </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:72.93%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Input</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:72.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Risk-free interest rate</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 4.12</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1.19</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:72.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Effective expiration date</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">06/06/2024</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">7/23/2026</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:72.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Dividend yield</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 0.00</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 0.00</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:72.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Expected volatility</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 6.4</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 12.1</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:72.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Exercise price</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 11.50</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 11.50</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:72.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Unit Price</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 9.81</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 9.71</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr></table> 0.0412 0.0119 06/06/2024 7/23/2026 0.0000 0.0000 0.064 0.121 11.50 11.50 9.81 9.71 10000.00 120000 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:83.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:83.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:14.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Private Placement </b></p></td></tr><tr><td style="vertical-align:bottom;width:83.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:14.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Warrant Liability</b></p></td></tr><tr><td style="vertical-align:bottom;width:83.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;">Fair value as of December 31, 2021</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 119,375</p></td></tr><tr><td style="vertical-align:bottom;width:83.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;"><span style="-sec-ix-hidden:Hidden_X73hwNixMkSbkL71q-igsw;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Change in fair value </span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (50,471)</p></td></tr><tr><td style="vertical-align:bottom;width:83.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;">Fair value as of March 31, 2022</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 68,904</p></td></tr><tr><td style="vertical-align:bottom;width:83.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;">Change in fair value</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (54,221)</p></td></tr><tr><td style="vertical-align:bottom;width:83.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;">Fair value as of June 30, 2022</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 14,683</p></td></tr><tr><td style="vertical-align:bottom;width:83.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;">Change in fair value</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (2,098)</p></td></tr><tr><td style="vertical-align:bottom;width:83.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;">Fair value as of September 30, 2022</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.36%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 12,585</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:70.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:70.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Private Placement</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Public</b></p></td></tr><tr><td style="vertical-align:bottom;width:70.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.63%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Warrant Liability</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.63%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Warrant Liability</b></p></td></tr><tr><td style="vertical-align:bottom;width:70.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;">Fair value as of January 1, 2021</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:70.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 6pt;">Issuance of warrants on March 8, 2021 (IPO)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 179,113</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 6,675,000</p></td></tr><tr><td style="vertical-align:bottom;width:70.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 6pt;">Issuance of warrants on March 12, 2021 (Over Allotment)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 7,565</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 378,250</p></td></tr><tr><td style="vertical-align:bottom;width:70.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 6pt;">Change in fair value </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (12,585)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (475,500)</p></td></tr><tr><td style="vertical-align:bottom;width:70.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 6pt;">Fair value as of March 31, 2021</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 174,903</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 6,577,750</p></td></tr><tr><td style="vertical-align:bottom;width:70.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 6pt;">Change in fair value </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 79,705</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,011,500</p></td></tr><tr><td style="vertical-align:bottom;width:70.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 6pt;">Transfer from Level 3 to Level 1</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (9,589,250)</p></td></tr><tr><td style="vertical-align:bottom;width:70.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 6pt;">Fair value as of June 30, 2021</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 253,798</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:70.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 6pt;">Change in fair value</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (109,070)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:70.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;">Fair value as of September 30, 2021</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 144,728</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td></tr></table> 119375 -50471 68904 -54221 14683 -2098 12585 179113 6675000 7565 378250 -12585 -475500 174903 6577750 79705 3011500 9589250 253798 -109070 144728 0 0 9589250 9589250 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">NOTE </b><b style="font-weight:bold;">11. SUBSEQUENT</b><b style="font-weight:bold;"> EVENTS</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">The Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the condensed financial statements were issued. Based upon this review, the Company did not identify any subsequent events that would have required adjustment or disclosure in the condensed financial statements. </p> EXCEL 51 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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how.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 53 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 54 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.2.2 html 195 230 1 false 45 0 false 7 false false R1.htm 00090 - Document - Document and Entity Information Sheet http://www.psagu.com/role/DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 00100 - Statement - CONDENSED BALANCE SHEETS Sheet http://www.psagu.com/role/StatementCondensedBalanceSheets CONDENSED BALANCE SHEETS Statements 2 false false R3.htm 00105 - Statement - CONDENSED BALANCE SHEETS (Parenthetical) Sheet http://www.psagu.com/role/StatementCondensedBalanceSheetsParenthetical CONDENSED BALANCE SHEETS (Parenthetical) Statements 3 false false R4.htm 00200 - Statement - CONDENSED STATEMENTS OF OPERATIONS Sheet http://www.psagu.com/role/StatementCondensedStatementsOfOperations CONDENSED STATEMENTS OF OPERATIONS Statements 4 false false R5.htm 00300 - Statement - CONDENSED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT Sheet http://www.psagu.com/role/StatementCondensedStatementsOfChangesInStockholdersDeficit CONDENSED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT Statements 5 false false R6.htm 00305 - Statement - CONDENSED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT (Parenthetical) Sheet http://www.psagu.com/role/StatementCondensedStatementsOfChangesInStockholdersDeficitParenthetical CONDENSED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT (Parenthetical) Statements 6 false false R7.htm 00400 - Statement - CONDENSED STATEMENTS OF CASH FLOWS Sheet http://www.psagu.com/role/StatementCondensedStatementsOfCashFlows CONDENSED STATEMENTS OF CASH FLOWS Statements 7 false false R8.htm 10101 - Disclosure - DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS Sheet http://www.psagu.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperations DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS Notes 8 false false R9.htm 10201 - Disclosure - REVISION OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS Sheet http://www.psagu.com/role/DisclosureRevisionOfPreviouslyIssuedFinancialStatements REVISION OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS Notes 9 false false R10.htm 10301 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Sheet http://www.psagu.com/role/DisclosureSummaryOfSignificantAccountingPolicies SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Notes 10 false false R11.htm 10401 - Disclosure - PUBLIC OFFERING Sheet http://www.psagu.com/role/DisclosurePublicOffering PUBLIC OFFERING Notes 11 false false R12.htm 10501 - Disclosure - PRIVATE PLACEMENT Sheet http://www.psagu.com/role/DisclosurePrivatePlacement PRIVATE PLACEMENT Notes 12 false false R13.htm 10601 - Disclosure - RELATED PARTY TRANSACTIONS Sheet http://www.psagu.com/role/DisclosureRelatedPartyTransactions RELATED PARTY TRANSACTIONS Notes 13 false false R14.htm 10701 - Disclosure - COMMITMENTS Sheet http://www.psagu.com/role/DisclosureCommitments COMMITMENTS Notes 14 false false R15.htm 10801 - Disclosure - STOCKHOLDERS' DEFICIT Sheet http://www.psagu.com/role/DisclosureStockholdersDeficit STOCKHOLDERS' DEFICIT Notes 15 false false R16.htm 10901 - Disclosure - WARRANTS Sheet http://www.psagu.com/role/DisclosureWarrants WARRANTS Notes 16 false false R17.htm 11001 - Disclosure - FAIR VALUE MEASUREMENTS Sheet http://www.psagu.com/role/DisclosureFairValueMeasurements FAIR VALUE MEASUREMENTS Notes 17 false false R18.htm 11101 - Disclosure - SUBSEQUENT EVENTS Sheet http://www.psagu.com/role/DisclosureSubsequentEvents SUBSEQUENT EVENTS Notes 18 false false R19.htm 20302 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Sheet http://www.psagu.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Policies 19 false false R20.htm 30203 - Disclosure - REVISION OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS (Tables) Sheet http://www.psagu.com/role/DisclosureRevisionOfPreviouslyIssuedFinancialStatementsTables REVISION OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS (Tables) Tables http://www.psagu.com/role/DisclosureRevisionOfPreviouslyIssuedFinancialStatements 20 false false R21.htm 30303 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) Sheet http://www.psagu.com/role/DisclosureSummaryOfSignificantAccountingPoliciesTables SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) Tables http://www.psagu.com/role/DisclosureSummaryOfSignificantAccountingPolicies 21 false false R22.htm 31003 - Disclosure - FAIR VALUE MEASUREMENTS (Tables) Sheet http://www.psagu.com/role/DisclosureFairValueMeasurementsTables FAIR VALUE MEASUREMENTS (Tables) Tables http://www.psagu.com/role/DisclosureFairValueMeasurements 22 false false R23.htm 40101 - Disclosure - DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS (Details) Sheet http://www.psagu.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS (Details) Details http://www.psagu.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperations 23 false false R24.htm 40201 - Disclosure - REVISION OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS - Schedule of impact of revision on financial statements (Details) Sheet http://www.psagu.com/role/DisclosureRevisionOfPreviouslyIssuedFinancialStatementsScheduleOfImpactOfRevisionOnFinancialStatementsDetails REVISION OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS - Schedule of impact of revision on financial statements (Details) Details 24 false false R25.htm 40301 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) Sheet http://www.psagu.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) Details http://www.psagu.com/role/DisclosureSummaryOfSignificantAccountingPoliciesTables 25 false false R26.htm 40302 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Class A common stock reflected in the balance sheet (Details) Sheet http://www.psagu.com/role/DisclosureSummaryOfSignificantAccountingPoliciesClassCommonStockReflectedInBalanceSheetDetails SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Class A common stock reflected in the balance sheet (Details) Details 26 false false R27.htm 40303 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Schedule of calculation of basic and diluted net income (loss) per common share (Details) Sheet http://www.psagu.com/role/DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfCalculationOfBasicAndDilutedNetIncomeLossPerCommonShareDetails SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Schedule of calculation of basic and diluted net income (loss) per common share (Details) Details 27 false false R28.htm 40401 - Disclosure - PUBLIC OFFERING (Details) Sheet http://www.psagu.com/role/DisclosurePublicOfferingDetails PUBLIC OFFERING (Details) Details http://www.psagu.com/role/DisclosurePublicOffering 28 false false R29.htm 40501 - Disclosure - PRIVATE PLACEMENT (Details) Sheet http://www.psagu.com/role/DisclosurePrivatePlacementDetails PRIVATE PLACEMENT (Details) Details http://www.psagu.com/role/DisclosurePrivatePlacement 29 false false R30.htm 40601 - Disclosure - RELATED PARTY TRANSACTIONS - Founder Shares (Details) Sheet http://www.psagu.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetails RELATED PARTY TRANSACTIONS - Founder Shares (Details) Details 30 false false R31.htm 40602 - Disclosure - RELATED PARTY TRANSACTIONS (Details) Sheet http://www.psagu.com/role/DisclosureRelatedPartyTransactionsDetails RELATED PARTY TRANSACTIONS (Details) Details http://www.psagu.com/role/DisclosureRelatedPartyTransactions 31 false false R32.htm 40701 - Disclosure - COMMITMENTS (Details) Sheet http://www.psagu.com/role/DisclosureCommitmentsDetails COMMITMENTS (Details) Details http://www.psagu.com/role/DisclosureCommitments 32 false false R33.htm 40801 - Disclosure - STOCKHOLDERS' DEFICIT - Preferred Stock (Details) Sheet http://www.psagu.com/role/DisclosureStockholdersDeficitPreferredStockDetails STOCKHOLDERS' DEFICIT - Preferred Stock (Details) Details 33 false false R34.htm 40802 - Disclosure - STOCKHOLDERS' DEFICIT - Common Stock (Details) Sheet http://www.psagu.com/role/DisclosureStockholdersDeficitCommonStockDetails STOCKHOLDERS' DEFICIT - Common Stock (Details) Details 34 false false R35.htm 40901 - Disclosure - WARRANTS (Details) Sheet http://www.psagu.com/role/DisclosureWarrantsDetails WARRANTS (Details) Details http://www.psagu.com/role/DisclosureWarrants 35 false false R36.htm 41001 - Disclosure - FAIR VALUE MEASUREMENTS (Details) Sheet http://www.psagu.com/role/DisclosureFairValueMeasurementsDetails FAIR VALUE MEASUREMENTS (Details) Details http://www.psagu.com/role/DisclosureFairValueMeasurementsTables 36 false false R37.htm 41002 - Disclosure - FAIR VALUE MEASUREMENTS - Initial and subsequent measurement of key inputs for Warrants (Details) Sheet http://www.psagu.com/role/DisclosureFairValueMeasurementsInitialAndSubsequentMeasurementOfKeyInputsForWarrantsDetails FAIR VALUE MEASUREMENTS - Initial and subsequent measurement of key inputs for Warrants (Details) Details 37 false false R38.htm 41003 - Disclosure - FAIR VALUE MEASUREMENTS - Change in the Fair Value of the Warrant Liabilities (Details) Sheet http://www.psagu.com/role/DisclosureFairValueMeasurementsChangeInFairValueOfWarrantLiabilitiesDetails FAIR VALUE MEASUREMENTS - Change in the Fair Value of the Warrant Liabilities (Details) Details 38 false false R39.htm 41004 - Disclosure - FAIR VALUE MEASUREMENTS - Additional Information (Details) Sheet http://www.psagu.com/role/DisclosureFairValueMeasurementsAdditionalInformationDetails FAIR VALUE MEASUREMENTS - Additional Information (Details) Details 39 false false All Reports Book All Reports [ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 57 fact(s) appearing in ix:hidden were eligible for transformation: psagu:ClassOfWarrantOrRightMinimumThresholdWrittenNoticePeriodForRedemptionOfWarrants, psagu:CommonStockSharesOutstandingIncludingSubjectToRedemption, psagu:NumberOfWarrantsIssuedPerUnit, psagu:RedemptionPeriod, psagu:RedemptionPeriodUponClosure, us-gaap:CommonStockSharesIssued, us-gaap:CommonStockSharesOutstanding, us-gaap:EarningsPerShareDiluted, us-gaap:PreferredStockSharesOutstanding, us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction, us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross, us-gaap:TemporaryEquitySharesIssued, us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding - psagu-20220930x10q.htm 9 [ix-0514-Hidden-Fact-Not-Referenced] WARN: 2 fact(s) appearing in ix:hidden were not referenced by any -sec-ix-hidden style property: us-gaap:CommitmentsAndContingencies - psagu-20220930x10q.htm 9 psagu-20220930x10q.htm psagu-20220930.xsd psagu-20220930_cal.xml psagu-20220930_def.xml psagu-20220930_lab.xml psagu-20220930_pre.xml psagu-20220930xex31d1.htm psagu-20220930xex31d2.htm psagu-20220930xex32d1.htm psagu-20220930xex32d2.htm http://fasb.org/us-gaap/2022 http://xbrl.sec.gov/dei/2022 true true JSON 57 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "psagu-20220930x10q.htm": { "axisCustom": 0, "axisStandard": 14, "contextCount": 195, "dts": { "calculationLink": { "local": [ "psagu-20220930_cal.xml" ] }, "definitionLink": { "local": [ "psagu-20220930_def.xml" ] }, "inline": { "local": [ "psagu-20220930x10q.htm" ] }, "labelLink": { "local": [ "psagu-20220930_lab.xml" ] }, "presentationLink": { "local": [ "psagu-20220930_pre.xml" ] }, "schema": { "local": [ "psagu-20220930.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/arcrole/esma-arcrole-2018-11-21.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd", "https://xbrl.sec.gov/country/2022/country-2022.xsd", "https://xbrl.sec.gov/dei/2022/dei-2022.xsd" ] } }, "elementCount": 364, "entityCount": 1, "hidden": { "http://fasb.org/us-gaap/2022": 52, "http://www.psagu.com/20220930": 8, "http://xbrl.sec.gov/dei/2022": 5, "total": 65 }, "keyCustom": 86, "keyStandard": 144, "memberCustom": 24, "memberStandard": 21, "nsprefix": "psagu", "nsuri": "http://www.psagu.com/20220930", "report": { "R1": { "firstAnchor": { "ancestors": [ "p", "div", "div", "body", "html" ], "baseRef": "psagu-20220930x10q.htm", "contextRef": "Duration_1_1_2022_To_9_30_2022_P1ibIaNCoEOsd0fnAfLGwQ", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "00090 - Document - Document and Entity Information", "role": "http://www.psagu.com/role/DocumentDocumentAndEntityInformation", "shortName": "Document and Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "div", "div", "body", "html" ], "baseRef": "psagu-20220930x10q.htm", "contextRef": "Duration_1_1_2022_To_9_30_2022_P1ibIaNCoEOsd0fnAfLGwQ", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "psagu-20220930x10q.htm", "contextRef": "Duration_1_1_2022_To_9_30_2022_P1ibIaNCoEOsd0fnAfLGwQ", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "10301 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES", "role": "http://www.psagu.com/role/DisclosureSummaryOfSignificantAccountingPolicies", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "psagu-20220930x10q.htm", "contextRef": "Duration_1_1_2022_To_9_30_2022_P1ibIaNCoEOsd0fnAfLGwQ", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "psagu-20220930x10q.htm", "contextRef": "Duration_1_1_2022_To_9_30_2022_P1ibIaNCoEOsd0fnAfLGwQ", "decimals": null, "first": true, "lang": "en-US", "name": "psagu:InitialPublicOfferingTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "10401 - Disclosure - PUBLIC OFFERING", "role": "http://www.psagu.com/role/DisclosurePublicOffering", "shortName": "PUBLIC OFFERING", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "psagu-20220930x10q.htm", "contextRef": "Duration_1_1_2022_To_9_30_2022_P1ibIaNCoEOsd0fnAfLGwQ", "decimals": null, "first": true, "lang": "en-US", "name": "psagu:InitialPublicOfferingTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "psagu-20220930x10q.htm", "contextRef": "Duration_1_1_2022_To_9_30_2022_P1ibIaNCoEOsd0fnAfLGwQ", "decimals": null, "first": true, "lang": "en-US", "name": "psagu:PrivatePlacementTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "10501 - Disclosure - PRIVATE PLACEMENT", "role": "http://www.psagu.com/role/DisclosurePrivatePlacement", "shortName": "PRIVATE PLACEMENT", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "psagu-20220930x10q.htm", "contextRef": "Duration_1_1_2022_To_9_30_2022_P1ibIaNCoEOsd0fnAfLGwQ", "decimals": null, "first": true, "lang": "en-US", "name": "psagu:PrivatePlacementTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "psagu-20220930x10q.htm", "contextRef": "Duration_1_1_2022_To_9_30_2022_P1ibIaNCoEOsd0fnAfLGwQ", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "10601 - Disclosure - RELATED PARTY TRANSACTIONS", "role": "http://www.psagu.com/role/DisclosureRelatedPartyTransactions", "shortName": "RELATED PARTY TRANSACTIONS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "psagu-20220930x10q.htm", "contextRef": "Duration_1_1_2022_To_9_30_2022_P1ibIaNCoEOsd0fnAfLGwQ", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "psagu-20220930x10q.htm", "contextRef": "Duration_1_1_2022_To_9_30_2022_P1ibIaNCoEOsd0fnAfLGwQ", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "10701 - Disclosure - COMMITMENTS", "role": "http://www.psagu.com/role/DisclosureCommitments", "shortName": "COMMITMENTS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "psagu-20220930x10q.htm", "contextRef": "Duration_1_1_2022_To_9_30_2022_P1ibIaNCoEOsd0fnAfLGwQ", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "psagu-20220930x10q.htm", "contextRef": "Duration_1_1_2022_To_9_30_2022_P1ibIaNCoEOsd0fnAfLGwQ", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "10801 - Disclosure - STOCKHOLDERS' DEFICIT", "role": "http://www.psagu.com/role/DisclosureStockholdersDeficit", "shortName": "STOCKHOLDERS' DEFICIT", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "psagu-20220930x10q.htm", "contextRef": "Duration_1_1_2022_To_9_30_2022_P1ibIaNCoEOsd0fnAfLGwQ", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "psagu-20220930x10q.htm", "contextRef": "Duration_1_1_2022_To_9_30_2022_P1ibIaNCoEOsd0fnAfLGwQ", "decimals": null, "first": true, "lang": "en-US", "name": "psagu:WarrantsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "10901 - Disclosure - WARRANTS", "role": "http://www.psagu.com/role/DisclosureWarrants", "shortName": "WARRANTS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "psagu-20220930x10q.htm", "contextRef": "Duration_1_1_2022_To_9_30_2022_P1ibIaNCoEOsd0fnAfLGwQ", "decimals": null, "first": true, "lang": "en-US", "name": "psagu:WarrantsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "psagu-20220930x10q.htm", "contextRef": "Duration_1_1_2022_To_9_30_2022_P1ibIaNCoEOsd0fnAfLGwQ", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "11001 - Disclosure - FAIR VALUE MEASUREMENTS", "role": "http://www.psagu.com/role/DisclosureFairValueMeasurements", "shortName": "FAIR VALUE MEASUREMENTS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "psagu-20220930x10q.htm", "contextRef": "Duration_1_1_2022_To_9_30_2022_P1ibIaNCoEOsd0fnAfLGwQ", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "psagu-20220930x10q.htm", "contextRef": "Duration_1_1_2022_To_9_30_2022_P1ibIaNCoEOsd0fnAfLGwQ", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "11101 - Disclosure - SUBSEQUENT EVENTS", "role": "http://www.psagu.com/role/DisclosureSubsequentEvents", "shortName": "SUBSEQUENT EVENTS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "psagu-20220930x10q.htm", "contextRef": "Duration_1_1_2022_To_9_30_2022_P1ibIaNCoEOsd0fnAfLGwQ", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "div", "div", "body", "html" ], "baseRef": "psagu-20220930x10q.htm", "contextRef": "Duration_1_1_2022_To_9_30_2022_P1ibIaNCoEOsd0fnAfLGwQ", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "20302 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)", "role": "http://www.psagu.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "div", "div", "body", "html" ], "baseRef": "psagu-20220930x10q.htm", "contextRef": "Duration_1_1_2022_To_9_30_2022_P1ibIaNCoEOsd0fnAfLGwQ", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "psagu-20220930x10q.htm", "contextRef": "As_Of_9_30_2022_B2YKg6CLDkiWSr1TxTzL0A", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_TdeqZ9l0P02Oucap8iDK8w", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00100 - Statement - CONDENSED BALANCE SHEETS", "role": "http://www.psagu.com/role/StatementCondensedBalanceSheets", "shortName": "CONDENSED BALANCE SHEETS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "psagu-20220930x10q.htm", "contextRef": "As_Of_9_30_2022_B2YKg6CLDkiWSr1TxTzL0A", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_TdeqZ9l0P02Oucap8iDK8w", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "us-gaap:ErrorCorrectionTextBlock", "div", "div", "body", "html" ], "baseRef": "psagu-20220930x10q.htm", "contextRef": "Duration_1_1_2022_To_9_30_2022_P1ibIaNCoEOsd0fnAfLGwQ", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "30203 - Disclosure - REVISION OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS (Tables)", "role": "http://www.psagu.com/role/DisclosureRevisionOfPreviouslyIssuedFinancialStatementsTables", "shortName": "REVISION OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:ErrorCorrectionTextBlock", "div", "div", "body", "html" ], "baseRef": "psagu-20220930x10q.htm", "contextRef": "Duration_1_1_2022_To_9_30_2022_P1ibIaNCoEOsd0fnAfLGwQ", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "psagu:TemporaryEquityPolicyPolicyTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "psagu-20220930x10q.htm", "contextRef": "Duration_1_1_2022_To_9_30_2022_P1ibIaNCoEOsd0fnAfLGwQ", "decimals": null, "first": true, "lang": "en-US", "name": "psagu:ScheduleOfReconciliationOfTemporaryEquity", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "30303 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)", "role": "http://www.psagu.com/role/DisclosureSummaryOfSignificantAccountingPoliciesTables", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "psagu:TemporaryEquityPolicyPolicyTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "psagu-20220930x10q.htm", "contextRef": "Duration_1_1_2022_To_9_30_2022_P1ibIaNCoEOsd0fnAfLGwQ", "decimals": null, "first": true, "lang": "en-US", "name": "psagu:ScheduleOfReconciliationOfTemporaryEquity", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "baseRef": "psagu-20220930x10q.htm", "contextRef": "Duration_1_1_2022_To_9_30_2022_P1ibIaNCoEOsd0fnAfLGwQ", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "31003 - Disclosure - FAIR VALUE MEASUREMENTS (Tables)", "role": "http://www.psagu.com/role/DisclosureFairValueMeasurementsTables", "shortName": "FAIR VALUE MEASUREMENTS (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "baseRef": "psagu-20220930x10q.htm", "contextRef": "Duration_1_1_2022_To_9_30_2022_P1ibIaNCoEOsd0fnAfLGwQ", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "p", "us-gaap:NatureOfOperations", "div", "div", "body", "html" ], "baseRef": "psagu-20220930x10q.htm", "contextRef": "As_Of_3_12_2021_8M9pVDp3v06IIbiIRCBWSQ", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:SharesIssuedPricePerShare", "reportCount": 1, "unitRef": "Unit_Divide_USD_shares_yE3MJj4siki26wIaFw0ivQ", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40101 - Disclosure - DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS (Details)", "role": "http://www.psagu.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails", "shortName": "DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:NatureOfOperations", "div", "div", "body", "html" ], "baseRef": "psagu-20220930x10q.htm", "contextRef": "Duration_1_1_2022_To_9_30_2022_P1ibIaNCoEOsd0fnAfLGwQ", "decimals": "INF", "lang": null, "name": "psagu:ConditionForFutureBusinessCombinationNumberOfBusinessesMinimum", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_item_FEZ9AEplZE-5lvx9AJwTtQ", "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "psagu-20220930x10q.htm", "contextRef": "Duration_1_1_2022_To_9_30_2022_P1ibIaNCoEOsd0fnAfLGwQ", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:LiabilitiesFairValueAdjustment", "reportCount": 1, "unitRef": "Unit_Standard_USD_TdeqZ9l0P02Oucap8iDK8w", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40201 - Disclosure - REVISION OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS - Schedule of impact of revision on financial statements (Details)", "role": "http://www.psagu.com/role/DisclosureRevisionOfPreviouslyIssuedFinancialStatementsScheduleOfImpactOfRevisionOnFinancialStatementsDetails", "shortName": "REVISION OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS - Schedule of impact of revision on financial statements (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "psagu-20220930x10q.htm", "contextRef": "Duration_1_1_2021_To_9_30_2021_srt_RestatementAxis_srt_ScenarioPreviouslyReportedMember_qaILSZV1skWpazEiwtNqUQ", "decimals": "0", "lang": null, "name": "us-gaap:StockIssuedDuringPeriodValueNewIssues", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_TdeqZ9l0P02Oucap8iDK8w", "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "p", "us-gaap:CashAndCashEquivalentsPolicyTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "psagu-20220930x10q.htm", "contextRef": "As_Of_9_30_2022_B2YKg6CLDkiWSr1TxTzL0A", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashEquivalentsAtCarryingValue", "reportCount": 1, "unitRef": "Unit_Standard_USD_TdeqZ9l0P02Oucap8iDK8w", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40301 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)", "role": "http://www.psagu.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "us-gaap:CashEquivalentsAtCarryingValue", "p", "us-gaap:CashAndCashEquivalentsPolicyTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "psagu-20220930x10q.htm", "contextRef": "As_Of_12_31_2021_bp6F1QsDlkS6uxjhwxeG0Q", "decimals": "0", "lang": null, "name": "us-gaap:CashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_TdeqZ9l0P02Oucap8iDK8w", "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "psagu:ScheduleOfReconciliationOfTemporaryEquity", "psagu:TemporaryEquityPolicyPolicyTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "psagu-20220930x10q.htm", "contextRef": "Duration_1_1_2021_To_12_31_2021_us-gaap_StatementClassOfStockAxis_psagu_CommonClassaSubjectToRedemptionMember_qkv7jKET8UGvzoTO1eFR8Q", "decimals": "0", "first": true, "lang": null, "name": "psagu:ProceedsFromIssuanceOfTemporaryEquity", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_TdeqZ9l0P02Oucap8iDK8w", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40302 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Class A common stock reflected in the balance sheet (Details)", "role": "http://www.psagu.com/role/DisclosureSummaryOfSignificantAccountingPoliciesClassCommonStockReflectedInBalanceSheetDetails", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Class A common stock reflected in the balance sheet (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "psagu:ScheduleOfReconciliationOfTemporaryEquity", "psagu:TemporaryEquityPolicyPolicyTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "psagu-20220930x10q.htm", "contextRef": "Duration_1_1_2021_To_12_31_2021_us-gaap_StatementClassOfStockAxis_psagu_CommonClassaSubjectToRedemptionMember_qkv7jKET8UGvzoTO1eFR8Q", "decimals": "0", "first": true, "lang": null, "name": "psagu:ProceedsFromIssuanceOfTemporaryEquity", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_TdeqZ9l0P02Oucap8iDK8w", "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "us-gaap:EarningsPerSharePolicyTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "psagu-20220930x10q.htm", "contextRef": "Duration_7_1_2022_To_9_30_2022_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember_MclzCIIh50OTH4kLry8-AA", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_TdeqZ9l0P02Oucap8iDK8w", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40303 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Schedule of calculation of basic and diluted net income (loss) per common share (Details)", "role": "http://www.psagu.com/role/DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfCalculationOfBasicAndDilutedNetIncomeLossPerCommonShareDetails", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Schedule of calculation of basic and diluted net income (loss) per common share (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "us-gaap:EarningsPerSharePolicyTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "psagu-20220930x10q.htm", "contextRef": "Duration_7_1_2022_To_9_30_2022_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember_MclzCIIh50OTH4kLry8-AA", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_TdeqZ9l0P02Oucap8iDK8w", "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "p", "us-gaap:NatureOfOperations", "div", "div", "body", "html" ], "baseRef": "psagu-20220930x10q.htm", "contextRef": "As_Of_3_12_2021_8M9pVDp3v06IIbiIRCBWSQ", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:SharesIssuedPricePerShare", "reportCount": 1, "unitRef": "Unit_Divide_USD_shares_yE3MJj4siki26wIaFw0ivQ", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40401 - Disclosure - PUBLIC OFFERING (Details)", "role": "http://www.psagu.com/role/DisclosurePublicOfferingDetails", "shortName": "PUBLIC OFFERING (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "psagu:InitialPublicOfferingTextBlock", "div", "div", "body", "html" ], "baseRef": "psagu-20220930x10q.htm", "contextRef": "As_Of_3_12_2021_us-gaap_ClassOfWarrantOrRightAxis_psagu_PublicWarrantsMember_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember_nZiqom9VdEmWvvrZZE61OA", "decimals": "INF", "lang": null, "name": "us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_shares_ps0sLWVwZ0Sn2Pm4JAw31w", "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "psagu-20220930x10q.htm", "contextRef": "Duration_1_1_2022_To_9_30_2022_P1ibIaNCoEOsd0fnAfLGwQ", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ProceedsFromIssuanceOfWarrants", "reportCount": 1, "unitRef": "Unit_Standard_USD_TdeqZ9l0P02Oucap8iDK8w", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40501 - Disclosure - PRIVATE PLACEMENT (Details)", "role": "http://www.psagu.com/role/DisclosurePrivatePlacementDetails", "shortName": "PRIVATE PLACEMENT (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "psagu:PrivatePlacementTextBlock", "div", "div", "body", "html" ], "baseRef": "psagu-20220930x10q.htm", "contextRef": "Duration_3_12_2021_To_3_12_2021_us-gaap_ClassOfWarrantOrRightAxis_psagu_PrivatePlacementUnitsMember_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_PrivatePlacementMember_kgr7zYFNPUaMRuXVpBNTqg", "decimals": "INF", "lang": null, "name": "psagu:NumberOfSharesIssuedPerUnit", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_shares_ps0sLWVwZ0Sn2Pm4JAw31w", "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "psagu-20220930x10q.htm", "contextRef": "As_Of_9_30_2022_B2YKg6CLDkiWSr1TxTzL0A", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "reportCount": 1, "unitRef": "Unit_Divide_USD_shares_yE3MJj4siki26wIaFw0ivQ", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00105 - Statement - CONDENSED BALANCE SHEETS (Parenthetical)", "role": "http://www.psagu.com/role/StatementCondensedBalanceSheetsParenthetical", "shortName": "CONDENSED BALANCE SHEETS (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "psagu-20220930x10q.htm", "contextRef": "As_Of_9_30_2022_us-gaap_StatementClassOfStockAxis_psagu_CommonClassaSubjectToRedemptionMember_MTGuxGIQEEKVY7DNpTa-DA", "decimals": "INF", "lang": null, "name": "us-gaap:TemporaryEquityParOrStatedValuePerShare", "reportCount": 1, "unique": true, "unitRef": "Unit_Divide_USD_shares_yE3MJj4siki26wIaFw0ivQ", "xsiNil": "false" } }, "R30": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "psagu-20220930x10q.htm", "contextRef": "Duration_1_1_2021_To_3_31_2021_xh0Ln0vXd0elGE8Tbgz_Vw", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:StockIssuedDuringPeriodValueNewIssues", "reportCount": 1, "unitRef": "Unit_Standard_USD_TdeqZ9l0P02Oucap8iDK8w", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40601 - Disclosure - RELATED PARTY TRANSACTIONS - Founder Shares (Details)", "role": "http://www.psagu.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetails", "shortName": "RELATED PARTY TRANSACTIONS - Founder Shares (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "psagu-20220930x10q.htm", "contextRef": "Duration_3_3_2021_To_3_3_2021_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_psagu_PropertySolutionsAcquisitionSponsorIiLlcMember_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassBMember_K9Tt1Gr4C023EeZwB35VLQ", "decimals": "1", "lang": null, "name": "us-gaap:StockholdersEquityNoteStockSplitConversionRatio1", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_pure_48o_v7-duE6W91XnkkA0qA", "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "psagu-20220930x10q.htm", "contextRef": "Duration_1_1_2022_To_9_30_2022_P1ibIaNCoEOsd0fnAfLGwQ", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:RepaymentsOfRelatedPartyDebt", "reportCount": 1, "unitRef": "Unit_Standard_USD_TdeqZ9l0P02Oucap8iDK8w", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40602 - Disclosure - RELATED PARTY TRANSACTIONS (Details)", "role": "http://www.psagu.com/role/DisclosureRelatedPartyTransactionsDetails", "shortName": "RELATED PARTY TRANSACTIONS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "psagu-20220930x10q.htm", "contextRef": "Duration_3_3_2021_To_3_3_2021_us-gaap_RelatedPartyTransactionAxis_psagu_AdministrativeSupportAgreementMember_G-OB1zGQfkaAkq3dag6u_A", "decimals": "0", "lang": null, "name": "psagu:RelatedPartyTransactionExpensesFromTransactionsWithRelatedPartyPerMonth", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_TdeqZ9l0P02Oucap8iDK8w", "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "p", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "psagu-20220930x10q.htm", "contextRef": "As_Of_9_30_2022_B2YKg6CLDkiWSr1TxTzL0A", "decimals": "INF", "first": true, "lang": null, "name": "psagu:MaximumNumberOfDemandsForRegistrationOfSecurities", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_item_FEZ9AEplZE-5lvx9AJwTtQ", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40701 - Disclosure - COMMITMENTS (Details)", "role": "http://www.psagu.com/role/DisclosureCommitmentsDetails", "shortName": "COMMITMENTS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "psagu-20220930x10q.htm", "contextRef": "As_Of_9_30_2022_B2YKg6CLDkiWSr1TxTzL0A", "decimals": "INF", "first": true, "lang": null, "name": "psagu:MaximumNumberOfDemandsForRegistrationOfSecurities", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_item_FEZ9AEplZE-5lvx9AJwTtQ", "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "psagu-20220930x10q.htm", "contextRef": "As_Of_9_30_2022_B2YKg6CLDkiWSr1TxTzL0A", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:PreferredStockSharesAuthorized", "reportCount": 1, "unitRef": "Unit_Standard_shares_ps0sLWVwZ0Sn2Pm4JAw31w", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40801 - Disclosure - STOCKHOLDERS' DEFICIT - Preferred Stock (Details)", "role": "http://www.psagu.com/role/DisclosureStockholdersDeficitPreferredStockDetails", "shortName": "STOCKHOLDERS' DEFICIT - Preferred Stock (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "psagu-20220930x10q.htm", "contextRef": "As_Of_3_8_2021_HiSaxH2VRUSAoKYVmVG9Hw", "decimals": "INF", "lang": null, "name": "us-gaap:PreferredStockSharesIssued", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_shares_ps0sLWVwZ0Sn2Pm4JAw31w", "xsiNil": "false" } }, "R34": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "psagu-20220930x10q.htm", "contextRef": "Duration_1_1_2022_To_9_30_2022_P1ibIaNCoEOsd0fnAfLGwQ", "decimals": "0", "first": true, "lang": null, "name": "psagu:ConvertibleStockConversionRatio", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_pure_48o_v7-duE6W91XnkkA0qA", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40802 - Disclosure - STOCKHOLDERS' DEFICIT - Common Stock (Details)", "role": "http://www.psagu.com/role/DisclosureStockholdersDeficitCommonStockDetails", "shortName": "STOCKHOLDERS' DEFICIT - Common Stock (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "psagu-20220930x10q.htm", "contextRef": "Duration_1_1_2022_To_9_30_2022_P1ibIaNCoEOsd0fnAfLGwQ", "decimals": "0", "first": true, "lang": null, "name": "psagu:ConvertibleStockConversionRatio", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_pure_48o_v7-duE6W91XnkkA0qA", "xsiNil": "false" } }, "R35": { "firstAnchor": { "ancestors": [ "p", "psagu:WarrantsTextBlock", "div", "div", "body", "html" ], "baseRef": "psagu-20220930x10q.htm", "contextRef": "Duration_1_1_2022_To_9_30_2022_P1ibIaNCoEOsd0fnAfLGwQ", "decimals": null, "first": true, "lang": "en-US", "name": "psagu:MaximumPeriodAfterBusinessCombinationInWhichToFileRegistrationStatement", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40901 - Disclosure - WARRANTS (Details)", "role": "http://www.psagu.com/role/DisclosureWarrantsDetails", "shortName": "WARRANTS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "psagu:WarrantsTextBlock", "div", "div", "body", "html" ], "baseRef": "psagu-20220930x10q.htm", "contextRef": "Duration_1_1_2022_To_9_30_2022_P1ibIaNCoEOsd0fnAfLGwQ", "decimals": null, "first": true, "lang": "en-US", "name": "psagu:MaximumPeriodAfterBusinessCombinationInWhichToFileRegistrationStatement", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R36": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "psagu-20220930x10q.htm", "contextRef": "As_Of_9_30_2022_B2YKg6CLDkiWSr1TxTzL0A", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AssetsHeldInTrustNoncurrent", "reportCount": 1, "unitRef": "Unit_Standard_USD_TdeqZ9l0P02Oucap8iDK8w", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "41001 - Disclosure - FAIR VALUE MEASUREMENTS (Details)", "role": "http://www.psagu.com/role/DisclosureFairValueMeasurementsDetails", "shortName": "FAIR VALUE MEASUREMENTS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "psagu-20220930x10q.htm", "contextRef": "As_Of_9_30_2022_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_nZXn4-Egn06CC_i_lRb_eg", "decimals": "0", "lang": null, "name": "us-gaap:AssetsHeldInTrustNoncurrent", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_TdeqZ9l0P02Oucap8iDK8w", "xsiNil": "false" } }, "R37": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "psagu-20220930x10q.htm", "contextRef": "As_Of_9_30_2022_us-gaap_ClassOfWarrantOrRightAxis_psagu_PrivatePlacementWarrantsMember_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputRiskFreeInterestRateMember_lLNm5LlnLkKGK__h1a00-A", "decimals": "4", "first": true, "lang": null, "name": "us-gaap:DerivativeLiabilityMeasurementInput", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_pure_48o_v7-duE6W91XnkkA0qA", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "41002 - Disclosure - FAIR VALUE MEASUREMENTS - Initial and subsequent measurement of key inputs for Warrants (Details)", "role": "http://www.psagu.com/role/DisclosureFairValueMeasurementsInitialAndSubsequentMeasurementOfKeyInputsForWarrantsDetails", "shortName": "FAIR VALUE MEASUREMENTS - Initial and subsequent measurement of key inputs for Warrants (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "psagu-20220930x10q.htm", "contextRef": "As_Of_9_30_2022_us-gaap_ClassOfWarrantOrRightAxis_psagu_PrivatePlacementWarrantsMember_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputRiskFreeInterestRateMember_lLNm5LlnLkKGK__h1a00-A", "decimals": "4", "first": true, "lang": null, "name": "us-gaap:DerivativeLiabilityMeasurementInput", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_pure_48o_v7-duE6W91XnkkA0qA", "xsiNil": "false" } }, "R38": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "psagu-20220930x10q.htm", "contextRef": "As_Of_6_30_2022_us-gaap_ClassOfWarrantOrRightAxis_psagu_PrivatePlacementWarrantsMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_FrMSj0k0cEOMTk-7GbCA6g", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue", "reportCount": 1, "unitRef": "Unit_Standard_USD_TdeqZ9l0P02Oucap8iDK8w", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "41003 - Disclosure - FAIR VALUE MEASUREMENTS - Change in the Fair Value of the Warrant Liabilities (Details)", "role": "http://www.psagu.com/role/DisclosureFairValueMeasurementsChangeInFairValueOfWarrantLiabilitiesDetails", "shortName": "FAIR VALUE MEASUREMENTS - Change in the Fair Value of the Warrant Liabilities (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "psagu-20220930x10q.htm", "contextRef": "Duration_7_1_2022_To_9_30_2022_us-gaap_ClassOfWarrantOrRightAxis_psagu_PrivatePlacementWarrantsMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_DIlX5wCpsUebJN1Hf9JrZA", "decimals": "0", "lang": null, "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_TdeqZ9l0P02Oucap8iDK8w", "xsiNil": "false" } }, "R39": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "psagu-20220930x10q.htm", "contextRef": "As_Of_9_30_2022_B2YKg6CLDkiWSr1TxTzL0A", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares", "reportCount": 1, "unitRef": "Unit_Standard_USD_TdeqZ9l0P02Oucap8iDK8w", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "41004 - Disclosure - FAIR VALUE MEASUREMENTS - Additional Information (Details)", "role": "http://www.psagu.com/role/DisclosureFairValueMeasurementsAdditionalInformationDetails", "shortName": "FAIR VALUE MEASUREMENTS - Additional Information (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R4": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "psagu-20220930x10q.htm", "contextRef": "Duration_7_1_2022_To_9_30_2022_KENXo6e8FEuStDF2-aGsrQ", "decimals": "0", "first": true, "lang": null, "name": "psagu:FormationAndOperationalIncomeCosts", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_TdeqZ9l0P02Oucap8iDK8w", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00200 - Statement - CONDENSED STATEMENTS OF OPERATIONS", "role": "http://www.psagu.com/role/StatementCondensedStatementsOfOperations", "shortName": "CONDENSED STATEMENTS OF OPERATIONS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "psagu-20220930x10q.htm", "contextRef": "Duration_7_1_2022_To_9_30_2022_KENXo6e8FEuStDF2-aGsrQ", "decimals": "0", "first": true, "lang": null, "name": "psagu:FormationAndOperationalIncomeCosts", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_TdeqZ9l0P02Oucap8iDK8w", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "b", "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "psagu-20220930x10q.htm", "contextRef": "As_Of_12_31_2020_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_0xxtyCkKnUKNtqjHMpIs7w", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unitRef": "Unit_Standard_USD_TdeqZ9l0P02Oucap8iDK8w", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00300 - Statement - CONDENSED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT", "role": "http://www.psagu.com/role/StatementCondensedStatementsOfChangesInStockholdersDeficit", "shortName": "CONDENSED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "psagu-20220930x10q.htm", "contextRef": "Duration_1_1_2021_To_3_31_2021_us-gaap_StatementClassOfStockAxis_us-gaap_CommonClassAMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_HUx3D3NDZkOE7U2GjDiwVQ", "decimals": "0", "lang": null, "name": "psagu:UnitsIssuedDuringPeriodValueNewIssuesForPrivatePlacementUnits", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_TdeqZ9l0P02Oucap8iDK8w", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "psagu-20220930x10q.htm", "contextRef": "As_Of_3_31_2021_us-gaap_ClassOfWarrantOrRightAxis_psagu_PrivatePlacementWarrantsMember_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_PrivatePlacementMember_eYj-6NbXE0m8XMXOoYljiQ", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights", "reportCount": 1, "unitRef": "Unit_Standard_shares_ps0sLWVwZ0Sn2Pm4JAw31w", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00305 - Statement - CONDENSED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT (Parenthetical)", "role": "http://www.psagu.com/role/StatementCondensedStatementsOfChangesInStockholdersDeficitParenthetical", "shortName": "CONDENSED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": null }, "R7": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "psagu-20220930x10q.htm", "contextRef": "Duration_1_1_2022_To_9_30_2022_P1ibIaNCoEOsd0fnAfLGwQ", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ProfitLoss", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_TdeqZ9l0P02Oucap8iDK8w", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00400 - Statement - CONDENSED STATEMENTS OF CASH FLOWS", "role": "http://www.psagu.com/role/StatementCondensedStatementsOfCashFlows", "shortName": "CONDENSED STATEMENTS OF CASH FLOWS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "psagu-20220930x10q.htm", "contextRef": "Duration_1_1_2022_To_9_30_2022_P1ibIaNCoEOsd0fnAfLGwQ", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ProfitLoss", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_TdeqZ9l0P02Oucap8iDK8w", "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "psagu-20220930x10q.htm", "contextRef": "Duration_1_1_2022_To_9_30_2022_P1ibIaNCoEOsd0fnAfLGwQ", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:NatureOfOperations", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "10101 - Disclosure - DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS", "role": "http://www.psagu.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperations", "shortName": "DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "psagu-20220930x10q.htm", "contextRef": "Duration_1_1_2022_To_9_30_2022_P1ibIaNCoEOsd0fnAfLGwQ", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:NatureOfOperations", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "psagu-20220930x10q.htm", "contextRef": "Duration_1_1_2022_To_9_30_2022_P1ibIaNCoEOsd0fnAfLGwQ", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ErrorCorrectionTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "10201 - Disclosure - REVISION OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS", "role": "http://www.psagu.com/role/DisclosureRevisionOfPreviouslyIssuedFinancialStatements", "shortName": "REVISION OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "psagu-20220930x10q.htm", "contextRef": "Duration_1_1_2022_To_9_30_2022_P1ibIaNCoEOsd0fnAfLGwQ", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ErrorCorrectionTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 45, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.psagu.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.psagu.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Document and Entity Information" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2022", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.psagu.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.psagu.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.psagu.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "gYearItemType" }, "dei_DocumentInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Document Information [Line Items]" } } }, "localname": "DocumentInformationLineItems", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.psagu.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "stringItemType" }, "dei_DocumentInformationTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package.", "label": "Document Information [Table]" } } }, "localname": "DocumentInformationTable", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.psagu.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.psagu.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r311" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.psagu.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r312" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.psagu.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.psagu.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.psagu.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.psagu.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.psagu.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address State Or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.psagu.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r309" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.psagu.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.psagu.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.psagu.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_EntityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.", "label": "Entity [Domain]" } } }, "localname": "EntityDomain", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.psagu.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails" ], "xbrltype": "domainItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r309" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.psagu.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r315" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Entity Ex Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.psagu.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.psagu.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r309" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.psagu.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.psagu.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r314" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.psagu.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r309" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.psagu.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r309" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.psagu.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r309" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.psagu.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r309" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.psagu.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "employerIdItemType" }, "dei_LegalEntityAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The set of legal entities associated with a report.", "label": "Legal Entity [Axis]" } } }, "localname": "LegalEntityAxis", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.psagu.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails" ], "xbrltype": "stringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.psagu.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r308" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.psagu.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r310" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.psagu.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.psagu.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "tradingSymbolItemType" }, "psagu_A.EbushMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This member stands for A. Ebush.", "label": "A. Ebush [Member]", "terseLabel": "A. Ebush" } } }, "localname": "A.EbushMember", "nsuri": "http://www.psagu.com/20220930", "presentation": [ "http://www.psagu.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetails" ], "xbrltype": "domainItemType" }, "psagu_A.SavarMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This member stands for A. Savar.", "label": "A. Savar [Member]", "terseLabel": "A. Savar" } } }, "localname": "A.SavarMember", "nsuri": "http://www.psagu.com/20220930", "presentation": [ "http://www.psagu.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetails" ], "xbrltype": "domainItemType" }, "psagu_AdministrativeSupportAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This member stands for Administrative Support Agreement.", "label": "Administrative Service Agreement [Member]", "terseLabel": "Administrative Service Agreement" } } }, "localname": "AdministrativeSupportAgreementMember", "nsuri": "http://www.psagu.com/20220930", "presentation": [ "http://www.psagu.com/role/DisclosureRelatedPartyTransactionsDetails" ], "xbrltype": "domainItemType" }, "psagu_AggregateDeferredUnderwritingFeePayable": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The value as of the underwriting compensation deferred in the aggregate if the underwriter's option to purchase additional units is exercised in full.", "label": "Aggregate deferred underwriting fee payable", "terseLabel": "Aggregate deferred underwriting fee payable" } } }, "localname": "AggregateDeferredUnderwritingFeePayable", "nsuri": "http://www.psagu.com/20220930", "presentation": [ "http://www.psagu.com/role/DisclosureCommitmentsDetails" ], "xbrltype": "monetaryItemType" }, "psagu_AggregateDeferredUnderwritingFeePayableOnFullExerciseOfOverAllotmentOption": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The value as of the underwriting compensation deferred in the aggregate if the underwriter's option to purchase additional units is exercised in full.", "label": "Aggregate Deferred Underwriting Fee Payable on Full Exercise of Over Allotment Option", "terseLabel": "Aggregate deferred underwriting fee Payable on full exercise of over allotment option" } } }, "localname": "AggregateDeferredUnderwritingFeePayableOnFullExerciseOfOverAllotmentOption", "nsuri": "http://www.psagu.com/20220930", "presentation": [ "http://www.psagu.com/role/DisclosureCommitmentsDetails" ], "xbrltype": "monetaryItemType" }, "psagu_AssetsHeldInTrustAccountPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The disclosure of accounting policy for assets held in trust.", "label": "Assets Held In Trust Account, Policy [Policy Text Block]", "terseLabel": "Marketable Securities Held in Trust Account" } } }, "localname": "AssetsHeldInTrustAccountPolicyPolicyTextBlock", "nsuri": "http://www.psagu.com/20220930", "presentation": [ "http://www.psagu.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "psagu_ChangeInFairValueOfWarrantLiabilityCashFlowsAdjustment": { "auth_ref": [], "calculation": { "http://www.psagu.com/role/StatementCondensedStatementsOfCashFlows": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount represents for transaction costs allocable to warrant liability, which is added back to net income when calculating cash provided by (used in) operations using the indirect method.", "label": "Change in Fair value of Warrant Liability, Cash Flows Adjustment", "terseLabel": "Transaction costs allocable to warrant liabilities" } } }, "localname": "ChangeInFairValueOfWarrantLiabilityCashFlowsAdjustment", "nsuri": "http://www.psagu.com/20220930", "presentation": [ "http://www.psagu.com/role/StatementCondensedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "psagu_ClassOfWarrantOrRightAdjustmentOfExercisePriceOfWarrantsOrRightsPercentBasedOnMarketValueAndNewlyIssuedPrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of adjustment of exercise price of warrants based on market value and newly issued price.", "label": "Class Of Warrant Or Right Adjustment Of Exercise Price Of Warrants Or Rights Percent Based On Market Value And Newly Issued Price", "terseLabel": "Adjustment of exercise price of warrants based on market value and newly issued price (as a percent)" } } }, "localname": "ClassOfWarrantOrRightAdjustmentOfExercisePriceOfWarrantsOrRightsPercentBasedOnMarketValueAndNewlyIssuedPrice", "nsuri": "http://www.psagu.com/20220930", "presentation": [ "http://www.psagu.com/role/DisclosureWarrantsDetails" ], "xbrltype": "percentItemType" }, "psagu_ClassOfWarrantOrRightAdjustmentOfRedemptionPriceOfWarrantsOrRightsPercentBasedOnMarketValueAndNewlyIssuedPrice1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of adjustment of redemption price of stock based on market value and newly issued price.", "label": "Class of Warrant or Right, Adjustment of Redemption Price of Warrants or Rights, Percent, Based On Market Value And Newly Issued Price 1", "terseLabel": "Adjustment one of redemption price of stock based on market value and newly issued price (as a percent)" } } }, "localname": "ClassOfWarrantOrRightAdjustmentOfRedemptionPriceOfWarrantsOrRightsPercentBasedOnMarketValueAndNewlyIssuedPrice1", "nsuri": "http://www.psagu.com/20220930", "presentation": [ "http://www.psagu.com/role/DisclosureWarrantsDetails" ], "xbrltype": "percentItemType" }, "psagu_ClassOfWarrantOrRightMinimumThresholdWrittenNoticePeriodForRedemptionOfWarrants": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The minimum threshold period during which a written notice is required for redemption of warrants, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Class Of Warrant Or Right, Minimum Threshold Written Notice Period For Redemption Of Warrants", "terseLabel": "Minimum threshold written notice period for redemption of public warrants" } } }, "localname": "ClassOfWarrantOrRightMinimumThresholdWrittenNoticePeriodForRedemptionOfWarrants", "nsuri": "http://www.psagu.com/20220930", "presentation": [ "http://www.psagu.com/role/DisclosureWarrantsDetails" ], "xbrltype": "durationItemType" }, "psagu_ClassOfWarrantOrRightPriceOfWarrantsOrRights": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Price per share or per unit of warrants or rights outstanding.", "label": "Class of Warrant or Right, Price of Warrants or Rights", "terseLabel": "Price of warrant (in dollars per share)", "verboseLabel": "Price of warrants (in dollars per share)" } } }, "localname": "ClassOfWarrantOrRightPriceOfWarrantsOrRights", "nsuri": "http://www.psagu.com/20220930", "presentation": [ "http://www.psagu.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails", "http://www.psagu.com/role/DisclosurePrivatePlacementDetails", "http://www.psagu.com/role/DisclosureRelatedPartyTransactionsDetails" ], "xbrltype": "perShareItemType" }, "psagu_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Price of the entity's common stock which would be required to be attained to trigger the redemption of warrants.", "label": "Class Of Warrant Or Right, Redemption Of Warrants Or Rights Stock Price Trigger", "terseLabel": "Stock price trigger for redemption of warrants (in dollars per share)" } } }, "localname": "ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger", "nsuri": "http://www.psagu.com/20220930", "presentation": [ "http://www.psagu.com/role/DisclosureWarrantsDetails" ], "xbrltype": "perShareItemType" }, "psagu_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Threshold number of specified consecutive trading days for stock price trigger considered for redemption of warrants.", "label": "Class Of Warrant Or Right, Redemption Of Warrants Or Rights, , Threshold Consecutive Trading Days", "terseLabel": "Threshold consecutive trading days for redemption of warrants" } } }, "localname": "ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays", "nsuri": "http://www.psagu.com/20220930", "presentation": [ "http://www.psagu.com/role/DisclosureWarrantsDetails" ], "xbrltype": "integerItemType" }, "psagu_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Threshold number of specified trading days for stock price trigger considered for redemption of warrants.", "label": "Class Of Warrant Or Right, Redemption Of Warrants Or Rights, , Threshold Trading Days", "terseLabel": "Threshold trading days for redemption of warrants" } } }, "localname": "ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays", "nsuri": "http://www.psagu.com/20220930", "presentation": [ "http://www.psagu.com/role/DisclosureWarrantsDetails" ], "xbrltype": "integerItemType" }, "psagu_ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Redemption price per share or per unit of warrants or rights outstanding.", "label": "Class Of Warrant Or Right, Redemption Price Of Warrants Or Rights", "terseLabel": "Redemption price per warrant (in dollars per share)" } } }, "localname": "ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights", "nsuri": "http://www.psagu.com/20220930", "presentation": [ "http://www.psagu.com/role/DisclosureWarrantsDetails" ], "xbrltype": "perShareItemType" }, "psagu_CommitmentsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represents the information pertaining to commitments.", "label": "COMMITMENTS [Line Items]", "terseLabel": "COMMITMENTS" } } }, "localname": "CommitmentsLineItems", "nsuri": "http://www.psagu.com/20220930", "presentation": [ "http://www.psagu.com/role/DisclosureCommitmentsDetails" ], "xbrltype": "stringItemType" }, "psagu_CommitmentsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of commitments.", "label": "COMMITMENTS [Table]" } } }, "localname": "CommitmentsTable", "nsuri": "http://www.psagu.com/20220930", "presentation": [ "http://www.psagu.com/role/DisclosureCommitmentsDetails" ], "xbrltype": "stringItemType" }, "psagu_CommonClassaNotSubjectToRedemptionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Classification of common stock representing ownership interest in a corporation that is not subject to redemption.", "label": "Class A Common Stock Not Subject to Redemption", "terseLabel": "Class A common stock not subject to redemption" } } }, "localname": "CommonClassaNotSubjectToRedemptionMember", "nsuri": "http://www.psagu.com/20220930", "presentation": [ "http://www.psagu.com/role/StatementCondensedBalanceSheets", "http://www.psagu.com/role/StatementCondensedBalanceSheetsParenthetical" ], "xbrltype": "domainItemType" }, "psagu_CommonClassaSubjectToRedemptionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Classification of common stock representing ownership interest in a corporation that is subject to redemption.", "label": "Class A Common Stock Subject to Redemption", "terseLabel": "Class A common stock subject to redemption" } } }, "localname": "CommonClassaSubjectToRedemptionMember", "nsuri": "http://www.psagu.com/20220930", "presentation": [ "http://www.psagu.com/role/DisclosureStockholdersDeficitCommonStockDetails", "http://www.psagu.com/role/DisclosureSummaryOfSignificantAccountingPoliciesClassCommonStockReflectedInBalanceSheetDetails", "http://www.psagu.com/role/StatementCondensedBalanceSheets", "http://www.psagu.com/role/StatementCondensedBalanceSheetsParenthetical" ], "xbrltype": "domainItemType" }, "psagu_CommonStockNumberOfVotesPerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The number of votes that each common share is entitled.", "label": "Common Stock, Number Of Votes Per Share", "terseLabel": "Common shares, votes per share" } } }, "localname": "CommonStockNumberOfVotesPerShare", "nsuri": "http://www.psagu.com/20220930", "presentation": [ "http://www.psagu.com/role/DisclosureStockholdersDeficitCommonStockDetails" ], "xbrltype": "integerItemType" }, "psagu_CommonStockSharesIssuedIncludingSubjectToRedemption": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding, including those that are subject to redemption.", "label": "Common Stock Shares Issued, Including Subject To Redemption", "terseLabel": "Common shares issued, including stocks subject to redemption (in shares)" } } }, "localname": "CommonStockSharesIssuedIncludingSubjectToRedemption", "nsuri": "http://www.psagu.com/20220930", "presentation": [ "http://www.psagu.com/role/DisclosureStockholdersDeficitCommonStockDetails" ], "xbrltype": "sharesItemType" }, "psagu_CommonStockSharesOutstandingIncludingSubjectToRedemption": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding, including those that are subject to redemption.", "label": "Common Stock Shares Outstanding, Including Subject To Redemption", "terseLabel": "Common shares outstanding, including stocks subject to redemption (in shares)" } } }, "localname": "CommonStockSharesOutstandingIncludingSubjectToRedemption", "nsuri": "http://www.psagu.com/20220930", "presentation": [ "http://www.psagu.com/role/DisclosureStockholdersDeficitCommonStockDetails" ], "xbrltype": "sharesItemType" }, "psagu_ConditionForFutureBusinessCombinationNumberOfBusinessesMinimum": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The minimum number of businesses which the reporting entity must acquire with the net proceeds of the offering.", "label": "Condition For Future Business Combination Number of Businesses Minimum", "terseLabel": "Condition for future business combination number of businesses minimum" } } }, "localname": "ConditionForFutureBusinessCombinationNumberOfBusinessesMinimum", "nsuri": "http://www.psagu.com/20220930", "presentation": [ "http://www.psagu.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails" ], "xbrltype": "integerItemType" }, "psagu_ConditionForFutureBusinessCombinationThresholdNetTangibleAssets": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The threshold net tangible assets which the reporting entity must maintain in order to proceed with a business combination utilizing the proceeds of the offering.", "label": "Condition For Future Business Combination Threshold Net Tangible Assets", "terseLabel": "Condition for future business combination threshold net tangible assets" } } }, "localname": "ConditionForFutureBusinessCombinationThresholdNetTangibleAssets", "nsuri": "http://www.psagu.com/20220930", "presentation": [ "http://www.psagu.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails" ], "xbrltype": "monetaryItemType" }, "psagu_ConditionForFutureBusinessCombinationThresholdPercentageOwnership": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The threshold percentage of voting interest to be acquired in a future business combination as specified for the use of proceeds from the offering.", "label": "Condition For Future Business Combination Threshold Percentage Ownership", "terseLabel": "Condition for future business combination threshold percentage ownership" } } }, "localname": "ConditionForFutureBusinessCombinationThresholdPercentageOwnership", "nsuri": "http://www.psagu.com/20220930", "presentation": [ "http://www.psagu.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails" ], "xbrltype": "pureItemType" }, "psagu_ConditionForFutureBusinessCombinationUseOfProceedsPercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The threshold percentage of the assets held in the trust account funded by proceeds from the offering which must be used for purposes of consummating a business combination.", "label": "Condition For Future Business Combination Use of Proceeds Percentage", "terseLabel": "Condition for future business combination use of proceeds percentage" } } }, "localname": "ConditionForFutureBusinessCombinationUseOfProceedsPercentage", "nsuri": "http://www.psagu.com/20220930", "presentation": [ "http://www.psagu.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails" ], "xbrltype": "pureItemType" }, "psagu_ConvertibleStockConversionRatio": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The ratio to be applied to the stock in a conversion of convertible stock.", "label": "Convertible Stock Conversion Ratio", "terseLabel": "Ratio to be applied to the stock in the conversion" } } }, "localname": "ConvertibleStockConversionRatio", "nsuri": "http://www.psagu.com/20220930", "presentation": [ "http://www.psagu.com/role/DisclosureStockholdersDeficitCommonStockDetails" ], "xbrltype": "pureItemType" }, "psagu_D.AmsterdamMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This member stands for D. Amsterdam.", "label": "D. Amsterdam [Member]", "terseLabel": "D. Amsterdam" } } }, "localname": "D.AmsterdamMember", "nsuri": "http://www.psagu.com/20220930", "presentation": [ "http://www.psagu.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetails" ], "xbrltype": "domainItemType" }, "psagu_DeferredFeePerUnit": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the deferred fee per unit.", "label": "Deferred Fee Per Unit", "terseLabel": "Deferred fee per unit" } } }, "localname": "DeferredFeePerUnit", "nsuri": "http://www.psagu.com/20220930", "presentation": [ "http://www.psagu.com/role/DisclosureCommitmentsDetails" ], "xbrltype": "perShareItemType" }, "psagu_DeferredOfferingCostsNoncurrent": { "auth_ref": [], "calculation": { "http://www.psagu.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails": { "order": 2.0, "parentTag": "psagu_TransactionCosts", "weight": 1.0 }, "http://www.psagu.com/role/StatementCondensedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The carrying value as of balance sheet date of underwriting fees payable or deferred, classified as noncurrent.", "label": "Deferred Offering Cost Non Current", "terseLabel": "Deferred underwriting fee payable" } } }, "localname": "DeferredOfferingCostsNoncurrent", "nsuri": "http://www.psagu.com/20220930", "presentation": [ "http://www.psagu.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails", "http://www.psagu.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails", "http://www.psagu.com/role/StatementCondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "psagu_DeferredUnderwritingFeePayable": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of underwriting fee payable deferred during the period, classified as non-cash investing and financing activity.", "label": "Deferred Underwriting Fee Payable", "terseLabel": "Deferred underwriting fee payable" } } }, "localname": "DeferredUnderwritingFeePayable", "nsuri": "http://www.psagu.com/20220930", "presentation": [ "http://www.psagu.com/role/StatementCondensedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "psagu_DenominatorForCalculationOfEarningsPerShareAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "No definition available.", "label": "Denominator for Calculation of Earnings Per Share [Abstract]", "verboseLabel": "Denominator:" } } }, "localname": "DenominatorForCalculationOfEarningsPerShareAbstract", "nsuri": "http://www.psagu.com/20220930", "presentation": [ "http://www.psagu.com/role/DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfCalculationOfBasicAndDilutedNetIncomeLossPerCommonShareDetails" ], "xbrltype": "stringItemType" }, "psagu_DerivativeLiabilityMeasurementInputDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of the effective expiration date on key inputs into derivative liability measurement input Warrants.", "label": "Derivative Liability Measurement Input Description", "terseLabel": "Derivative Liability, Measurement Input" } } }, "localname": "DerivativeLiabilityMeasurementInputDescription", "nsuri": "http://www.psagu.com/20220930", "presentation": [ "http://www.psagu.com/role/DisclosureFairValueMeasurementsInitialAndSubsequentMeasurementOfKeyInputsForWarrantsDetails" ], "xbrltype": "stringItemType" }, "psagu_DescriptionOfOrganizationAndBusinessOperationsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represents the information pertaining to description of organization and business operations.", "label": "DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS [Line Items]", "terseLabel": "DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS" } } }, "localname": "DescriptionOfOrganizationAndBusinessOperationsLineItems", "nsuri": "http://www.psagu.com/20220930", "presentation": [ "http://www.psagu.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails" ], "xbrltype": "stringItemType" }, "psagu_DescriptionOfOrganizationAndBusinessOperationsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of description of organization and business operations.", "label": "DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS [Table]" } } }, "localname": "DescriptionOfOrganizationAndBusinessOperationsTable", "nsuri": "http://www.psagu.com/20220930", "presentation": [ "http://www.psagu.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails" ], "xbrltype": "stringItemType" }, "psagu_EarlyBirdCapitalIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This member is stands for Early Bird Capital Inc.", "label": "Early Bird Capital [Member]", "terseLabel": "Early Bird Capital" } } }, "localname": "EarlyBirdCapitalIncMember", "nsuri": "http://www.psagu.com/20220930", "presentation": [ "http://www.psagu.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails" ], "xbrltype": "domainItemType" }, "psagu_EarlybirdcapitalInc.Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the information pertaining to EarlyBirdCapital,Inc. (\"EarlyBirdCapital\").", "label": "EarlyBirdCapital,Inc." } } }, "localname": "EarlybirdcapitalInc.Member", "nsuri": "http://www.psagu.com/20220930", "presentation": [ "http://www.psagu.com/role/DisclosurePrivatePlacementDetails" ], "xbrltype": "domainItemType" }, "psagu_EmergingGrowthCompanyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the accounting policy on emerging growth company.", "label": "Emerging Growth Company [Policy Text Block]", "terseLabel": "Emerging Growth Company" } } }, "localname": "EmergingGrowthCompanyPolicyTextBlock", "nsuri": "http://www.psagu.com/20220930", "presentation": [ "http://www.psagu.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "psagu_FormationAndOperationalIncomeCosts": { "auth_ref": [], "calculation": { "http://www.psagu.com/role/StatementCondensedStatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of formation and operational (income) costs.", "label": "Formation and Operational Income Costs", "terseLabel": "Formation and operational costs" } } }, "localname": "FormationAndOperationalIncomeCosts", "nsuri": "http://www.psagu.com/20220930", "presentation": [ "http://www.psagu.com/role/StatementCondensedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "psagu_FounderSharesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the information pertaining to Founder Shares.", "label": "Founder Shares [Member]", "terseLabel": "Founder Shares" } } }, "localname": "FounderSharesMember", "nsuri": "http://www.psagu.com/20220930", "presentation": [ "http://www.psagu.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetails" ], "xbrltype": "domainItemType" }, "psagu_IndependentDirectorsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This member stands for independent directors.", "label": "Independent Directors [Member]", "terseLabel": "Independent Directors" } } }, "localname": "IndependentDirectorsMember", "nsuri": "http://www.psagu.com/20220930", "presentation": [ "http://www.psagu.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetails" ], "xbrltype": "domainItemType" }, "psagu_InitialBusinessCombinationSharesIssuableAsPercentOfOutstandingShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of outstanding stock after stock conversion issuable pursuant to initial business combination transaction", "label": "Initial Business Combination Shares Issuable As percent Of Outstanding Share", "terseLabel": "Aggregated shares issued upon converted basis (in percent)" } } }, "localname": "InitialBusinessCombinationSharesIssuableAsPercentOfOutstandingShare", "nsuri": "http://www.psagu.com/20220930", "presentation": [ "http://www.psagu.com/role/DisclosureStockholdersDeficitCommonStockDetails" ], "xbrltype": "percentItemType" }, "psagu_InitialClassificationOfOverAllotmentLiability": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the information pertaining to initial classification of over-allotment liability.", "label": "Initial Classification of Over-allotment Liability", "terseLabel": "Initial classification of over-allotment liability", "verboseLabel": "Initial classification of over-allotment Liability" } } }, "localname": "InitialClassificationOfOverAllotmentLiability", "nsuri": "http://www.psagu.com/20220930", "presentation": [ "http://www.psagu.com/role/DisclosureRevisionOfPreviouslyIssuedFinancialStatementsScheduleOfImpactOfRevisionOnFinancialStatementsDetails", "http://www.psagu.com/role/StatementCondensedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "psagu_InitialClassificationOfPrivateWarrants": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the information pertaining to Initial Classification Of Private Warrants.", "label": "Initial Classification Of Private Warrants", "terseLabel": "Initial classification of Private Warrants" } } }, "localname": "InitialClassificationOfPrivateWarrants", "nsuri": "http://www.psagu.com/20220930", "presentation": [ "http://www.psagu.com/role/StatementCondensedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "psagu_InitialClassificationOfPublicWarrants": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the information pertaining to Initial Classification Of Public Warrants.", "label": "Initial Classification Of Public Warrants", "terseLabel": "Initial classification of Public Warrants" } } }, "localname": "InitialClassificationOfPublicWarrants", "nsuri": "http://www.psagu.com/20220930", "presentation": [ "http://www.psagu.com/role/StatementCondensedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "psagu_InitialPublicOfferingTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The entire disclosure on information about initial public offering.", "label": "Public Offering [Text Block]", "terseLabel": "PUBLIC OFFERING" } } }, "localname": "InitialPublicOfferingTextBlock", "nsuri": "http://www.psagu.com/20220930", "presentation": [ "http://www.psagu.com/role/DisclosurePublicOffering" ], "xbrltype": "textBlockItemType" }, "psagu_MaximumBorrowingCapacityOfRelatedPartyPromissoryNote": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of maximum borrowing capacity of related party promissory note.", "label": "Maximum Borrowing Capacity of Related Party Promissory Note", "terseLabel": "Maximum borrowing capacity of related party promissory note" } } }, "localname": "MaximumBorrowingCapacityOfRelatedPartyPromissoryNote", "nsuri": "http://www.psagu.com/20220930", "presentation": [ "http://www.psagu.com/role/DisclosureRelatedPartyTransactionsDetails" ], "xbrltype": "monetaryItemType" }, "psagu_MaximumCommonStockSharesSubjectToForfeiture": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the maximum number of common stock shares subject to forfeiture.", "label": "Maximum Common Stock Shares Subject To Forfeiture", "terseLabel": "Maximum shares subject to forfeiture (in shares)" } } }, "localname": "MaximumCommonStockSharesSubjectToForfeiture", "nsuri": "http://www.psagu.com/20220930", "presentation": [ "http://www.psagu.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetails" ], "xbrltype": "sharesItemType" }, "psagu_MaximumLoansConvertibleIntoWarrants": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The maximum amount which a potential loan could have repaid through issuance of warrants.", "label": "Maximum Loans Convertible Into Warrants", "terseLabel": "Loan conversion agreement warrant" } } }, "localname": "MaximumLoansConvertibleIntoWarrants", "nsuri": "http://www.psagu.com/20220930", "presentation": [ "http://www.psagu.com/role/DisclosureRelatedPartyTransactionsDetails" ], "xbrltype": "monetaryItemType" }, "psagu_MaximumNumberOfDemandsForRegistrationOfSecurities": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the maximum number of demands for registration of securities.", "label": "Maximum Number of Demands for Registration of Securities", "terseLabel": "Maximum number of demands for registration of securities" } } }, "localname": "MaximumNumberOfDemandsForRegistrationOfSecurities", "nsuri": "http://www.psagu.com/20220930", "presentation": [ "http://www.psagu.com/role/DisclosureCommitmentsDetails" ], "xbrltype": "integerItemType" }, "psagu_MaximumPeriodAfterBusinessCombinationInWhichToFileRegistrationStatement": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The period of time after completion of a business combination in which the reporting entity is required to file a registration statement with the SEC.", "label": "Maximum Period After Business Combination In Which To File Registration Statement", "terseLabel": "Maximum period after business combination in which to file registration statement" } } }, "localname": "MaximumPeriodAfterBusinessCombinationInWhichToFileRegistrationStatement", "nsuri": "http://www.psagu.com/20220930", "presentation": [ "http://www.psagu.com/role/DisclosureWarrantsDetails" ], "xbrltype": "durationItemType" }, "psagu_NetProceedsFromInitialPublicOffering": { "auth_ref": [], "calculation": { "http://www.psagu.com/role/StatementCondensedStatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow associated with the amount received from entity's first offering of stock to the public, net of underwriting discounts paid.", "label": "Net Proceeds From Initial Public Offering", "terseLabel": "Proceeds from sale of Units, net of underwriting discounts paid" } } }, "localname": "NetProceedsFromInitialPublicOffering", "nsuri": "http://www.psagu.com/20220930", "presentation": [ "http://www.psagu.com/role/StatementCondensedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "psagu_NumberOfDilutiveSecurities": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of securities that have dilutive effect.", "label": "Number of Dilutive Securities", "terseLabel": "Number of dilutive securities" } } }, "localname": "NumberOfDilutiveSecurities", "nsuri": "http://www.psagu.com/20220930", "presentation": [ "http://www.psagu.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "sharesItemType" }, "psagu_NumberOfSharesForfeited": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The number of shares forfeited by the Founders as a result of the underwriters' partially exercising their over-allotment option.", "label": "Number of Shares Forfeited", "terseLabel": "Number of shares forfeited" } } }, "localname": "NumberOfSharesForfeited", "nsuri": "http://www.psagu.com/20220930", "presentation": [ "http://www.psagu.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetails" ], "xbrltype": "sharesItemType" }, "psagu_NumberOfSharesIssuedPerUnit": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the number of shares in a unit.", "label": "Number of Shares Issued Per Unit", "terseLabel": "Number of shares in a unit" } } }, "localname": "NumberOfSharesIssuedPerUnit", "nsuri": "http://www.psagu.com/20220930", "presentation": [ "http://www.psagu.com/role/DisclosureFairValueMeasurementsAdditionalInformationDetails", "http://www.psagu.com/role/DisclosurePrivatePlacementDetails", "http://www.psagu.com/role/DisclosurePublicOfferingDetails" ], "xbrltype": "sharesItemType" }, "psagu_NumberOfSharesNoLongerSubjectToForfeiture": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares of the company that were no longer subject to forfeiture.", "label": "Number of Shares No Longer Subject To Forfeiture", "terseLabel": "Number of shares no longer subject to forfeiture" } } }, "localname": "NumberOfSharesNoLongerSubjectToForfeiture", "nsuri": "http://www.psagu.com/20220930", "presentation": [ "http://www.psagu.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetails" ], "xbrltype": "sharesItemType" }, "psagu_NumberOfUnitsForWhichUnderwritersForfeitedTheirOptionToPurchase": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of additional units for which underwriters forfeited their option.", "label": "Number of Units for Which Underwriters Forfeited Their Option to Purchase", "terseLabel": "Number of units for which underwriters forfeited their option to purchase" } } }, "localname": "NumberOfUnitsForWhichUnderwritersForfeitedTheirOptionToPurchase", "nsuri": "http://www.psagu.com/20220930", "presentation": [ "http://www.psagu.com/role/DisclosureCommitmentsDetails" ], "xbrltype": "sharesItemType" }, "psagu_NumberOfWarrantsIssuedPerUnit": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the number of warrants in a unit.", "label": "Number of Warrants Issued Per Unit", "terseLabel": "Number of warrants in a unit (in shares)" } } }, "localname": "NumberOfWarrantsIssuedPerUnit", "nsuri": "http://www.psagu.com/20220930", "presentation": [ "http://www.psagu.com/role/DisclosureFairValueMeasurementsAdditionalInformationDetails", "http://www.psagu.com/role/DisclosurePrivatePlacementDetails", "http://www.psagu.com/role/DisclosurePublicOfferingDetails" ], "xbrltype": "sharesItemType" }, "psagu_NumeratorForCalculationOfEarningsPerShareAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "No definition available.", "label": "Numerator For Calculation Of Earnings Per Share Abstract", "terseLabel": "Numerator:" } } }, "localname": "NumeratorForCalculationOfEarningsPerShareAbstract", "nsuri": "http://www.psagu.com/20220930", "presentation": [ "http://www.psagu.com/role/DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfCalculationOfBasicAndDilutedNetIncomeLossPerCommonShareDetails" ], "xbrltype": "stringItemType" }, "psagu_OfferingCostsIncludedInAccountsPayableAccruedExpenses": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of offering costs included in accounts payable or accrued expenses that were incurred during a noncash or partial noncash transaction.", "label": "Offering Costs Included In Accounts Payable Accrued Expenses", "terseLabel": "Offering costs included in accrued offering costs" } } }, "localname": "OfferingCostsIncludedInAccountsPayableAccruedExpenses", "nsuri": "http://www.psagu.com/20220930", "presentation": [ "http://www.psagu.com/role/StatementCondensedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "psagu_OperatingBankAccounts": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of operating bank accounts.", "label": "Operating Bank Accounts", "terseLabel": "Operating bank accounts" } } }, "localname": "OperatingBankAccounts", "nsuri": "http://www.psagu.com/20220930", "presentation": [ "http://www.psagu.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails" ], "xbrltype": "monetaryItemType" }, "psagu_PartialExerciseOfUnderwritersOverAllotmentOptionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the information pertaining to partial exercise of the underwriter's over-allotment option.", "label": "Partial Exercise of Underwriter's Over-Allotment Option [Member]", "terseLabel": "Partial exercise of underwriter's over-allotment option", "verboseLabel": "Partial exercise of underwriter's over-allotment option" } } }, "localname": "PartialExerciseOfUnderwritersOverAllotmentOptionMember", "nsuri": "http://www.psagu.com/20220930", "presentation": [ "http://www.psagu.com/role/DisclosureCommitmentsDetails", "http://www.psagu.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails", "http://www.psagu.com/role/DisclosurePrivatePlacementDetails", "http://www.psagu.com/role/DisclosurePublicOfferingDetails" ], "xbrltype": "domainItemType" }, "psagu_PaymentsForInvestmentOfCashInTrustAccount": { "auth_ref": [], "calculation": { "http://www.psagu.com/role/StatementCondensedStatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of cash outflow for investment of cash in trust account.", "label": "Payments For Investment Of Cash In Trust Account", "negatedLabel": "Investment of cash into Trust Account", "verboseLabel": "Payments for investment of cash in Trust Account" } } }, "localname": "PaymentsForInvestmentOfCashInTrustAccount", "nsuri": "http://www.psagu.com/20220930", "presentation": [ "http://www.psagu.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails", "http://www.psagu.com/role/StatementCondensedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "psagu_PaymentsOfFranchiseAndIncomeTaxesFromCashWithdrawnFromTrustAccount": { "auth_ref": [], "calculation": { "http://www.psagu.com/role/StatementCondensedStatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow representing the payment of franchise and income taxes from cash withdrawn from trust account.", "label": "Payments of Franchise and Income Taxes from Cash withdrawn from Trust Account", "negatedLabel": "Cash withdrawn from Trust Account to pay franchise and income taxes" } } }, "localname": "PaymentsOfFranchiseAndIncomeTaxesFromCashWithdrawnFromTrustAccount", "nsuri": "http://www.psagu.com/20220930", "presentation": [ "http://www.psagu.com/role/StatementCondensedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "psagu_PercentageObligationToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the percentage of shares which the reporting entity is obligated to redeem if a business combination is not consummated using the offering proceeds within a specified period.", "label": "Percentage Obligation To Redeem Public Shares If Entity Does Not Complete A Business Combination", "terseLabel": "Obligation to redeem Public Shares if entity does not complete a Business Combination (as a percent)" } } }, "localname": "PercentageObligationToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination", "nsuri": "http://www.psagu.com/20220930", "presentation": [ "http://www.psagu.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails" ], "xbrltype": "percentItemType" }, "psagu_PercentageOfGrossProceedsOnTotalEquityProceed": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the percentage of gross proceeds on total equity proceeds.", "label": "Percentage of Gross Proceeds on Total Equity Proceed", "terseLabel": "Percentage of gross proceeds on total equity proceeds" } } }, "localname": "PercentageOfGrossProceedsOnTotalEquityProceed", "nsuri": "http://www.psagu.com/20220930", "presentation": [ "http://www.psagu.com/role/DisclosureWarrantsDetails" ], "xbrltype": "percentItemType" }, "psagu_PercentageOfIssuedAndOutstandingSharesAfterInitialPublicOfferingCollectivelyHeldByInitialStockholders": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The expected ownership percentage by the founders after completion of the proposed public offering.", "label": "Percentage of Issued and Outstanding Shares After the Initial Public Offering Collectively Held By Initial Stockholders", "terseLabel": "Percentage of issued and outstanding shares after the Initial Public Offering collectively held by initial stockholders" } } }, "localname": "PercentageOfIssuedAndOutstandingSharesAfterInitialPublicOfferingCollectivelyHeldByInitialStockholders", "nsuri": "http://www.psagu.com/20220930", "presentation": [ "http://www.psagu.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetails" ], "xbrltype": "percentItemType" }, "psagu_PrivatePlacementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "No definition available.", "label": "PRIVATE PLACEMENT." } } }, "localname": "PrivatePlacementAbstract", "nsuri": "http://www.psagu.com/20220930", "xbrltype": "stringItemType" }, "psagu_PrivatePlacementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represents the information pertaining to private placement.", "label": "PRIVATE PLACEMENT [Line Items]", "terseLabel": "PRIVATE PLACEMENT" } } }, "localname": "PrivatePlacementLineItems", "nsuri": "http://www.psagu.com/20220930", "presentation": [ "http://www.psagu.com/role/DisclosurePrivatePlacementDetails" ], "xbrltype": "stringItemType" }, "psagu_PrivatePlacementTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of private placement.", "label": "PRIVATE PLACEMENT [Table]" } } }, "localname": "PrivatePlacementTable", "nsuri": "http://www.psagu.com/20220930", "presentation": [ "http://www.psagu.com/role/DisclosurePrivatePlacementDetails" ], "xbrltype": "stringItemType" }, "psagu_PrivatePlacementTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The entire disclosure on information about private placement.", "label": "Private Placement [Text Block]", "terseLabel": "PRIVATE PLACEMENT" } } }, "localname": "PrivatePlacementTextBlock", "nsuri": "http://www.psagu.com/20220930", "presentation": [ "http://www.psagu.com/role/DisclosurePrivatePlacement" ], "xbrltype": "textBlockItemType" }, "psagu_PrivatePlacementUnitsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the information pertaining to Private Placement Units.", "label": "Private Placement Units [Member]", "terseLabel": "Private Placement Units" } } }, "localname": "PrivatePlacementUnitsMember", "nsuri": "http://www.psagu.com/20220930", "presentation": [ "http://www.psagu.com/role/DisclosurePrivatePlacementDetails" ], "xbrltype": "domainItemType" }, "psagu_PrivatePlacementWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents a redeemable warrant (Private Placement Warrant) that entitles the holder to purchase shares of common stock if the underwriter's option is exercised in full.", "label": "Private Placement Warrants [Member]", "terseLabel": "Private Placement Warrants" } } }, "localname": "PrivatePlacementWarrantsMember", "nsuri": "http://www.psagu.com/20220930", "presentation": [ "http://www.psagu.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails", "http://www.psagu.com/role/DisclosureFairValueMeasurementsAdditionalInformationDetails", "http://www.psagu.com/role/DisclosureFairValueMeasurementsChangeInFairValueOfWarrantLiabilitiesDetails", "http://www.psagu.com/role/DisclosureFairValueMeasurementsDetails", "http://www.psagu.com/role/DisclosureFairValueMeasurementsInitialAndSubsequentMeasurementOfKeyInputsForWarrantsDetails", "http://www.psagu.com/role/DisclosurePrivatePlacementDetails", "http://www.psagu.com/role/DisclosureWarrantsDetails", "http://www.psagu.com/role/StatementCondensedStatementsOfChangesInStockholdersDeficitParenthetical" ], "xbrltype": "domainItemType" }, "psagu_ProceedsFromIssuanceOfTemporaryEquity": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Cash inflow from issuance of temporary equity.", "label": "Proceeds from Issuance of Temporary Equity", "terseLabel": "Gross proceeds" } } }, "localname": "ProceedsFromIssuanceOfTemporaryEquity", "nsuri": "http://www.psagu.com/20220930", "presentation": [ "http://www.psagu.com/role/DisclosureSummaryOfSignificantAccountingPoliciesClassCommonStockReflectedInBalanceSheetDetails" ], "xbrltype": "monetaryItemType" }, "psagu_PromissoryNoteWithRelatedPartyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This member stands for promissory note with related party.", "label": "Promissory Note with Related Party [Member]", "terseLabel": "Promissory Note with Related Party" } } }, "localname": "PromissoryNoteWithRelatedPartyMember", "nsuri": "http://www.psagu.com/20220930", "presentation": [ "http://www.psagu.com/role/DisclosureRelatedPartyTransactionsDetails" ], "xbrltype": "domainItemType" }, "psagu_PropertySolutionsAcquisitionSponsorIiLlcAndEarlybirdcapitalInc.Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the information pertaining to Property Solutions Acquisition Sponsor II, LLC (the \"Sponsor\")and EarlyBirdCapital,Inc. (\"EarlyBirdCapital\").", "label": "Sponsor and EarlyBirdCapital" } } }, "localname": "PropertySolutionsAcquisitionSponsorIiLlcAndEarlybirdcapitalInc.Member", "nsuri": "http://www.psagu.com/20220930", "presentation": [ "http://www.psagu.com/role/DisclosurePrivatePlacementDetails" ], "xbrltype": "domainItemType" }, "psagu_PropertySolutionsAcquisitionSponsorIiLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the information pertaining to Property Solutions Acquisition Sponsor II, LLC (the \"Sponsor\").", "label": "Sponsor [Member]", "terseLabel": "Sponsor" } } }, "localname": "PropertySolutionsAcquisitionSponsorIiLlcMember", "nsuri": "http://www.psagu.com/20220930", "presentation": [ "http://www.psagu.com/role/DisclosurePrivatePlacementDetails", "http://www.psagu.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetails" ], "xbrltype": "domainItemType" }, "psagu_PublicOfferingAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "No definition available.", "label": "PUBLIC OFFERING" } } }, "localname": "PublicOfferingAbstract", "nsuri": "http://www.psagu.com/20220930", "xbrltype": "stringItemType" }, "psagu_PublicOfferingLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represents the information pertaining to public offering.", "label": "PUBLIC OFFERING [Line Items]", "terseLabel": "PUBLIC OFFERING" } } }, "localname": "PublicOfferingLineItems", "nsuri": "http://www.psagu.com/20220930", "presentation": [ "http://www.psagu.com/role/DisclosurePublicOfferingDetails" ], "xbrltype": "stringItemType" }, "psagu_PublicOfferingMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the sale of stock by a private company to the public.", "label": "Public offering" } } }, "localname": "PublicOfferingMember", "nsuri": "http://www.psagu.com/20220930", "presentation": [ "http://www.psagu.com/role/DisclosurePublicOfferingDetails" ], "xbrltype": "domainItemType" }, "psagu_PublicOfferingTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of public offering.", "label": "PUBLIC OFFERING [Table]" } } }, "localname": "PublicOfferingTable", "nsuri": "http://www.psagu.com/20220930", "presentation": [ "http://www.psagu.com/role/DisclosurePublicOfferingDetails" ], "xbrltype": "stringItemType" }, "psagu_PublicWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents a redeemable warrant (Public Warrant) that entitles the holder to purchase shares of common stock subject to adjustment.", "label": "Public Warrants [Member]", "terseLabel": "Public Warrants", "verboseLabel": "Public Warrants" } } }, "localname": "PublicWarrantsMember", "nsuri": "http://www.psagu.com/20220930", "presentation": [ "http://www.psagu.com/role/DisclosureFairValueMeasurementsAdditionalInformationDetails", "http://www.psagu.com/role/DisclosureFairValueMeasurementsChangeInFairValueOfWarrantLiabilitiesDetails", "http://www.psagu.com/role/DisclosureFairValueMeasurementsDetails", "http://www.psagu.com/role/DisclosurePublicOfferingDetails", "http://www.psagu.com/role/DisclosureWarrantsDetails" ], "xbrltype": "domainItemType" }, "psagu_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This member stands for the scenario, where redemption of warrants when the price per share of class a common stock equals or exceeds $10.00.", "label": "Redemption of Warrants When the Price per Class A Common Stock Equals or Exceeds $10.00", "terseLabel": "Redemption of warrants when the price per Class A common stock equals or exceeds $10.00" } } }, "localname": "RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member", "nsuri": "http://www.psagu.com/20220930", "presentation": [ "http://www.psagu.com/role/DisclosureWarrantsDetails" ], "xbrltype": "domainItemType" }, "psagu_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This member stands for the scenario, where redemption of warrants when the price per share of class a common stock equals or exceeds $18.00.", "label": "Redemption of Warrants When the Price per Class A Common Stock Equals or Exceeds $18.00", "terseLabel": "Redemption of warrants when the price per Class A common stock equals or exceeds $18.00" } } }, "localname": "RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member", "nsuri": "http://www.psagu.com/20220930", "presentation": [ "http://www.psagu.com/role/DisclosureWarrantsDetails" ], "xbrltype": "domainItemType" }, "psagu_RedemptionPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Redemption period.", "label": "Redemption Period", "terseLabel": "Redemption period" } } }, "localname": "RedemptionPeriod", "nsuri": "http://www.psagu.com/20220930", "presentation": [ "http://www.psagu.com/role/DisclosureWarrantsDetails" ], "xbrltype": "durationItemType" }, "psagu_RedemptionPeriodUponClosure": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The period of time in which the reporting entity must redeem shares issued pursuant to the offering.", "label": "Redemption Period Upon Closure", "terseLabel": "Redemption period upon closure" } } }, "localname": "RedemptionPeriodUponClosure", "nsuri": "http://www.psagu.com/20220930", "presentation": [ "http://www.psagu.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails" ], "xbrltype": "durationItemType" }, "psagu_RelatedPartyLoansMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This member stands for related party loans.", "label": "Related Party Loans [Member]", "terseLabel": "Related Party Loans" } } }, "localname": "RelatedPartyLoansMember", "nsuri": "http://www.psagu.com/20220930", "presentation": [ "http://www.psagu.com/role/DisclosureRelatedPartyTransactionsDetails" ], "xbrltype": "domainItemType" }, "psagu_RelatedPartyTransactionExpensesFromTransactionsWithRelatedPartyPerMonth": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The contractual monthly amount to be paid for support services.", "label": "Related Party Transaction, Expenses from Transactions with Related Party Per Month", "terseLabel": "Expenses per month" } } }, "localname": "RelatedPartyTransactionExpensesFromTransactionsWithRelatedPartyPerMonth", "nsuri": "http://www.psagu.com/20220930", "presentation": [ "http://www.psagu.com/role/DisclosureRelatedPartyTransactionsDetails" ], "xbrltype": "monetaryItemType" }, "psagu_RemeasurementOfCommonStockSubjectToPossibleRedemption": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of remeasurement of common stock subject to possible redemption.", "label": "Remeasurement of Common Stock Subject to Possible Redemption", "terseLabel": "Remeasurement of common stock subject to possible redemption" } } }, "localname": "RemeasurementOfCommonStockSubjectToPossibleRedemption", "nsuri": "http://www.psagu.com/20220930", "presentation": [ "http://www.psagu.com/role/StatementCondensedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "psagu_RepresentativeShareTransactionCosts": { "auth_ref": [], "calculation": { "http://www.psagu.com/role/StatementCondensedStatementsOfOperations": { "order": 3.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of representative share transaction costs.", "label": "Representative Share Transaction Costs", "negatedLabel": "Representative Share Transaction Costs" } } }, "localname": "RepresentativeShareTransactionCosts", "nsuri": "http://www.psagu.com/20220930", "presentation": [ "http://www.psagu.com/role/StatementCondensedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "psagu_RepresentativeSharesEstimatedFairValue": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of estimated fair value of representative shares.", "label": "Representative Shares, Estimated, Fair Value", "terseLabel": "Estimated fair value of Representative Shares" } } }, "localname": "RepresentativeSharesEstimatedFairValue", "nsuri": "http://www.psagu.com/20220930", "presentation": [ "http://www.psagu.com/role/DisclosureWarrantsDetails" ], "xbrltype": "monetaryItemType" }, "psagu_RestrictionsOnTransferPeriodOfTimeAfterBusinessCombinationCompletion": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The period of time after completion of a business combination during which the shares or warrant may not be transferred.", "label": "Restrictions on Transfer Period of Time After Business Combination Completion", "terseLabel": "Restrictions on transfer period of time after business combination completion" } } }, "localname": "RestrictionsOnTransferPeriodOfTimeAfterBusinessCombinationCompletion", "nsuri": "http://www.psagu.com/20220930", "presentation": [ "http://www.psagu.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetails", "http://www.psagu.com/role/DisclosureWarrantsDetails" ], "xbrltype": "durationItemType" }, "psagu_SaleOfStockOtherOfferingCosts": { "auth_ref": [], "calculation": { "http://www.psagu.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails": { "order": 3.0, "parentTag": "psagu_TransactionCosts", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the amount of other offering costs incurred.", "label": "Sale of Stock, Other Offering Costs", "terseLabel": "Other offering costs" } } }, "localname": "SaleOfStockOtherOfferingCosts", "nsuri": "http://www.psagu.com/20220930", "presentation": [ "http://www.psagu.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails", "http://www.psagu.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "monetaryItemType" }, "psagu_SaleOfStockOtherOfferingCostsExpensed": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the amount of other offering costs expensed as incurred.", "label": "Sale of Stock, Other Offering Costs, Expensed", "terseLabel": "Sale of stock, other offering costs, expensed" } } }, "localname": "SaleOfStockOtherOfferingCostsExpensed", "nsuri": "http://www.psagu.com/20220930", "presentation": [ "http://www.psagu.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "monetaryItemType" }, "psagu_SaleOfStockOtherOfferingCostsTempEquity": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the amount of other offering costs charged to temporary equity.", "label": "Sale of Stock, Other Offering Costs, Temporary Equity", "terseLabel": "Sale of stock, other offering costs, temporary equity" } } }, "localname": "SaleOfStockOtherOfferingCostsTempEquity", "nsuri": "http://www.psagu.com/20220930", "presentation": [ "http://www.psagu.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "monetaryItemType" }, "psagu_SaleOfStockUnderwritingFees": { "auth_ref": [], "calculation": { "http://www.psagu.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails": { "order": 1.0, "parentTag": "psagu_TransactionCosts", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the amount of offering fees incurred and paid for underwriters.", "label": "Sale of Stock, Underwriting fees", "terseLabel": "Underwriting fees" } } }, "localname": "SaleOfStockUnderwritingFees", "nsuri": "http://www.psagu.com/20220930", "presentation": [ "http://www.psagu.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails", "http://www.psagu.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "monetaryItemType" }, "psagu_ScheduleOfReconciliationOfTemporaryEquity": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the ordinary shares subject to possible redemption reflected on the balance sheet.", "label": "Schedule Of Reconciliation Of Temporary Equity", "terseLabel": "Schedule of Class A common stock reflected in the condensed balance sheet" } } }, "localname": "ScheduleOfReconciliationOfTemporaryEquity", "nsuri": "http://www.psagu.com/20220930", "presentation": [ "http://www.psagu.com/role/DisclosureSummaryOfSignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "psagu_StockIssuedDuringPeriodPublicSharesIssuedToUnderwritersMaximum": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued in lieu of cash for underwriters.", "label": "Stock Issued During Period Public Shares Issued To Underwriters Maximum", "terseLabel": "Number of shares granted to underwriters" } } }, "localname": "StockIssuedDuringPeriodPublicSharesIssuedToUnderwritersMaximum", "nsuri": "http://www.psagu.com/20220930", "presentation": [ "http://www.psagu.com/role/DisclosureCommitmentsDetails" ], "xbrltype": "sharesItemType" }, "psagu_SummaryOfSignificantAccountingPoliciesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represents the information pertaining to summary of significant accounting policies.", "label": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES [Line Items]", "terseLabel": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES" } } }, "localname": "SummaryOfSignificantAccountingPoliciesLineItems", "nsuri": "http://www.psagu.com/20220930", "presentation": [ "http://www.psagu.com/role/DisclosureSummaryOfSignificantAccountingPoliciesClassCommonStockReflectedInBalanceSheetDetails", "http://www.psagu.com/role/DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfCalculationOfBasicAndDilutedNetIncomeLossPerCommonShareDetails" ], "xbrltype": "stringItemType" }, "psagu_SummaryOfSignificantAccountingPoliciesTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of summary of significant accounting policies.", "label": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES [Table]" } } }, "localname": "SummaryOfSignificantAccountingPoliciesTable", "nsuri": "http://www.psagu.com/20220930", "presentation": [ "http://www.psagu.com/role/DisclosureSummaryOfSignificantAccountingPoliciesClassCommonStockReflectedInBalanceSheetDetails", "http://www.psagu.com/role/DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfCalculationOfBasicAndDilutedNetIncomeLossPerCommonShareDetails" ], "xbrltype": "stringItemType" }, "psagu_TemporaryEquityIssuanceCosts": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of issuance costs related to temporary equity.", "label": "Temporary Equity, Issuance Costs", "terseLabel": "Class A common stock issuance costs" } } }, "localname": "TemporaryEquityIssuanceCosts", "nsuri": "http://www.psagu.com/20220930", "presentation": [ "http://www.psagu.com/role/DisclosureSummaryOfSignificantAccountingPoliciesClassCommonStockReflectedInBalanceSheetDetails" ], "xbrltype": "monetaryItemType" }, "psagu_TemporaryEquityPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The disclosure of accounting policy for temporary equity.", "label": "Temporary Equity, Policy [Policy Text Block]", "terseLabel": "Class A Common Stock Subject to Possible Redemption" } } }, "localname": "TemporaryEquityPolicyPolicyTextBlock", "nsuri": "http://www.psagu.com/20220930", "presentation": [ "http://www.psagu.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "psagu_TemporaryEquityProceedsAllocatedToWarrants": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of gross proceeds allocated from temporary equity to warrants.", "label": "Temporary Equity , Proceeds Allocated To Warrants", "terseLabel": "Proceeds allocated to Public Warrants" } } }, "localname": "TemporaryEquityProceedsAllocatedToWarrants", "nsuri": "http://www.psagu.com/20220930", "presentation": [ "http://www.psagu.com/role/DisclosureSummaryOfSignificantAccountingPoliciesClassCommonStockReflectedInBalanceSheetDetails" ], "xbrltype": "monetaryItemType" }, "psagu_ThresholdNumberOfBusinessDaysBeforeSendingNoticeOfRedemptionToWarrantHolders": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Threshold number of business days before sending notice of redemption to warrant holders.", "label": "Threshold Number of Business Days Before Sending Notice of Redemption to Warrant Holders", "terseLabel": "Threshold number of business days before sending notice of redemption to warrant holders" } } }, "localname": "ThresholdNumberOfBusinessDaysBeforeSendingNoticeOfRedemptionToWarrantHolders", "nsuri": "http://www.psagu.com/20220930", "presentation": [ "http://www.psagu.com/role/DisclosureWarrantsDetails" ], "xbrltype": "integerItemType" }, "psagu_ThresholdPeriodAfterBusinessCombinationInWhichSpecifiedTradingDaysWithinAnySpecifiedTradingDayPeriodCommences": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The period of time after a business combination which must elapse before consideration of the share price condition for transfer of shares.", "label": "Threshold Period After Business Combination in Which Specified Trading Days Within Any Specified Trading Day Period Commences", "terseLabel": "Threshold period after the business combination in which the 20 trading days within any 30 trading day period commences" } } }, "localname": "ThresholdPeriodAfterBusinessCombinationInWhichSpecifiedTradingDaysWithinAnySpecifiedTradingDayPeriodCommences", "nsuri": "http://www.psagu.com/20220930", "presentation": [ "http://www.psagu.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetails" ], "xbrltype": "durationItemType" }, "psagu_TransactionCosts": { "auth_ref": [], "calculation": { "http://www.psagu.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the amount of transaction costs incurred.", "label": "Transaction Costs", "totalLabel": "Transaction costs", "verboseLabel": "Transaction costs" } } }, "localname": "TransactionCosts", "nsuri": "http://www.psagu.com/20220930", "presentation": [ "http://www.psagu.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails", "http://www.psagu.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "monetaryItemType" }, "psagu_TransactionCostsAllocableToRepresentativeShares": { "auth_ref": [], "calculation": { "http://www.psagu.com/role/StatementCondensedStatementsOfCashFlows": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount represents for transaction costs allocable to representative shares.", "label": "Transaction Costs Allocable To Representative Shares", "negatedLabel": "Transaction costs allocable to representative shares", "terseLabel": "Transaction costs allocable to representative shares" } } }, "localname": "TransactionCostsAllocableToRepresentativeShares", "nsuri": "http://www.psagu.com/20220930", "presentation": [ "http://www.psagu.com/role/DisclosureRevisionOfPreviouslyIssuedFinancialStatementsScheduleOfImpactOfRevisionOnFinancialStatementsDetails", "http://www.psagu.com/role/StatementCondensedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "psagu_TransactionCostsAllocableToWarrantLiability": { "auth_ref": [], "calculation": { "http://www.psagu.com/role/StatementCondensedStatementsOfOperations": { "order": 5.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount represents for transaction costs allocable to warrant liability.", "label": "Transaction Costs Allocable To Warrant Liability", "negatedLabel": "Transaction costs allocable to warrant liability" } } }, "localname": "TransactionCostsAllocableToWarrantLiability", "nsuri": "http://www.psagu.com/20220930", "presentation": [ "http://www.psagu.com/role/StatementCondensedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "psagu_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationStockPriceTrigger": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The share price threshold that must be achieved in order to waive the restriction on transfer of shares during a restricted period after a business combination.", "label": "Transfer, Assign or Sell Any Shares or Warrants After Completion of Initial Business Combination, Stock Price Trigger", "terseLabel": "Stock price trigger to transfer, assign or sell any shares or warrants of the company, after the completion of the initial business combination (in dollars per share)" } } }, "localname": "TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationStockPriceTrigger", "nsuri": "http://www.psagu.com/20220930", "presentation": [ "http://www.psagu.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetails" ], "xbrltype": "perShareItemType" }, "psagu_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdConsecutiveTradingDays": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "When determining the condition for transfer of shares without restriction after a business combination, the number of consecutive trading days used to observe the share price.", "label": "Transfer, Assign or Sell Any Shares or Warrants After Completion of Initial Business Combination, Threshold Consecutive Trading Days", "terseLabel": "Threshold consecutive trading days for transfer, assign or sale of shares or warrants, after the completion of the initial business combination" } } }, "localname": "TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdConsecutiveTradingDays", "nsuri": "http://www.psagu.com/20220930", "presentation": [ "http://www.psagu.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetails" ], "xbrltype": "integerItemType" }, "psagu_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdTradingDays": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "When determining the condition for transfer of shares without restriction after a business combination, the number of days in which the share price must exceed the specified amount.", "label": "Transfer, Assign or Sell Any Shares or Warrants After Completion of Initial Business Combination, Threshold Trading Days", "terseLabel": "Threshold trading days for transfer, assign or sale of shares or warrants, after the completion of the initial business combination" } } }, "localname": "TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdTradingDays", "nsuri": "http://www.psagu.com/20220930", "presentation": [ "http://www.psagu.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetails" ], "xbrltype": "integerItemType" }, "psagu_UnderwritingAgreementOptionPeriodGranted": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Underwriting agreement option period granted.", "label": "Underwriting Agreement Option Period Granted", "terseLabel": "Underwriting agreement option period granted" } } }, "localname": "UnderwritingAgreementOptionPeriodGranted", "nsuri": "http://www.psagu.com/20220930", "presentation": [ "http://www.psagu.com/role/DisclosureCommitmentsDetails" ], "xbrltype": "integerItemType" }, "psagu_UnitsEachConsistingOfOneShareOfClassCommonStockAndOneFourthOfOneWarrantMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Units, each consisting of one share of Class A Common Stock and one-fourth of one Warrant.", "label": "Units, Each Consisting of One Share of Class A Common Stock and One-Fourth of One Warrant [Member]", "terseLabel": "Units, each consisting of one share of Class A Common Stock and one-fourth of one Warrant" } } }, "localname": "UnitsEachConsistingOfOneShareOfClassCommonStockAndOneFourthOfOneWarrantMember", "nsuri": "http://www.psagu.com/20220930", "presentation": [ "http://www.psagu.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "domainItemType" }, "psagu_UnitsIssuedDuringPeriodAdditionalSharesNewIssues": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents for units issued during period additional shares new issues.", "label": "Units Issued During Period Additional Shares New Issues", "terseLabel": "Sale of an additional Private Placement Units" } } }, "localname": "UnitsIssuedDuringPeriodAdditionalSharesNewIssues", "nsuri": "http://www.psagu.com/20220930", "presentation": [ "http://www.psagu.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails" ], "xbrltype": "sharesItemType" }, "psagu_UnitsIssuedDuringPeriodSharesNewIssues": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of new units issued during the period.", "label": "Units Issued During Period, Shares, New Issues", "verboseLabel": "Number of units sold" } } }, "localname": "UnitsIssuedDuringPeriodSharesNewIssues", "nsuri": "http://www.psagu.com/20220930", "presentation": [ "http://www.psagu.com/role/DisclosureCommitmentsDetails", "http://www.psagu.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails", "http://www.psagu.com/role/DisclosurePublicOfferingDetails" ], "xbrltype": "sharesItemType" }, "psagu_UnitsIssuedDuringPeriodSharesNewIssuesForPrivatePlacementUnits": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of units issued during period shares new issues for private placement units.", "label": "Units Issued During Period Shares New Issues for Private Placement Units", "terseLabel": "Sale of 839,000 Private Placement Units (in shares)" } } }, "localname": "UnitsIssuedDuringPeriodSharesNewIssuesForPrivatePlacementUnits", "nsuri": "http://www.psagu.com/20220930", "presentation": [ "http://www.psagu.com/role/StatementCondensedStatementsOfChangesInStockholdersDeficit" ], "xbrltype": "sharesItemType" }, "psagu_UnitsIssuedDuringPeriodValueNewIssues": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Equity impact of the value of new unit issued during the period.", "label": "Units Issued During Period, Value, New Issues", "verboseLabel": "Units issued aggregate amount" } } }, "localname": "UnitsIssuedDuringPeriodValueNewIssues", "nsuri": "http://www.psagu.com/20220930", "presentation": [ "http://www.psagu.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails" ], "xbrltype": "monetaryItemType" }, "psagu_UnitsIssuedDuringPeriodValueNewIssuesForPrivatePlacementUnits": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "number of units issued during period value new issues for private placement units", "label": "Units Issued During Period Value New Issues for Private Placement Units", "terseLabel": "Sale of 839,000 Private Placement Units" } } }, "localname": "UnitsIssuedDuringPeriodValueNewIssuesForPrivatePlacementUnits", "nsuri": "http://www.psagu.com/20220930", "presentation": [ "http://www.psagu.com/role/StatementCondensedStatementsOfChangesInStockholdersDeficit" ], "xbrltype": "monetaryItemType" }, "psagu_WarrantExercisePeriodConditionOne": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The period of time after completion of a business combination before a warrant may be exercised.", "label": "Warrant Exercise Period Condition One", "terseLabel": "Warrant exercise period condition one" } } }, "localname": "WarrantExercisePeriodConditionOne", "nsuri": "http://www.psagu.com/20220930", "presentation": [ "http://www.psagu.com/role/DisclosureWarrantsDetails" ], "xbrltype": "durationItemType" }, "psagu_WarrantLiabilityPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the details pertaining to warrant liability.", "label": "Warrant Liability [Policy Text Block]", "terseLabel": "Warrant Liability" } } }, "localname": "WarrantLiabilityPolicyTextBlock", "nsuri": "http://www.psagu.com/20220930", "presentation": [ "http://www.psagu.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "psagu_WarrantsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "N/A.", "label": "WARRANTS." } } }, "localname": "WarrantsAbstract", "nsuri": "http://www.psagu.com/20220930", "xbrltype": "stringItemType" }, "psagu_WarrantsEachWholeWarrantExercisableForOneShareOfClassCommonStockAtExercisePriceMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price.", "label": "Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50" } } }, "localname": "WarrantsEachWholeWarrantExercisableForOneShareOfClassCommonStockAtExercisePriceMember", "nsuri": "http://www.psagu.com/20220930", "presentation": [ "http://www.psagu.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "domainItemType" }, "psagu_WarrantsTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The entire disclosure of warrants", "label": "Warrants (Text block)", "terseLabel": "WARRANTS" } } }, "localname": "WarrantsTextBlock", "nsuri": "http://www.psagu.com/20220930", "presentation": [ "http://www.psagu.com/role/DisclosureWarrants" ], "xbrltype": "textBlockItemType" }, "psagu_WorkingCapital": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of working capital.", "label": "Working Capital", "terseLabel": "Working capital" } } }, "localname": "WorkingCapital", "nsuri": "http://www.psagu.com/20220930", "presentation": [ "http://www.psagu.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails" ], "xbrltype": "monetaryItemType" }, "psagu_WorkingCapitalLoansWarrantMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the information regarding working capital loans warrant.", "label": "Working Capital Loans [Member]", "terseLabel": "Working Capital Loans" } } }, "localname": "WorkingCapitalLoansWarrantMember", "nsuri": "http://www.psagu.com/20220930", "presentation": [ "http://www.psagu.com/role/DisclosureRelatedPartyTransactionsDetails" ], "xbrltype": "domainItemType" }, "srt_RestatementAxis": { "auth_ref": [ "r1", "r58", "r59", "r60", "r61", "r62", "r63", "r64", "r65", "r66", "r68", "r69", "r70", "r71", "r72", "r73", "r87", "r117", "r118", "r203", "r219", "r220", "r221", "r222", "r245", "r246", "r247", "r297", "r298", "r299", "r300", "r301", "r302", "r303", "r304", "r305", "r306" ], "lang": { "en-us": { "role": { "label": "Revision of Prior Period [Axis]" } } }, "localname": "RestatementAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.psagu.com/role/DisclosureRevisionOfPreviouslyIssuedFinancialStatementsScheduleOfImpactOfRevisionOnFinancialStatementsDetails" ], "xbrltype": "stringItemType" }, "srt_RestatementDomain": { "auth_ref": [ "r1", "r58", "r59", "r60", "r61", "r62", "r63", "r64", "r65", "r66", "r68", "r69", "r70", "r71", "r72", "r73", "r87", "r117", "r118", "r203", "r219", "r220", "r221", "r222", "r245", "r246", "r247", "r297", "r298", "r299", "r300", "r301", "r302", "r303", "r304", "r305", "r306" ], "lang": { "en-us": { "role": { "label": "Revision of Prior Period [Domain]" } } }, "localname": "RestatementDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.psagu.com/role/DisclosureRevisionOfPreviouslyIssuedFinancialStatementsScheduleOfImpactOfRevisionOnFinancialStatementsDetails" ], "xbrltype": "domainItemType" }, "srt_RevisionOfPriorPeriodErrorCorrectionAdjustmentMember": { "auth_ref": [ "r63", "r64", "r65", "r68", "r69", "r71", "r72" ], "lang": { "en-us": { "role": { "label": "Revision of Prior Period, Error Correction, Adjustment [Member]", "terseLabel": "Adjustment" } } }, "localname": "RevisionOfPriorPeriodErrorCorrectionAdjustmentMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.psagu.com/role/DisclosureRevisionOfPreviouslyIssuedFinancialStatementsScheduleOfImpactOfRevisionOnFinancialStatementsDetails" ], "xbrltype": "domainItemType" }, "srt_ScenarioPreviouslyReportedMember": { "auth_ref": [ "r1", "r58", "r60", "r61", "r62", "r63", "r64", "r65", "r66", "r68", "r69", "r71", "r72", "r87", "r117", "r118", "r203", "r219", "r220", "r221", "r222", "r245", "r246", "r247", "r297", "r298", "r299", "r300", "r301", "r302", "r303", "r304", "r305", "r306" ], "lang": { "en-us": { "role": { "label": "Previously Reported [Member]", "terseLabel": "As Previously Reported" } } }, "localname": "ScenarioPreviouslyReportedMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.psagu.com/role/DisclosureRevisionOfPreviouslyIssuedFinancialStatementsScheduleOfImpactOfRevisionOnFinancialStatementsDetails" ], "xbrltype": "domainItemType" }, "srt_ScenarioUnspecifiedDomain": { "auth_ref": [ "r67", "r73", "r124", "r182" ], "lang": { "en-us": { "role": { "label": "Scenario [Domain]" } } }, "localname": "ScenarioUnspecifiedDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.psagu.com/role/DisclosureWarrantsDetails" ], "xbrltype": "domainItemType" }, "srt_StatementScenarioAxis": { "auth_ref": [ "r67", "r73", "r124", "r182", "r261" ], "lang": { "en-us": { "role": { "label": "Scenario [Axis]" } } }, "localname": "StatementScenarioAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.psagu.com/role/DisclosureWarrantsDetails" ], "xbrltype": "stringItemType" }, "srt_TitleOfIndividualAxis": { "auth_ref": [ "r113", "r253" ], "lang": { "en-us": { "role": { "label": "Title of Individual [Axis]" } } }, "localname": "TitleOfIndividualAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.psagu.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetails" ], "xbrltype": "stringItemType" }, "srt_TitleOfIndividualWithRelationshipToEntityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Title of Individual [Domain]" } } }, "localname": "TitleOfIndividualWithRelationshipToEntityDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.psagu.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccountingChangesAndErrorCorrectionsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "REVISION OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS" } } }, "localname": "AccountingChangesAndErrorCorrectionsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_AccruedLiabilitiesCurrent": { "auth_ref": [ "r23" ], "calculation": { "http://www.psagu.com/role/StatementCondensedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued liabilities - current", "terseLabel": "Accrued expenses" } } }, "localname": "AccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/StatementCondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedLiabilitiesMember": { "auth_ref": [ "r23" ], "lang": { "en-us": { "role": { "documentation": "This item represents obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered.", "label": "Accrued Expenses [Member]", "terseLabel": "Accrued expenses" } } }, "localname": "AccruedLiabilitiesMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/DisclosureRelatedPartyTransactionsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AdditionalPaidInCapital": { "auth_ref": [ "r14", "r259" ], "calculation": { "http://www.psagu.com/role/StatementCondensedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.", "label": "Additional Paid in Capital", "terseLabel": "Additional paid-in capital" } } }, "localname": "AdditionalPaidInCapital", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/StatementCondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r58", "r59", "r60", "r188", "r189", "r190", "r220" ], "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-in Capital", "terseLabel": "Additional Paid-in Capital" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/StatementCondensedStatementsOfChangesInStockholdersDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments to reconcile net loss to net cash used in operating activities:", "terseLabel": "Adjustments to reconcile net income to net cash used in operating activities:" } } }, "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/StatementCondensedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_AllocatedShareBasedCompensationExpense": { "auth_ref": [ "r186" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.", "label": "Share-based Payment Arrangement, Expense", "terseLabel": "Stock-based compensation expense" } } }, "localname": "AllocatedShareBasedCompensationExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_Assets": { "auth_ref": [ "r10", "r53", "r105", "r107", "r111", "r115", "r126", "r127", "r128", "r129", "r130", "r131", "r132", "r133", "r134", "r135", "r136", "r208", "r212", "r237", "r257", "r259", "r280", "r288" ], "calculation": { "http://www.psagu.com/role/StatementCondensedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets", "totalLabel": "TOTAL ASSETS" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/StatementCondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets [Abstract]", "terseLabel": "ASSETS" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/StatementCondensedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r5", "r20", "r53", "r115", "r126", "r127", "r128", "r129", "r130", "r131", "r132", "r133", "r134", "r135", "r136", "r208", "r212", "r237", "r257", "r259" ], "calculation": { "http://www.psagu.com/role/StatementCondensedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Current", "totalLabel": "Total Current Assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/StatementCondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets, Current [Abstract]", "terseLabel": "Current assets" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/StatementCondensedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsFairValueDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets, Fair Value Disclosure [Abstract]", "terseLabel": "Assets:" } } }, "localname": "AssetsFairValueDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/DisclosureFairValueMeasurementsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsHeldInTrustNoncurrent": { "auth_ref": [ "r50" ], "calculation": { "http://www.psagu.com/role/StatementCondensedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of cash, securities, or other assets held by a third-party trustee pursuant to the terms of an agreement which assets are available to be used by beneficiaries to that agreement only within the specific terms thereof and which agreement is expected to terminate more than one year from the balance sheet date (or operating cycle, if longer) at which time the assets held-in-trust will be released or forfeited.", "label": "Marketable securities held in Trust Account", "verboseLabel": "Marketable securities held in Trust Account" } } }, "localname": "AssetsHeldInTrustNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/DisclosureFairValueMeasurementsDetails", "http://www.psagu.com/role/StatementCondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_BalanceSheetLocationAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by location on balance sheet (statement of financial position).", "label": "Balance Sheet Location [Axis]" } } }, "localname": "BalanceSheetLocationAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/DisclosureRelatedPartyTransactionsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BalanceSheetLocationDomain": { "auth_ref": [ "r216", "r217" ], "lang": { "en-us": { "role": { "documentation": "Location in the balance sheet (statement of financial position).", "label": "Balance Sheet Location [Domain]" } } }, "localname": "BalanceSheetLocationDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/DisclosureRelatedPartyTransactionsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).", "label": "Basis of Accounting, Policy [Policy Text Block]", "terseLabel": "Basis of Presentation" } } }, "localname": "BasisOfAccountingPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r57" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS). Accounting policies describe all significant accounting policies of the reporting entity.", "label": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES [TEXT BLOCK]", "terseLabel": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES" } } }, "localname": "BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/DisclosureSummaryOfSignificantAccountingPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r3", "r8", "r47" ], "calculation": { "http://www.psagu.com/role/StatementCondensedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash held outside the Trust Account", "terseLabel": "Cash" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/StatementCondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsPolicyTextBlock": { "auth_ref": [ "r48" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.", "label": "Cash and Cash Equivalents, Policy [Policy Text Block]", "terseLabel": "Cash and Cash Equivalents" } } }, "localname": "CashAndCashEquivalentsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r42", "r47", "r49" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents", "periodEndLabel": "Cash - End of period", "periodStartLabel": "Cash - Beginning of period" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/StatementCondensedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "auth_ref": [ "r42", "r238" ], "calculation": { "http://www.psagu.com/role/StatementCondensedStatementsOfCashFlows": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "totalLabel": "Net Change in Cash" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/StatementCondensedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashEquivalentsAtCarryingValue": { "auth_ref": [ "r8" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash Equivalents, at Carrying Value", "terseLabel": "Cash equivalents" } } }, "localname": "CashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Supplemental Disclosure of Non-Cash Investing and Financing Activities:", "terseLabel": "Non-Cash investing and financing activities:" } } }, "localname": "CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/StatementCondensedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_ClassOfStockDomain": { "auth_ref": [ "r11", "r12", "r13", "r51", "r53", "r77", "r78", "r79", "r82", "r84", "r90", "r91", "r92", "r115", "r126", "r130", "r131", "r132", "r135", "r136", "r146", "r147", "r151", "r155", "r162", "r237", "r313" ], "lang": { "en-us": { "role": { "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.", "label": "Class of Stock [Domain]" } } }, "localname": "ClassOfStockDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/DisclosureFairValueMeasurementsAdditionalInformationDetails", "http://www.psagu.com/role/DisclosurePrivatePlacementDetails", "http://www.psagu.com/role/DisclosurePublicOfferingDetails", "http://www.psagu.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetails", "http://www.psagu.com/role/DisclosureRevisionOfPreviouslyIssuedFinancialStatementsScheduleOfImpactOfRevisionOnFinancialStatementsDetails", "http://www.psagu.com/role/DisclosureStockholdersDeficitCommonStockDetails", "http://www.psagu.com/role/DisclosureSummaryOfSignificantAccountingPoliciesClassCommonStockReflectedInBalanceSheetDetails", "http://www.psagu.com/role/DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfCalculationOfBasicAndDilutedNetIncomeLossPerCommonShareDetails", "http://www.psagu.com/role/DisclosureWarrantsDetails", "http://www.psagu.com/role/DocumentDocumentAndEntityInformation", "http://www.psagu.com/role/StatementCondensedBalanceSheets", "http://www.psagu.com/role/StatementCondensedBalanceSheetsParenthetical", "http://www.psagu.com/role/StatementCondensedStatementsOfChangesInStockholdersDeficit", "http://www.psagu.com/role/StatementCondensedStatementsOfOperations" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfStockLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Class of Stock [Line Items]", "terseLabel": "Class of Stock" } } }, "localname": "ClassOfStockLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/DisclosureStockholdersDeficitCommonStockDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ClassOfWarrantOrRightAxis": { "auth_ref": [ "r171", "r183" ], "lang": { "en-us": { "role": { "documentation": "Information by type of warrant or right issued.", "label": "Class of Warrant or Right [Axis]" } } }, "localname": "ClassOfWarrantOrRightAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails", "http://www.psagu.com/role/DisclosureFairValueMeasurementsAdditionalInformationDetails", "http://www.psagu.com/role/DisclosureFairValueMeasurementsChangeInFairValueOfWarrantLiabilitiesDetails", "http://www.psagu.com/role/DisclosureFairValueMeasurementsDetails", "http://www.psagu.com/role/DisclosureFairValueMeasurementsInitialAndSubsequentMeasurementOfKeyInputsForWarrantsDetails", "http://www.psagu.com/role/DisclosurePrivatePlacementDetails", "http://www.psagu.com/role/DisclosurePublicOfferingDetails", "http://www.psagu.com/role/DisclosureRelatedPartyTransactionsDetails", "http://www.psagu.com/role/DisclosureWarrantsDetails", "http://www.psagu.com/role/StatementCondensedStatementsOfChangesInStockholdersDeficitParenthetical" ], "xbrltype": "stringItemType" }, "us-gaap_ClassOfWarrantOrRightDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the class or type of warrant or right outstanding. Warrants and rights represent derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months.", "label": "Class of Warrant or Right [Domain]" } } }, "localname": "ClassOfWarrantOrRightDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails", "http://www.psagu.com/role/DisclosureFairValueMeasurementsAdditionalInformationDetails", "http://www.psagu.com/role/DisclosureFairValueMeasurementsChangeInFairValueOfWarrantLiabilitiesDetails", "http://www.psagu.com/role/DisclosureFairValueMeasurementsDetails", "http://www.psagu.com/role/DisclosureFairValueMeasurementsInitialAndSubsequentMeasurementOfKeyInputsForWarrantsDetails", "http://www.psagu.com/role/DisclosurePrivatePlacementDetails", "http://www.psagu.com/role/DisclosurePublicOfferingDetails", "http://www.psagu.com/role/DisclosureRelatedPartyTransactionsDetails", "http://www.psagu.com/role/DisclosureWarrantsDetails", "http://www.psagu.com/role/StatementCondensedStatementsOfChangesInStockholdersDeficitParenthetical" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": { "auth_ref": [ "r163" ], "lang": { "en-us": { "role": { "documentation": "Exercise price per share or per unit of warrants or rights outstanding.", "label": "Class of Warrant or Right, Exercise Price of Warrants or Rights", "terseLabel": "Exercise price of warrants" } } }, "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/DisclosurePrivatePlacementDetails", "http://www.psagu.com/role/DisclosurePublicOfferingDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ClassOfWarrantOrRightLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Class of Warrant or Right [Line Items]", "terseLabel": "Class of Warrant or Right" } } }, "localname": "ClassOfWarrantOrRightLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/DisclosureWarrantsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of securities into which each warrant or right may be converted. For example, but not limited to, each warrant may be converted into two shares.", "label": "Class of Warrant or Right, Number of Securities Called by Each Warrant or Right", "terseLabel": "Number of shares issuable per warrant", "verboseLabel": "Number of shares per warrant" } } }, "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/DisclosurePrivatePlacementDetails", "http://www.psagu.com/role/DisclosurePublicOfferingDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights": { "auth_ref": [ "r163" ], "lang": { "en-us": { "role": { "documentation": "Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.", "label": "Class of Warrant or Right, Number of Securities Called by Warrants or Rights", "terseLabel": "Sale of Private Placement Units (in shares)", "verboseLabel": "Warrants exercisable to purchase common stock" } } }, "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails", "http://www.psagu.com/role/DisclosurePrivatePlacementDetails", "http://www.psagu.com/role/StatementCondensedStatementsOfChangesInStockholdersDeficitParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_ClassOfWarrantOrRightTable": { "auth_ref": [ "r171", "r183" ], "lang": { "en-us": { "role": { "documentation": "Disclosure for warrants or rights issued, which includes the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.", "label": "Class of Warrant or Right [Table]" } } }, "localname": "ClassOfWarrantOrRightTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/DisclosureWarrantsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingencies": { "auth_ref": [ "r25", "r282", "r291" ], "calculation": { "http://www.psagu.com/role/StatementCondensedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.", "label": "Commitments and Contingencies", "terseLabel": "Commitments" } } }, "localname": "CommitmentsAndContingencies", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/StatementCondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "COMMITMENTS" } } }, "localname": "CommitmentsAndContingenciesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "auth_ref": [ "r121", "r122", "r123", "r125", "r307" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for commitments and contingencies.", "label": "Commitments and Contingencies Disclosure [Text Block]", "terseLabel": "COMMITMENTS" } } }, "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/DisclosureCommitments" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommonClassAMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Classification of common stock representing ownership interest in a corporation.", "label": "Common Class A [Member]", "verboseLabel": "Class A Common Stock" } } }, "localname": "CommonClassAMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/DisclosureFairValueMeasurementsAdditionalInformationDetails", "http://www.psagu.com/role/DisclosurePrivatePlacementDetails", "http://www.psagu.com/role/DisclosurePublicOfferingDetails", "http://www.psagu.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetails", "http://www.psagu.com/role/DisclosureRevisionOfPreviouslyIssuedFinancialStatementsScheduleOfImpactOfRevisionOnFinancialStatementsDetails", "http://www.psagu.com/role/DisclosureStockholdersDeficitCommonStockDetails", "http://www.psagu.com/role/DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfCalculationOfBasicAndDilutedNetIncomeLossPerCommonShareDetails", "http://www.psagu.com/role/DisclosureWarrantsDetails", "http://www.psagu.com/role/DocumentDocumentAndEntityInformation", "http://www.psagu.com/role/StatementCondensedBalanceSheets", "http://www.psagu.com/role/StatementCondensedBalanceSheetsParenthetical", "http://www.psagu.com/role/StatementCondensedStatementsOfChangesInStockholdersDeficit", "http://www.psagu.com/role/StatementCondensedStatementsOfOperations" ], "xbrltype": "domainItemType" }, "us-gaap_CommonClassBMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Classification of common stock that has different rights than Common Class A, representing ownership interest in a corporation.", "label": "Common Class B [Member]", "verboseLabel": "Class B Common Stock" } } }, "localname": "CommonClassBMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetails", "http://www.psagu.com/role/DisclosureRevisionOfPreviouslyIssuedFinancialStatementsScheduleOfImpactOfRevisionOnFinancialStatementsDetails", "http://www.psagu.com/role/DisclosureStockholdersDeficitCommonStockDetails", "http://www.psagu.com/role/DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfCalculationOfBasicAndDilutedNetIncomeLossPerCommonShareDetails", "http://www.psagu.com/role/DocumentDocumentAndEntityInformation", "http://www.psagu.com/role/StatementCondensedBalanceSheets", "http://www.psagu.com/role/StatementCondensedBalanceSheetsParenthetical", "http://www.psagu.com/role/StatementCondensedStatementsOfChangesInStockholdersDeficit", "http://www.psagu.com/role/StatementCondensedStatementsOfOperations" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r58", "r59", "r220" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock", "terseLabel": "Common Stock" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/StatementCondensedStatementsOfChangesInStockholdersDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common Stock, Par or Stated Value Per Share", "terseLabel": "Common shares, par value, (per share)", "verboseLabel": "Common shares, par value (in dollars per share)" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/DisclosureStockholdersDeficitCommonStockDetails", "http://www.psagu.com/role/StatementCondensedBalanceSheetsParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common Stock, Shares Authorized", "terseLabel": "Common shares, shares authorized", "verboseLabel": "Common shares, shares authorized (in shares)" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/DisclosureStockholdersDeficitCommonStockDetails", "http://www.psagu.com/role/StatementCondensedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common Stock, Shares, Issued", "terseLabel": "Common shares, shares issued", "verboseLabel": "Common shares, shares issued (in shares)" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/DisclosureStockholdersDeficitCommonStockDetails", "http://www.psagu.com/role/StatementCondensedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r13", "r162" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common Stock, Shares, Outstanding", "terseLabel": "Common shares, shares outstanding", "verboseLabel": "Common shares, shares outstanding (in shares)" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetails", "http://www.psagu.com/role/DisclosureStockholdersDeficitCommonStockDetails", "http://www.psagu.com/role/StatementCondensedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r13", "r259" ], "calculation": { "http://www.psagu.com/role/StatementCondensedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common Stock, Value, Issued", "terseLabel": "Common stock" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/StatementCondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConcentrationRiskCreditRisk": { "auth_ref": [ "r96", "r287" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for credit risk.", "label": "Concentration Risk, Credit Risk, Policy [Policy Text Block]", "terseLabel": "Concentration of Credit Risk" } } }, "localname": "ConcentrationRiskCreditRisk", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_DeferredChargesPolicyTextBlock": { "auth_ref": [ "r9" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for deferral and amortization of significant deferred charges.", "label": "Offering Costs" } } }, "localname": "DeferredChargesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_DerivativeLiabilityMeasurementInput": { "auth_ref": [ "r227" ], "lang": { "en-us": { "role": { "documentation": "Value of input used to measure derivative liability.", "label": "Derivative Liability, Measurement Input", "terseLabel": "Public Warrants and Private Placement Warrants" } } }, "localname": "DerivativeLiabilityMeasurementInput", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/DisclosureFairValueMeasurementsInitialAndSubsequentMeasurementOfKeyInputsForWarrantsDetails" ], "xbrltype": "decimalItemType" }, "us-gaap_EarningsPerShareAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Non-Redeemable Common Stock", "terseLabel": "Basic and diluted net income per ordinary share" } } }, "localname": "EarningsPerShareAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfCalculationOfBasicAndDilutedNetIncomeLossPerCommonShareDetails" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareBasic": { "auth_ref": [ "r35", "r63", "r64", "r66", "r67", "r68", "r74", "r77", "r82", "r83", "r84", "r87", "r88", "r221", "r222", "r285", "r294" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.", "label": "Earnings Per Share, Basic", "terseLabel": "Earnings Per Share, Basic", "verboseLabel": "Basic net income per ordinary share (in dollars per share)" } } }, "localname": "EarningsPerShareBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfCalculationOfBasicAndDilutedNetIncomeLossPerCommonShareDetails", "http://www.psagu.com/role/StatementCondensedStatementsOfOperations" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareDiluted": { "auth_ref": [ "r35", "r63", "r64", "r66", "r67", "r68", "r77", "r82", "r83", "r84", "r87", "r88", "r221", "r222", "r285", "r294" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Earnings Per Share, Diluted", "terseLabel": "Diluted net income per ordinary share (in dollars per share)", "verboseLabel": "Earnings Per Share, Diluted" } } }, "localname": "EarningsPerShareDiluted", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfCalculationOfBasicAndDilutedNetIncomeLossPerCommonShareDetails", "http://www.psagu.com/role/StatementCondensedStatementsOfOperations" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerSharePolicyTextBlock": { "auth_ref": [ "r85", "r86" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.", "label": "Earnings Per Share, Policy [Policy Text Block]", "terseLabel": "Net Income (Loss) per Common Share" } } }, "localname": "EarningsPerSharePolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_EffectiveIncomeTaxRateContinuingOperations": { "auth_ref": [ "r195" ], "lang": { "en-us": { "role": { "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Effective Income Tax Rate Reconciliation, Percent", "terseLabel": "Effective Tax Rate" } } }, "localname": "EffectiveIncomeTaxRateContinuingOperations", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": { "auth_ref": [ "r54", "r195", "r205" ], "lang": { "en-us": { "role": { "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss).", "label": "Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent", "terseLabel": "Statutory federal income tax rate" } } }, "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r0", "r30", "r31", "r32", "r58", "r59", "r60", "r62", "r69", "r72", "r89", "r116", "r162", "r169", "r188", "r189", "r190", "r202", "r203", "r220", "r239", "r240", "r241", "r242", "r243", "r244", "r247", "r297", "r298", "r299" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.", "label": "Equity Component [Domain]" } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/StatementCondensedStatementsOfChangesInStockholdersDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_ErrorCorrectionTextBlock": { "auth_ref": [ "r70" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for reporting error correction.", "label": "Accounting Changes and Error Corrections [Text Block]", "terseLabel": "REVISION OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS" } } }, "localname": "ErrorCorrectionTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/DisclosureRevisionOfPreviouslyIssuedFinancialStatements" ], "xbrltype": "textBlockItemType" }, "us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Error Corrections and Prior Period Adjustments Restatement [Line Items]", "terseLabel": "REVISION OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS" } } }, "localname": "ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/DisclosureRevisionOfPreviouslyIssuedFinancialStatementsScheduleOfImpactOfRevisionOnFinancialStatementsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAdjustmentOfWarrants": { "auth_ref": [ "r45", "r140" ], "calculation": { "http://www.psagu.com/role/StatementCondensedStatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://www.psagu.com/role/StatementCondensedStatementsOfOperations": { "order": 4.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense (income) related to adjustment to fair value of warrant liability.", "label": "Fair Value Adjustment of Warrants", "negatedLabel": "Change in fair value of warrant liability", "terseLabel": "Change in fair value of warrant liability" } } }, "localname": "FairValueAdjustmentOfWarrants", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/StatementCondensedStatementsOfCashFlows", "http://www.psagu.com/role/StatementCondensedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]", "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/DisclosureFairValueMeasurementsAdditionalInformationDetails", "http://www.psagu.com/role/DisclosureFairValueMeasurementsDetails", "http://www.psagu.com/role/DisclosureFairValueMeasurementsInitialAndSubsequentMeasurementOfKeyInputsForWarrantsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": { "auth_ref": [ "r223", "r224", "r233" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.", "label": "Fair Value, Recurring and Nonrecurring [Table]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/DisclosureFairValueMeasurementsAdditionalInformationDetails", "http://www.psagu.com/role/DisclosureFairValueMeasurementsDetails", "http://www.psagu.com/role/DisclosureFairValueMeasurementsInitialAndSubsequentMeasurementOfKeyInputsForWarrantsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock": { "auth_ref": [ "r225" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.", "label": "Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]", "verboseLabel": "Schedule of initial and subsequent measurement of key inputs" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/DisclosureFairValueMeasurementsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock": { "auth_ref": [ "r223", "r224" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of assets, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).", "label": "Schedule of Company's assets that are measured at fair value on a recurring basis" } } }, "localname": "FairValueAssetsMeasuredOnRecurringBasisTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/DisclosureFairValueMeasurementsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "auth_ref": [ "r137", "r138", "r139", "r173", "r174", "r175", "r176", "r177", "r178", "r179", "r181", "r224", "r263", "r264", "r265" ], "lang": { "en-us": { "role": { "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.", "label": "Fair Value Hierarchy and NAV [Axis]" } } }, "localname": "FairValueByFairValueHierarchyLevelAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/DisclosureFairValueMeasurementsAdditionalInformationDetails", "http://www.psagu.com/role/DisclosureFairValueMeasurementsChangeInFairValueOfWarrantLiabilitiesDetails", "http://www.psagu.com/role/DisclosureFairValueMeasurementsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByMeasurementFrequencyAxis": { "auth_ref": [ "r223", "r224", "r226", "r227", "r234" ], "lang": { "en-us": { "role": { "documentation": "Information by measurement frequency.", "label": "Measurement Frequency [Axis]" } } }, "localname": "FairValueByMeasurementFrequencyAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/DisclosureFairValueMeasurementsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "FAIR VALUE MEASUREMENTS" } } }, "localname": "FairValueDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresTextBlock": { "auth_ref": [ "r232" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.", "label": "Fair Value Disclosures [Text Block]", "terseLabel": "FAIR VALUE MEASUREMENTS" } } }, "localname": "FairValueDisclosuresTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/DisclosureFairValueMeasurements" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueInputsLevel1Member": { "auth_ref": [ "r137", "r173", "r174", "r179", "r181", "r224", "r263" ], "lang": { "en-us": { "role": { "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.", "label": "Level 1", "terseLabel": "Level 1" } } }, "localname": "FairValueInputsLevel1Member", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/DisclosureFairValueMeasurementsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel3Member": { "auth_ref": [ "r137", "r138", "r139", "r173", "r174", "r175", "r176", "r177", "r178", "r179", "r181", "r224", "r265" ], "lang": { "en-us": { "role": { "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Level 3", "terseLabel": "Level 3" } } }, "localname": "FairValueInputsLevel3Member", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/DisclosureFairValueMeasurementsAdditionalInformationDetails", "http://www.psagu.com/role/DisclosureFairValueMeasurementsChangeInFairValueOfWarrantLiabilitiesDetails", "http://www.psagu.com/role/DisclosureFairValueMeasurementsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]", "terseLabel": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation" } } }, "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/DisclosureFairValueMeasurementsChangeInFairValueOfWarrantLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]", "terseLabel": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation" } } }, "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/DisclosureFairValueMeasurementsChangeInFairValueOfWarrantLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable": { "auth_ref": [ "r228", "r233" ], "lang": { "en-us": { "role": { "documentation": "Schedule of information required and determined to be provided for purposes of reconciling beginning and ending balances of fair value measurements of liabilities using significant unobservable inputs (level 3). Separately presenting changes during the period, attributable to: (1) total gains or losses for the period (realized and unrealized) and location reported in the statement of income (or activities); (2) purchases, sales, issuances, and settlements (net); (3) transfers in and/or out of Level 3.", "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]" } } }, "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/DisclosureFairValueMeasurementsChangeInFairValueOfWarrantLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock": { "auth_ref": [ "r228", "r233" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.", "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]", "terseLabel": "Schedule of change in the fair value of the warrant liabilities" } } }, "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/DisclosureFairValueMeasurementsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueMeasurementFrequencyDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Measurement frequency.", "label": "Measurement Frequency [Domain]" } } }, "localname": "FairValueMeasurementFrequencyDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/DisclosureFairValueMeasurementsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3": { "auth_ref": [ "r231" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of transfers of financial instrument classified as a liability out of level 3 of the fair value hierarchy.", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers out of Level 3", "negatedLabel": "Transfer from Level 3 to Level 1", "terseLabel": "Transfers from Level 3" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/DisclosureFairValueMeasurementsAdditionalInformationDetails", "http://www.psagu.com/role/DisclosureFairValueMeasurementsChangeInFairValueOfWarrantLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings": { "auth_ref": [ "r229" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3).", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings", "verboseLabel": "Change in fair value" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/DisclosureFairValueMeasurementsChangeInFairValueOfWarrantLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues": { "auth_ref": [ "r230" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of issuances of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances", "verboseLabel": "Issuance of warrants" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/DisclosureFairValueMeasurementsChangeInFairValueOfWarrantLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue": { "auth_ref": [ "r228" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value", "periodEndLabel": "Fair value ending balance", "periodStartLabel": "Fair value beginning balance" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/DisclosureFairValueMeasurementsChangeInFairValueOfWarrantLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "auth_ref": [ "r137", "r138", "r139", "r173", "r174", "r175", "r176", "r177", "r178", "r179", "r181", "r263", "r264", "r265" ], "lang": { "en-us": { "role": { "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.", "label": "Fair Value Hierarchy and NAV [Domain]" } } }, "localname": "FairValueMeasurementsFairValueHierarchyDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/DisclosureFairValueMeasurementsAdditionalInformationDetails", "http://www.psagu.com/role/DisclosureFairValueMeasurementsChangeInFairValueOfWarrantLiabilitiesDetails", "http://www.psagu.com/role/DisclosureFairValueMeasurementsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementsRecurringMember": { "auth_ref": [ "r232", "r234" ], "lang": { "en-us": { "role": { "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.", "label": "Recurring", "terseLabel": "Recurring" } } }, "localname": "FairValueMeasurementsRecurringMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/DisclosureFairValueMeasurementsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueOfFinancialInstrumentsPolicy": { "auth_ref": [ "r235", "r236" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments.", "label": "Fair Value of Financial Instruments, Policy [Policy Text Block]", "terseLabel": "Fair Value of Financial Instruments" } } }, "localname": "FairValueOfFinancialInstrumentsPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList": { "auth_ref": [ "r229" ], "lang": { "en-us": { "role": { "documentation": "Indicates line item in statement in which net income is reported that includes gain (loss) from liability measured at fair value using unobservable input (level 3).", "label": "Fair Value, Liability, Recurring Basis, Unobservable Input Reconciliation, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]", "terseLabel": "Fair Value, Liability, Recurring Basis, Unobservable Input Reconciliation, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]" } } }, "localname": "FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/DisclosureFairValueMeasurementsChangeInFairValueOfWarrantLiabilitiesDetails" ], "xbrltype": "enumerationSetItemType" }, "us-gaap_IPOMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "First sale of stock by a private company to the public.", "label": "IPO [Member]", "terseLabel": "Initial Public Offering" } } }, "localname": "IPOMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails", "http://www.psagu.com/role/DisclosureFairValueMeasurementsChangeInFairValueOfWarrantLiabilitiesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "auth_ref": [ "r33", "r105", "r106", "r109", "r110", "r112", "r279", "r283", "r286", "r295" ], "calculation": { "http://www.psagu.com/role/StatementCondensedStatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.", "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest", "totalLabel": "Income before provision for income taxes" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/StatementCondensedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CONDENSED STATEMENTS OF OPERATIONS" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/DisclosureRevisionOfPreviouslyIssuedFinancialStatementsScheduleOfImpactOfRevisionOnFinancialStatementsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxExpenseBenefit": { "auth_ref": [ "r55", "r71", "r72", "r104", "r194", "r204", "r206", "r296" ], "calculation": { "http://www.psagu.com/role/StatementCondensedStatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Income Tax Expense (Benefit)", "negatedLabel": "Provision for income taxes" } } }, "localname": "IncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/StatementCondensedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxPolicyTextBlock": { "auth_ref": [ "r29", "r192", "r193", "r198", "r199", "r200", "r201" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.", "label": "Income Tax, Policy [Policy Text Block]", "terseLabel": "Income Taxes" } } }, "localname": "IncomeTaxPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable": { "auth_ref": [ "r44" ], "calculation": { "http://www.psagu.com/role/StatementCondensedStatementsOfCashFlows": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.", "label": "Increase (Decrease) in Income Taxes Payable", "terseLabel": "Income taxes payable" } } }, "localname": "IncreaseDecreaseInAccruedIncomeTaxesPayable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/StatementCondensedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccruedLiabilities": { "auth_ref": [ "r44" ], "calculation": { "http://www.psagu.com/role/StatementCondensedStatementsOfCashFlows": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.", "label": "Increase (Decrease) in Accrued Liabilities", "terseLabel": "Accrued expenses" } } }, "localname": "IncreaseDecreaseInAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/StatementCondensedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Changes in operating assets and liabilities:", "terseLabel": "Changes in operating assets and liabilities:" } } }, "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/StatementCondensedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInPrepaidExpense": { "auth_ref": [ "r44" ], "calculation": { "http://www.psagu.com/role/StatementCondensedStatementsOfCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods.", "label": "Increase (Decrease) in Prepaid Expense", "negatedLabel": "Prepaid expenses" } } }, "localname": "IncreaseDecreaseInPrepaidExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/StatementCondensedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]", "terseLabel": "Increase (Decrease) in Stockholders' Equity" } } }, "localname": "IncreaseDecreaseInStockholdersEquityRollForward", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/StatementCondensedStatementsOfChangesInStockholdersDeficit" ], "xbrltype": "stringItemType" }, "us-gaap_InvestmentIncomeInterest": { "auth_ref": [ "r36", "r103" ], "calculation": { "http://www.psagu.com/role/StatementCondensedStatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 }, "http://www.psagu.com/role/StatementCondensedStatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.", "label": "Investment Income, Interest", "negatedLabel": "Interest earned on marketable securities held in Trust Account", "terseLabel": "Interest earned on marketable securities held in Trust Account" } } }, "localname": "InvestmentIncomeInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/StatementCondensedStatementsOfCashFlows", "http://www.psagu.com/role/StatementCondensedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r22", "r53", "r108", "r115", "r126", "r127", "r128", "r130", "r131", "r132", "r133", "r134", "r135", "r136", "r209", "r212", "r213", "r237", "r257", "r258" ], "calculation": { "http://www.psagu.com/role/StatementCondensedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "Liabilities", "totalLabel": "Total Liabilities" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/StatementCondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r18", "r53", "r115", "r237", "r259", "r281", "r290" ], "calculation": { "http://www.psagu.com/role/StatementCondensedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities and Equity", "totalLabel": "TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/StatementCondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities and Equity [Abstract]", "terseLabel": "LIABILITIES AND STOCKHOLDERS' DEFICIT" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/StatementCondensedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r6", "r24", "r53", "r115", "r126", "r127", "r128", "r130", "r131", "r132", "r133", "r134", "r135", "r136", "r209", "r212", "r213", "r237", "r257", "r258", "r259" ], "calculation": { "http://www.psagu.com/role/StatementCondensedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Liabilities, Current", "totalLabel": "Total Current Liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/StatementCondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities, Current [Abstract]", "terseLabel": "Current liabilities" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/StatementCondensedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesFairValueAdjustment": { "auth_ref": [], "calculation": { "http://www.psagu.com/role/StatementCondensedStatementsOfCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 }, "http://www.psagu.com/role/StatementCondensedStatementsOfOperations": { "order": 6.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of addition (reduction) to the amount at which a liability could be incurred (settled) in a current transaction between willing parties.", "label": "Liabilities, Fair Value Adjustment", "negatedLabel": "Change in fair value of over-allotment liability", "terseLabel": "Change in fair value of overallotment liability", "verboseLabel": "Change in fair value of over-allotment liability" } } }, "localname": "LiabilitiesFairValueAdjustment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/DisclosureRevisionOfPreviouslyIssuedFinancialStatementsScheduleOfImpactOfRevisionOnFinancialStatementsDetails", "http://www.psagu.com/role/StatementCondensedStatementsOfCashFlows", "http://www.psagu.com/role/StatementCondensedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesFairValueDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities, Fair Value Disclosure [Abstract]", "terseLabel": "Liabilities:" } } }, "localname": "LiabilitiesFairValueDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/DisclosureFairValueMeasurementsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_MeasurementInputExercisePriceMember": { "auth_ref": [ "r225" ], "lang": { "en-us": { "role": { "documentation": "Measurement input using agreed upon price for exchange of underlying asset.", "label": "Exercise price", "terseLabel": "Exercise price" } } }, "localname": "MeasurementInputExercisePriceMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/DisclosureFairValueMeasurementsInitialAndSubsequentMeasurementOfKeyInputsForWarrantsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MeasurementInputExpectedDividendRateMember": { "auth_ref": [ "r225" ], "lang": { "en-us": { "role": { "documentation": "Measurement input using expected dividend rate to be paid to holder of share per year.", "label": "Dividend yield", "terseLabel": "Dividend yield" } } }, "localname": "MeasurementInputExpectedDividendRateMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/DisclosureFairValueMeasurementsInitialAndSubsequentMeasurementOfKeyInputsForWarrantsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MeasurementInputMaturityMember": { "auth_ref": [ "r225" ], "lang": { "en-us": { "role": { "documentation": "Measurement input using due date of last payment of principal and interest for financial instrument. Excludes expected term.", "label": "Effective expiration date", "terseLabel": "Effective expiration date" } } }, "localname": "MeasurementInputMaturityMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/DisclosureFairValueMeasurementsInitialAndSubsequentMeasurementOfKeyInputsForWarrantsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MeasurementInputPriceVolatilityMember": { "auth_ref": [ "r225" ], "lang": { "en-us": { "role": { "documentation": "Measurement input using rate at which price of security will increase (decrease) for given set of returns.", "label": "Expected volatility", "terseLabel": "Expected volatility" } } }, "localname": "MeasurementInputPriceVolatilityMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/DisclosureFairValueMeasurementsInitialAndSubsequentMeasurementOfKeyInputsForWarrantsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MeasurementInputRiskFreeInterestRateMember": { "auth_ref": [ "r225" ], "lang": { "en-us": { "role": { "documentation": "Measurement input using interest rate on instrument with zero risk of financial loss.", "label": "Risk-free interest rate", "terseLabel": "Risk-free interest rate" } } }, "localname": "MeasurementInputRiskFreeInterestRateMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/DisclosureFairValueMeasurementsInitialAndSubsequentMeasurementOfKeyInputsForWarrantsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MeasurementInputSharePriceMember": { "auth_ref": [ "r225" ], "lang": { "en-us": { "role": { "documentation": "Measurement input using share price of saleable stock.", "label": "Unit Price", "terseLabel": "Unit Price" } } }, "localname": "MeasurementInputSharePriceMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/DisclosureFairValueMeasurementsInitialAndSubsequentMeasurementOfKeyInputsForWarrantsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MeasurementInputTypeAxis": { "auth_ref": [ "r225" ], "lang": { "en-us": { "role": { "documentation": "Information by type of measurement input used to determine value of asset and liability.", "label": "Measurement Input Type [Axis]" } } }, "localname": "MeasurementInputTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/DisclosureFairValueMeasurementsInitialAndSubsequentMeasurementOfKeyInputsForWarrantsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_MeasurementInputTypeDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Measurement input used to determine value of asset and liability.", "label": "Measurement Input Type [Domain]" } } }, "localname": "MeasurementInputTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/DisclosureFairValueMeasurementsInitialAndSubsequentMeasurementOfKeyInputsForWarrantsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_NatureOfOperations": { "auth_ref": [ "r93", "r102" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.", "label": "DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS [TEXT BLOCK]", "terseLabel": "DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS" } } }, "localname": "NatureOfOperations", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperations" ], "xbrltype": "textBlockItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r42" ], "calculation": { "http://www.psagu.com/role/StatementCondensedStatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "Net cash provided by financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/StatementCondensedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash Flows from Financing Activities:", "terseLabel": "Cash Flows from Financing Activities:" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/StatementCondensedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r42" ], "calculation": { "http://www.psagu.com/role/StatementCondensedStatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Net Cash Provided by (Used in) Investing Activities", "totalLabel": "Net cash provided by (used in) investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/StatementCondensedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash Flows from Investing Activities:", "terseLabel": "Cash Flows from Investing Activities:" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/StatementCondensedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r42", "r43", "r46" ], "calculation": { "http://www.psagu.com/role/StatementCondensedStatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities", "totalLabel": "Net cash used in operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/StatementCondensedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash Flows from Operating Activities:", "terseLabel": "Cash Flows from Operating Activities:" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/StatementCondensedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r2", "r27", "r28", "r32", "r34", "r46", "r53", "r61", "r63", "r64", "r66", "r67", "r71", "r72", "r80", "r105", "r106", "r109", "r110", "r112", "r115", "r126", "r127", "r128", "r130", "r131", "r132", "r133", "r134", "r135", "r136", "r222", "r237", "r284", "r293" ], "calculation": { "http://www.psagu.com/role/StatementCondensedStatementsOfOperations": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net Income (Loss) Attributable to Parent", "terseLabel": "Net Loss", "totalLabel": "Net income", "verboseLabel": "Net income (loss)" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/DisclosureRevisionOfPreviouslyIssuedFinancialStatementsScheduleOfImpactOfRevisionOnFinancialStatementsDetails", "http://www.psagu.com/role/StatementCondensedStatementsOfChangesInStockholdersDeficit", "http://www.psagu.com/role/StatementCondensedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": { "auth_ref": [ "r63", "r64", "r66", "r67", "r74", "r75", "r81", "r84", "r105", "r106", "r109", "r110", "r112" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.", "label": "Net Income (Loss) Available to Common Stockholders, Basic", "verboseLabel": "Allocation of net income, as adjusted" } } }, "localname": "NetIncomeLossAvailableToCommonStockholdersBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfCalculationOfBasicAndDilutedNetIncomeLossPerCommonShareDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.", "label": "New Accounting Pronouncements, Policy [Policy Text Block]", "terseLabel": "Recent Accounting Standards" } } }, "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_NonoperatingIncomeExpense": { "auth_ref": [ "r37" ], "calculation": { "http://www.psagu.com/role/StatementCondensedStatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).", "label": "Nonoperating Income (Expense)", "totalLabel": "Total other income, net" } } }, "localname": "NonoperatingIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/StatementCondensedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_NonoperatingIncomeExpenseAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other income:", "terseLabel": "Other income:" } } }, "localname": "NonoperatingIncomeExpenseAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/StatementCondensedStatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_NotesPayableRelatedPartiesCurrentAndNoncurrent": { "auth_ref": [ "r56", "r251", "r292" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount for notes payable (written promise to pay), due to related parties.", "label": "Notes Payable, Related Parties", "terseLabel": "Outstanding balance of related party note" } } }, "localname": "NotesPayableRelatedPartiesCurrentAndNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/DisclosureRelatedPartyTransactionsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [ "r105", "r106", "r109", "r110", "r112" ], "calculation": { "http://www.psagu.com/role/StatementCondensedStatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "Operating Income (Loss)", "totalLabel": "Loss from operations" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/StatementCondensedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_OverAllotmentOptionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Right given to the underwriter to sell additional shares over the initial allotment.", "label": "Over-Allotment Option [Member]", "terseLabel": "Over-allotment option", "verboseLabel": "Over-allotment option" } } }, "localname": "OverAllotmentOptionMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/DisclosureCommitmentsDetails", "http://www.psagu.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails", "http://www.psagu.com/role/DisclosureFairValueMeasurementsChangeInFairValueOfWarrantLiabilitiesDetails", "http://www.psagu.com/role/DisclosurePrivatePlacementDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PaymentsOfStockIssuanceCosts": { "auth_ref": [ "r40" ], "calculation": { "http://www.psagu.com/role/StatementCondensedStatementsOfCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for cost incurred directly with the issuance of an equity security.", "label": "Payments of Stock Issuance Costs", "negatedLabel": "Payment of offering costs" } } }, "localname": "PaymentsOfStockIssuanceCosts", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/StatementCondensedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "auth_ref": [ "r12", "r146" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.", "label": "Preferred Stock, Par or Stated Value Per Share", "terseLabel": "Preferred stock, par value, (per share)", "verboseLabel": "Preferred stock, par value, (per share)" } } }, "localname": "PreferredStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/DisclosureStockholdersDeficitPreferredStockDetails", "http://www.psagu.com/role/StatementCondensedBalanceSheetsParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockSharesAuthorized": { "auth_ref": [ "r12" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.", "label": "Preferred Stock, Shares Authorized", "terseLabel": "Preferred stock, shares authorized", "verboseLabel": "Preferred shares, shares authorized" } } }, "localname": "PreferredStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/DisclosureStockholdersDeficitPreferredStockDetails", "http://www.psagu.com/role/StatementCondensedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesIssued": { "auth_ref": [ "r12", "r146" ], "lang": { "en-us": { "role": { "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.", "label": "Preferred Stock, Shares Issued", "terseLabel": "Preferred stock, shares issued", "verboseLabel": "Preferred shares, shares issued" } } }, "localname": "PreferredStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/DisclosureStockholdersDeficitPreferredStockDetails", "http://www.psagu.com/role/StatementCondensedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesOutstanding": { "auth_ref": [ "r12" ], "lang": { "en-us": { "role": { "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.", "label": "Preferred Stock, Shares Outstanding", "terseLabel": "Preferred stock, shares outstanding", "verboseLabel": "Preferred shares, shares outstanding" } } }, "localname": "PreferredStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/DisclosureStockholdersDeficitPreferredStockDetails", "http://www.psagu.com/role/StatementCondensedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockValue": { "auth_ref": [ "r12", "r259" ], "calculation": { "http://www.psagu.com/role/StatementCondensedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Preferred Stock, Value, Issued", "terseLabel": "Preferred stock, $0.0001 par value; 1,000,000 shares authorized; none issued or outstanding" } } }, "localname": "PreferredStockValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/StatementCondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidExpenseCurrent": { "auth_ref": [ "r4", "r19", "r119", "r120" ], "calculation": { "http://www.psagu.com/role/StatementCondensedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.", "label": "Prepaid Expense, Current", "verboseLabel": "Prepaid expenses- Short-term" } } }, "localname": "PrepaidExpenseCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/StatementCondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidExpenseNoncurrent": { "auth_ref": [ "r9" ], "calculation": { "http://www.psagu.com/role/StatementCondensedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of amounts paid in advance for expenses which will be charged against earnings in periods after one year or beyond the operating cycle, if longer.", "label": "Prepaid Expense, Noncurrent", "terseLabel": "Prepaid expenses- Long-term" } } }, "localname": "PrepaidExpenseNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/StatementCondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrivatePlacementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A private placement is a direct offering of securities to a limited number of sophisticated investors such as insurance companies, pension funds, mezzanine funds, stock funds and trusts.", "label": "Private Placement [Member]", "terseLabel": "Private Placement" } } }, "localname": "PrivatePlacementMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails", "http://www.psagu.com/role/DisclosurePrivatePlacementDetails", "http://www.psagu.com/role/StatementCondensedStatementsOfChangesInStockholdersDeficitParenthetical" ], "xbrltype": "domainItemType" }, "us-gaap_ProceedsFromIssuanceInitialPublicOffering": { "auth_ref": [ "r38" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow associated with the amount received from entity's first offering of stock to the public.", "label": "Proceeds from issuance initial public offering", "terseLabel": "Proceeds from issuance of initial public offering" } } }, "localname": "ProceedsFromIssuanceInitialPublicOffering", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfCommonStock": { "auth_ref": [ "r38" ], "calculation": { "http://www.psagu.com/role/StatementCondensedStatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from the additional capital contribution to the entity.", "label": "Proceeds from Issuance of Common Stock", "verboseLabel": "Proceeds from issuance of Representative Shares" } } }, "localname": "ProceedsFromIssuanceOfCommonStock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/StatementCondensedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfWarrants": { "auth_ref": [ "r38" ], "calculation": { "http://www.psagu.com/role/StatementCondensedStatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt).", "label": "Proceeds from Issuance of Warrants", "terseLabel": "Proceeds from sale of Private Placement Units", "verboseLabel": "Aggregate purchase price" } } }, "localname": "ProceedsFromIssuanceOfWarrants", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails", "http://www.psagu.com/role/DisclosurePrivatePlacementDetails", "http://www.psagu.com/role/StatementCondensedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProfitLoss": { "auth_ref": [ "r2", "r27", "r28", "r32", "r41", "r53", "r61", "r71", "r72", "r105", "r106", "r109", "r110", "r112", "r115", "r126", "r127", "r128", "r130", "r131", "r132", "r133", "r134", "r135", "r136", "r207", "r210", "r211", "r214", "r215", "r222", "r237", "r286" ], "calculation": { "http://www.psagu.com/role/StatementCondensedStatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.", "label": "Net loss", "terseLabel": "Net income" } } }, "localname": "ProfitLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/StatementCondensedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_RelatedPartyDomain": { "auth_ref": [ "r180", "r250", "r251" ], "lang": { "en-us": { "role": { "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party [Domain]" } } }, "localname": "RelatedPartyDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/DisclosurePrivatePlacementDetails", "http://www.psagu.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionAxis": { "auth_ref": [ "r180", "r250", "r251", "r254" ], "lang": { "en-us": { "role": { "documentation": "Information by type of related party transaction.", "label": "Related Party Transaction [Axis]" } } }, "localname": "RelatedPartyTransactionAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/DisclosureRelatedPartyTransactionsDetails", "http://www.psagu.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionDomain": { "auth_ref": [ "r180" ], "lang": { "en-us": { "role": { "documentation": "Transaction between related party.", "label": "Related Party Transaction [Domain]" } } }, "localname": "RelatedPartyTransactionDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/DisclosureRelatedPartyTransactionsDetails", "http://www.psagu.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty": { "auth_ref": [ "r250" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Expenses recognized resulting from transactions (excluding transactions that are eliminated in consolidated or combined financial statements) with related party.", "label": "Related Party Transaction, Expenses from Transactions with Related Party", "verboseLabel": "Expenses incurred and paid" } } }, "localname": "RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/DisclosureRelatedPartyTransactionsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RelatedPartyTransactionLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Related Party Transaction [Line Items]", "terseLabel": "RELATED PARTY TRANSACTIONS" } } }, "localname": "RelatedPartyTransactionLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/DisclosureRelatedPartyTransactionsDetails", "http://www.psagu.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "RELATED PARTY TRANSACTIONS" } } }, "localname": "RelatedPartyTransactionsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": { "auth_ref": [ "r180", "r250", "r254", "r267", "r268", "r269", "r270", "r271", "r272", "r273", "r274", "r275", "r276", "r277", "r278" ], "lang": { "en-us": { "role": { "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party [Axis]" } } }, "localname": "RelatedPartyTransactionsByRelatedPartyAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/DisclosurePrivatePlacementDetails", "http://www.psagu.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": { "auth_ref": [ "r248", "r249", "r251", "r255", "r256" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "Related Party Transactions Disclosure [Text Block]", "terseLabel": "RELATED PARTY TRANSACTIONS" } } }, "localname": "RelatedPartyTransactionsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/DisclosureRelatedPartyTransactions" ], "xbrltype": "textBlockItemType" }, "us-gaap_RepaymentsOfRelatedPartyDebt": { "auth_ref": [ "r39" ], "calculation": { "http://www.psagu.com/role/StatementCondensedStatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for the payment of a long-term borrowing made from a related party where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Payments for Advances from Affiliates.", "label": "Repayments of Related Party Debt", "negatedLabel": "Repayment of promissory note-related party", "terseLabel": "Repayment of promissory note - related party" } } }, "localname": "RepaymentsOfRelatedPartyDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/DisclosureRelatedPartyTransactionsDetails", "http://www.psagu.com/role/StatementCondensedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r15", "r169", "r259", "r289", "r301", "r306" ], "calculation": { "http://www.psagu.com/role/StatementCondensedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings (Accumulated Deficit)", "terseLabel": "Accumulated deficit" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/StatementCondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r0", "r58", "r59", "r60", "r62", "r69", "r72", "r116", "r188", "r189", "r190", "r202", "r203", "r220", "r297", "r299" ], "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Accumulated Deficit", "terseLabel": "Accumulated Deficit" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/StatementCondensedStatementsOfChangesInStockholdersDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_SaleOfStockNameOfTransactionDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement.", "label": "Sale of Stock [Domain]" } } }, "localname": "SaleOfStockNameOfTransactionDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/DisclosureCommitmentsDetails", "http://www.psagu.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails", "http://www.psagu.com/role/DisclosureFairValueMeasurementsChangeInFairValueOfWarrantLiabilitiesDetails", "http://www.psagu.com/role/DisclosurePrivatePlacementDetails", "http://www.psagu.com/role/DisclosurePublicOfferingDetails", "http://www.psagu.com/role/StatementCondensedStatementsOfChangesInStockholdersDeficitParenthetical" ], "xbrltype": "domainItemType" }, "us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.", "label": "Sale of Stock, Number of Shares Issued in Transaction", "verboseLabel": "Number of shares transferred (in shares)" } } }, "localname": "SaleOfStockNumberOfSharesIssuedInTransaction", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "auth_ref": [ "r84" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.", "label": "Reconciliation of Net Loss per Common Share", "terseLabel": "Schedule of calculation of basic and diluted net income (loss) per common share" } } }, "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/DisclosureSummaryOfSignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable": { "auth_ref": [ "r63", "r64", "r65", "r68", "r69", "r71", "r72", "r87" ], "lang": { "en-us": { "role": { "documentation": "Schedule of prior period adjustments to correct an error in previously issued financial statements. The disclosure may include, but is not limited to: (1) the effect of the correction on each financial statement line item and any per-share amounts affected for each prior period presented (2) the cumulative effect of the change on retained earnings or other appropriate components of equity or net assets in the statement of financial position, as of the beginning of the earliest period presented, and (3) the effect of the prior period adjustment (both gross and net of applicable income tax) on the net income of each prior period presented in the entity's annual report for the year in which the adjustments are made. This table can be used to disclose the amounts as previously reported and the effect of the correction or other adjustment on per line item or per share amount basis. This table uses as its line items financial statement line items that are affected by prior period adjustments.", "label": "Schedule of Error Corrections and Prior Period Adjustment Restatement [Table]" } } }, "localname": "ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/DisclosureRevisionOfPreviouslyIssuedFinancialStatementsScheduleOfImpactOfRevisionOnFinancialStatementsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock": { "auth_ref": [ "r70", "r71", "r72" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of prior period adjustments to previously issued financial statements including (1) the effect of the correction on each financial statement line item and any per-share amounts affected for each prior period presented (2) the cumulative effect of the change on retained earnings or other appropriate components of equity or net assets in the statement of financial position, as of the beginning of the earliest period presented, and (3) the effect of the prior period adjustments (both gross and net of applicable income tax) on the net income of each prior period presented in the entity's annual report for the year in which the adjustments are made.", "label": "Schedule of Error Corrections and Prior Period Adjustments [Table Text Block]", "terseLabel": "Schedule of impact of revision on financial statements" } } }, "localname": "ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/DisclosureRevisionOfPreviouslyIssuedFinancialStatementsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": { "auth_ref": [ "r252", "r254" ], "lang": { "en-us": { "role": { "documentation": "Schedule of quantitative and qualitative information pertaining to related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "Schedule of Related Party Transactions, by Related Party [Table]" } } }, "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/DisclosureRelatedPartyTransactionsDetails", "http://www.psagu.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfStockByClassTable": { "auth_ref": [ "r11", "r12", "r13", "r51", "r90", "r91", "r142", "r144", "r145", "r146", "r147", "r148", "r149", "r151", "r155", "r160", "r162", "r163", "r164", "r165", "r166", "r167", "r168", "r169" ], "lang": { "en-us": { "role": { "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity.", "label": "Schedule of Stock by Class [Table]" } } }, "localname": "ScheduleOfStockByClassTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/DisclosureStockholdersDeficitCommonStockDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": { "auth_ref": [ "r184" ], "lang": { "en-us": { "role": { "documentation": "Gross number of share options (or share units) granted during the period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross", "verboseLabel": "Number of shares grant (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue": { "auth_ref": [ "r185" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value", "terseLabel": "Total aggregate value of shares" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": { "auth_ref": [ "r184" ], "lang": { "en-us": { "role": { "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.", "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price", "terseLabel": "Share, per share" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_SharePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Price of a single share of a number of saleable stocks of a company.", "label": "Share Price", "terseLabel": "Share price" } } }, "localname": "SharePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/DisclosureWarrantsDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_SharesIssued": { "auth_ref": [ "r162" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.", "label": "Shares, Issued", "periodEndLabel": "Balance at the end (in shares)", "periodStartLabel": "Balance at the beginning (in shares)" } } }, "localname": "SharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/StatementCondensedStatementsOfChangesInStockholdersDeficit" ], "xbrltype": "sharesItemType" }, "us-gaap_SharesIssuedPricePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Per share or per unit amount of equity securities issued.", "label": "Purchase price, per unit", "terseLabel": "Purchase price per unit" } } }, "localname": "SharesIssuedPricePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails", "http://www.psagu.com/role/DisclosurePublicOfferingDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares": { "auth_ref": [ "r141" ], "calculation": { "http://www.psagu.com/role/StatementCondensedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The fair value of shares that would be issued, determined under the conditions specified in the contract if the settlement were to occur at the reporting date.", "label": "Financial Instruments Subject to Mandatory Redemption, Settlement Terms, Fair Value of Shares", "terseLabel": "Warrant Liability", "verboseLabel": "Aggregate values of Warrants" } } }, "localname": "SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/DisclosureFairValueMeasurementsAdditionalInformationDetails", "http://www.psagu.com/role/DisclosureFairValueMeasurementsDetails", "http://www.psagu.com/role/StatementCondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_StatementClassOfStockAxis": { "auth_ref": [ "r11", "r12", "r13", "r51", "r53", "r77", "r78", "r79", "r82", "r84", "r90", "r91", "r92", "r115", "r126", "r130", "r131", "r132", "r135", "r136", "r146", "r147", "r151", "r155", "r162", "r237", "r313" ], "lang": { "en-us": { "role": { "documentation": "Information by the different classes of stock of the entity.", "label": "Class of Stock [Axis]" } } }, "localname": "StatementClassOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/DisclosureFairValueMeasurementsAdditionalInformationDetails", "http://www.psagu.com/role/DisclosurePrivatePlacementDetails", "http://www.psagu.com/role/DisclosurePublicOfferingDetails", "http://www.psagu.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetails", "http://www.psagu.com/role/DisclosureRevisionOfPreviouslyIssuedFinancialStatementsScheduleOfImpactOfRevisionOnFinancialStatementsDetails", "http://www.psagu.com/role/DisclosureStockholdersDeficitCommonStockDetails", "http://www.psagu.com/role/DisclosureSummaryOfSignificantAccountingPoliciesClassCommonStockReflectedInBalanceSheetDetails", "http://www.psagu.com/role/DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfCalculationOfBasicAndDilutedNetIncomeLossPerCommonShareDetails", "http://www.psagu.com/role/DisclosureWarrantsDetails", "http://www.psagu.com/role/DocumentDocumentAndEntityInformation", "http://www.psagu.com/role/StatementCondensedBalanceSheets", "http://www.psagu.com/role/StatementCondensedBalanceSheetsParenthetical", "http://www.psagu.com/role/StatementCondensedStatementsOfChangesInStockholdersDeficit", "http://www.psagu.com/role/StatementCondensedStatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r0", "r26", "r30", "r31", "r32", "r58", "r59", "r60", "r62", "r69", "r72", "r89", "r116", "r162", "r169", "r188", "r189", "r190", "r202", "r203", "r220", "r239", "r240", "r241", "r242", "r243", "r244", "r247", "r297", "r298", "r299" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/StatementCondensedStatementsOfChangesInStockholdersDeficit" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]", "terseLabel": "Statement" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/StatementCondensedBalanceSheets", "http://www.psagu.com/role/StatementCondensedBalanceSheetsParenthetical", "http://www.psagu.com/role/StatementCondensedStatementsOfChangesInStockholdersDeficit", "http://www.psagu.com/role/StatementCondensedStatementsOfChangesInStockholdersDeficitParenthetical", "http://www.psagu.com/role/StatementCondensedStatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CONDENSED STATEMENTS OF CASH FLOWS" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/DisclosureRevisionOfPreviouslyIssuedFinancialStatementsScheduleOfImpactOfRevisionOnFinancialStatementsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CONDENSED BALANCE SHEETS" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CONDENSED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT" } } }, "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/DisclosureRevisionOfPreviouslyIssuedFinancialStatementsScheduleOfImpactOfRevisionOnFinancialStatementsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r58", "r59", "r60", "r89", "r266" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/StatementCondensedBalanceSheets", "http://www.psagu.com/role/StatementCondensedBalanceSheetsParenthetical", "http://www.psagu.com/role/StatementCondensedStatementsOfChangesInStockholdersDeficit", "http://www.psagu.com/role/StatementCondensedStatementsOfChangesInStockholdersDeficitParenthetical", "http://www.psagu.com/role/StatementCondensedStatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_StockIssuedDuringPeriodSharesNewIssues": { "auth_ref": [ "r12", "r13", "r162", "r169" ], "lang": { "en-us": { "role": { "documentation": "Number of new stock issued during the period.", "label": "Stock Issued During Period, Shares, New Issues", "terseLabel": "Issuance of Representative Shares (in shares)", "verboseLabel": "Number of shares issued (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesNewIssues", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetails", "http://www.psagu.com/role/DisclosureWarrantsDetails", "http://www.psagu.com/role/StatementCondensedStatementsOfChangesInStockholdersDeficit" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares (or other type of equity) forfeited during the period.", "label": "Shares Issued, Shares, Share-based Payment Arrangement, Forfeited", "negatedLabel": "Forfeiture of Founder Shares (in Shares)" } } }, "localname": "StockIssuedDuringPeriodSharesShareBasedCompensationForfeited", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/StatementCondensedStatementsOfChangesInStockholdersDeficit" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueNewIssues": { "auth_ref": [ "r12", "r13", "r162", "r169" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.", "label": "Stock Issued During Period, Value, New Issues", "terseLabel": "Issuance of Representative Shares", "verboseLabel": "Aggregate purchase price" } } }, "localname": "StockIssuedDuringPeriodValueNewIssues", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetails", "http://www.psagu.com/role/DisclosureRevisionOfPreviouslyIssuedFinancialStatementsScheduleOfImpactOfRevisionOnFinancialStatementsDetails", "http://www.psagu.com/role/DisclosureWarrantsDetails", "http://www.psagu.com/role/StatementCondensedStatementsOfChangesInStockholdersDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited": { "auth_ref": [ "r187" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Value of forfeited shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).", "label": "Shares Issued, Value, Share-based Payment Arrangement, Forfeited", "negatedLabel": "Forfeiture of Founder Shares" } } }, "localname": "StockIssuedDuringPeriodValueShareBasedCompensationForfeited", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/StatementCondensedStatementsOfCashFlows", "http://www.psagu.com/role/StatementCondensedStatementsOfChangesInStockholdersDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockRepurchasedDuringPeriodShares": { "auth_ref": [ "r12", "r13", "r162", "r169" ], "lang": { "en-us": { "role": { "documentation": "Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.", "label": "Stock Repurchased During Period, Shares", "terseLabel": "Purchase of aggregate shares" } } }, "localname": "StockRepurchasedDuringPeriodShares", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r13", "r16", "r17", "r53", "r114", "r115", "r237", "r259" ], "calculation": { "http://www.psagu.com/role/StatementCondensedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.", "label": "Stockholders' Equity Attributable to Parent", "periodEndLabel": "Balance at the end", "periodStartLabel": "Balance at the beginning", "totalLabel": "Total Stockholders' Deficit" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/StatementCondensedBalanceSheets", "http://www.psagu.com/role/StatementCondensedStatementsOfChangesInStockholdersDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders' Equity Attributable to Parent [Abstract]", "terseLabel": "Stockholders' Deficit" } } }, "localname": "StockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/StatementCondensedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityNoteAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "STOCKHOLDERS' DEFICIT" } } }, "localname": "StockholdersEquityNoteAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "auth_ref": [ "r52", "r147", "r150", "r151", "r152", "r153", "r154", "r155", "r156", "r157", "r158", "r159", "r161", "r169", "r172", "r218" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.", "label": "Stockholders' Equity Note Disclosure [Text Block]", "verboseLabel": "STOCKHOLDERS' DEFICIT" } } }, "localname": "StockholdersEquityNoteDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/DisclosureStockholdersDeficit" ], "xbrltype": "textBlockItemType" }, "us-gaap_StockholdersEquityNoteStockSplitConversionRatio1": { "auth_ref": [ "r170" ], "lang": { "en-us": { "role": { "documentation": "Ratio applied to the conversion of stock split, for example but not limited to, one share converted to two or two shares converted to one.", "label": "Stockholders' Equity Note, Stock Split, Conversion Ratio", "terseLabel": "Stock split ratio" } } }, "localname": "StockholdersEquityNoteStockSplitConversionRatio1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetails" ], "xbrltype": "pureItemType" }, "us-gaap_SubsequentEventsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "SUBSEQUENT EVENTS" } } }, "localname": "SubsequentEventsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventsTextBlock": { "auth_ref": [ "r260", "r262" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.", "label": "Subsequent Events [Text Block]", "terseLabel": "SUBSEQUENT EVENTS" } } }, "localname": "SubsequentEventsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/DisclosureSubsequentEvents" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubsidiarySaleOfStockAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of sale of the entity's stock.", "label": "Sale of Stock [Axis]" } } }, "localname": "SubsidiarySaleOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/DisclosureCommitmentsDetails", "http://www.psagu.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails", "http://www.psagu.com/role/DisclosureFairValueMeasurementsChangeInFairValueOfWarrantLiabilitiesDetails", "http://www.psagu.com/role/DisclosurePrivatePlacementDetails", "http://www.psagu.com/role/DisclosurePublicOfferingDetails", "http://www.psagu.com/role/StatementCondensedStatementsOfChangesInStockholdersDeficitParenthetical" ], "xbrltype": "stringItemType" }, "us-gaap_TaxesPayableCurrent": { "auth_ref": [ "r21" ], "calculation": { "http://www.psagu.com/role/StatementCondensedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Taxes Payable, Current", "terseLabel": "Income taxes payable" } } }, "localname": "TaxesPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/StatementCondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_TemporaryEquityAccretionToRedemptionValue": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of accretion of temporary equity to its redemption value during the period.", "label": "Temporary Equity, Accretion to Redemption Value", "verboseLabel": "Remeasurement to amount subject to redemption" } } }, "localname": "TemporaryEquityAccretionToRedemptionValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/DisclosureSummaryOfSignificantAccountingPoliciesClassCommonStockReflectedInBalanceSheetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of decrease to net income for accretion of temporary equity to its redemption value to derive net income apportioned to common stockholders.", "label": "Temporary Equity, Accretion to Redemption Value, Adjustment", "negatedLabel": "Remeasurement to amount subject to redemption", "terseLabel": "Remeasurement to amount subject to redemption" } } }, "localname": "TemporaryEquityAccretionToRedemptionValueAdjustment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/DisclosureRevisionOfPreviouslyIssuedFinancialStatementsScheduleOfImpactOfRevisionOnFinancialStatementsDetails", "http://www.psagu.com/role/StatementCondensedStatementsOfChangesInStockholdersDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_TemporaryEquityCarryingAmountAttributableToParent": { "auth_ref": [ "r126", "r130", "r131", "r132", "r135", "r136" ], "calculation": { "http://www.psagu.com/role/StatementCondensedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.", "label": "Temporary Equity, Carrying Amount, Attributable to Parent", "terseLabel": "Class A common stock subject to possible redemption", "verboseLabel": "Class A common stock, $0.0001 par value, subject to possible redemption, 31,700,000 shares at redemption value of approximately $10.04 and $10.00 at September 30, 2022 and December 31, 2021, respectively" } } }, "localname": "TemporaryEquityCarryingAmountAttributableToParent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/DisclosureSummaryOfSignificantAccountingPoliciesClassCommonStockReflectedInBalanceSheetDetails", "http://www.psagu.com/role/StatementCondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_TemporaryEquityParOrStatedValuePerShare": { "auth_ref": [ "r7", "r143" ], "lang": { "en-us": { "role": { "documentation": "Per share amount of par value or stated value of stock classified as temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable.", "label": "Temporary Equity, Par or Stated Value Per Share" } } }, "localname": "TemporaryEquityParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/StatementCondensedBalanceSheetsParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_TemporaryEquityRedemptionPricePerShare": { "auth_ref": [ "r7", "r143" ], "lang": { "en-us": { "role": { "documentation": "Amount to be paid per share that is classified as temporary equity by entity upon redemption. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.", "label": "Temporary Equity, Redemption Price Per Share", "terseLabel": "Temporary equity, redemption value per share" } } }, "localname": "TemporaryEquityRedemptionPricePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/StatementCondensedBalanceSheetsParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_TemporaryEquitySharesIssued": { "auth_ref": [ "r11" ], "lang": { "en-us": { "role": { "documentation": "The number of securities classified as temporary equity that have been sold (or granted) to the entity's shareholders. Securities issued include securities outstanding and securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.", "label": "Temporary equity, shares issued", "terseLabel": "Class A common stock subject to possible redemption, issued (in shares)" } } }, "localname": "TemporaryEquitySharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/DisclosureStockholdersDeficitCommonStockDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_TemporaryEquitySharesOutstanding": { "auth_ref": [ "r11" ], "lang": { "en-us": { "role": { "documentation": "The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.", "label": "Temporary equity, shares outstanding", "terseLabel": "Class A common stock subject to possible redemption, outstanding (in shares)" } } }, "localname": "TemporaryEquitySharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/DisclosureStockholdersDeficitCommonStockDetails", "http://www.psagu.com/role/StatementCondensedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_UnrealizedGainLossOnInvestments": { "auth_ref": [ "r45" ], "calculation": { "http://www.psagu.com/role/StatementCondensedStatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 }, "http://www.psagu.com/role/StatementCondensedStatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of unrealized gain (loss) on investment.", "label": "Unrealized Gain (Loss) on Investments", "negatedLabel": "Unrealized gain on marketable securities held in Trust Account", "terseLabel": "Unrealized gain on marketable securities held in Trust Account" } } }, "localname": "UnrealizedGainLossOnInvestments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/StatementCondensedStatementsOfCashFlows", "http://www.psagu.com/role/StatementCondensedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefits": { "auth_ref": [ "r191", "r197" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of unrecognized tax benefits.", "label": "Unrecognized Tax Benefits", "terseLabel": "Unrecognized tax benefits" } } }, "localname": "UnrecognizedTaxBenefits", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued": { "auth_ref": [ "r196" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.", "label": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued", "terseLabel": "Unrecognized tax benefits accrued for interest and penalties" } } }, "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UseOfEstimates": { "auth_ref": [ "r94", "r95", "r97", "r98", "r99", "r100", "r101" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.", "label": "Use of Estimates, Policy [Policy Text Block]", "terseLabel": "Use of Estimates" } } }, "localname": "UseOfEstimates", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_WarrantMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.", "label": "Warrant [Member]", "terseLabel": "Warrants" } } }, "localname": "WarrantMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails", "http://www.psagu.com/role/DisclosureWarrantsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_WarrantsAndRightsOutstandingTerm": { "auth_ref": [ "r227" ], "lang": { "en-us": { "role": { "documentation": "Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Warrants and Rights Outstanding, Term", "terseLabel": "Public Warrants expiration term" } } }, "localname": "WarrantsAndRightsOutstandingTerm", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/DisclosureWarrantsDetails" ], "xbrltype": "durationItemType" }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "auth_ref": [ "r76", "r84" ], "lang": { "en-us": { "role": { "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.", "label": "Weighted Average Number of Shares Outstanding, Diluted", "terseLabel": "Diluted weighted average ordinary share outstanding (in shares)", "verboseLabel": "Weighted Average Number of Shares Outstanding, Diluted" } } }, "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfCalculationOfBasicAndDilutedNetIncomeLossPerCommonShareDetails", "http://www.psagu.com/role/StatementCondensedStatementsOfOperations" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "auth_ref": [ "r74", "r84" ], "lang": { "en-us": { "role": { "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.", "label": "Weighted Average Number of Shares Outstanding, Basic", "terseLabel": "Basic weighted average ordinary share outstanding (in shares)", "verboseLabel": "Weighted Average Number of Shares Outstanding, Basic" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.psagu.com/role/DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfCalculationOfBasicAndDilutedNetIncomeLossPerCommonShareDetails", "http://www.psagu.com/role/StatementCondensedStatementsOfOperations" ], "xbrltype": "sharesItemType" } }, "unitCount": 7 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "105", "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "105", "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(18))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592" }, "r102": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "275", "URI": "https://asc.fasb.org/topic&trid=2134479" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27)(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4647-111522" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(3)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(4)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "05", "SubTopic": "10", "Topic": "340", "URI": "https://asc.fasb.org/extlink&oid=126905020&loc=d3e5879-108316" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "340", "URI": "https://asc.fasb.org/extlink&oid=6387103&loc=d3e6435-108320" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "440", "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "440", "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308" }, "r123": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "440", "URI": "https://asc.fasb.org/topic&trid=2144648" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349" }, "r125": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "450", "URI": "https://asc.fasb.org/topic&trid=2127136" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "69B", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "69C", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Topic": "480", "URI": "https://asc.fasb.org/extlink&oid=109262497&loc=d3e20148-110875" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "480", "URI": "https://asc.fasb.org/extlink&oid=109262807&loc=d3e22047-110879" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(CFRR 211.02)", "Topic": "480", "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Topic": "480", "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=65888546&loc=d3e21300-112643" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21553-112644" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21484-112644" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21488-112644" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21521-112644" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21538-112644" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 4.C)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187143-122770" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "50", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=6784392&loc=d3e188667-122775" }, "r172": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "505", "URI": "https://asc.fasb.org/topic&trid=2208762" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(ii)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(01)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(A)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(B)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(C)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(03)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(n)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(f)(3)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5047-113901" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "c(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(7))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "10B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=SL37586934-109318" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319" }, "r2": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(9))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.7)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.4)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19,20)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "4J", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "4K", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=SL126733271-114008" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(b)(2)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(4)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(1)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(2)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(3)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "6A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=SL6742756-110258" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "60", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=7493716&loc=d3e21868-110260" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13279-108611" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(01)", "Topic": "848", "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(03)", "Topic": "848", "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.25)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864" }, "r256": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "850", "URI": "https://asc.fasb.org/topic&trid=2122745" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "855", "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314020-165662" }, "r262": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "855", "URI": "https://asc.fasb.org/topic&trid=2122774" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(1)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(2)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "940", "URI": "https://asc.fasb.org/extlink&oid=126941158&loc=d3e41242-110953" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.17)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(15))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(27))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.9-05(b)(2))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126941378&loc=d3e61044-112788" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.(a),19)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.17)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(23))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(8))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(9))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(1)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(ii)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(iii)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(iv)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(1)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "440", "Subparagraph": "(a)", "Topic": "954", "URI": "https://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629" }, "r308": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r309": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067" }, "r310": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r311": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a" }, "r312": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1" }, "r313": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1402" }, "r314": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405" }, "r315": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(10))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(25))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7(b))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3000-108585" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4273-108586" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(b))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(d))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(e)(1))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(2))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(k)(1))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r57": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "https://asc.fasb.org/topic&trid=2122369" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=SL124452830-107794" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(27)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.M.Q2)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1377-109256" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1505-109256" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1278-109256" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "55", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e2626-109256" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "52", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(17))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592" } }, "version": "2.1" } ZIP 58 0001104659-22-120302-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001104659-22-120302-xbrl.zip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�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end